Tumor	0
Adenomatous polyposis coli (APC) tumor	0
Adenomatous polyposis coli	0
Adenomatous	0
Colorectal cancers	0
Cancers	0
Polyposis	0
APC	0
Adenomatous polyposis	0
Cancer	0
Polyposis coli	0
Dystrophic chicken muscle	1
Cardiac	1
Hypertrophic cardiomyopathy	1
Dystrophic	1
Familial hypertrophic cardiomyopathy	1
Cardiomyopathy	1
Dystrophic muscles	1
Familial adenomatous polyposis	2
Adenomatous polyposis coli	2
Adenomatous	2
Polyposis	2
Adenomatous polyposis	2
Polyposis coli	2
Sporadic cancer	3
Breast cancer	3
Malignancy	3
Genomic instability	3
Ataxia	3
Sporadic T-PLL	3
Associated	3
ATM	3
Sporadic disease	3
Leukaemia	3
T-PLL	3
Cancer	3
Malignancies	3
A-T	3
Tumorigenesis	3
Ataxia telangiectasia	3
Tumour	3
COS	4
Paroxysmal nocturnal haemoglobinuria	5
Author	5
Haemoglobinuria	5
Turner syndrome	6
Genetic conditions	6
Dental anomalies	6
Cleft lip and palate	6
Beckwith-Wiedemann syndrome	6
Dysplasia	6
Wiedemann syndrome	6
Treacher Collins syndrome	6
Marfan syndrome	6
Cleidocranial dysplasia	6
Dystonias	7
Tumor	9
Glomus tumors	9
Hereditary glomus jugulare tumor	9
Glomus tumor	9
Tumors	9
Diagnosis	9
Loss of heterozygosity	9
Tumoral	9
Breast carcinoma	10
Carcinoma	10
Sporadic breast carcinomas	10
Allelic loss	10
Breast carcinomas	10
Carcinomas	10
Autosomal dominant	11
Hereditary neuralgic amyotrophy	11
HNA	11
Amyotrophy	11
Neuropathy	11
Associated	11
Genetic defect	11
Neurofibromatosis	12
Retinal abnormalities	12
Neurofibromatosis type 2	12
Dysmorphism	13
Psychomotor retardation	13
Coffin-Lowry syndrome	13
Premature	13
Associated	13
CLS	13
X-linked disorder	13
Facial dysmorphism	13
Digit abnormalities	13
Disorder	13
Volunteer deficient	14
Tumor	15
Type II	15
Parental LNCaP tumors	15
Apoptosis	15
LNCaP tumors	15
Growth	15
Tumorigenicity	15
Associated	15
Parental tumors	15
Cancer	15
Tumors	15
Prostate cancer	15
Lesch-Nyhan	17
Nephropathy	17
Lesch-Nyhan disease	17
Pigment dispersion syndrome	18
PDS	18
Anterior segment changes	18
Glaucomas	18
Anterior segment abnormalities	18
Glaucoma	18
Retinal ganglion cell death	18
Associated	18
Iris pigment dispersion	18
Nerve atrophy	18
Iris atrophy	18
Blindness	18
DBA	18
Atrophy	18
Pigment dispersion	18
Stromal atrophy	18
G6PD A	19
G6PD deficient	19
Glucose 6-phosphate dehydrogenase (G6PD) deficiency	19
G6PD-deficient	19
G6PD deficiency	19
Pancreas	20
Central nervous system	20
Glucose toxicity and diabetes complications	20
Adenomatous polyposis coli	21
Adenomatous	21
Colon carcinoma	21
Cancers	21
Polyposis	21
Carcinoma	21
Hepatocellular carcinomas	21
APC	21
Adenomatous polyposis	21
Neoplastic transformation	21
Consensus TCF	21
Neoplastic	21
Gastric and hepatocellular carcinomas	21
LEF	21
Cancer	21
Carcinomas	21
Medulloblastomas	21
Colon cancers	21
Adenomatous polyposis coli (APC) tumour	21
Tumour	21
Colon-cancer	21
Polyposis coli	21
Melanomas	21
Prostate cancer	21
Von Willebrand	22
Von Willebrand disease	22
VWF	22
Type IID von Willebrand disease	22
Familial adenomatous polyposis	23
Adenomas	23
Ulcerative colitis	23
Duodenal adenomas	23
Neoplasms	23
Sporadic colonic neoplasms	23
Adenomatous	23
Upper gastrointestinal polyps and extraintestinal tumors	23
Polyposis	23
Associated	23
APC	23
Adenomatous polyposis	23
Intestinal adenomas	23
Carcinoid neoplasms	23
Carcinoid tumors	23
Tumors	23
Gastrointestinal polyps	23
FAP	23
Polyps	23
Linkage disequilibrium	24
Familial mediterranean fever	25
Granuloma	25
FMF	25
Mediterranean fever	25
METHODS	25
AA	25
Immunological abnormalities	25
Amyloid deposition	25
Fever	25
Mycobacterium tuberculosis	25
Autoimmune	25
Amyloidosis	25
Tuberculosis	25
Bacteria	25
Familial Mediterranean fever	25
AA type amyloidosis	25
HDL	26
PL	26
Body mass index	26
Associated	26
BMI	26
Coronary artery disease	26
Dyslipoproteinemia	26
Prader-Willi	27
Uniparental disomy	27
Maternal uniparental disomy 14	27
Maternal uniparental disomy	27
HH	28
JH	28
Wild type	28
Associated	28
Hemochromatosis	28
Aggressive disorder	28
Diagnosis	28
Disorder	28
CETP	29
HDL	29
Type IIb hyperlipidemia	29
Hyperlipidemic	29
Hyperlipidemia	29
Plasma	29
Type II	30
Growth	30
Gastrulation	30
Gastrulation defect	30
Type I	30
METHODS	31
Associated	31
Greater abnormality	31
Muscular dystrophy	31
Duchenne muscular dystrophy	31
DMD	31
Incomplete ERG abnormalities	31
ERG abnormalities	31
Prader-Willi	32
Prader-Willi syndrome	32
PWS	32
Uniparental disomy	32
Maternal disomy	32
Associated	32
Maternal UPD	32
Maternal uniparental disomy	32
UPD	32
Alpha	32
X-linked mental retardation	34
Mental retardation	34
Speech abnormalities	34
Neuropsychological data	34
MRX	34
X-linked nonspecific mental retardation	34
Lipomas	35
Lipoma	35
Macular degeneration	37
NEIN	38
Molecular defect	38
Brachydactyly	38
Molecular abnormalities	38
Multilayered patella	38
Multiple epiphyseal dysplasia	38
Diastrophic dysplasia	38
Dysplasia	38
MED	38
Diagnosis	38
Incipient flavimaculatus disease	39
Fundus flavimaculatus	39
Pure fundus flavimaculatus	39
Prader-Willi	40
Prader-Willi syndrome	40
Obesity	40
ADHD	41
FXS	41
Neuropsychiatric dysfunctions	41
Fragile X	41
Schizotypal personality disorder	41
Mental retardation	41
Language abnormalities	41
Attention-deficit hpyeractivity disorder	41
Fragile X Syndrome	41
Neurobehavioral	41
Neuropsychiatric testing	41
Avoidant disorder	41
Mood disorders	41
Anziety disorders	41
Neuropsychiatric disorders	41
Deficits in turn	41
Neuropsychiatric	41
Behavior	41
Developmental disorders	41
Disorder	41
Nonmelanoma skin cancer	42
Internal cancers	42
Skin cancer	42
Cutaneous cancer	42
A total of 6 noncutaneous cancers	42
METHODS	42
Cancers	42
Psoriasis	42
Carcinoma	42
Basal cell carcinoma	42
Malignant tumors	42
Melanoma	42
Malignant melanoma	42
Cancer	42
Tumors	42
Cell carcinoma	42
UVA	42
Congenital clubfoot	43
Generalized arthrogryposis	43
Hypotonia	43
Muscular weakness	43
Myotonic dystrophy	43
Feeding difficulties	43
Weakness	43
Cerebral abnormalities	43
Ventricular dilatation	43
Arthrogryposis	43
Associated	43
Central nervous system	43
Congenital myotonic dystrophy	43
Myoencephalopathy	43
Neurological condition	43
Hypoplasia	43
Was hypoplasia of the corpus callosum	43
Cognitive impairment	43
Inherited the disease	44
Microcephaly	44
Neuronal proliferation disorder	44
MR	44
Lissencephaly	44
Mental retardation	44
Pachygyria	44
Type I	44
Karyotypic abnormalities	44
Disorder	44
Juvenile polyposis coli	45
Polyposis	45
Juvenile polyposis	45
Polyposis coli	45
Epstein-Barr	46
Epstein-Barr virus	46
Lymphoma	46
Lymphomas	46
Carcinomas	46
X-linked recessive condition	47
Syndromic or non-syndromic X-linked mental retardation	47
Hypsarrhythmia	47
Syndrome of infantile spasms	47
XLMR	47
Infantile spasms	47
X-linked mental retardation	47
Adrenal hypoplasia	47
Non-syndromic X-linked mental retardation	47
Mental retardation	47
Early infancy	47
Epilepsy	47
AHC	47
Refinement of the disease	47
X-linked infantile spasms	47
Hypoplasia	47
West syndrome	47
Tumor	48
Apoptosis	48
PK	48
Ataxia	48
ATM	48
Ataxia telangectasia	48
Cancer	48
Plasma	48
Lymphomas	49
Leukemias	49
T-cell leukemias	49
Tumor	50
Functional ataxia telangiectasia	50
Hypersensitivity	50
Ataxia	50
ARF tumor	50
Loss of the ARF tumor	50
Premature	50
ARF	50
Lymphomas	50
Ataxia telangiectasia	50
Familial adenomatous polyposis	51
Adenomatous polyposis coli	51
Colonic polyps	51
Adenomatous	51
Polyposis	51
Premature	51
APC	51
Adenomatous polyposis	51
FAP	51
Polyposis coli	51
Polyps	51
Hypercholesterolemia	52
Hyperlipidemia	52
Coronary heart disease	52
Heart disease	52
Plasma	52
Malignancy	53
Lung cancer	53
Lung malignancy	53
Cancer	53
NAD	53
Biological abnormalities	54
Apoptosis	54
AT	54
Ataxia	54
Radiosensitivity	54
ATM	54
Cancer	54
Ataxia telangiectasia	54
Angelman syndrome	55
Muscular dystrophy	56
Duchenne muscular dystrophy	56
Diagnosis	56
Prenatal diagnosis	56
Short stature	58
Growth failure	58
Generalized osteopenia	58
Spondylo-articular problems	58
Vertebral endplates, epiphyseal flattening of the long bones	58
Growth	58
Desbuquois dysplasia	58
Postnatal growth failure	58
Osteopenia	58
Diastrophic dysplasia	58
Minor spondylo-articular problems	58
Dysplasia	58
Spondylo-articular deformities	58
Skeletal dysplasia	58
Disorder	58
Paroxysmal nocturnal hemoglobinuria	60
PNH	60
Aplastic anemia	60
Glycosylphosphatidylinositol (GPI) anchors	60
Associated	60
Genetic instability	60
Hematologic disorder	60
Anemia	60
Disorder	60
Autosomal dominant	61
Benign familial neonatal convulsions	61
Idiopathic epilepsies	61
Associated	61
Epilepsy	61
Autosomal dominant nocturnal frontal lobe epilepsy	61
Familial neonatal convulsions	61
Alpha	61
METHODS	62
Hemolysis	62
Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency	62
PD	62
Neonatal hyperbilirubinemia	62
Emphasis	62
Hyperbilirubinemia	62
Glucose-6-phosphate dehydrogenase-deficient	62
OBJECTIVES	62
Chromatography	62
Especial emphasis	62
G-6-PD deficiency	62
Gilbert's syndrome	62
Sensorineural deafness	63
Deafness	63
Megaloblastic anaemia	63
Rogers syndrome	63
Recessive disorder	63
Anaemia	63
Thiamine-responsive megaloblastic anaemia	63
TRMA syndrome	63
Associated	63
Diabetes mellitus	63
TRMA	63
Autosomal recessive disorder	63
Disorder	63
PKU	64
Associated	64
Phenylketonuria	64
PMD	65
Leukodystrophy	65
Associated	65
Oligodendrocyte cell death	65
Pelizaeus-Merzbacher disease	65
GGM	66
Recessive disorder	66
Galactose	66
Glucose-galactose malabsorption	66
Autosomal recessive disorder	66
Diagnosis	66
Disorder	66
Alimentary glucose and galactose	66
HC	67
Cyclic syndromes	67
Familial hemiplegic migraine	67
Hemicrania	67
Familial hemiplegic migraine and hemicrania continua	67
FHM	67
X-linked dilated cardiomyopathy	68
XLDC	68
Cardiac	68
Dystrophic	68
Muscular dystrophies	68
Duchenne and Becker muscular dystrophies	68
Genetic disease	68
Dilated cardiomyopathy	68
Cardiomyopathy	68
Rare disease	68
Familial neurohypophysial diabetes insipidus	69
Vasopressin deficiency	69
Diabetes insipidus	69
Tumor	70
SF-1	70
Wilms' tumor	70
SF	70
Microcephaly	71
PKU	71
MPKU syndrome	71
Maternal phenylketonuria	71
OBJECTIVES	71
Comparison of number of women	71
Maternal PKU syndrome	71
Phenylketonuria	71
Congenital malformations	71
Tumor	72
Glioblastoma	72
Glioma	72
Tumorigenicity	72
Retinoblastoma	72
PTEN	72
Tumors	72
PTEN tumor	72
CC	73
Rab escort protein-1	73
Visual acuity	73
X-linked recessive hereditary disease	73
REP-1	73
Chorioretinal dystrophy	73
CHM	73
Visual impairment	73
Hereditary disease	73
Choroideremia	73
Childhood cerebral adrenoleukodystrophy	75
Adrenomyeloneuropathy	75
Premature	75
Addison disease	75
Adrenoleukodystrophy	75
Phagocytosis	76
Growth	76
Myeloid	76
Epidermal growth	76
Dentatorubral-pallidoluysian atrophy	77
DRPLA	77
HD	77
Neurodegenerative disorders	77
Neuronal dysfunction	77
Huntington's disease	77
Atrophy	77
Neurodegenerative disorder	78
HD	78
Huntington's disease	78
Neuroblastoma	78
Disorder	78
Muscular atrophy	79
Hexosaminidase A deficiency	79
A deficiency	79
Atrophy	79
Neuromuscular impairment	80
Wechsler Adult Intelligence Scale	80
METHODS	80
Myotonic dystrophy	80
DM	80
NC	80
Schedule for Affective Disorders and Schizophrenia	80
PK	80
Hypothesis	80
Cardiac	80
Schizophrenia	80
Neuropsychiatric evaluation	80
Cardiac and cognitive impairment	80
WAIS	80
Central nervous system	80
SADS	80
Spinal muscle atrophy	80
CNS	80
SMA	80
Neuropsychiatric	80
Cognitive impairment	80
Multisystemic disease	80
Atrophy	80
Gastric cancer	81
Gastric cancers	81
Cardiac	81
Familial gastric cancer	81
Cancers	81
Cancer	81
Familial gastric cancers	81
Criteria	81
MM	82
CHO	82
COS	82
Plasma	82
Misdiagnosis	83
Deafness	83
Autoimmune thyroiditis	83
PDS	83
Hearing loss	83
Pendred syndrome	83
Other thyroid disorders	83
Sensorineural hearing loss	83
Autoimmune	83
Congenital sensorineural hearing loss	83
Goiter	83
Familial goiter and congenital deafness	83
Congenital deafness	83
Thyroiditis	83
Diagnosis	83
Cochlear dysfunction	84
METHODS	84
Hearing loss	84
OBJECTIVES	84
Muscular dystrophies	84
Sensorineural hearing loss	84
Muscular dystrophy	84
Inherited muscular dystrophies	84
Duchenne muscular dystrophy	84
Dystrophin-deficient	84
Metastasis	85
Associated	85
Autosomal dominant	86
Hypothalamus	86
Neurohypophyseal diabetes insipidus	86
Autosomal dominant neurohypophyseal diabetes insipidus	86
Associated	86
Attenuated posterior	86
Neurodegeneration	86
ADNDI	86
Inherited disease	86
Diabetes insipidus	86
Encephalopathy	87
Hepatomegaly	87
Hypotonia	87
VLCAD deficiency	87
Very-long-chain acyl-coenzyme A dehydrogenase deficiency	87
Medium	87
Hypertrophic cardiomyopathy	87
Ventricular hypertrophy	87
Hypertrophy	87
Cardiomyopathy	87
Disorder of fatty acid beta oxidation	87
Very-long-chain acyl-coenzyme A dehydrogenase ( VLCAD ) deficiency	87
Disorder	87
Tumor	88
Breast cancer	88
Breast carcinomas	88
Cancer	88
Carcinomas	88
Tumors	88
Loss of heterozygosity	88
Linkage disequilibrium	89
Ataxia	89
Autosomal recessive syndrome	89
Coronary heart disease	89
Cancer	89
A-T	89
Heart disease	89
Ataxia-telangiectasia	89
Neoplasms	90
Neoplasia	90
Mesenchymal tumors	90
Osteoarthritis	90
OA	90
Chromosomal abnormalities	90
Osteophytes	90
Spectrum of disorders	90
Associated	90
Neoplastic	90
Malignant and benign mesenchymal tumors	90
Tumors	90
Eczema	91
Growth	91
Associated	91
WASP	91
Malignancies	91
Immune deficiency	91
WAS	91
Donors	91
EBV	91
Wiskott-Aldrich syndrome	91
Thrombocytopenia	91
PLN	92
DM heart failure	92
Heart failure	92
Myotonic dystrophy	92
DM	92
Cardiac contractility	92
Cardiac	92
DMPK	92
Cardiac conduction	92
Cardiovascular disease	92
Cardiac myocytes	92
Tumor	93
Ovarian cancer	93
Premature	93
Cancer	93
Familial ovarian cancer	93
Tumorigenesis	93
Ovarian tumor	93
Short stature	94
Cerebral malformations	94
Hypotonia	94
Kyphoscoliosis	94
Microcephaly	94
Spastic diplegia	94
Micro syndrome	94
New syndrome	94
Mental retardation	94
Psychomotor retardation	94
Cataract	94
Ptosis	94
Congenital cataract	94
Optic atrophy	94
Diagnosis	94
Atrophy	94
Microphthalmia	94
Tumor	95
Von Hippel-Lindau disease	95
Von Hippel-Lindau (VHL) disease	95
Von Hippel-Lindau	95
VHL	95
VHL gene abnormalities	95
Short stature	96
Type II	96
Molecular defect	96
GT	96
Kniest dysplasia	96
Dysplasia	96
Blindness	96
Chondrodysplasia	96
Disorder	96
Breast sarcoma cancer family syndrome	98
Tumor	98
Breast cancer	98
Cancers	98
Cancer	98
Tumors	98
Loss of heterozygosity	98
Other cancers	98
Lysosomal disorder	99
Linkage disequilibrium	99
ARSA deficiency	99
Leukodystrophy	99
Metachromatic leukodystrophy	99
Associated	99
MLD	99
Disorder	99
Tumor	100
Pancreatic cancer	100
Hereditary cancer	100
III	100
Growth	100
Colorectal cancers	100
JPS	100
Cancers	100
Polyposis	100
Juvenile Polyposis Syndrome	100
Colorectal carcinogenesis	100
DCC	100
Cancer	100
LOH	100
Tumors	100
Loss of heterozygosity	100
Peroxisomal beta-oxidation	101
Impaired peroxisomal beta-oxidation	101
Neurodegenerative disorder	101
X-ALD	101
Carbon atoms	101
Associated	101
X-linked adrenoleukodystrophy	101
ALD	101
Peroxisome biogenesis disorders	101
Adrenoleukodystrophy	101
Peroxisomal beta-oxidation deficiencies	101
Peroxisomal VLCFA beta-oxidation	101
Plasma	101
Peroxisomal beta-oxidation disorders	101
Disorder	101
PG	102
Cardiac	103
Inherited conotruncal malformations	103
DiGeorge, velocardiofacial, or other syndromes	103
Associated	103
Inherited canine conotruncal heart defects	103
Conotruncal defects	103
CTD	103
Heart defects	103
DGS	103
CTDs	103
Conotruncal heart defects	103
Pigment epithelial cell layer	104
Retinal degeneration	104
Dystrophic	104
Dystrophic retinal degeneration	104
Behavior	104
Genetic defect	104
Intrinsic genetic defect	104
Linkage disequilibrium	105
Genetic disease	105
Cystinuria	105
Tumor	106
Metastasis	106
Abdominal wall implantation metastasis	106
Ovarian cancer	106
Advanced ovarian cancer	106
Cancer	106
Abdominal wall metastasis	106
Metastatic tumor	106
Diagnosis	106
Tumor	107
Hypothesis	107
Intrapleural tumor	107
Adenovirus-mediated cancer	107
Cancer	107
Intraperitoneal tumors	107
Intraperitoneal tumor	107
Tumors	107
Improvement in anti-tumor	107
LEF	108
Myotonia	109
Neonatal SJS	109
Schwartz-Jampel syndrome type 2	109
Contractures , and early death	109
Neuromuscular disorder	109
Feeding difficulties	109
Hypothesis	109
SJS type 2 are the same disorder	109
Stuve-Wiedemann syndrome	109
Bone dysplasia	109
Schwartz-Jampel syndrome	109
Campomelia	109
Dysplasia	109
SWS	109
Wiedemann syndrome	109
Skeletal dysplasia	109
SJS	109
Hyperthermia	109
Campomelic-metaphyseal skeletal dysplasia	109
Disorder	109
Heart failure	110
HH	110
Cirrhosis	110
Hemochromatosis	110
Arthritis	110
Excess	110
Disorder	110
Hereditary hemochromatosis	110
GC	111
Growth	111
Myelodysplastic syndrome	112
Refractory anemia	112
Eosinophilia	112
Eosinophilic leukemia	112
Hematologic malignancies	112
AEL	112
AML	112
Malignancies	112
Leukemia	112
Basophilia	112
Anemia	112
Acute myelogenous leukemia	112
Excess	112
Developmental delay	113
Albinism	113
Angelman syndrome	113
Global developmental delay	113
Gastrulation	114
Embryonic lethality	114
Disorganized visceral endoderm	114
GT	115
Hermaphroditic fish	115
GT	116
Fragile X	116
Mental retardation	116
Fragile X mental retardation	116
Xenopus laevis	117
Chromatography	117
Galactose	118
HDL	119
Hyperinsulinemic fatty Zucker rats	119
Associated	119
Hyperinsulinemic fatty Zucker rat	119
Vivo hyperinsulinemia	119
Hyperinsulinemia	119
Fatty hyperinsulinemic Zucker rats	119
Plasma	119
Ataxia	120
ATM	120
Genetic disease	120
Ataxia telangiectasia	120
Hirsutism	121
Ptosis	121
Congenital anomalies	121
Developmental and language delay	121
XLA	122
Immunodeficiency	122
X-linked agammaglobulinemia	122
Tumor	123
Glioblastoma	123
Hereditary cancer	123
Growth	123
Cancers	123
PTEN	123
Cancer	123
Crystal structure of the PTEN tumor	123
Glioblastoma tumor	123
PTEN tumor	123
Hereditary cancer predisposition syndromes	123
Oral leukoplakias	124
Moderate dysplasia	124
HGD	124
Dysplastic	124
Parabasal layers	124
HGD of the oral mucosa	124
Basal layer of the floor of the mouth and the tongue epithelia	124
Grade leukoplakias	124
Dysplasia	124
LGD	124
Precursor lesions	124
Donors	124
Dysplastic epithelia	124
Dysplastic leukoplakias	124
Angelman syndrome	125
Angelman syndrome-like phenotype	125
Muscle degeneration	126
Muscular dystrophy	126
Duchenne muscular dystrophy	126
DMD	126
GC	127
BAC	127
Tumor	128
RCCs	128
Von Hippel-Lindau disease-associated tumors	128
Von Hippel-Lindau tumor	128
GC	128
Growth	128
Renal cell carcinoma	128
Von Hippel-Lindau disease	128
RCC	128
Carcinoma	128
Associated	128
VHL-responsive element	128
Embryonic kidney	128
Clear-cell renal cell carcinoma	128
Von Hippel-Lindau	128
Tumors	128
Cell carcinoma	128
VHL	128
Tumor	129
Tumor necrosis	129
Tropical diseases	129
G6PD deficiencies	129
Necrosis	129
Growth	129
Glucose-6-phosphate dehydrogenase-deficient	129
Associated	129
Malaria	129
TNF	129
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	129
A/T	129
G6PD-deficient	129
Trauma	129
G6PD deficiency	129
Alpha	129
HH	130
Recessive disorder	130
Autosomal-recessive disorder	130
Hemochromatosis	130
Disorder	130
Hereditary hemochromatosis	130
Machado-Joseph disease	131
Spinocerebellar ataxia type 3	131
Polyglutamine (polygln) diseases	131
Ataxia	131
Spinocerebellar ataxia	131
SCA3/MJD disease	131
Inherited neurodegenerative disorders	131
Polyglutamine disease	131
Spinocerebellar ataxia type 3/Machado-Joseph disease	131
Neurodegenerative disorders	131
MJD	131
SCA3	131
Tumor	132
METHODS	132
C4	132
RB	132
Half-automatic	132
Gene defects	132
Diagnosis	132
RB tumor	132
Apc	133
Cancer	133
Copper toxicosis	134
Wilson disease	134
Inherited disorder	134
Liver disease	134
Canine copper toxicosis	134
Copper storage disease	134
Bedlington terriers	134
Disorder	134
PMD	135
Dysmyelinating disorder	135
Peripheral neuropathy	135
Neuropathy	135
Central nervous system	135
Pelizaeus-Merzbacher disease	135
Dysmyelinating	135
Disorder	135
Bilateral sensorineural hearing loss	136
Deafness	136
Hearing loss	136
Non-syndromic hearing loss	136
Syndromic deafness	136
Sensorineural hearing loss	136
Recessive non-syndromic deafness	136
Recessive deafness	136
Non-syndromic deafness	136
Alpha	136
Orofaciodigital syndrome	137
Type I	137
Ataxia	138
ATM	138
Genetic disorder	138
A-T	138
Disorder	138
Ataxia-telangiectasia	138
Paroxysmal nocturnal hemoglobinuria	139
Haematopoietic	139
Paroxysmal nocturnal haemoglobinuria	139
Haemoglobinuria	139
DAF	139
Donors	139
Flow cytometry	139
Diagnosis	139
Premature	140
X-linked recessive Emery-Dreifuss muscular dystrophy	141
Emery-Dreifuss muscular dystrophy	141
BAF	141
Embryonic lethality	141
Mitosis	141
Muscular dystrophy	141
Breakthroughs in cancer	142
Ovarian cancer	142
Genetic predisposition	142
Breast/ovarian	142
Contre le Cancer	142
Associated	142
AIM	142
Breast/ovarian cancer	142
Measure of cancer	142
Cancer	142
Tumors	142
High fat	143
CETP	143
HDL	143
Hypothesis	143
Atherosclerosis	143
Aortic atherosclerosis	143
Plasma	143
Rhabdomyosarcoma	144
Growth	144
Alveolar rhabdomyosarcoma	144
Alveolar	144
Type II	145
III	145
Tumor	146
Malignancy	146
Colonic polyps	146
Hereditary cancer	146
Genomic instability	146
Carcinoma	146
Colorectal tumor	146
Certain hereditary cancer syndromes	146
Colon cancer	146
Cancer	146
Colorectal premalignant polyp	146
Sporadic tumor	146
Polyps	146
Neisserial infection	147
Meningitis	147
Molecular defects leading to human complement component C6 deficiency	147
Meningitis or other neisserial infection	147
C6 deficiency	147
Premature	147
C6D	147
Complement component C6 deficiency	147
Meningococcal meningitis	147
Molecular defects	147
Plasma	148
Alpha	148
Tumor	149
Adenomas	149
Invasive adenocarcinomas	149
Inflammatory polyps in the glandular stomach	149
Juvenile polyps	149
Growth	149
Pancreatic carcinoma	149
Polyposis	149
Familial juvenile polyposis	149
Carcinoma	149
Adenocarcinoma	149
PTEN	149
Adenocarcinomas	149
Juvenile polyposis	149
Apc	149
Plasma	149
Loss of heterozygosity	149
Polyps	149
Cancers	150
Tumours	150
Cancer	150
Malignancies	150
Refractory prostate cancer	150
Prostate cancer	150
Mental retardation	151
Fragile-X	151
Fragile-X syndrome	151
Disorder	151
Fragile-X mental retardation	151
Cancer	152
AT	153
Tumors	153
Obvious	154
Anglian cancer	155
Breast, ovarian and rectal tumours	155
Cancers	155
Tumours	155
Melanoma	155
Ovarian cancers	155
Cancer	155
Multiple cancer	155
Tumour	155
Bladder and ovarian cancers	155
Diagnosis	155
Gastric cancer	156
Cancer	156
Li-Fraumeni syndrome	156
Familial adenomatous polyposis	157
Adenomas at colectomy	157
Adenomas	157
Adenomatous	157
Colorectal carcinomas	157
Attenuated FAP	157
Polyposis	157
Associated	157
Colorectal adenomas	157
APC	157
Adenomatous polyposis	157
Colorectal adenomatosis	157
Carcinomas	157
FAP	157
DZ-pairs	158
DZ	158
MA	158
Migraine with aura	158
Haematopoietic abnormalities	159
X-linked recessive disorder	159
Haematopoietic	159
XS	159
Recessive disorder	159
McLeod syndrome	159
McLeod	159
XK gene defects	159
Gene defects	159
DMD	159
Disorder	159
Immunodeficiency disease	160
X-linked immunodeficiency	160
Haematopoietic	160
Immunodeficiency	160
WASP	160
WAS	160
X-linked immunodeficiency disease	160
Wiskott-Aldrich syndrome	160
Diagnosis	160
III	161
Favism	161
G6PD A	161
Associated	161
Class III	161
Only abnormality	161
G6PD deficient	161
Enzyme deficiency	161
G6PD Santamaria	161
Anxiety	162
Hemochromatosis	163
Hereditary hemochromatosis	163
Hemochromatosis	164
Alpha	165
Apoptosis	166
Associated	166
Melanoma	166
TAM	166
Tamoxifen	166
Coiled-coil structure	167
Apoptosis	167
Familial cancer	168
Pancreatic cancer	168
Genetic predisposition	168
Hereditary cancer	168
Early-onset disease	168
Cancer syndrome	168
Associated	168
Adenocarcinoma	168
Hereditary cancer syndrome	168
Cancer	168
Pancreatic adenocarcinoma	168
Familial cancer syndromes	168
Criteria	168
Cancer	169
Type II human complement C2 deficiency	170
C2 deficiency	170
Type II	170
Impaired C2 secretion	170
Type I C2 deficiency	170
Type II C2 deficiency	170
Type I	170
Type II deficiency	170
Type II complement protein C2 deficiency	170
AP	171
CC	171
Associated	171
Temperature-dependent sex determination	172
TSD	172
Schmid-Fraccaro syndrome	173
Also cat eye syndrome	173
Anorectal atresia	173
Diagnosis	173
Cat eye syndrome	173
Schmid-Fraccaro's syndrome	173
Associated	174
Hemochromatosis	174
Hereditary hemochromatosis	174
Bipolar Disorder	176
Defined under Model II	176
III	176
Bipolar affective disorder	176
Schizophrenia	176
Bipolar disorder	176
Diagnosis	176
Disorder	176
Breast cancer	177
Male breast cancer	177
METHODS	177
BC	177
Cancer	177
Female breast cancer	177
Ataxia	178
Recessive disorder	178
ATM	178
A-T	178
Autosomal recessive disorder	178
Disorder	178
Ataxia-telangiectasia	178
Tumor	179
Ovarian carcinoma	179
Non-cancerous	179
Primary lung carcinomas	179
Cancers of colon	179
Colorectal carcinomas	179
Insulin resistant disorders	179
Cancers	179
Cancerous	179
Carcinoma	179
Associated	179
Cancer	179
Carcinomas	179
Cancerous and non-cancerous	179
Adenomatous polyposis coli	180
Adenomatous	180
Polyposis	180
APC	180
Adenomatous polyposis	180
COS	180
Polyposis coli	180
Adenomatous polyposis coli gene product	180
Rhabdomyosarcoma	181
Alveolar rhabdomyosarcoma	181
Pediatric cancer alveolar rhabdomyosarcoma	181
Associated	181
Alveolar	181
Cancer	181
Retino-vascular malformations	182
Vascular malformations	182
Gastrulation	183
Neurofibromatosis	184
Schwannoma	184
Rhabdomyosarcoma	185
Alveolar rhabdomyosarcoma	185
Associated	185
Alveolar	185
Tumor	186
Familial adenomatous polyposis	186
Adenomatous	186
FAP tumors	186
Colorectal cancers	186
Colorectal cancer	186
Cancers	186
Polyposis	186
Associated	186
Allelic loss, whereas tumors	186
Colorectal tumors	186
APC	186
Adenomatous polyposis	186
Allelic loss	186
Cancer	186
Tumors	186
FAP	186
FMF	187
Mediterranean fever	187
MEFV	187
Attacks of serositis	187
Serositis	187
Fever	187
Absolutely disease	187
Autosomal recessive disease	187
Recessive disease	187
Familial Mediterranean fever	187
Myotonic dystrophy	188
DM	188
Tumor	189
Breast cancer	189
METHODS	189
Cancer	189
CSF	189
SDH deficiency	190
Leigh syndrome	190
LS	190
Deficiencies in complex II activity	190
Tumor	191
Growth	191
Neoplastic transformation and tumorigenesis	191
Associated	191
Neoplastic transformation	191
Neoplastic	191
Mitosis	191
Tumorigenesis	191
Tumor	192
Familial adenomatous polyposis	192
Hepatoblastoma	192
Adenomatous polyposis coli	192
HB	192
Adenomatous	192
NH	192
Familial adenomatous polyposis syndrome	192
Polyposis	192
Associated	192
APC	192
Adenomatous polyposis	192
Malignant hepatic tumor	192
Cancer	192
Tumorigenesis	192
Polyposis coli	192
Type II	193
Intra-articular deposition	193
Rheumatoid arthritis	193
Collagen-induced arthritis	193
Deficiency of the C5 complement component	193
Human rheumatoid arthritis	193
Autoimmune arthritis	193
TNF	193
Autoimmune	193
DBA	193
Autoimmune polyarthritis	193
CIA	193
Arthritis	193
C5-deficient	193
Alpha	193
Breast cancer	194
Ovarian cancer	194
Ovarian or other cancers	194
Breast-ovarian	194
Cancers	194
Inherited breast cancer	194
Breast-ovarian cancer	194
Cancer	194
Breast Cancer	194
Other cancers	194
Female breast cancer	194
Breast cancer	195
Ovarian cancer	195
Male breast cancer	195
Breast and/or ovarian cancer	195
Cancer	195
Breast and ovarian cancer	195
Moderate-risk cancer	195
Female breast cancer	195
Ovarian cancer	196
Cancer	196
Breast and ovarian cancer	196
Hereditary breast and ovarian cancer	196
Bacterial infection	197
C9 deficiency	197
C4	197
Invasive bacterial infection	197
Premature	197
Plasma	197
Familial juvenile hyperuricemic nephropathy	198
METHODS	198
Autosomal-dominant disease	198
Chronic renal failure	198
Renal failure	198
Nephropathy	198
Hyperuricemia	198
FJHN	198
Diagnosis	198
Tolbutamide methyl hydroxylation	199
Neuroblasts	200
Autism	200
Apoptosis	201
Hypothesis	201
Ataxia	201
ROI	201
Defective ROI-detoxification	201
ATM	201
In ataxia telangiectasia	201
Ataxia telangiectasia	201
Familial schizophrenia	202
Complex disorder	202
Schizophrenia	202
Disorder	202
Tumor	203
Inherited syndrome	203
Familial adenomatous polyposis	203
Adenomas	203
Adenomatous polyposis coli	203
Apoptosis	203
Adenomatous	203
APC-mediated tumor	203
Familial adenomatous polyposis coli	203
Colorectal cancer	203
Cancers	203
Polyposis	203
Colorectal adenomas	203
APC	203
Adenomatous polyposis	203
Colon cancer	203
Cancer	203
Carcinomas	203
Tumors	203
FAP	203
Polyposis coli	203
Colonic epithelial cell homeostasis	203
Colon tumors	203
Adenomatous polyposis coli tumor	203
Ovarian carcinoma	204
Breast cancer	204
Fallopian tube carcinoma	204
METHODS	204
BRCA testing	204
Cancers	204
Carcinoma	204
OBJECTIVES	204
Gynecologic cancers	204
Abnormality in the breast cancer	204
Cancer	204
Ovarian or peritoneal carcinoma	204
Ovarian and peritoneal carcinoma	204
Fallopian tube cancer	204
EDMD	205
Emery-Dreifuss muscular dystrophy	205
EMDM	205
Associated	205
Muscular dystrophy	205
Retarded bone maturation	206
Silver-Russell syndrome	206
Postnatal growth retardation	206
Growth	206
Uniparental disomy	206
Trisomy 7	206
Hemihypotrophy	206
Growth retardation	206
Isodisomy	206
SRS	206
Maternal UPD	206
Heterodisomy	206
Maternal uniparental disomy	206
Diagnosis	206
UPD	206
Prenatal diagnosis	206
Type II	207
Associated	207
McLeod	207
Erythropoiesis	207
Nerve abnormalities	207
Muscular dystrophy	207
Anemia	207
Inherited deficiency	209
EC	209
Perinatal lethal disease	209
Gaucher disease	209
Gaucher	209
Associated	209
Glucocerebrosidase	209
ARMS	209
Deficiency of the enzyme glucocerebrosidase	209
AT	210
PI	210
Ataxia	210
Associated	210
ATR	210
ATM	210
Embryonic lethality	210
Ataxia Telangiectasia	210
Pleiotropic disorder	210
Ataxia telangiectasia	210
Disorder	210
Leukodystrophy	211
Metachromatic leukodystrophy	211
Dysarthria	211
Psychotic disturbances	211
MLD	211
Gait disturbances	211
Tumor	212
Breast cancer	212
Rb	212
Retinoblastoma	212
Cancer	212
Galactosemia	213
Galactose	213
Classic galactosemia	213
Disorder	213
SLOS	214
Dysmorphic facies, limb malformations	214
Mental retardation	214
Developmental abnormalities	214
Autosomal recessive genetic disorder	214
Smith-Lemli-Opitz (RSH) syndrome	214
Recessive genetic disorder	214
Genetic disorder	214
Opitz syndrome	214
RSH syndrome	214
Smith-Lemli-Opitz syndrome	214
Plasma	214
Disorder	214
Breast cancer	215
Genetic predisposition	215
Cancers	215
Postmenopausal breast cancer	215
Cancer	215
Breast and other cancers	215
Other cancers	215
Linkage disequilibrium	216
LD	216
G6PD A	216
Associated	216
Malaria	216
Cancers	217
Prostate and other cancers	217
Associated	217
BAC	217
PTEN	217
BPH	217
Cancer	217
Tumour	217
Other cancers	217
Prostate cancer	217
Advanced prostate cancer	217
FMF	218
Mediterranean fever	218
MEFV	218
AA	218
Episodes	218
Fever	218
Associated	218
Renal amyloidosis	218
Amyloidosis	218
Diagnosis	218
Familial Mediterranean fever	218
Inherited disease	218
GT	219
Uniparental disomy	219
Isodisomy	219
Maternal UPD	219
Maternal uniparental disomy	219
Isodisomy of the short arm	219
UPD	219
WND	220
Recessive disorder	220
Wilson disease	220
Neurological symptoms	220
Autosomal recessive disorder	220
Diagnosis	220
Plasma	220
Disorder	220
C2 deficiency	221
Transient renal disease	221
Deficient individuals	221
Lupus erythematosus	221
Alternative complement pathway	221
C4	221
Renal disease	221
Deficiency of the second component of complement (C2) and discoid lupus erythematosus	221
Arthralgia	221
Hereditary deficiency of the second component of complement and discoid lupus erythematosus	221
C3-deficient	221
Deficiency of the second component of complement	221
Systemic lupus erythematosus	221
Plasma	221
HD	222
Neurological symptoms	222
Huntington's disease	222
Diagnosis	222
METHODS	223
Lumbosacral cord	223
OBJECTIVES	223
Multisegmental lower	223
Tumor	224
Rhabdomyosarcoma	224
Apoptosis	224
Solid tumors	224
RMS	224
Associated	224
Tumors	224
Tumor	225
METHODS	225
Growth	225
Breast cancer	226
Ovarian cancer	226
Male breast cancer	226
Breast or ovarian cancer	226
Breast or ovarian cancers	226
Cancers	226
Associated	226
Breast and ovarian cancers	226
Ovarian cancers	226
Cancer	226
Breast and ovarian cancer	226
Age at diagnosis	226
Diagnosis	226
Hispanic	226
Female breast cancer	226
Autosomal dominant	227
Inherited syndrome	227
Benign familial neonatal convulsions	227
BFNC	227
Familial neonatal convulsions	227
Pyoderma	228
Pyoderma gangrenosum	228
Haemolytic anaemia	228
C4	228
Complement deficiency	228
PG	228
Systemic diseases	228
Anaemia	228
Congenital deficiency of complement factors C2 and C4	228
Associated	228
Autoimmune	228
Congenital deficiency	228
Autoimmune haemolytic anaemia	228
Hereditary diseases	229
Retinal atrophy	229
GPRA	229
RDS	229
Retinitis pigmentosa	229
Generalised progressive retinal atrophy	229
Atrophy	229
Sachs disease	230
Tay-Sachs	230
Hexosaminidase A deficiency	230
Tay-Sachs disease	230
Premature	230
Inherited disorder	230
TSD	230
A deficiency	230
Disorder	230
Developmental delay	231
METHODS	231
Fragile X	231
Mental retardation	231
Fragile X syndrome	231
Criteria	231
Inherited mental retardation	231
Diagnosis	231
Krabbe disease	232
Fragile X	233
Associated	233
Fragile X syndrome	233
SEP	234
Apoptosis	235
Rd	235
Retinitis pigmentosa	235
Retinal degeneration	235
Blindness	235
Human-inherited retinal blindness	235
Alpha	235
METHODS	236
Myotonic dystrophy	236
DM	236
Myotonic myopathy	236
Myopathy	236
Associated	236
Inherited disorder	236
Dominantly inherited disorder	236
Inherited disorders	236
PROMM	236
Disorder	236
Familial adenomatous polyposis	237
Adenomatous polyposis coli	237
METHODS	237
Adenomatous	237
Colorectal cancer	237
Polyposis	237
Associated	237
AIMS	237
APC	237
Adenomatous polyposis	237
Cancer	237
FAP	237
Polyposis coli	237
Protein C deficiency	238
PROC gene lesions	238
Thrombotic	238
Diagnosis	238
Plasma	238
Copper-dependent redistribution	239
WND	239
Wilson disease	239
CysProCys/	239
Diagnosis	239
METHODS	240
Classical adenomatous polyposis	240
Adenomatous	240
Attenuated FAP	240
Polyposis	240
AFAP	240
Heteroduplex	240
Eight tumors	240
APC	240
Adenomatous polyposis	240
Tumors	240
FAP	240
MYH	240
Loss of heterozygosity	240
Megakaryoblastic leukemia	241
Associated	241
AML	241
Leukemia	241
AML-M7	241
Molecular abnormalities	242
Enzyme deficiencies	242
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	242
Kuwaitis	242
G6PD-deficient	242
Donors	242
Prader-Willi	243
Prader-Willi syndrome	243
PWS	243
METHODS	243
AS	243
Mental retardation	243
Angelman syndrome	243
Congenital anomalies	243
IGHD	244
Short stature	244
Isolated growth hormone deficiency	244
GH	244
Growth	244
Hormone deficiency	244
Criteria	244
Growth hormone deficiency	244
Myotonia	245
HypoPP	245
DHPR gene defects	245
Weakness	245
Associated	245
Episodic muscle weakness	245
Gene defects	245
Hereditary muscle diseases	245
Hypokalemic periodic paralysis	245
Familial hypokalemic periodic paralysis	245
Hypokalemic	245
Muscle weakness	245
Alpha	245
HDL	247
Atherogenic lipid profile	247
Hydrolysis	247
Body mass index	247
Associated	247
Plasma	247
METHODS	248
Ataxia	248
Associated	248
ATM	248
Genetic disorder	248
A-T	248
Flow cytometry	248
Disorder	248
Ataxia-telangiectasia	248
Deafness	249
Genetic diseases	249
DFNB10	249
BAC	249
Autosomal recessive nonsyndromic deafness DFNB10	249
Autosomal recessive nonsyndromic deafness	249
Caenorhabditis elegans proteins	250
Drosophila melanogaster	250
Gastrulation	250
Embryonic lethality	250
Caenorhabditis	250
Hypermethylation	251
Associated	251
Cerebro-hepato-renal syndrome	252
Growth	252
Peroxisomal biogenesis disorders	252
Zellweger syndrome	252
Associated	252
Congenital disorder	252
Zellweger cerebro-hepato-renal syndrome	252
Specific gene defect	252
Zellweger	252
Disorder	252
Breast cancer	253
Ovarian cancer	253
Cancer syndrome	253
Cancers	253
Associated	253
Cancer	253
Breast and ovarian cancer	253
Tumourigenesis	253
Hereditary breast and ovarian cancer	253
Hereditary ovarian cancer	253
Myotonic dystrophy	255
DM	255
Hypothesis	255
Donors	255
Tumor	256
Cancers	256
APC	256
LEF	256
Tumorigenesis	256
Tumor	257
PI	257
Impaired glucose tolerance	258
FA	258
Ataxia	258
Associated	258
Autosomal recessive disease	258
Recessive disease	258
Friedreich's ataxia	258
Disorder	258
Parameters of glucose metabolism	258
Tumor	259
Non-cancerous	259
Oral squamous cell carcinoma	259
Adenomatous Polyposis Coli (APC) tumor	259
Adenomatous	259
Adenomatous polyposis Coli	259
Cancerous	259
Polyposis	259
Carcinoma	259
APC	259
Adenomatous polyposis	259
OSCC	259
Cancer	259
LOH	259
Squamous cell carcinoma	259
Diagnosis	259
Cell carcinoma	259
Loss of heterozygosity	259
Adenomatous Polyposis Coli	259
Growth	260
Emphasis	260
Echinococcus granulosus hydatid disease	260
Associated	260
C5-deficient	260
Echinococcus granulosus hydatid infection	260
Xenopus laevis	261
Familial adenomatous polyposis	262
HNPCC	262
Neoplasia	262
METHODS	262
Adenomatous	262
Diagnostic criteria	262
Colorectal neoplasia	262
Colorectal cancer	262
Polyposis	262
Associated	262
Hereditary colorectal cancer	262
AIMS	262
Amsterdam II criteria	262
Hereditary non-polyposis colorectal cancer	262
Adenomatous polyposis	262
Cancer	262
Criteria	262
Diagnosis	262
Behavior	263
Genetic conditions	264
GS	264
Leukodystrophy	264
Deficient arylsulfatase A	264
Metachromatic leukodystrophy	264
MLD	264
HPD	265
Tyrosine hydroxylase	265
Dystonia	265
Dopa-responsive dystonia	265
Hereditary progressive dystonia	265
Criteria	265
Diagnosis	265
Ovarian cancer	266
KD	266
Inherited breast and ovarian cancer	266
Cancer	266
Breast and ovarian cancer	266
Tumour	266
Familial adenomatous polyposis	267
Adenomatous polyposis coli	267
Adenomatous	267
Familial adenomatous polyposis coli	267
Polyposis	267
Heteroduplex	267
APC	267
Adenomatous polyposis	267
Cancer	267
Cancer Research Campaign	267
FAP	267
Polyposis coli	267
Diagnosis	267
Recessive hyperphenylalaninemia	268
HPA	268
Dystonia	268
Associated	268
Dopa-responsive dystonia	268
Hyperphenylalaninemia	268
DRD	268
Paroxysmal nocturnal hemoglobinuria	269
GPI anchor deficit	269
PNH	269
Glycosylphosphatidylinositol (GPI) anchors	269
Deficiencies of specific GPI anchor proteins	269
Neurological dysfunction	270
Autosomal dominant	270
Hereditary coproporphyria	270
HC	270
III	270
Gene defects	270
Porphyria	270
Infectious diseases	270
CPO	270
CPO gene defects	270
Lesch-Nyhan syndrome	271
Lesch-Nyhan	271
Neurobehavioral	271
Complete deficiency of erythrocyte	271
Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency	271
Hyperuricemia	271
Lesch-Nyhan disease	271
Neurological manifestations	271
HPRT deficiency	271
CB	272
Von Willebrand	272
Type I	272
Von Willebrand disease	272
VWF	272
VWD	272
Diagnosis	272
Plasma	272
TD	273
Non-dopa-responsive dystonia	273
Dystonia	273
NDRD	273
Dopa-responsive dystonia	273
Hereditary torsion dystonia	273
DRD	273
Torsion dystonia	273
Autosomal dominant	274
HGF	274
Hereditary gingival fibromatosis	274
Autosomal dominant	275
DMPK deficiency	275
Abnormality of the human disease	275
Human disease	275
Myotonic dystrophy	275
DM	275
Associated	275
DMPK	275
Autosomal dominant disorder	275
Abnormality of human myotonic muscular dystrophy	275
Muscular dystrophy	275
DMPK loss	275
Disorder	275
Colonic carcinomas	276
III	276
Colorectal carcinomas	276
Carcinoma	276
Associated	276
Tumours	276
Colorectal carcinoma	276
Cancer	276
Carcinomas	276
Autosomal dominant cataracts	277
Autosomal dominant	277
ADCs	277
METHODS	277
Radial opacities in the posterior embryonal nucleus	277
Neurofibromatosis	277
Cataract	277
Cataracts	277
ADC	277
Prader-Willi	278
Prader-Willi syndrome	278
Neurodevelopmental disorder	278
Disorder	278
Alpha	279
Thyroid diseases	280
Hypothyroidism	280
Including thyroid cancer	280
Congenital hypothyroidism	280
Thyroid cancer	280
TSH	280
Cancer	280
NIS	280
Ataxia	281
ATM	281
Gamma-ionizing radiation	281
Mitosis	281
Tumour	281
Ataxia-telangiectasia	281
Hemochromatosis	282
Hereditary hemochromatosis	282
Autosomal dominant	283
Idiopathic sporadic ataxia	283
Symptomatic ataxia	283
Idiopathic cerebellar ataxias	283
Sporadic cerebellar ataxia	283
Ataxia	283
Spinocerebellar ataxia	283
Autosomal dominant ataxia	283
Associated	283
Spinocerebellar ataxia types 1	283
Idiopathic ataxia	283
Cerebellar ataxia	283
SCA2	283
SCA1	283
SCA3	283
SCA6	283
Friedreich's ataxia	283
System atrophy	283
Diagnosis	283
Sporadic ataxia	283
Atrophy	283
GT	284
XI	284
Renal disease	284
Hypertension	284
Associated	284
ESRD	284
Plasma	284
End-stage renal disease	284
Growth	285
Cardiac	285
Cardiovascular diseases	285
MAP	285
Vascular endothelial cell growth	285
Cardiac myocytes	285
Bacterial death	286
HD	286
Medium	286
Huntington's disease	286
Myeloid	287
Hemolytic anemia	287
Deficiency , the enzyme-deficient	287
Chronic nonspherocytic hemolytic anemia	287
Anemia	287
Enzyme deficiency	287
Excess	287
G6PD deficiency	287
Cystic fibrosis	288
Linkage disequilibrium	288
Gaucher disease	288
Fibrosis	288
Gaucher	288
Glucocerebrosidase	288
Adenomatous polyposis coli	289
Various cancers	289
Esophagogastric junction adenocarcinoma	289
Adenomatous	289
Cancers	289
Polyposis	289
Carcinoma	289
Esophageal adenocarcinomas	289
Adenocarcinoma	289
Colorectal carcinoma	289
Esophagogastric junction adenocarcinomas	289
Adenocarcinomas	289
APC	289
Adenomatous polyposis	289
Allelic loss	289
Tumorigenesis	289
Tumors	289
Polyposis coli	289
Breast cancer	290
Ovarian cancer	290
Breast/ovarian	290
Hereditary breast/ovarian cancer	290
Cancers	290
Associated	290
Heteroduplex	290
Breast/ovarian cancer	290
Cancer	290
Criteria	290
Other cancers	290
Breast and ovary cancer	290
Tumor	291
Rhabdomyosarcoma	291
Solid tumors	291
Alveolar rhabdomyosarcoma	291
Associated	291
Alveolar	291
Tumors	291
Deficiency of hepatic phenylalanine hydroxylase	292
PKU	292
Recessive disorder	292
A deficiency	292
Phenylketonuria	292
Autosomal recessive disorder	292
Disorder	292
Myotonia	293
Chondrodystrophic myotonia	293
Schwartz-Jampel syndrome	293
METHODS	294
Neurodegenerative disorder	294
Ataxia	294
Autosomal recessive neurodegenerative disorder	294
OBJECTIVES	294
Friedreich's ataxia	294
FRDA	294
Disorder	294
FOP	295
Sporadic FOP	295
Fibrodysplasia ossificans progressiva	295
Fibrodysplasia	295
Associated	295
Genetic disorder	295
Disorder	295
Autosomal dominant	296
AdRP	296
METHODS	296
Autosomal dominant retinitis pigmentosa	296
Premature	296
Retinitis pigmentosa	296
Associated	296
Heteroduplex	296
Dystrophinopathy	297
Becker muscular dystrophy	297
Weakness	297
Duchenne and Becker muscular dystrophy	297
Dilated cardiomyopathy	297
Cardiomyopathy	297
Muscular dystrophy	297
Cardiological abnormalities	297
Muscle weakness	297
Tumor	298
Ovarian cancer	298
Hyperphosphorylated and accumulate	298
Cancer	298
Breast and ovarian cancer	298
FMF	299
Mediterranean fever	299
Hereditary disorder	299
Genetic testing	299
Fever	299
Kidney failure	299
Amyloidosis	299
Familial Mediterranean fever	299
Disorder	299
METHODS	300
GT	300
Associated	300
Breast cancer	301
Ovarian cancer	301
Associated	301
Cancer	301
Breast and ovarian cancer	301
Tumour	301
Hereditary breast and ovarian cancer	301
Hepatomegaly	302
Very long-chain acyl-CoA dehydrogenase deficiency	302
Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency	302
VLCAD deficiency	302
Medium	302
Cardiomegaly	302
Fatty liver	302
Hypoglycaemia	302
Hypoketotic hypoglycaemia	302
Diagnosis	302
Plasma	302
Contralateral eye can	303
Chorioretinopathy	303
METHODS	303
Color vision defects	303
SD	303
Visual acuity	303
Color vision defect	303
Central serous chorioretinopathy	303
CSC	303
Color Vision Meter 712 anomaloscope	303
Mesenchymal tumors	304
AT	304
Uterine leiomyoma	304
Leiomyomas	304
Uterine leiomyomas	304
Tumors	304
Ovarian cancer	305
Hospital-based cancer	305
Associated	305
Cancer	305
Breast and ovarian cancer	305
Hereditary breast and ovarian cancer	305
Bacterial infection	307
Chronic meningococcemia	307
Meningism	307
Neisseria	307
Acute polysynovitis	307
Acute polyarthritis	307
Neisseria meningitidis	307
Neisseria gonorrhoeae	307
Reactive arthritides	307
Rare disease	307
Vasculitis	307
Diagnosis	307
Hereditary inflammatory disease	308
FMF	308
Mediterranean fever	308
Apoptosis	308
MEFV	308
Attacks of fever	308
Myeloid	308
Chronic renal failure	308
Serositis	308
Renal failure	308
Fever	308
Renal amyloidosis	308
Amyloidosis	308
Familial Mediterranean fever	308
Alpha	308
Lysosomal storage disease	309
Lysosomal storage disorders	309
Adenoviral vectors	309
HAE	309
Endocytosis	309
Lysosomal storage disease mucopolysaccharidosis type VII	309
Mucopolysaccharidosis	309
Congenital lysosomal storage disorders	309
VII	309
Human amniotic epithelial	309
Autosomal dominant	310
AD CMD	310
AD	310
SD	310
AR spondylocostal dysplasia	310
Dysplasia	310
Craniotubular dysplasia	310
Craniometaphyseal dysplasia	310
AR SD	310
CMD	310
CTD	310
AR craniometaphyseal dysplasia	310
Diagnosis	310
Disorder	310
GLC1I glaucoma	311
OAG	311
Open angle glaucoma	311
Complex disorder	311
Glaucoma	311
AAD	311
Age at diagnosis	311
Diagnosis	311
Disorder	311
Late-onset disease	312
Hereditary prostate cancer	312
OMIM	312
HPC	312
HPCX-linked prostate cancer	312
Cancer	312
Diagnosis	312
Prostate cancer	312
Tumor	313
Ovarian cancer	313
Associated	313
Cancer	313
Breast and ovarian cancer	313
Hereditary breast and ovarian cancer	313
Uremic syndrome	314
Familial hemolytic uremic syndrome	314
Genetic predisposition	314
HUS	314
Familial HUS/TTP	314
Premature	314
Associated	314
TTP	314
Factor H	314
Deficiencies in factor H	314
Autosomal-recessive hemolytic uremic syndrome	314
Hemolytic uremic syndrome	314
METHODS	315
HD	315
AS	315
Wild type	315
Heteroduplex	315
PTEN	315
Nonsyndromic hearing impairment	316
Golgi apparatus	316
Melanoma	316
Inner-ear dysfunction	316
Myoclonic epilepsy	317
Osteoprotegerin, syndecan-2	317
Cohen syndrome	317
Hereditary spastic paraplegia	317
Epilepsy	317
Klip-Feil syndrome	317
Spastic paraplegia	317
Type I	317
Trichorhinophalangeal syndrome type I	317
Langer-Giedion syndrome	317
Autosomal dominant	318
Autosomal dominant Emery-Dreifuss muscular dystrophy	318
EDMD	318
X-linked recessive Emery-Dreifuss muscular dystrophy	318
AD	318
Emery-Dreifuss muscular dystrophy	318
X-EDMD	318
AD-EDMD	318
Muscular dystrophy	318
Tumor	319
AT	319
Ataxia	319
ATM	319
In ataxia telangiectasia	319
Ataxia telangiectasia	319
Phagocytosis	320
Multisystemic disorder	320
Wiskott-Aldrich syndrome	320
Wiskott-Aldrich Syndrome	320
Disorder	320
Wolfram (DIDMOAD) syndrome	321
Neurodegenerative disorder	321
Insulin-dependent diabetes mellitus	321
Hypothesis	321
Wolfram syndrome	321
Associated	321
Areas, olfactory tubercle	321
Autosomal recessive neurodegenerative disorder	321
Psychiatric, behavioral and emotional abnormalities	321
Diabetes mellitus	321
DIDMOAD	321
Insulin-dependent diabetes	321
Optic atrophy	321
Disorder	321
Atrophy	321
Tumor	322
Breast cancer	322
PK	322
Pancreatic carcinoma	322
Cancers	322
Radiosensitivity	322
Carcinoma	322
BRCA2-deficient	322
Cancer	322
DSB	322
Familial cancers	322
Muscular disorder	323
Cardiac dysfunctions	323
Weakness affecting humero-peroneal muscles	323
Inherited muscular disorder	323
Growth	323
Joint abnormalities	323
Emery-Dreifuss muscular dystrophy	323
Fragility of myonuclei	323
Cardiac	323
Weakness	323
Associated	323
Emerin deficiency	323
Cardiomyopathy	323
Muscular dystrophy	323
EMD	323
Muscle weakness	323
Disorder	323
Breast cancer	324
Bilateral breast cancer	324
Right tumours	324
Ataxia	324
Inherited breast cancer	324
ATM	324
Tumours	324
Allelic loss	324
Cancer	324
LOH	324
Ataxia Telangiectasia	324
Tumour	324
Loss of heterozygosity	324
METHODS	325
III	325
Hypertension	325
Non-parametric linkage	325
OBJECTIVES	325
NPL	325
Meningococcal infection	326
C7 deficiency	326
Meningitis	326
Associated	326
Complement C7 deficiency	326
C7-deficient	326
Meningococcal meningitis	326
Myotonic dystrophy	327
DM	327
Associated	327
DMPK	327
Peripheral retina	328
METHODS	328
Rd	328
COS	328
Retinoschisis	328
X-linked juvenile retinoschisis	328
X-linked retinoschisis	328
Disulfide-linked oligomeric protein complex	328
Benign smooth-muscle tumor	329
Tumor	329
Mesenchymal tumors	329
Uterine leiomyoma	329
Neoplasm	329
Leiomyomas	329
Uterine leiomyomas	329
Tumorigenesis	329
Tumors	329
Enhancer	329
Bannayan-Zonana syndrome	330
Ruvalcaba-Riley-Smith syndrome	330
Malignancy	330
Malignant melanoma and thyroid tumours	330
CD	330
Breast , skin and gastrointestinal tract	330
Malignant breast disease	330
BZS	330
Tumours	330
Central nervous system	330
PTEN	330
Melanoma	330
Malignant melanoma	330
Cancer	330
Carcinomas	330
Cowden disease	330
Breast involvement	330
Tumour	330
Kidney cancer	330
Endometrial carcinomas	330
Hamartoma	330
Breast disease	330
Hypothyroidism	332
CH	332
Congenital hypothyroidism	332
Anomalous	332
TIOD	332
Isodisomy	332
Isodisomy of the short arm of chromosome 2	332
Isodisomy of the short arm	332
Total iodide organification defect	332
Obvious	333
Associated	333
Autosomal dominant	334
METHODS	334
Myotonic dystrophy	334
Bilateral optic nerve atrophy	334
Nerve atrophy	334
DMPK	334
Autosomal dominant disorder	334
Optic atrophy	334
Diagnosis	334
Disorder	334
Atrophy	334
Recessive multiple epiphyseal dysplasia	335
Disorders of sulfate metabolism	335
Multiple epiphyseal dysplasia	335
Diastrophic dysplasia	335
Atelosteogenesis type 2	335
Associated	335
AO2	335
Dysplasia	335
Skeletal dysplasia	335
RMED	335
DTD	335
METHODS	336
Hemophilia B	336
Diagnosis	336
Prenatal diagnosis	336
Hemophilia	336
Growth	337
CCAAT	337
AlF-C2	337
Hepatoma	337
Hereditary prostate cancer	338
HPC	338
Major prostate cancer	338
Cancer	338
Sporadic prostate cancer	338
Excess	338
Prostate cancer	338
Mental disorders	339
Associated	339
Anxiety	339
Developmental defects	340
METHODS	340
Associated	340
Optic nerve malformation	340
Disc coloboma	340
Hypoplasia	340
Congenital optic nerve malformation	340
Optic nerve hypoplasia	340
Systemic developmental defects	340
Wolf-Hirschhorn syndrome	341
Developmental disorder	341
Wolf-Hirschhorn	341
Hypothesis	341
Glaucoma	341
Congenital glaucoma	341
Associated	341
Ocular anomalies	341
Disorder	341
ALPS	342
Autoimmune lymphoproliferative syndrome	342
Autoimmune	342
Hypothesis	343
Associated	343
Myotonic dystrophy	344
Growth	344
Hypothesis	344
DM1	344
Myelogenous leukaemia	345
CCAAT	345
Carcinoma	345
Lymphoma	345
Carcinoma A549	345
Leukaemia	345
Cancer	345
Tumoral	345
Congenital abnormality	346
METHODS	346
Associated	346
X-linked immunodeficiency	347
Immunodeficiency	347
Associated	347
WASP	347
WAS	347
Wiskott-Aldrich syndrome	347
Breast cancer	348
Ovarian cancer	348
Breast/ovarian	348
METHODS	348
Breast-ovarian	348
Cancers	348
Heteroduplex	348
Breast and ovarian cancers	348
Ovarian cancers	348
Cancer	348
Breast and ovarian cancer	348
Familial breast and ovarian cancers	348
Breast Cancer	348
Diagnosis	348
Hereditary breast and ovarian cancer	348
Myotonic dystrophy	349
DM	349
Brain atrophy	349
Imaging, disease duration, muscular disability	349
Putamen, globus pallidus	349
Atrophy	349
Hypomania	350
Mania	350
Episodes	350
Bipolar affective disorder	350
Psychiatric disorder	350
Hypothesis	350
Mental health wellness	350
Genetic disorders	350
BPAD	350
Disorder	350
Dominant optic atrophy	351
BAC	351
DOA	351
Optic atrophy	351
Atrophy	351
Premature	352
Associated	352
Hemochromatosis	352
Diagnosis	352
Disorder	352
Alpha	352
Hereditary hemochromatosis	352
Nonfamilial hemochromatosis	352
METHODS	353
Iron deficiency	353
Hemochromatotics	353
Deficiency anemia	353
AIMS	353
Abnormal iron metabolism	353
Iron deficiency anemia	353
Hemochromatosis	353
Anemia	353
Tumor	354
Apoptosis	354
Cancer	354
Tumors	354
Polycystic kidney disease	355
Tumor	355
Autosomal dominant	355
Hereditary hyperparathyroidism-jaw tumor syndrome	355
Hyperparathyroidism	355
Hamartomas	355
HPT-JT	355
Neoplasia	355
Cystic kidney disease	355
Renal hamartomas	355
MEN1	355
Renal lesions	355
Parathyroid tumor	355
JT	355
OMIM	355
Multiple endocrine neoplasia	355
Wild type	355
Autosomal dominant disease	355
Associated	355
Jaw tumor syndrome	355
Kidney disease	355
Parathyroid	355
Loss of heterozygosity	355
HPT-JT syndrome	355
Crohn's disease	356
METHODS	356
CD	356
Late onset disease	356
Hematologic autoimmunity	357
Autoimmune lymphoproliferative syndrome	357
Apoptosis	357
Hematologic cytopenias	357
Autoimmune	357
Defective IL-2	357
Local hypoplastic AI	358
AMBN	358
Hypoplastic amelogenesis imperfecta	358
AI	358
Associated	358
Amelogenesis imperfecta	358
Inherited enamel defect	358
Hypoplastic	358
Linkage disequilibrium	359
Hypercholesterolemia	359
FH	359
Polygenic hypercholesterolemia	359
Familial hypercholesterolemia	359
Diagnosis	359
Prenatal diagnosis	359
Anal anomalies	360
Multiple congenital anomalies of which coloboma of the iris and anal atresia	360
Iris coloboma	360
Pre-auricular anomalies	360
Mental retardation	360
Cat-Eye syndrome	360
Congenital anomalies	360
CES	360
Mentally retarded	360
Moderate mental retardation	360
Disorder	360
Hyperalphalipoproteinemia	362
Genetic abnormalties	362
Angelman syndrome	363
Associated	363
Autistic	363
Autism	363
Autism-spectrum disorders	363
Axolemma	364
Associated	364
CNS	364
Hematopoietic failure	365
Paroxysmal nocturnal hemoglobinuria	365
Reticulocytosis	365
PNH	365
Hemolysis	365
AA	365
Aplastic anemia	365
Hemolytic anemia	365
Erythropoiesis	365
Deficient hematopoiesis	365
Intravascular hemolysis	365
Autoimmune	365
Anemia	365
Disorder	365
Autosomal dominant	366
Myotonic dystrophy	366
DM	366
Autosomal dominant disease	366
Congenital myotonic dystrophy	366
CDM	366
Coma	367
Glasgow Coma	367
DAI	367
SEP	367
Trauma	367
Neurologic ward	367
Hypercoagulability	368
Venous thrombosis	368
METHODS	368
NS	368
Inflammatory bowel disease	368
Inherited coagulation abnormalities	368
Prothrombotic inherited abnormalities	368
OBJECTIVES	368
Thrombosis	368
Thrombotic	368
Thromboembolism	368
Bowel disease	368
Neoplasms	369
Neurological dysfunction	370
Syndromic and non-syndromic hearing loss	370
Hearing loss	370
Non-syndromic hearing loss	370
Associated	370
Neurological symptoms	370
Glucosephosphate dehydrogenase deficiency	371
Hemolytic anemia	371
Hyperbilirubinemia	371
Neinatal hyperbilirubinemia	371
DG6F deficiency	371
Anemia	371
Partial deficiency	371
MS	372
Neurologic improvement	372
Associated	372
Demyelination	372
Autoimmune	372
CNS	372
Autoimmune demyelinating disease	372
Encephalomyelitis	372
EAE	372
Multiple sclerosis	372
Tumor	373
Apoptosis	373
Human disease	373
Growth	373
Cancers	373
Programmed cell death	373
Associated	373
PTEN	373
Breast and thyroid cancers	373
Tumorigenesis	373
Hyperplasia	373
Thyroid cancers	373
Cowden and Bannayan-Zonana syndromes	373
PTEN tumor	373
Neurodegenerative disorder	374
Ataxia	374
Spinocerebellar ataxia	374
SCA	374
Autosomal recessive neurodegenerative disorder	374
Hereditary spinocerebellar ataxia	374
Friedreich's ataxia	374
FRDA	374
Disorder	374
Alloimmune thrombocytopenia	375
METHODS	375
HPA	375
Neonatal alloimmune thrombocytopenia	375
Oncologic diseases	375
Thrombocytopenia	375
PKU	376
Mental retardation	376
Metabolic disorders	376
Phenylketonuria	376
Diagnosis	376
Prenatal diagnosis	376
Inborn errors of metabolic disorders	376
Lysosomal storage disease	378
Endocytosis	378
Epstein-Barr	378
Epstein-Barr virus	378
Medium	378
Aspartylglycosaminuria	378
AGU	378
Metabolic defect	378
EBV	378
Deficiency of the lysosomal enzyme, glycosylasparaginase	378
Diaphragmatic paralysis	379
Hypotonia	379
Facial diplegia	379
Myotonic dystrophy	379
Feeding difficulties	379
Arthrogryposis	379
Autosomal disease	379
Congenital myotonic dystrophy	379
Myotonic discharges	379
Diagnosis	379
Breast cancer	380
Lymphoid malignancies	380
Malignancy	380
Sporadic lymphoid malignancies	380
Sporadic lymphoid malignancy	380
Non-Hodgkin's lymphoma	380
AT	380
Hodgkin's lymphoma	380
Autosomal, recessive disease	380
Ataxia	380
Chronic lymphocytic leukaemia	380
Thymic lymphoma	380
Lymphoma	380
ATM	380
Leukaemia	380
T-PLL	380
Genome instability	380
Cancer	380
Malignancies	380
CLL	380
Recessive disease	380
Mantle cell lymphoma	380
MCL	380
Ataxia telangiectasia	380
Tumour	380
Lymphoid malignancy	380
Sporadic T cell prolymphocytic leukaemia	380
Neuronal degeneration	380
Loss of heterozygosity	380
CETP	381
HDL	381
III	381
Vascular disease	381
Associated	381
Hemodialysis	381
Atherosclerosis	381
Preneoplasia	382
Ovariectomy	382
Mammary carcinoma	382
Carcinoma	382
Associated	382
Mammary hyperplasia	382
Alveolar	382
Neoplastic	382
Hyperplasia	382
Alveolar preneoplasia	382
Tumor	383
Short stature	383
Insulin-like growth	383
Growth	383
Genetic diseases	383
Classical phenylketonuria	383
Contiguous gene syndrome	383
Phenylketonuria	383
Diagnosis	383
Putative prostate cancer	384
Hereditary prostate cancer	384
HPC	384
Cancer	384
Age at diagnosis	384
Diagnosis	384
Loss of heterozygosity	384
Prostate cancer	384
Alpha	384
Autosomal dominant	385
Neurodegenerative disorder	385
Associated	385
Machado-Joseph Disease	385
Autosomal dominant neurodegenerative disorder	385
MJD	385
Disorder	385
Galactosemia	387
LA	387
D / D	387
Wild type	387
Associated	387
Galactose	387
Sensorineural deafness	388
Deafness	388
DFNB10	388
Congenital autosomal recessive sensorineural deafness	388
Non-syndromic autosomal recessive deafness	388
Recessive deafness	388
Hydrolysis	389
Ductal carcinoma of the breast 3	390
Hepatic hemosiderosis	390
Hypertension	390
Metastatic carcinomatous	390
Cirrhosis	390
Carcinoma	390
Fibrosis	390
Associated	390
Metastatic carcinoma	390
Ductal carcinoma	390
Liver failure	390
Portal hypertension	390
Carcinoma of the breast	390
Peroxisomal beta-oxidation	391
Deficient racemase	391
Deficiency and malabsorption	391
Peroxisomal 2-methylacyl-CoA racemase deficiency	391
Diagnosis	391
Plasma	391
Racemase deficiencies	391
Vitamin K deficiency	391
Deficient degradation of racemic	391
Prader-Willi	393
Prader-Willi and Angelman syndromes	393
Prader-Willi syndrome	393
PWS	393
METHODS	393
Center defects	393
AS	393
MA	393
MS	393
Angelman syndromes	393
Uniparental disomy	393
Angelman syndrome	393
UPD15	393
Uniparental disomy for chromosome 15	393
Associated	393
Genomic abnormalities	393
MS-MLPA	393
Diagnosis	393
UPD	393
Tumor	394
Metastasis	394
Neoplasms	394
Growth	394
Tumorigenicity	394
Prostate neoplasms	394
Cancer	394
LOH	394
Prostate tumors	394
Tumors	394
SCID	394
Loss of heterozygosity	394
Prostate cancer	394
Obvious	395
Cystic fibrosis	395
Myalgias	395
CF	395
Airway epithelial ion transport defect	395
Recessive disorder	395
Fibrosis	395
Fever	395
Autosomal recessive disorder	395
Disorder	395
Adenoviral dose	395
Ovarian cancer	396
ID	396
Hereditary breast and ovarian cancers	396
Cancers	396
Breast and ovarian cancers	396
Ovarian cancers	396
Cancer	396
Tumor	397
Decreased in ovarian tumors	397
Ovarian tumors	397
Growth	397
Cancers	397
APS	397
PTEN	397
Cancer	397
Tumors	397
Flow cytometry	397
METHODS	398
ALS	398
Abnormal posterior tibial nerve	398
Needle EMG	398
Amyotrophic lateral sclerosis	398
Fragile X (FRAXA) syndrome	399
FMR	399
MS	399
Fragile X	399
Mental retardation	399
Hypermethylation	399
FRAXA syndrome	399
Clonality and skewing phenomena	399
Inherited mental retardation	399
Apoptosis	400
AT	400
Ataxia	400
Recessive disorder	400
ATM	400
Ataxia telangiectasia	400
Autosomal recessive disorder	400
Disorder	400
Malarial infection	401
Malaria	401
Myoclonic features	402
Dystonic symptoms	402
Parkinsonism	402
Dystonia	402
Dystonic	402
Associated	402
Neuropathology	402
Polymorphisms in dystonia	402
Movement disorder	402
EOP	402
Disorder	402
FMF	403
Mediterranean fever	403
MEFV	403
Fever	403
Familial Mediterranean fever	403
Deficient in glucose and galactose transport activity	404
Galactose	404
Type II Gaucher disease	405
Type II	405
Type II GD	405
GD	405
Gaucher disease	405
Gaucher	405
Neurologic symptoms	405
Lysosomal storage diseases	405
Deficiency of lysosomal acid beta-glucosidase	405
Type IV	406
Mucolipidosis IV	406
ML IV	406
Mucolipidosis type IV	406
SF-1	407
SF	407
Adrenal and gonadal development	407
Friedreich ataxia	408
Apoptosis	408
Loss of dorsal root ganglia	408
Ataxia	408
Frataxin deficiency	408
Carcinoma	408
Embryonic carcinoma	408
Ganglia	408
Tumor	409
Tumor necrosis	409
Necrosis	409
TNF	409
HDAC	409
Fechtner syndrome	410
Autosomal dominant	410
Sensorineural deafness	410
Alport syndrome	410
Glomerular	410
Deafness	410
Collagen disorders	410
METHODS	410
FS	410
AS	410
AS-phenotype plus hypercholesterolaemia	410
Renal failure	410
Ocular abnormalities	410
Hypercholesterolaemia	410
Hereditary disease	410
Autosomal dominant Alport syndrome	410
METHODS	411
III	412
Von Willebrand	412
Hemorrhagic syndrome	412
COS	412
Type I	412
VWF	412
Plasma	412
GM2 gangliosidosis	413
Gangliosidosis	413
Tumor	414
Tumor necrosis	414
Anterior telencephalon	414
Necrosis	414
Xenopus laevis	414
Survival and cell death	414
Cranial ganglia	414
Ganglia	414
C4	415
PKU	416
Background abnormalities	416
Electroencephalographic findings	416
Phenylketonuria	416
Ataxia	417
ATM	417
Ataxia-telangiectasia	417
PJS	418
Peutz-Jeghers syndrome	418
Myotonic dystrophy	419
Definite congenital involvement	419
Congenital myotonic dystrophy	419
Disorder	419
Deficiency of von Willebrand	421
Bleeding disorder	421
Molecular defect	421
Autosomally inherited bleeding disorder	421
Von Willebrand	421
Associated	421
Trauma	421
Von Willebrand disease	421
VWF	421
VWD	421
Genetic lesions	421
Diagnosis	421
Disorder	421
Protein C deficiency	422
Linkage disequilibrium	422
Deficient individuals	422
Type I protein C deficiency	422
Type I	422
Thrombophilia	422
Apoptosis	423
MM	423
NM	423
Growth	423
Malignant pleural mesothelial	423
Associated	423
Cancer	423
Normal mesothelial	423
Retinitis pigmentosa	424
Retinal degeneration	424
Associated	424
Recessive retinitis pigmentosa	424
Ultrastructural improvement	424
Deficiencies of other multisubunit proteins	425
Von Willebrand	425
Von Willebrand disease type 1	425
Associated	425
Von Willebrand disease	425
Multimeric VWF	425
VWF	425
Lesch-Nyhan syndrome	426
Lesch-Nyhan	426
Total deficiency	427
C7 deficiency	427
Lupus erythematosus	427
Combined total deficiency of C7	427
Combined subtotal C6/C7 deficiency	427
Meningitis	427
Premature	427
Associated	427
Complement C7 deficiency	427
Total or subtotal deficiency	427
Subtotal C7 deficiency	427
Meningococcal meningitis	427
Systemic lupus erythematosus	427
Molecular defects	427
Prader-Willi	428
Prader-Willi syndromes	428
Developmental delays	428
Autistic	428
Skin cancer	429
Apoptosis	429
ATR	429
ATM	429
Cancer	429
UVA	429
GEF	430
Regulator of G protein signaling	430
Insulin-like growth	430
Growth	430
RGS	430
Associated	430
Guanine nucleotide exchange factor	430
Leukemia	430
Galactosaemia	431
Galactosaemic	431
Galactose	431
Type II	432
Hypochondrogenesis	432
Platyspondylic dwarfism	432
Voluminous cranium and polyhydramnios	432
Achondrogenesis II	432
Dysplasias	432
Lethal dysplasia	432
Dysplasia	432
II abnormalities	432
Diagnosis	432
Short extremities	432
Tumor	433
Biphasic tumors	433
Monophasic tumors	433
Sarcomas	433
Synovial sarcomas	433
Associated	433
Mesenchymal tumor	433
Tumors	433
Monophasic fibrous tumors	433
Synovial sarcoma	433
Muscle degeneration	434
Dystrophic	434
Truncated dystrophins	434
Muscular dystrophy	434
Duchenne muscular dystrophy	434
DMD	434
Dystrophin-deficient	434
Ovarian cancer	435
Breast cancers	435
Sporadic breast cancers	435
KD	435
BRCA1 tumour	435
Cancers	435
Breast malignancies	435
Epigenetic loss	435
Breast and ovarian cancers	435
Ovarian cancers	435
Sporadic cancers	435
Breast carcinomas	435
Breast , invasive lobular cancers	435
Cancer	435
Malignancies	435
Carcinomas	435
Ductal carcinomas	435
BRCA1 in non-familial cancers	435
Breast and ovarian cancer	435
Tumour	435
Familial breast and ovarian cancers	435
Hereditary breast and ovarian cancer	435
Familial cancers	435
Tumor	436
Wilms' tumor	436
WT	436
LOH	436
Wilms' tumors	436
Various chromosome numbers	436
WT1 abnormalities	436
Tumors	436
Ploidy	436
Loss of heterozygosity	436
Pseudodiploidy	436
Macrocephaly	437
Micrognathia	437
Psychomotor retardation	437
Trisomy 1q42-qter syndrome	437
Associated	437
Autosomal dominant	438
Short stature	438
Type II	438
Spondyloepiphyseal dysplasia congenita	438
SEDC	438
Short-limb short stature	438
Dysplasia	438
Spondyloepiphyseal dysplasia	438
Skeletal dysplasia	438
Pseudoachondroplasia	438
PSACH	438
Growth failure	439
Developmental delay	439
Microcephaly	439
Phenotypic abnormalities	439
Growth	439
Uniparental disomy	439
Postnatal growth failure	439
Maternal disomy	439
Isodisomy	439
Maternal UPD	439
Heterodisomy	439
Maternal uniparental disomy	439
Psychomotor developmental delay	439
Diagnosis	439
UPD	439
Prenatal diagnosis	439
SS	440
Associated	440
G6PD deficient	440
G6PD-deficient	440
Glucose 6-phosphate dehydrogenase deficiency	440
Anemia	440
Sickle cell anemia	440
G6PD deficiency	440
Polymicrogyria	441
Tuberous sclerosis	441
Developmental delay	441
Epileptogenic brain malformations	441
Gyral abnormality	441
XLIS	441
Infantile spasms	441
Familial occurrence	441
Agyria-pachygyria	441
Lissencephaly	441
Mental retardation	441
TS	441
Subcortical band heterotopia	441
Genetic testing	441
X-linked bilateral periventricular nodular heterotopia	441
SBH	441
Schizencephaly	441
Associated	441
Epilepsy	441
Cleft brain	441
Pachygyria	441
Autosomal recessive lissencephaly	441
Cerebellar hypoplasia	441
BPNH	441
Hypoplasia	441
Disorder	441
Prenatal lethality	441
FMF	442
Mediterranean fever	442
MEFV	442
METHODS	442
Renal disease	442
Attacks of fever	442
Recessive disorder	442
Serositis	442
Renal failure	442
Nephrotic syndrome	442
Fever	442
Associated	442
Proteinuria	442
Renal amyloidosis	442
CRI	442
Renal insufficiency	442
Amyloidosis	442
Autosomal recessive disorder	442
Diagnosis	442
Familial Mediterranean fever	442
Disorder	442
Gastroenterological diseases	443
Multiple disorders	443
METHODS	443
Spondylitis	443
AS	443
IBD	443
Hypothesis	443
Inflammatory bowel disease	443
Enteropathic spondylarthritis	443
Multiple co-disorders	443
Secondary disorders	443
Psoriasis	443
Associated	443
Secondary disorder	443
Spondyloarthritis	443
Ankylosing spondylitis	443
Iritis	443
Disorder	443
Bowel disease	443
Tumor	444
Ovarian cancer	444
Breast-ovarian	444
Breast-ovarian cancer	444
Associated	444
Chromosomal instability	444
Cancer	444
Tumors	444
Apoptosis	446
Wild type	446
Lymphoma	446
Tumor	447
Reactive hyperplasia	447
Epstein-Barr	447
Angioimmunoblastic T-cell lymphoma	447
PTL	447
Systemic disease	447
Lymphoma	447
Neoplastic T	447
Hyperplastic	447
Neoplastic	447
Hyperplasia	447
Reactive lymphoid hyperplasia	447
Diagnosis	447
AITL	447
Alloimmune thrombocytopenia	448
CB	448
HPA	448
Neonatal alloimmune thrombocytopenia	448
Wiskott-Aldrich syndrome	448
Thrombocytopenia	448
NAIT	448
Tumor	449
Breast cancer	449
Apoptosis	449
Growth	449
Hypothesis	449
Cancer	449
Prostate cancer	449
Eczema	450
Immunodeficiency disorder	450
Microthrombocytopenia	450
Immunodeficiency	450
Premature	450
WAS	450
Wiskott-Aldrich syndrome	450
Persistent thrombocytopenia	450
Disorder	450
Thrombocytopenia	450
Breast cancer	451
Ovarian cancer	451
Breast/ovarian	451
German breast/ovarian cancer	451
Breast or ovarian cancer	451
Breast/ovarian cancer	451
Cancer	451
Tumorigenesis	451
Breast and ovarian cancer	451
Diagnosis	451
Pilomatricomas	452
Fish-eye disease	453
Eye disease	453
Inherited human disorder	453
FED	453
Disorder	453
Autosomal dominant	454
Rieger syndrome	454
Axenfeld-Rieger syndrome	454
METHODS	454
Glaucoma	454
Anterior segment defects	454
Rieger Syndrome	454
Axenfeld-Rieger	454
Autosomal dominant disorder	454
Disorder	454
Extraocular anomalies	454
Eczema	455
Progressive T cell immunodeficiency	455
X-linked recessive disorder	455
US	455
Recessive disorder	455
Immunodeficiency	455
WAS	455
Donors	455
Wiskott-Aldrich syndrome	455
Wiskott-Aldrich Syndrome	455
Disorder	455
Thrombocytopenia	455
Alloimmune thrombocytopenia	456
HPA	456
Associated	456
Neonatal alloimmune thrombocytopenia	456
Donors	456
Thrombocytopenia	456
NAIT	456
Neurological disorder	457
ND	457
Ganglion cell layer	457
Retinal ganglion cell layer	457
Norrie disease	457
X-linked recessive neurological disorder	457
Outer nuclear layer	457
Disorder	457
Especially lymphoid neoplasias	458
Malignancy	458
Clonal malignancy	458
Sporadic T-cell prolymphocytic leukaemia	458
Ataxia	458
Sporadic T-PLL	458
Associated	458
ATM	458
Tumours	458
Leukaemia	458
T-PLL	458
T-cell leukaemia	458
Chromosomal instability	458
Lymphomas	458
Cancer	458
A-T	458
Tumour	458
B-NHL	458
Disorder	458
Ataxia-telangiectasia	458
Tumor	459
Hemangioblastoma	459
Solitary cerebellar hemangioblastoma	459
Von Hippel-Lindau tumor	459
Childhood cerebellar hemangioblastoma	459
Von Hippel-Lindau disease	459
Allelic loss	459
Von Hippel-Lindau	459
Von Hippel-Lindau allelic loss	459
Tumorigenesis	459
Cerebellar hemangioblastoma	459
Von Hippel-Lindau gene	459
Venous thrombosis	460
Type III protein S (PS) deficiency	460
Mesenteric venous thrombosis	460
III	460
PS	460
Associated	460
Thrombosis	460
Colorectal cancer	461
DCC	461
Cancer	461
Neuroblastoma	461
Fragile X	462
Associated	462
Fragile X syndrome	462
Female breast carcinoma	463
Breast carcinoma	463
Familial breast carcinomas	463
Carcinoma	463
Associated	463
Sporadic breast carcinomas	463
Male breast carcinoma	463
Breast carcinomas	463
Carcinomas	463
Prader-Willi	464
Prader-Willi syndrome	464
PWS	464
Adipose tissue	464
Obesity	464
AT	464
Abnormal body composition	464
Gene defects	464
Leptin receptor deficiency	464
Plasma	464
Lysosomal storage disorder	465
Mucopolysaccharidosis	465
N-acetylgalactosamine-6-sulfate sulfatase	465
IVA	465
MPS IVA	465
Autosomal recessive lysosomal storage disorder	465
Colombian MPS IVA	465
Genetic defect	465
Disorder	465
Mucopolysaccharidosis IVA	465
Tumor	466
Apoptosis	466
Growth	466
Ataxia	466
ATM	466
In ataxia telangiectasia	466
Ataxia telangiectasia	466
Glucosylceramide	467
Hydrolysis	467
Gaucher disease	467
Gaucher	467
Glucocerebrosidase	467
Papillon-Lef  vre syndrome	468
Premature	468
Palmoplantar keratoderma	468
Autosomal recessive palmoplantar keratoderma	468
Cerebellar hemisphere hypoplasia	469
Prader-Willi	469
Prader-Willi syndrome	469
Brain abnormalities	469
PWS	469
AS	469
Partial cerebellar hypoplasia	469
CNS	469
Cerebellar hypoplasia	469
Hypoplasia	469
Enzymopathy	470
Stem cell transplantations	470
Chronic myeloid leukemia	470
X-linked hemolytic enzymopathy	470
Hemolysis	470
Myeloid leukemia	470
Myeloid	470
Glucose-6-phosphate dehydrogenase deficiency	470
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	470
G6PD deficient	470
SCT	470
CML	470
Leukemia	470
Donors	470
G6PD deficiency	470
Tumor	471
Metastasis	471
RCCs	471
Sporadic renal cell carcinomas	471
VHL tumor	471
Renal cell carcinoma	471
Von Hippel-Lindau disease	471
Hypermethylation	471
RCC	471
Carcinoma	471
Sporadic renal cell carcinoma	471
Allelic loss	471
Von Hippel-Lindau	471
LOH	471
Renal cell carcinomas	471
Carcinomas	471
Tumorigenesis	471
Cell carcinoma	471
VHL	471
Congenital chloride diarrhea	472
HNPCC	474
Colorectal cancer	474
Polyposis	474
Associated	474
Hereditary non-polyposis colorectal cancer	474
APC	474
Absence of cancer	474
Cancer	474
Canadian hereditary non-polyposis colorectal cancer	474
HPA	475
Breast cancer	476
Ataxia	476
ATM	476
Cancer	476
A-T	476
Ataxia telangiectasia	476
Very-long-chain acyl-CoA dehydrogenase deficiency	477
Neurodegenerative disorder	478
Insulin-dependent diabetes mellitus	478
OMIM	478
Wolfram syndrome	478
Non-immune insulin-dependent diabetes mellitus	478
Associated	478
Autosomal recessive neurodegenerative disorder	478
BAC	478
Diabetes mellitus	478
WFS	478
Insulin-dependent diabetes	478
Optic atrophy	478
Disorder	478
Atrophy	478
HH	479
Cancer	479
Hemochromatosis	479
Hereditary hemochromatosis	479
Hypercholesterolemia	480
Autosomal-dominant familial hypercholesterolemia	480
Familial hypercholesterolemia	480
Autosomal dominant	481
Iris hypoplasia	481
METHODS	481
Panocular eye condition	481
Premature	481
Familial aniridia	481
Aniridia	481
Aniridic	481
Hypoplasia	481
Posterior eye defects	481
MMDM	483
III	483
Insulin-dependent diabetes mellitus	483
NIDDM	483
Associated	483
Class III	483
IDDM	483
Autoimmune	483
Diabetes mellitus	483
Insulin-dependent diabetes	483
Polygenic disorder	483
Malnutrition-modulated diabetes mellitus	483
Non-insulin-dependent diabetes mellitus	483
Disorder	483
Chromophobe renal cell carcinomas	484
Sporadic renal cell carcinomas	484
HD	484
Renal oncocytomas	484
Renal cell carcinoma	484
Non-papillary renal cell carcinoma	484
Carcinoma	484
Associated	484
Heteroduplex	484
Tumours	484
Renal cell carcinomas	484
Carcinomas	484
Papillary renal cell tumours	484
Cell carcinoma	484
Non-papillary renal cell carcinomas	484
VHL	484
Arrhythmias	485
Genetic abnormality	485
METHODS	485
Myotonic dystrophy	485
Conduction disturbances	485
Neurologic disease	485
QRS	485
Myopathy	485
Cardiac	485
Genetic testing	485
Arrhythmia	485
Cardiac conduction involvement	485
Cardiac conduction	485
Diagnosis	485
Cardiac myopathy	485
Cardiac involvement	485
Tumor	486
Hypoxia	486
Growth	486
Renal cell carcinoma	486
Von Hippel-Lindau (VHL) tumor	486
Carcinoma	486
Associated	486
VHL-mediated hypoxia	486
Von Hippel-Lindau	486
Tumors	486
Renal carcinoma	486
PVHL-deficient	486
Cell carcinoma	486
VHL	486
Autosomal dominant	487
Cleft lip, or palate	487
Van der Woude syndrome	487
VWS	487
Autosomal dominant craniofacial syndrome	487
Congenital pits and sinuses in the lower lip together	487
Stria vascularis	488
Sensorineural deafness	488
Deafness	488
Hearing loss	488
Mental retardation	488
X-linked recessive syndrome of blindness	488
Norrie disease	488
Blindness	488
Vascular defects	488
PMD	489
Leukodystrophy	489
Associated	489
X-linked leukodystrophy	489
Oligodendrocyte cell death	489
COS	489
Pelizaeus-Merzbacher disease	489
Plasma	489
Tumor	490
Rb	490
CCAAT	490
Retinoblastoma	490
Enhancer	490
Retinoblastoma (Rb) tumor	490
Alpha	490
Associated	491
Anxiety	491
Bipolar disorder	491
Psychiatric disorders	491
Disorder	491
SF-1	492
AF	492
SF	492
Associated	492
Adrenal and gonadal development	492
Bacterial infections	493
ALPS	493
Autoimmune lymphoproliferative syndrome	493
Apoptosis	493
Humoral immunodeficiency	493
Meningitis	493
Lymphadenopathy	493
Pneumococcal meningitis	493
Immunodeficiency	493
Associated	493
Gammopathy	493
Autoimmune	493
Splenomegaly	493
Monoclonal gammopathy	493
Autosomal dominant	494
Nonsyndromic hearing impairment	494
Autosomal dominant nonsyndromic hearing impairment	494
Associated	494
Autosomal dominant hearing impairment	494
Developmental delay	495
Growth	495
Craniofacial and limb anomalies	495
Chotzen syndrome	495
Craniosynostosis	495
Saethre-Chotzen syndrome	495
Craniosynostosis syndromes	495
Common craniosynostosis syndrome	495
Diagnosis	495
Limb anomalies	495
Disorder	495
Linkage disequilibrium	496
LD	496
Genetic mapping	496
Schizophrenia	496
Bipolar disorder	496
BP-I	496
Psychiatric disorders	496
Disorder	496
Deficiency of hepatic phenylalanine hydroxylase	497
PKU	497
Adenoviral vectors	497
Classical phenylketonuria	497
Recessive disorder	497
A deficiency	497
Phenylketonuria	497
Autosomal recessive disorder	497
Disorder	497
Opsonic defects	498
Immunodeificency	499
Eczema	499
X-linked recessive immunodeficiency	499
Immunodeficiency	499
Premature	499
Associated	499
WASP	499
WAS	499
Wiskott-Aldrich syndrome	499
Wiskott-Aldrich Syndrome	499
Thrombocytopenia	499
Tumor	500
Human disease	500
Growth	500
Ataxia	500
Behavioral abnormalities	500
Meiotic failure	500
Thymic lymphoma	500
Lymphoma	500
ATM	500
Growth retardation	500
Immune defects	500
Lymphomas	500
Thymic lymphomas	500
Growth-retarded	500
Ataxia-telangiectasia	500
Tumor	501
Frasier syndrome	501
Wilms tumor	501
Catalytic efficiency	502
Tumorigenesis	502
Hispanic	502
Breast cancer	503
Ovarian cancer	503
Male breast cancer	503
Breast / ovarian cancer	503
Inherited breast / ovarian cancer	503
Cancer	503
Breast and / or ovarian cancer	503
Tumor	504
Glioma	504
Several other extracellular proteins from rodents	504
Myopathy	504
Hereditary inclusion body myopathy	504
SCP	504
MC	505
WASP	505
Intracellular WAS	505
WAS	505
Wiskott-Aldrich syndrome	505
Diagnosis	505
FCM	505
WAGR syndrome	506
Genitourinary anomalies	506
Complete WAGR syndrome	506
Mental retardation	506
WAGR	506
WAGR anomalies	506
Hypospadias	506
Aniridia	506
Tumour	506
Wilms tumour	506
Bernard-Soulier syndromes	507
Such disorders	507
Familial thrombocytopenias	507
OBJECTIVES	507
Thrombocytopenias	507
Sebastian, Fetchner, and Epstein syndromes	507
Inherited thrombocytopenias	507
May-Hegglin anomaly	507
Thrombocytopenia	507
Familial or sporadic bilateral retinoblastoma	509
Hereditary retinoblastoma	509
Bilateral retinoblastoma	509
Retinoblastoma	509
Hyperlipidaemia	510
Tumor	511
Von Hippel-Lindau tumor	511
Apoptosis	511
Renal cancer	511
VHL-mediated renal tumor	511
Von Hippel-Lindau disease	511
Cancers	511
Von Hippel-Lindau	511
Cancer	511
Clear-cell renal cancer	511
Renal tumor	511
Renal cancers	511
VHL	511
Tumor	512
Rhabdomyosarcoma	512
Apoptosis	512
Growth	512
RB	512
RMS	512
Associated	512
Alveolar	512
Allelic loss	512
Soft tissue tumors	512
Behavior	512
ARMS	512
Tumors	512
HH	513
Iron deficiency	513
Hemochromatosis	513
Genetic defect	513
Plasma	513
Hereditary hemochromatosis	513
Myasthenia gravis	514
Obesity	515
METHODS	515
Hearing loss	515
Insulin-dependent diabetes mellitus	515
Recessive disorder	515
Alstr  m syndrome	515
Hyperglycemia	515
Renal failure	515
Genetic criteria	515
Nephropathy	515
Pigmentary degeneration	515
Sensorineural hearing loss	515
Diabetes mellitus	515
Blindness	515
Hyperinsulinism	515
Insulin-dependent diabetes	515
Blindness, hearing loss	515
Autosomal recessive disorder	515
Criteria	515
Non-insulin-dependent diabetes mellitus	515
Diagnosis	515
Disorder	515
Chronic nephropathy	515
Tumor	516
SF-1	516
Wilms' tumor	516
SF	516
Associated	516
Pseudohermaphroditism	516
Denys-Drash syndrome	516
MIS	516
Wilms tumor	516
Diagnostic criteria	517
Ataxia	517
Frataxin deficiency	517
Sporadic degenerative ataxia	517
Mitochondrial dysfunction	517
Axonal degeneration, and cell death	517
Associated	517
Deficiency of frataxin	517
Molecular testing	517
Tendon reflexes	517
Friedreich's ataxia	517
Inherited ataxia	517
Criteria	517
Apoptosis	518
AT	518
Growth	518
Ataxia	518
ATM	518
Cancer	518
Growth defect	518
Increased cancer	518
Ataxia-telangiectasia	518
METHODS	519
Associated	519
Plasma	519
Tumor	520
Breast cancer	520
Breast cancers	520
METHODS	520
Sporadic breast cancers	520
Cancers	520
Gland tumors	520
Cancer	520
LOH	520
Tumors	520
Haploinsufficiency in breast carcinogenesis	520
Loss of heterozygosity	520
Familial breast cancers	520
Autosomal dominant	521
Short stature	521
Type II	521
Multiple epiphyseal dysplasia	521
Premature	521
Dysplasia	521
Spondyloepiphyseal dysplasia	521
SED	521
Arthropathy	521
Disorder	521
Activation-induced cell death	522
Apoptosis	522
TNF	522
CCALD	523
Major X-ALD	523
ALMN	523
Adrenomyeloneuropathy	523
Wiley-Liss	523
X-ALD	523
Demyelination	523
X-linked adrenoleukodystrophy	523
CBS	523
Cerebral demyelination	523
ALD	523
AMN	523
CNS demyelination	523
Adrenoleukomyeloneuropathy	523
Cystathionine beta-synthase	523
CNS	523
Adrenoleukodystrophy	523
Confluent cerebral demyelination	523
Neurodegeneration	523
Skin and genital anomalies	524
Autosomal dominant	524
Cleft lip or palate	524
Cleft lip and palate	524
PPS	524
Medial edge of the fusing palate	524
Van der Woude syndrome	524
OMIM	524
Van der Woude and popliteal pterygium syndromes	524
Lip pits	524
Popliteal pterygium syndrome	524
Genitalia	524
VWS	524
Disorder	524
Alpha	524
Complete deficiency of C9	525
C9 deficiency	525
C9-deficient	525
Hypothesis	526
Neuropathic	526
Behavior	526
Alpha	526
Inherited C9 deficiency	527
Neisseria infections	527
C9 deficiency	527
Deficiency of terminal complement	527
Associated	527
Neisseria	527
Associated	528
Tumours	528
Malignant Rhabdoid Tumours	528
Tumour	528
MRT	528
AT	529
MM	529
PI	529
SS	529
SZ	529
DBS	529
Dried blood spot	529
Alpha	529
Cerebrotendinous xanthomatosis	530
Xanthomatosis	530
Autosomal dominant	531
Hypothalamus	531
Neurohypophyseal diabetes insipidus	531
Hypothesis	531
Autosomal dominant neurohypophyseal diabetes insipidus	531
Associated	531
Deficiency of the hormone arginine vasopressin	531
ADNDI	531
Inherited disease	531
Diabetes insipidus	531
C2 deficiency	533
Connective tissue disorders	533
Factor B and C2 deficiency	533
Deficiency of the second component of complement	533
Breast cancer	534
Gastric carcinoma	534
Breast and stomach cancers	534
Global cancer	534
Lung cancer	534
Cancers	534
Carcinoma	534
Associated	534
Stomach cancer	534
Male stomach cancer	534
Malignant tumour	534
Cancer	534
Tumour	534
Criteria	534
Cancer ranks second to lung cancer	534
Female breast cancer	534
Hereditary diffuse gastric carcinoma	534
HDCG	534
Fragile X	535
Behavior	535
Fragile X syndrome	535
Ataxia	536
Radiosensitivity	536
ATM	536
Deficiency of A-T	536
Cancer	536
Autosomal recessive disease	536
A-T	536
Recessive disease	536
A deficiency	536
UV-sensitive A-T	536
Ataxia-telangiectasia	536
Spasticity	537
Spasticity of the legs	537
XLMR	537
Genetic abnormality	537
X-linked mental retardation	537
DM	537
MR	537
Mental retardation	537
Ataxia	537
PRTS	537
Weakness	537
Facial muscle weakness	537
Dystonic	537
Dysarthria	537
Dysdiadochokinesis	537
Partington syndrome	537
Cerebellar involvement	537
Dystonic movements	537
Behavior	537
Neurological symptoms	537
Moderate mental retardation	537
Neurological features	537
Muscle weakness	537
Medium chain acyl CoA dehydrogenase (MCAD) deficiency	538
Hepatomegaly	538
Hypotonia	538
Carnitine/acylcarnitine translocase deficiency	538
Persistent hypoglycemia	538
Mass spectrometry	538
Medium	538
Acidosis	538
Episodes	538
OMIM	538
Cardiac	538
Cardiac decompensations	538
Cardiac arrest	538
Carnitine deficiency	538
Metabolic acidosis	538
Hypocalcemia	538
MCADD	538
Dilated cardiomyopathy	538
Progressive dyspnea	538
Cardiomyopathy	538
Hypoglycemia	538
Chromatography	538
Hyperkalemia	538
Anemia	538
Generalized hypotonia	538
Plasma	538
MPS VII	539
GUS	539
Mucopolysaccharidosis	539
Deficiency of beta-glucuronidase	539
Mucopolysaccharidosis VII	539
Sly syndrome	539
Associated	539
A deficiency	539
VII	539
Glycosaminoglycans	539
Breast cancer	540
Ovarian cancer	540
Neoplasms	540
Breast/ovarian	540
Breast or ovarian cancer	540
Breast and/or ovarian cancer	540
Associated	540
Breast/ovarian cancer	540
Cancer	540
Age at diagnosis	540
Diagnosis	540
Tumor	541
HBs	541
METHODS	541
HB	541
VHL tumor	541
Von hippel-lindau mutations	541
Von Hippel-Lindau (VHL) disease	541
Von Hippel-Lindau	541
Tumorigenesis	541
Tumors	541
Criteria	541
Hemangioblastomas	541
VHL	541
BH4-responsive PAH deficiency	542
Deficiency of phenylalanine hydroxylase	542
HPA	542
PAH deficiency	542
Hyperphenylalaninemia	542
A deficiency	542
Genetic lesions	542
Dyslipidemia	543
HDL	543
Adipose tissue	543
III	543
Atherogenic syndrome	543
Hydrolysis	543
Endothelial dysfunction	543
Hypertension	543
Premature	543
CAD	543
Familial combined hyperlipidemia	543
Metabolic abnormalities	543
Hyperlipidemia	543
Cholesterol ester transfer protein, and hepatic lipase	543
Coronary artery disease	543
Hyperapobetalipoproteinemia	543
Atherosclerosis	543
Metabolic syndrome	543
Hypertriglyceridemia	543
Familial dyslipidemic hypertension, and syndrome X	543
Diagnosis	543
LDL and the dyslipidemia	543
Plasma	543
Retinoschisis	544
Pelizaeus-Merzbacher disease	545
Diagnosis	545
Prenatal diagnosis	545
Idiopathic CD4+ T lymphocytopenia	546
CD4+ T lymphocytopenia	546
ICL	546
Chronic mucocutaneous candidiasis	546
Ulcerous lesions	546
Immunodeficiency	546
Recurrent panlymphocytopenia	546
CMC	546
Non-endometrioid endometrial carcinomas	547
Microsatellite instability	547
Hypermethylation	547
EECs	547
RAS	547
Associated	547
APC	547
Cancer	547
Endometrioid endometrial carcinomas	547
LOH	547
Carcinomas	547
ECs	547
Endometrial carcinomas	547
Endometrioid	547
Loss of heterozygosity	547
NEECs	547
Endometrial cancer	547
Inherited storage disease	548
Deficiency of arylsulfatase A	548
Leukodystrophy	548
Metachromatic leukodystrophy	548
MLD	548
Hereditary disease	549
Breast cancer	551
Ovarian cancer	551
METHODS	551
Associated	551
Cancer	551
WT	552
Tumour	552
Wilms tumour	552
Haemolytic effects	553
G6PD-deficient	553
Haemolysis	553
Alpha-galactosidase	554
Alpha-galactosidase A	554
METHODS	554
Microvascular diseases	554
Catabolism	554
Kidney disease	554
Diagnosis	554
X-linked recessive inborn error of glycosphingolipid catabolism	554
Fabry's disease	554
Alpha	554
HALP	555
CETP	555
HDL	555
Hyperalphalipoproteinemia	555
CETP deficiency	555
Cholesteryl ester transfer protein (CETP) deficiency	555
Plasma	555
Genomic instability	556
Associated	556
Recessive genetic disorder	556
Genetic disorder	556
LOH	556
Malignancies	556
Nijmegen breakage syndrome	556
Disorder	556
Neurological dysfunction	557
Lesch-Nyhan syndrome	557
Uric acid nephrolithiasis	557
Hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiency	557
Neurological manifestation	557
Lesch-Nyhan	557
Kelley-Seegmiller syndrome	557
HPRT deficient	557
Choreoathetosis	557
Neurologic impairment	557
Associated	557
Complete hypoxanthine-guanine phosphoribosyltransferase deficiency	557
Nephrolithiasis	557
Hyperuricemia	557
HPRT deficiency	557
Motor impairment	557
Lesch Nyhan disease	557
G6PD deficiency	557
Tumor	558
Genetic information	558
AT	558
Essential multifunctional protein	558
AT-like" disorder	558
Disorder	558
Prader-Willi	559
Insulin-like growth	559
Albright hereditary osteodystrophy	559
Growth	559
Angelman syndromes	559
Russell-Silver syndrome	559
Prader-Willi/Angelman syndromes	559
Beckwith-Wiedemann syndrome	559
Wiedemann syndrome	559
Malignancies	559
Loss of heterozygosity	559
Meningococcal infection	560
Complement deficiencies	560
C4	560
Complement deficiency	560
Associated	560
C7-deficient	560
Systemic meningococcal infection	560
Meningococcal disease	560
Deficiency of the seventh component of complement	560
Ataxia	561
Associated	561
ATM	561
A-T	561
Cerebellar ataxia	561
Ataxia-telangiectasia	561
Spinal deformity	562
Dysautonomia	562
St  ve-Wiedemann syndrome	562
Skeletal abnormalities	562
Ve-Wiedemann syndrome	562
Wiedemann syndrome	562
Neurological symptoms	562
Malaria infections	563
Control malaria infections	563
Antimalarial drugs	563
Malaria	563
Widespread disease	563
Clearing malaria	563
Endocytosis	565
Iron deficiency	565
Hemochromatosis	565
Plasma	565
Tumor	566
Canceration	566
PJS	566
Autosomal dominantly inherited disease	566
PJS and their cancerations	566
Cancerous	566
Premature	566
Chromatography	566
Peutz-Jeghers syndrome	566
Polyps	566
Inherited disease	566
Hypothalamus	567
XY	567
Adrenal failure	567
Ventromedial hypothalamus	567
Pituitary gonadotroph	567
Apoptosis	568
Ataxia	568
Treatment of human tumours	568
Associated	568
Tumours	568
T-cell lymphomas	568
Lymphomas	568
Cancer	568
Tumorigenesis	568
Tumour	568
Li-Fraumeni syndrome	568
Ataxia-telangiectasia	568
Hepatocellular carcinoma	569
HCV	569
HCC	569
Chronic hepatitis	569
Virus-infected	569
Liver cancer	569
Cirrhosis	569
Carcinoma	569
Chronic liver disease	569
Hepatitis	569
Liver disease	569
Cirrhosis and 91 hepatocellular carcinoma	569
Cancer	569
Donors	569
Age at diagnosis	569
Diagnosis	569
Mass spectrometry	570
CD	570
Circular dichroism	570
Alpha	570
HNPCC	571
Inherited cancer predisposition syndrome	571
Colorectal cancer	571
Polyposis	571
Associated	571
Hereditary non-polyposis colorectal cancer	571
Cancer	571
CRC	571
Age at diagnosis	571
Increased cancer	571
Diagnosis	571
TCM syndrome	572
METHODS	572
WD	572
Wilson disease	572
Syndrome of "spondylo-epi-metaphyseal dysplasia	573
Obvious	573
Facial malformation	573
New syndrome	573
Hypertrophied acetabular bones	573
Bone dysplasia	573
Spondylo-meta-epiphyseal dysplasia	573
Premature	573
Dysplasia	573
Metaphyseal dysplasia	573
Metatropic dysplasia	573
Mental decline	574
METHODS	574
Schizophrenia-like behavioral abnormalities	574
Leukodystrophy	574
Ataxia	574
Metachromatic leukodystrophy	574
Behavioral abnormalities	574
Schizophrenia	574
Mental disturbance	574
Social dysfunction	574
Progressive gait disturbance	574
Motor deficits	574
Cerebellar ataxia	574
MLD	574
Tumor	575
Ovarian-specific tumor	575
Ploidy	575
Bilateral gonadectomy	576
Tumor	576
Glomerular	576
Frasier syndrome	576
FSGS	576
METHODS	576
Segmental glomerular sclerosis	576
Related disorders	576
Renal disease	576
XY	576
Eleven tumors	576
Gonadoblastoma	576
Tissue tumor	576
Nephropathy	576
Drash or Frasier syndrome	576
Bladder papilloma	576
ESRD	576
Female genitalia	576
Genitalia	576
Wilms' tumors	576
DMS	576
Tumors	576
Mesangial sclerosis	576
End-stage renal disease	576
Hemophilia B	577
Hemophilia	577
OCD	578
Neurologic condition	578
Neurologic disorders	578
Chronic psychiatric disease	578
Fragile X	578
Associated	578
Psychiatric disease	578
Speech impairment	578
FRAXE	578
Disorder	578
Obsessive-compulsive disorder	578
Cognitive dysfunction	579
Myotonic dystrophy	579
DM	579
Associated	579
DMPK	579
Neurodegenerative disorder	580
Adrenomyeloneuropathy	580
Addison disease	580
X-linked adrenoleukodystrophy	580
Adrenoleukodystrophy	580
Disorder	580
Chemosensory dependence	581
Gorillas	581
Von Hippel-Lindau ( VHL ) disease	584
Haemangioblastomas	584
Haemangioblastoma	584
Von Hippel-Lindau disease tumour	584
Growth	584
Renal cell carcinoma	584
Hypothesis	584
Von Hippel-Lindau disease	584
Carcinoma	584
Sporadic renal cell carcinoma	584
Central nervous system	584
Phaeochromocytoma	584
Von Hippel-Lindau	584
Tumour	584
Cell carcinoma	584
VHL	584
Apoptosis	585
Growth	585
Ataxia	585
Paradoxically deficient	585
Wild type	585
ATM	585
Clonogenic lethality	585
Ataxia telangiectasia	585
DSB	585
Activates ataxia telangiectasia	585
Canavan disease	586
Inherited leukodystrophy	586
Leukodystrophy	586
COS	586
Enzyme deficiency	586
Familial hypobetalipoproteinemia	587
FHBL	587
Hypobetalipoproteinemia	587
Plasma	587
Friedreich ataxia	588
Ataxia	588
FRDA	588
METHODS	589
Associated	589
OBJECTIVES	589
Hemochromatosis	589
Donors	589
EDMD	590
Temporal delays	590
Emery-Dreifuss muscular dystrophy	590
Hypothesis	590
Cardiac	590
Associated	590
Muscular dystrophies	590
Dilated cardiomyopathy	590
Cardiomyopathy	590
Muscular dystrophy	590
Sarcolemma	590
Cardiac conduction	590
Cardiac conduction defect	590
Neuromuscular degenerative condition	590
Familial adenomatous polyposis	591
Hepatoblastoma	591
Adenomatous polyposis coli	591
METHODS	591
Classical adenomatous polyposis	591
Adenomatous	591
Colorectal cancers	591
Medullablastoma	591
Cancers	591
Polyposis	591
Associated	591
OBJECTIVES	591
Osteomas	591
APC	591
Adenomatous polyposis	591
Hyperplastic	591
Cancer	591
Gland polyposis	591
Hereditary mixed polyposis syndrome	591
Fundic gland polyposis	591
Age at diagnosis	591
HMPS	591
FAP	591
MYH	591
Polyposis coli	591
Diagnosis	591
Polyps	591
FHBL	592
Upper gastrointestinal endoscopy	592
Familial hypobetalipoproteinaemia	592
Vitamin E deficiency	592
Familial heterozygous hypobetalipoproteinaemia	592
Diagnosis	592
PKU	593
Phenylketonuria	593
Tumor	594
Superficial fibrosarcoma	594
Malignancy	594
DP	594
Chromosomal abnormalities	594
Fibroblastoma	594
Fibrosarcoma	594
Associated	594
Bednar tumor	594
Neoplasm	594
Dermatofibrosarcoma protuberans	594
Dermatofibrosarcoma protuberans family of tumors	594
Tumors	594
Alpha	594
CETP	595
HDL	595
METHODS	595
Atherogenic lipid profile	595
CC	595
NS	595
Hypothesis	595
Plasma	595
Autosomal dominant	596
Arrhythmias	596
Neuromuscular disorders	596
Heterogeneous disease	596
Cardiac and neuromuscular involvement	596
Quadriceps muscle myopathy	596
Conduction defects	596
Myopathy	596
Cardiac	596
Associated	596
Atrial/ventricular arrhythmias	596
Cardiac abnormalities	596
Skeletal muscle myopathy	596
Dilated cardiomyopathy	596
Conduction-system disease	596
COS	596
Cardiomyopathy	596
Ventricular arrhythmias	596
Tumor	597
Ovarian cancer	597
Malignancy	597
Apoptosis	597
Growth	597
Cancers	597
Associated	597
Brca1-deficiency	597
Cancer	597
Breast and ovarian cancer	597
METHODS	598
Hodgkin's lymphoma	598
RA	598
Rheumatoid arthritis	598
Rheumatic disease	598
Lymphoma	598
Childhood cancer	598
Malignant lymphomas	598
Lymphomas	598
Cancer	598
Arthritis	598
French melanoma	599
Melanoma	599
Autosomal dominant	600
Neuromuscular disease	600
Multisystem disorder	600
Myotonic dystrophy	600
DM	600
Autosomal dominant multisystem disorder	600
Associated	600
Dystrophia myotonica	600
DMPK	600
Hereditary adult neuromuscular disease	600
Enhancer	600
Disorder	600
Tumor	601
Lung adenocarcinoma	601
Ovarian tumors	601
Autosomal recessive juvenile parkinsonism	601
Hypothesis	601
Parkinsonism	601
Associated	601
Malignant breast and ovarian tumors	601
Adenocarcinoma	601
Cancer	601
LOH	601
Tumors	601
Ovarian tumor	601
Loss of heterozygosity	601
Afibrinogenemia	602
METHODS	603
Iron deficiency	603
Oligodendrocyte precursor	604
Growth	604
OP	604
Colorectal Cancer	604
Increased OP cell death	604
DCC	604
Cancer	604
Alpha	604
Neurodegenerative disorder	605
Sachs disease	605
Tay-Sachs	605
Genetic testing	605
Tay-Sachs disease	605
Tay-Sachs Disease	605
Autosomal recessive neurodegenerative disorder	605
TSD	605
Disorder	605
Tumor	606
Immunodeficiency disease	606
Immunodeficiency	606
Cancer	606
Paroxysmal nocturnal hemoglobinuria	607
Bacterial infections	607
Bacterial infection	607
PNH	607
Hemolysis	607
Chemotactic defect	607
Symptoms of the disease	607
LAP deficiency	607
Neutropenia	607
Bacteria	607
G6PD Mediterranean-type	608
Glucose-6-phosphate dehydrogenase-deficient	608
G6PD deficient	608
G6PD deficiency	608
Antiphospholipid syndrome	609
Glomerulosclerosis	609
METHODS	609
Thrombotic vascular complications	609
Acute renal failure	609
Episodes	609
Mesangial C3 nephropathy	609
Renal failure	609
Nephrotic syndrome	609
APS	609
Associated	609
Segmental glomerulosclerosis	609
Nephropathy	609
Renal symptoms	609
Renal diseases	609
Proteinuria	609
Thrombotic	609
Glomerulonephritis	609
APS nephropathy	609
HIV	610
METHODS	610
Advanced HIV infection	610
Antenatal care	610
Malaria	610
Malaria parasitemia	610
Alpha	610
Linkage disequilibrium	611
Demographic	611
Growth	611
LD	611
Broad-range tumour	612
Breast cancer	612
Cancers	612
Gastric, and hepatocellular carcinomas	612
Hepatocellular carcinomas	612
Colon cancer	612
Cancer	612
Carcinomas	612
Tumour	612
Gastric, and 48 hepatocellular carcinomas	612
Loss of heterozygosity	612
Misdiagnosis	613
Hypotonia	613
METHODS	613
Progressive cerebellar ataxia	613
Ataxia	613
Spinocerebellar ataxia	613
Parkinsonism	613
SCA	613
Macular degeneration	613
SCA1; hyporeflexia for SCA2; nystagmus, bulging eye, and dystonia	613
Dystonia	613
Spinocerebellar ataxia types 1	613
Atypical parkinsonism	613
Cerebellar ataxia	613
SCA2	613
SCA1	613
SCA3	613
SCA6	613
Optic atrophy	613
System atrophy	613
Diagnosis	613
Atrophy	613
Lesch-Nyhan syndrome	614
Mass spectrometry	614
CV	614
Lesch-Nyhan	614
SD	614
Nephrolithiasis	614
LNS	614
Chromatography	614
Behavior	614
HPRT dysfunction	614
Diagnosis	614
Tumor	615
Microsatellite instability	615
Microsatellite stable	615
Colorectal cancer	615
MSS tumor	615
Carcinoma	615
Colorectal cell lines and primary tumors	615
Colorectal tumors	615
Colorectal carcinoma	615
Cancer	615
LOH	615
Chromatography	615
Tumors	615
MSI	615
MSS	615
Loss of heterozygosity	615
Hyperammonemia	617
Tumor	618
C4	618
PI	618
Hydrolysis	618
PTEN	618
Tumors	618
Dystonia	619
Dopa-responsive dystonia	619
Autosomal dominant	620
Autosomal dominant familial neurohypophyseal diabetes insipidus	620
A rare disorder	620
Familial neurohypophyseal diabetes insipidus	620
Rare disorder	620
Neurohypophyseal diabetes insipidus	620
AdFNDI	620
Postnatal arginine vasopressin (AVP) deficiency	620
Disorder	620
Diabetes insipidus	620
AT	621
Ataxia	621
Ataxia-telangiectasia	621
Retinal detachment	622
Inferior yellow exudative retinal detachment	622
Glaucoma	622
Anomalous	622
Vascular abnormalities	622
Secondary open-angle glaucoma	622
Coats' syndrome	622
Vitrectomy, retinal reattachment	622
Coats' disease	622
Autosomal dominant	623
METHODS	623
Epilepsy	623
Autosomal dominant nocturnal frontal lobe epilepsy	623
ADNFLE	623
PKU	624
Congenital abnormalities	624
METHODS	624
Associated	624
Maternal phenylketonuria	624
Phenylketonuric	624
Phenylketonuria	624
Complex neurological syndrome	625
PMD	625
Autosomal recessive condition	625
Hypomyelination	625
Disorders of the central nervous system	625
Central nervous system	625
X-linked disorder	625
Pelizaeus-Merzbacher-like disease	625
Pelizaeus-Merzbacher disease	625
PMLD	625
Diagnosis	625
Disorder	625
METHODS	626
Spondylitis	626
AS	626
Growth	626
Associated	626
Non-parametric linkage	626
OBJECTIVES	626
Ankylosing spondylitis	626
Ankylosing Spondylitis	626
AUG	627
COS	627
Hypothesis	628
Ataxia	628
Friedreich Ataxia	628
Inherited ataxia	628
FRDA	628
ADRP	629
Autosomal dominant	629
Autosomal dominant retinitis pigmentosa	629
Photoreceptor degeneration	629
Retinitis pigmentosa	629
Degenerative diseases	629
A deficiency	629
Autosomal dominant	630
Myotonia	630
CH	630
Autosomal dominant myotonia congenita	630
Myotonia congenita	630
Inherited disorder	630
Disorder	630
Tumor	631
Malignancy	631
Ataxia	631
Cancers	631
Radiosensitivity	631
ATM	631
Autosomal recessive syndrome	631
Sporadic cancers	631
Cancer	631
A-T	631
Familial and sporadic cancers	631
Ataxia-telangiectasia	631
FMF	632
Mediterranean fever	632
MEFV	632
METHODS	632
Amyloid A	632
Fever	632
OBJECTIVES	632
Age at diagnosis	632
Diagnosis	632
Familial Mediterranean fever	632
Congenital muscular dystrophy	633
Becker muscular dystrophy	633
Growth	633
Fibrosis	633
Dystrophic	633
Associated	633
BMD	633
Muscle fibrosis	633
CMD	633
Advanced fibrosis	633
Muscular dystrophy	633
Duchenne muscular dystrophy	633
DMD	633
Sarcolemma	633
Dystrophic muscles	633
Alpha	633
METHODS	634
Photoreceptor dystrophies	634
Retinal degeneration	634
Autosomal-dominant oral facial disorder	635
Van der Woude syndrome	635
VWS	635
Disorder	635
NBS-deficient	636
CPT	636
DSB	636
NBS	636
Autosomal dominant	637
Deafness	637
Nonsyndromic hearing impairment	637
Wolfram syndrome	637
Associated	637
Diabetes mellitus	637
Psychiatric disease	637
Psychiatric diseases	637
Autosomal dominant low frequency sensorineural hearing impairment	637
LFSNHI	637
Optic atrophy	637
Autosomal recessive Wolfram syndrome	637
Diabetes insipidus	637
Atrophy	637
Immunostains	638
Tumor	638
Diffuse-type cancers	638
Gastric carcinoma	638
Adenomatous polyposis coli	638
Gastric cancer	638
Adenomatous	638
Gastric cancers	638
IM	638
Gastric carcinomas	638
Cancers	638
Polyposis	638
Carcinoma	638
Neoplastic process	638
Associated	638
Carcinoma of the distal stomach	638
Adenocarcinoma	638
Gastric mucosa	638
Adenocarcinomas	638
APC	638
Adenomatous polyposis	638
Neoplastic	638
Observed abnormalities	638
Precursor lesions	638
Cancer	638
Carcinomas	638
Tumors	638
Polyposis coli	638
Carcinoma and noninvolved mucosa	638
Intestinal metaplasia	638
Gastric adenocarcinomas	638
Familial adenomatous polyposis	639
Colorectal tumours	639
Adenomatous polyposis coli	639
Adenomatous	639
Hypothesis	639
Colorectal carcinomas	639
Colorectal cancer	639
Cancers	639
Polyposis	639
Tumours	639
APC	639
Adenomatous polyposis	639
Cancer	639
Carcinomas	639
Tumorigenesis	639
Colon cancers	639
Polyposis coli	639
GBM	640
Alport syndrome	640
Glomerulosclerosis	640
Glomerular	640
FSGS	640
Retinopathy	640
Coincidental disease	640
Much less	640
X-linked Alport syndrome	640
Coincidental hematuria	640
TBMN	640
Renal impairment	640
Segmental glomerulosclerosis	640
Nephropathy	640
Proteinuria	640
Autosomal-recessive Alport syndrome	640
Glomerulonephritis	640
Diagnosis	640
Hematuria	640
Salivary glands, pancreas	641
METHODS	641
KD	641
Pancreas	641
AIMS	641
Gallbladder	641
Autosomal dominant	642
Autosomal dominant distal myopathy	642
METHODS	642
Muscle disorders	642
Myopathy	642
Weakness	642
Finger or hand extensor muscle involvement	642
Distal myopathies	642
Dilated cardiomyopathy	642
Cardiomyopathy	642
Hand or finger extensors and neck muscles	642
Idiopathic dilated cardiomyopathy	642
MPD	642
Autosomal dominant	643
AdRP	643
Autosomal dominant retinitis pigmentosa	643
RDS	643
Retinitis pigmentosa	643
Retinal degeneration	643
Fragile X	644
Huntington's disease	645
Myeloid leukemia	646
Desmoplastic small round cell tumour	646
WT	646
Juvenile granulosa cell tumour	646
Myeloid	646
Renal nephropathy	646
Tumours	646
Nephropathy	646
Cancer	646
Leukemia	646
Tumour	646
Denys-Drash syndrome	646
Kidney cancer	646
Gonadal anomaly	646
Wilms tumours	646
Childhood kidney cancer	646
Wilms tumour	646
Familial adenomatous polyposis	647
Adult cancers	647
Adenomatous	647
RB	647
Colorectal cancer	647
Cancers	647
Polyposis	647
Paediatric and adult cancers	647
Retinoblastoma	647
Tumours	647
Adenomatous polyposis	647
Colon cancer	647
DCC	647
Familial adenomatous polyposis/colorectal cancer	647
Cancer	647
CRC	647
FAP	647
Autosomal dominant	648
Myotonic dystrophy	648
Myopathy	648
Associated	648
DMPK	648
DM1	648
Breast cancer	649
Ovarian cancer	649
Tumours	649
Breast carcinomas	649
Cancer	649
Carcinomas	649
Breast and ovarian cancer	649
Tumour	649
Breast and / or ovarian cancer	649
Familial adenomatous polyposis	650
Inherited the disease	650
Adenomatous	650
Polyposis	650
Adenomatous polyposis	650
FAP	650
Diagnosis	650
Prenatal diagnosis	650
Familial adenomatous polyposis	651
Adenomatous	651
Genetic mapping	651
Polyposis	651
Adenomatous polyposis	651
Genetic defect	651
Diagnosis	651
Tumor	652
Wilms' tumor	652
WT	652
Associated	652
Beckwith-Wiedemann syndrome	652
Wiedemann syndrome	652
Aniridia	652
Congenital disorders	652
Autosomal dominant	653
HNPCC	653
Adenomatous	653
Colorectal Cancer	653
Colorectal cancers	653
Non-polyposis Colorectal Cancer	653
Colorectal cancer	653
Dukes' A cancer	653
Cancers	653
Polyposis	653
Familial Adenomatous Polyposis	653
APC	653
Colonoscopic surveillance	653
Cancer	653
FAP	653
Diagnosis	653
Polyps	653
Prenatal diagnosis	653
Adenomatous Polyposis Coli	653
Deficiency of enzyme	654
Chronic hemolytic disease	654
Associated	654
Tumor	655
Breast cancer	655
Neoplasms	655
Wilms' tumor	655
Neurofibromatosis	655
Rb	655
Colorectal cancer	655
Cancers	655
Wider range of neoplasms	655
Retinoblastoma	655
Associated	655
Neoplastic	655
Involvement of tumor	655
Cancer	655
Excess	655
Familial cancers	655
Myopathy	656
BMD	656
X-linked muscular dystrophy	656
Muscular dystrophy	656
DMD	656
Diagnosis	656
Prenatal diagnosis	656
Particular disease	657
Familial mediterranean fever	657
Obvious	657
Mediterranean fever	657
Growth	657
Gonadic disturbances	657
Fever	657
Growth retardation	657
Amyloidosis	657
Virus infection	658
Associated	659
Leukodystrophy	660
SAP-1 deficiency	660
Murine leukemia	660
Metachromatic leukodystrophy	660
Leukemia	660
Linkage disequilibrium	661
Plasma	661
Excess	661
Alpha	661
Muscular dystrophy	662
Duchenne muscular dystrophy	662
DMD	662
Muscular atrophy	663
Immunostains	663
Congenital myopathy	663
Deficiency and unclassified limb-girdle muscular dystrophy	663
Becker muscular dystrophy	663
Limb-girdle muscular dystrophy	663
Myopathy	663
Duchenne and Becker muscular dystrophy	663
BMD	663
Muscular dystrophy	663
Duchenne muscular dystrophy	663
DMD	663
Sarcolemma	663
Diagnosis	663
Dystrophin deficiency	663
Atrophy	663
Growth	664
Dystrophin immunostaining abnormalities	665
Vastus lateralis	665
Muscular dystrophy	665
Duchenne muscular dystrophy	665
DMD	665
Muscular dystrophy	666
Duchenne muscular dystrophy	666
Cardiac rhythm disturbance	668
Cardiac	668
Malfunction	668
IVF	668
Sudden deaths	668
Idiopathic ventricular fibrillation	668
Sudden death	668
Disorder	668
Afibrinogenemia	669
Congenital afibrinogenemia	669
C4	671
Becker muscular dystrophy	672
Duchenne/Becker muscular dystrophy	672
Muscular dystrophy	672
DMD	672
Huntington disease	673
Obvious	674
Inherited diseases	674
Genetic disorders	674
Huntington disease	674
GT	675
EDMD	676
Emery-Dreifuss muscular dystrophy	676
X-linked dystrophies	676
Muscular dystrophy	676
Duchenne muscular dystrophy	676
DMD	676
Diagnosis	676
Retinoblastoma	677
Glucose-6-phosphate dehydrogenase deficiency	678
Variant color vision	679
Anomalous	679
Anomalous color vision	679
Chromosome abnormalities	680
Familial aniridia	680
Aniridia	680
Associated	681
Blindness	681
Anomaloscopic	681
G6PD deficiency	681
Developmental disorder	682
VCFS	682
Velocardiofacial syndrome	682
Heart defects	682
Conotruncal heart defects	682
Disorder	682
Craniofacial anomalies	682
Familial adenomatous polyposis	683
Pancreatic cancer	683
Adenomatous polyposis coli	683
Sporadic tumors of the colon and stomach	683
Adenomatous	683
Cancers	683
Polyposis	683
Pancreas	683
Associated	683
Sporadic (nonfamilial) renal cell carcinomas	683
Cancers of the lung and pancreas	683
Hepatocellular carcinomas	683
Role in tumors	683
APC	683
Adenomatous polyposis	683
Cancer	683
Renal cell carcinomas	683
Carcinomas	683
Pancreatic cancers	683
Tumors	683
Polyposis coli	683
C-T	684
Alpha	684
Cardiac	685
Muscular dystrophy	685
Duchenne muscular dystrophy	685
DMD	685
Diagnosis	685
Prenatal diagnosis	685
Autosomal dominant	686
AdRP	686
Autosomal dominant retinitis pigmentosa	686
RDS	686
Retinitis pigmentosa	686
Heteroduplex	686
Methemoglobinemia	688
Hemolysis	688
Intravascular hemolysis	688
G6PD deficiency	688
Medium	689
Isovaleric acidemia	690
Molecular defects	690
PKU	691
Biochemical abnormalities	691
Growth	691
Intrauterine growth retardation	691
Nonphenylketonuric	691
Enlarged cerebral ventricles	691
Growth retardation	691
Esophageal atresia	691
Congenital anomalies	691
Mentally retarded	691
Comparison of phenylketonuric	691
Hypoplasia	691
Phenylketonuric	691
Phenylketonuria	691
Autosomal dominant	692
Vitreoretinochoroidopathy	692
Koro syndrome	693
A syndrome	693
Associated	694
Hereditary breast cancer	695
Breast cancer	695
BRCA2 tumors	695
Breast cancers	695
Sporadic breast cancers	695
BRCA1 tumors	695
Genetic testing	695
Cancers	695
Associated	695
Breast carcinomas	695
Cancer	695
Carcinomas	695
Ductal carcinomas	695
Tumors	695
Tumoral	695
Familial breast cancers	695
Maple syrup urine disease	696
Autosomal recessive inborn error	696
MSUD	696
Autosomal recessive inborn error disorder	696
Neurometabolic disease	696
Disorder	696
Autosomal dominant	697
Hypothesis	697
Coronal synostosis	697
Autosomal dominant condition	697
Hypertelorism	697
Ptosis	697
Chotzen syndrome	697
Craniosynostosis	697
Saethre-Chotzen syndrome	697
Brachycephaly	697
Limb anomalies	697
Human disease	698
Growth	698
Fragile X	698
Mental retardation	698
FRAXE syndrome	698
MEK	698
Fragile X syndrome	698
MAP	698
Mental retardation disorder	698
FRAXE	698
FRAXE mental retardation syndrome	698
Disorder	698
Autosomal dominant	699
Isolated axoplasm	699
Autosomal dominant neurodegenerative diseases	699
Neurodegenerative diseases	699
Essential cellular process	699
Ataxia	700
Friedreich's ataxia	700
Attenuated phenotypes	701
GM2 gangliosidosis	701
Gangliosidosis	701
Alpha	701
Myotonic dystrophy	702
DM	702
Associated	702
DMPK	702
Tumor	703
Adenomatous polyposis coli	703
Adenomatous	703
Colorectal cancer	703
Colorectal tumorigenesis	703
Polyposis	703
APC	703
Adenomatous polyposis	703
Cancer	703
Tumorigenesis	703
Polyposis coli	703
METHODS	704
DD	704
Abnormalities of retinal vascular	704
Vascular abnormalities	704
Capillaries, multiple aneurysms	704
Choroidial vascular	704
Bilateral coats disease	704
Coats disease	704
Fundus fluorescein angiography	704
FFA	704
Myotonic dystrophy	705
Fragile X	705
Fragile X syndrome	705
WD	706
Hypercholesterolemic	707
MDA	707
MDA-LDL concentration	707
Malondialdehyde	707
FMF	708
Autoinflammatory periodic disorder	708
Mediterranean fever	708
MEFV	708
METHODS	708
Fever	708
Familial Mediterranean Fever	708
Familial Mediterranean fever	708
Disorder	708
N-acetylgalactosamine-6-sulfate sulfatase deficiency	709
Mucopolysaccharidosis	709
KS	709
N-acetylgalactosamine-6-sulfate sulfatase	709
Recessive disorder	709
IVA	709
Deficiency of N-acetylgalactosamine-6-sulfate sulfatase	709
Renal tubular epithelial	709
Deficiency of N	709
A deficiency	709
Autosomal recessive disorder	709
Keratan sulfate	709
Morquio A disease	709
Disorder	709
Mucopolysaccharidosis IVA	709
Apoptosis	710
Corneal dystrophy	710
CTX	710
Chromatography	710
Cerebrotendinous xanthomatosis	710
Plasma	710
Xanthomatosis	710
Tumor	711
GC	711
Growth	711
Associated	711
MEK	711
Gastric diseases	711
Heterogeneous disease	712
PC	712
Hereditary prostate cancer	712
HPC	712
Brain cancer	712
Cancer	712
Prostate cancer	712
Malignant diseases	713
XLT	713
Microthrombocytopenia	713
Immunodeficiency	713
WASP	713
Autoimmune	713
Atopic dermatitis	713
FINDINGS	713
WAS	713
X-linked thrombocytopenia	713
Pathogenesis of the syndrome	713
Thrombopoiesis	713
Wiskott-Aldrich syndrome	713
Thrombocytopenia	713
Chronic microthrombocytopenia	713
Breast cancer	714
Ovarian cancer	714
METHODS	714
Ataxia	714
Associated	714
ATM	714
Cancer	714
Breast and ovarian cancer	714
Tumour	714
Ataxia-telangiectasia	714
Retinoblastoma	715
Hypotonia	716
Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency	716
VLCAD deficiency	716
Continuous cervical muscular exercise	716
Early infancy	716
Weakness	716
Hyper-creatine kinasemia	716
Persistent hypertonicity of the cervical muscles	716
Diagnosis	716
Muscle weakness	716
Disorder	716
Very-long-chain Acyl-CoA dehydrogenase deficiency	716
PKU	717
Wechsler Adult Intelligence Scale	717
METHODS	717
Maternal phenylketonuria	717
Hyperphenylalaninemia	717
Maternal phenylketonuria outcome	717
MHP	717
Phenylketonuria	717
Machado-Joseph disease	718
Spinocerebellar ataxia type 3	718
Neurodegenerative disorder	718
Ataxia	718
Spinocerebellar ataxia	718
Machado-Joseph disease/spinocerebellar ataxia type 3	718
Circular dichroism	718
Disorder	718
Hypothalamus	719
Complete deficiency of AVP	719
Insulin-like growth	719
Brattleboro rats	719
Growth	719
Associated	719
Hypertonic saline injection	719
Neuroendocrine disease	719
Central nervous system	719
Growth retardation	719
CDI	719
Neuroendocrine diseases	719
Plasma	719
Diabetes insipidus	719
Tumor	720
Devastating disease	720
Apoptosis	720
Prostatic adenocarcinoma	720
Tumorigenicity	720
Prostate carcinomas	720
Programmed cell death	720
Carcinoma	720
Adenocarcinoma	720
Androgen independent	720
Neoplastic transformation	720
Neoplastic	720
Prostate adenocarcinoma	720
Cancer	720
Carcinomas	720
Prostate cancer	720
Prostate carcinoma	720
Male cancer	720
Spastic diplegia	721
Leukodystrophy	721
Peripheral neuropathy	721
Neuropathy	721
Associated	721
MBP	721
Dysmyelination	721
Congenital long QT syndrome	722
Arrhythmias	722
QT syndrome	722
Spontaneous ventricular fibrillation	722
Cardiac	722
Associated	722
Genetic defects	722
Brugada syndrome	722
Ventricular arrhythmias	722
Tumor	723
Apoptosis	723
Embryonic lethality	723
RCCs	724
Non-cancerous	724
None of the non-tumour	724
METHODS	724
Renal cancer	724
Dialytic kidneys	724
Renal cell carcinoma	724
Von Hippel-Lindau disease	724
Renal disease	724
RCC	724
Cancerous	724
Carcinoma	724
Tumours	724
Dialysis-specific carcinoma	724
Von Hippel-Lindau	724
Cancer	724
VHL tumour	724
Carcinomas	724
VHL disease	724
Tumour	724
Renal carcinomas	724
Cell carcinoma	724
Dialysis	724
VHL	724
End-stage renal disease	724
Becker muscular dystrophy	725
Duchenne and Becker muscular dystrophy	725
BMD	725
Muscular dystrophy	725
DMD	725
Lesch-Nyhan syndrome	726
HPRT-deficiency	726
Lesch-nyhan syndrome	726
Lesch-Nyhan	726
Additional abnormalities	726
Behavioral abnormalities	726
Associated	726
Complete hypoxanthine-guanine phosphoribosyl-transferase ( HPRT ) deficiency	726
APRT deficiency	726
Behavior	726
Prader-Willi	727
Prader-Willi syndrome	727
Hypothalamic dysfunction	727
PWS	727
Obesity	727
Central hypersomnia	727
Fever	727
Associated	727
Adrenal insufficiency	727
Death or critical illness	727
Rapid demise	727
Critical illness	727
Respiratory failure	727
Haploinsufficiency of the transcription factor FOXC1	728
Ophthalmologic abnormalities	728
Developmental defects	728
Eye anterior chamber developmental defects	728
Hearing loss	728
Growth	728
Mental retardation	728
XY	728
Associated	728
Central nervous system	728
Cerebral dysgenesis	728
Eye anomalies	728
Autosomal dominant	729
Epidermolytic hyperkeratosis	729
Autosomal dominant inherited skin disorder	729
Associated	729
Palmoplantar keratoderma	729
Behavior	729
Disorder	729
Alpha	729
X-ALD	730
ALD	730
MS	731
Multiple sclerosis	731
Progressive ataxia	732
Episodic ataxia	732
Episodic ataxia type 2	732
Episodes	732
Ataxia	732
Weakness	732
Associated	732
Epilepsy	732
Episodes of ataxia	732
Chromatography	732
Weakness accompanied the ataxia	732
Mental impairment	733
Fragile X	733
Mental retardation	733
Fragile X mental retardation	733
Fragile X syndrome	733
Enhancer	733
Neurofibromas	734
LOH-positive tumors	734
MPNSTs	734
Microsatellite instability	734
Neurofibromatosis	734
Hypermethylation	734
Benign and malignant tumors	734
Malignant tumors	734
Total of four tumors	734
LOH	734
Chromatography	734
Tumorigenesis	734
Tumors	734
MSI	734
Genetic defect	734
Malignant peripheral nerve sheath tumors	734
Loss of heterozygosity	734
Ninety-one tumors	734
Galactosemic	735
Endogenous galactose formation	735
Newborns	735
Galactose	735
Plasma	735
Spondylarthropathy	736
Autosomal dominant	736
Juvenile rheumatoid arthritis	736
Pseudorheumatoid dysplasia	736
Osteoarthritis	736
Spondyloepiphyseal dysplasias	736
Synovial chondromatosis	736
Rheumatoid arthritis	736
Dysplasias	736
Dysplasia	736
Bone dysplasias	736
Hypoplasia	736
Hypoplastic	736
Arthritis	736
Myoclonic epilepsy	737
Epilepsy syndrome	737
METHODS	737
Diagnostic criteria	737
Epilepsy	737
Genetic abnormalities	737
Criteria	737
Alpha	737
Associated	738
ABL	738
Autosomal recessive disease	738
Recessive disease	738
MTP	738
Abetalipoproteinemic	738
Abetalipoproteinemia	738
Prader-Willi	739
Prader-Willi syndrome	739
PWS	739
METHODS	739
Uniparental disomy	739
UPD15	739
Genetic defects	739
Genetic disorder	739
Basic defect	739
Maternal UPD	739
Maternal uniparental disomy	739
Diagnosis	739
Disorder	739
UPD	739
FMD	740
METHODS	740
ENOS	740
Arteriolar density	740
Genetic diseases	740
Gracilis	740
Vascular structure	740
Duchenne's muscular dystrophy	740
Duchenne'	740
Cardiac	740
Premature	740
Decreased vascular density	740
Vascular density	740
Muscular dystrophy	740
DMD	740
Dystrophin deficiency	740
Endothelial NO synthase	740
Short stature	741
X-linked spondyloepiphyseal dysplasia tarda	741
Dysplasia	741
Spondyloepiphyseal dysplasia	741
Progressive skeletal disorder	741
Disorder	741
HP	742
Associated	742
Malignant tumors	742
Autoimmune	742
Allergic illness	742
Autoimmune diseases	742
Tumors	742
Alpha	742
Tumor	743
Colorectal cancers	743
Colorectal cancer	743
Cancers	743
Cancer	743
Hereditary breast cancer	744
Breast cancer	744
Ovarian cancer	744
Male breast cancer	744
Breast / ovarian cancer	744
Inherited breast / ovarian cancer	744
Inherited breast cancer	744
Cancer	744
Familial breast cancer	744
Tumor	745
Apoptosis	745
LNCaP tumors	745
AI	745
Growth	745
Wilms' tumor	745
LNCaP tumor	745
Associated	745
Androgen independent	745
Prostate tumor	745
WT1-LNCaP tumors	745
Cancer	745
Tumors	745
Prostate cancer	745
C5 deficient	746
Amyloid deposition	746
Chronic inflammation	746
Associated	746
Secondary amyloidosis	746
C5 deficiency	746
Amyloidosis	746
Primary neurofibrosarcoma	747
Cancers	748
Breast and prostate cancers	748
Prostate cancers	748
Male map lengths	748
CRI	748
MAP	748
Friedreich ataxia	749
Ataxia	749
FRDA	749
Hereditary ataxia	749
Hemipelvectomy	750
Posterior scalp defects	751
Posterior scalp defect	751
Opitz syndrome	751
Associated	753
Galactosemia	754
Papillon-Lef  vre syndrome	755
Prepubertal periodontitis	755
PLS	755
Heterogeneous disease	755
SD	755
Palmoplantar keratosis	755
Autosomal recessive condition	755
Periodontitis	755
Autoimmune type 1 diabetes mellitus	756
Autoimmune	756
Diabetes mellitus	756
Type 1 diabetes mellitus	756
Galactosemia	757
Disorder galactosemia	757
Impacts	757
Metabolic disorder	757
Galactose	757
Disorder	757
Tumor	758
Breast cancer	758
Wild type	758
BRCA1 breast cancer tumor	758
Cancer	758
BRCA1 breast cancer	758
Fragile X	759
Mental retardation	759
Fragile X mental retardation	759
Fragile X syndrome	759
Neurobiology of the syndrome	759
Enzymopathy	760
X-linked hereditary enzymopathy	760
Mass spectrometry	760
MS	760
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	760
ARMS	760
Hereditary enzymopathy	760
Retinitis pigmentosa	761
Sectorial retinitis pigmentosa	761
Fundus albipunctatus	761
Familial mediterranean fever	762
FMF	762
Mediterranean fever	762
MEFV	762
METHODS	762
Amyloid A	762
Fever	762
Associated	762
Renal amyloidosis	762
Amyloidosis	762
Familial Mediterranean fever	762
Inherited disease	762
Alpha	762
Autosomal dominant	763
Abnormalities in brain structure	763
Anterior cerebrum volume	763
Van der Woude syndrome	763
Clefts of the lip and/or palate	763
Isolated clefts	763
Lip pits	763
Neurodevelopmental disorders	763
Cleft lip and/or palate	763
Autosomal dominant disorder	763
Volumes of the posterior cerebrum	763
VWS	763
Disorder	763
Hereditary hemmorrhagic telangiectasia	764
Autosomal dominant	764
HHT	764
Osler-Rendu-Weber syndrome	764
Autosomal dominant disease	764
Hereditary hemorrhagic telangiectasia	764
GKD	765
GK deficiency	765
Glyceroluria	765
Plasma	765
Glycerol kinase deficiency	765
Tumor	766
Endolymphatic sac (ELS) tumors	766
Neoplasia	766
METHODS	766
Hearing loss	766
Bilateral ELS lesions	766
Von Hippel-Lindau disease	766
Pancreas	766
Neoplastic process	766
Associated	766
Vestibular dysfunction	766
Von Hippel-Lindau (VHL) disease	766
Central nervous system	766
Endolymphatic sac tumors	766
Hereditary multiple-neoplasia syndrome	766
Neoplastic	766
Vestibulopathy	766
Endolymphatic dysfunction	766
Von Hippel-Lindau	766
Imbalance and aural fullness	766
ELS tumor	766
VHL disease	766
Inner ear disease	766
Tumors	766
Pheochromocytomas	766
ELS tumors	766
VHL	766
ELS	766
Complement deficiencies	767
C4	767
Complement deficiency	767
Emphasis	767
Associated	767
Diagnosis	767
Auto-immune diseases	767
METHODS	769
Mass spectrometry	769
MM	769
MS	769
Retinal layers	769
Characteristic layered cellular anatomy of the retina	769
Chromatography	769
Pigmented deposits	770
Ochronotic arthropathy	770
Bony sclerosis	770
Degenerative joint disease	770
Arthroplasty	770
Associated	770
Metabolic disorder	770
Hereditary metabolic disorder	770
Alkaptonuria	770
Arthropathy	770
Total right hip arthroplasty	770
Ochronosis	770
Total joint arthroplasty	770
Disorder	770
Gene defects	771
Cold thyroid nodules	771
Molecular defects	771
NIS	771
Plasma	771
CTNs	771
COS	772
Hypofibrinogenemia	772
Tumor	773
Tissue sarcomas	773
FSA	773
Apoptosis	773
Sarcomas	773
Vaccine-associated sarcoma	773
Growth	773
VAS tumors	773
Fibrosarcoma	773
Associated	773
Tumors	773
Soft tissue sarcomas	773
VAS	773
Soft-tissue sarcoma	773
Oculocerebrorenal syndrome	774
Lowe syndrome	774
OCRL	774
Oculocerebrorenal syndrome of Lowe	774
Abnormalities of eyes, nervous system, and kidneys	774
X-linked disorder	774
Disorder	774
X-linked disorders	775
Autistic disorder	775
Tuberous sclerosis	775
Spina bifida	775
Cytogenetic abnormalities	775
PDD	775
Developmental disorder	775
DZ	775
Mental Disorders	775
Fragile X	775
Mental retardation	775
Diagnostic criteria	775
Chromosomal abnormalities	775
Much less	775
A syndrome	775
Asperger disorder	775
Associated	775
Autistic	775
ASD	775
Epilepsy	775
Autism	775
Gene defects	775
Heritable disorder	775
Congenital anomalies	775
Cancer	775
Fragile X syndrome	775
Social disorders	775
Developmental disorders	775
Criteria	775
ASDs	775
Diagnosis	775
Rett syndrome	775
Disorder	775
Prenatal diagnosis	775
Pervasive developmental disorder	775
Familial adenomatous polyposis	776
HNPCC	776
Adenomatous	776
Hereditary nonpolyposis colorectal cancer	776
Colorectal cancer	776
Polyposis	776
APC	776
Adenomatous polyposis	776
Attenuated polypotic syndromes	776
Cancer	776
CRC	776
FAP	776
Polyps	776
Lysosomal storage disease	777
Autosomal recessive lysosomal storage disease	777
Dysmorphic gestalt	777
Hypertelorism	777
AGU	777
Aspartylglucosaminuria	777
Diagnosis	777
Myotonic dystrophy	778
DM	778
Breast cancer	779
Sporadic tumours	779
Sporadic breast cancer	779
Associated	779
High-grade tumours	779
ATM	779
Tumours	779
Cancer	779
LOH	779
Carcinomas	779
Ductal carcinomas	779
Tumour	779
DSB	779
Loss of heterozygosity	779
ALPS	780
Autoimmune lymphoproliferative syndrome	780
Apoptosis	780
Lymphadenopathy	780
Programmed cell death	780
Autoimmune	780
Splenomegaly	780
HUS	781
Associated	781
Factor H	781
Diagnosis	781
Hemolytic Uremic Syndrome	781
Sphingolipidosis	782
Gaucher disease	782
Gaucher	782
Tumor	783
Rhabdoid tumors	783
Growth	783
Malignant rhabdoid tumor	783
Retinoblastoma	783
Associated	783
Tumors	783
Malignant rhabdoid tumors	783
Pancreatic cancer	784
Venous thrombosis	784
Advanced disease	784
Protein S deficiency	784
Hereditary protein S deficiency	784
Thrombosis	784
Cancer	784
Thrombotic	784
Myotonic dystrophy	785
Neuromuscular disorder	785
WD	785
DMWD	785
DMPK	785
DM1	785
Disorder	785
Disorder of purine metabolism	786
Lesch-Nyhan syndrome	786
Hypotonia	786
Lesch-Nyhan	786
Muscular hypotonia	786
LNS	786
Diagnosis	786
Disorder	786
Comparison of human	787
Tumor	788
Hepatoblastoma	788
Malignant liver tumors	788
Hepatoblastomas	788
AFP	788
Tumorigenesis	788
Tumors	788
Alpha	788
Sensorineural deafness	789
Deafness	789
Hearing loss	789
Non-syndromic X-linked deafness	789
Congenital profound sensorineural hearing loss	789
Sensorineural hearing loss	789
Non-syndromic sensorineural deafness	789
Genetic deafness	789
X-linked deafness	789
Hereditary hearing loss	789
Sachs disease	790
Tay-Sachs	790
Hex A deficiency	790
Tay-Sachs disease	790
TSD	790
Melanoma	790
Chromatography	790
Deficiency of hex A	790
A deficiency	790
Diagnosis	790
Prenatal diagnosis	790
Tumor	791
Bilateral gonadoblastoma	791
Genetic information	791
METHODS	791
NS	791
Wilms' tumor	791
WT	791
Isolated SRNS	791
Renal disease	791
Edema	791
Genital abnormalities	791
Nephrotic syndrome	791
Gonadoblastoma	791
Hyperlipidemia	791
ESRD	791
Proteinuria	791
Chromatography	791
SRNS	791
Hypoalbuminemia	791
Steroid-resistant nephrotic syndrome	791
SSNS	791
Steroid-sensitive nephrotic syndrome	791
End-stage renal disease	791
Ovarian cancer	792
Cancer	792
Donors	792
A rare disorder	793
Rare disorder	793
Disorder of glycoprotein metabolism	793
AGU	793
Course of the disease	793
Chromatography	793
Aspartylglucosaminuria	793
Diagnosis	793
Disorder	793
Deficiency of the lysosomal enzyme aspartylglucosaminidase	793
Familial adenomatous polyposis	794
Adenomas	794
Attenuated polyposis	794
Adenomatous	794
Dutch polyposis	794
Attenuated FAP	794
Polyposis	794
APC	794
Adenomatous polyposis	794
FAP	794
Polyps	794
Obvious	795
Genetic disease	795
Genetic disorder	795
Diagnosis	795
Disorder	795
X-linked immunodeficiencies	795
CC	796
Hypothesis	796
Associated	796
ATM	796
Developing prostate cancer	796
Cancer	796
Prostate cancer	796
Defect for the deficiency	797
Uremic syndrome	797
FH	797
Complement deficiency	797
KD	797
Idiopathic hemolytic uremic syndrome	797
Renal disease	797
HUS	797
Factor H deficiency	797
Associated	797
Heterozygous deficiency	797
Acute renal disease	797
Factor H	797
Complement factor H deficiency	797
Idiopathic HUS	797
Hemolytic uremic syndrome	797
Apoptosis	799
Growth	799
Carcinoma	799
Canadensis	799
Epidermoid carcinoma	799
Cancer	799
Flow cytometry	799
Cancer-related deaths	799
Prostate cancer	799
Prostate carcinoma	799
Hypercoagulability	800
A rare disorder	800
Rare disorder	800
Congenital analbuminemia	800
Growth	800
Recessive disorder	800
Placental and body oedema	800
Intrauterine growth retardation	800
Growth retardation	800
Analbuminemia	800
Atherosclerosis	800
Lipodystrophy	800
Autosomal recessive disorder	800
Hypercholesterolaemia	800
Diagnosis	800
Congenital analbuminaemia	800
Disorder	800
Osteoporosis	800
GKD	801
METHODS	801
Episodes	801
Hypoglycaemic	801
Hypoglycaemia	801
AIM	801
Ketonaemia	801
Isolated GKD	801
Glycerol kinase deficiency	801
Paroxysmal nocturnal hemoglobinuria	802
PNH	802
Hemolytic anemia	802
Flow cytometry	802
Anemia	802
Developmental delay	803
Ichthyosis	803
Growth	803
Shortness, hypoplasia of the corpus callosum	803
Contiguous gene syndromes	803
Associated	803
BAC	803
Growth retardation	803
Hypogonadism	803
Hypoplasia	803
Atrophy of the cerebral hemispheres and hypoplasia of the cerebellum and corpus callosum	803
Chondrodysplasia	803
Atrophy	803
Crystalline lens colouration	804
Macular pigmentation	804
Macular pigment	804
Prader-Willi	805
Prader-Willi syndrome	805
PWS	805
AS	805
Heterodisomy	805
Aspartylglycosaminuria	807
AGU	807
Glycosylasparaginase-deficient	807
Alpha	807
Autosomal recessive trinucleotide-repeat disease	809
Friedreich ataxia	809
Ataxia	809
FRDA	809
Bleeding disorder	810
X-linked recessive disorder	810
Haemophilia B	810
Recessive disorder	810
Associated	810
Haemophilia	810
Disorder	810
Hereditary breast cancer	811
Breast cancer	811
Ovarian cancer	811
Breast cancers	811
Hereditary cancer	811
Breast or ovarian cancer	811
Cancers	811
Cancer	811
Hereditary breast cancers	811
Hereditary breast or ovarian cancer	811
Arthogryposis	812
OMIM	812
Recessive disorder	812
Congenital contractural syndrome type 2	812
Associated	812
Autosomal recessive disorder	812
Disorder	812
Neurological abnormalities	813
Genomic instability	813
Ataxia	813
Radiosensitivity	813
Genetic disorders	813
ATM	813
Cancer	813
A-T	813
Ataxia-telangiectasia	813
Breast cancer	814
Melanoma-breast cancer	814
Melanoma	814
Cancer	814
Tumors	814
Alloimmune thrombocytopenia	815
HPA	815
Associated	815
Neonatal alloimmune thrombocytopenia	815
Thrombocytopenia	815
PC-1	816
METHODS	816
PC	816
Pachyonychia congenita	816
Associated	816
Type I	816
Diagnosis	816
Disorder	816
Cardiac	817
Tumor	818
Characteristic desmoplasia	818
Desmoplastic small round cell tumor	818
PDGF-Rbeta	818
Growth	818
Desmoplastic small round cell tumors	818
Associated	818
Desmoplastic stroma	818
Neoplastic	818
Tumor-associated desmoplasia	818
Tumors	818
Stromal desmoplasia	818
DZ	819
AP	819
Hypothesis	819
Autism	819
Epigenetic abnormalities	819
EC	820
Growth	820
Wild type	820
Neurospora crassa	820
Tumor	821
Metastasis	821
Malignant change of oral ED	821
METHODS	821
ED	821
Buccal SCC	821
Parabasal layers	821
Buccal epithelial dysplasia	821
Buccal lesions	821
SCC	821
Carcinoma	821
Associated	821
Dysplasia	821
Carcinomas	821
Malignant change of epithelial dysplasia	821
Squamous cell carcinoma	821
Cell carcinoma	821
Oral carcinoma	821
FHM1	822
MA	822
Migraine with aura	822
Associated	822
Familial hemiplegic migraine	822
Non-parametric linkage	822
Familial hemiplegic migraine type 1	822
Alpha	822
Metastasis	823
Steroid receptor positive tumours	823
Breast cancer	823
Contralateral breast cancer	823
Ovarian cancer	823
METHODS	823
Breast or ovarian cancer	823
Associated	823
Tumours	823
Disease-free survival	823
Cancer	823
Tumour	823
Diagnosis	823
ATM	824
DSB	824
Nijmegen breakage syndrome	824
HR repair	824
Neutropenia	825
Autoimmune	825
FINDINGS	825
X-linked thrombocytopenia	825
Wiskott-Aldrich syndrome	825
Autoimmune disease	825
Thrombocytopenia	825
Fibrosarcoma	826
Coiled-coil conformation	826
Alpha	826
Family hypercholesterolemia	827
Epstein-Barr	827
Epstein-Barr virus	827
Hypercholesterolemia	827
FH	827
Virus infection	827
Premature	827
Familial hypercholesterolemia	827
Genetic disorder	827
Coronary artery disease	827
EBV	827
Flow cytometry	827
Disorder	827
AP	828
Uniparental disomy	828
Angelman syndrome	828
Paternal uniparental disomy	828
Ataxia	829
Radiosensitivity	829
Premature	829
ATM	829
UAA	829
Ataxia-telangiectsia	829
A-T	829
METHODS	830
Deficiency of G6PD	830
Associated	830
Enzyme deficiency	830
Glomerulosclerosis	831
Chronic diseases	831
Hypertension	831
Renal failure	831
DDS	831
Proteinuria	831
Diabetes and hypertension	831
Denys-Drash syndrome	831
Optical density	832
OD	832
Behavior	832
Autosomal dominant	833
Hypercholesterolemia	833
FH	833
Familial Hypercholesterolemia	833
Alpha	833
Bilateral sensorineural hearing loss	834
Deafness	834
Hypothyroidism	834
Thyroidectomy	834
Hearing loss	834
PS	834
Nonprogressive deafness	834
Pendred syndrome	834
Associated	834
Syndromic deafness	834
Sensorineural hearing loss	834
Inner ear malformations	834
Goiter	834
Progressive deafness	834
Autosomal-recessive hearing loss	834
Enlarged vestibular aqueduct	834
Neisserial infections	835
Infection or infection	835
Terminal complement deficiencies	835
Neisserial infection	835
Complement deficiencies	835
Complement deficiency	835
Autoimmune	835
Neisseria	835
Inherited deficiencies of the terminal components of human complement	835
Neisseria meningitidis	835
Autoimmune diseases	835
Meningococcal disease	835
Epidemic	835
Recurrent disease	835
Cancer	836
Excess	836
HNPCC	837
Sporadic tumours	837
Genomic instability	837
Microsatellite instability	837
Hereditary nonpolyposis colorectal cancer	837
Colorectal cancer	837
Carcinoma	837
Heteroduplex	837
Tumours	837
Cancer	837
Carcinomas	837
Endometrial carcinoma	837
Endometrial carcinomas	837
Endometrial cancer	837
Associated	838
BAC	838
Myotonic dystrophy	839
DMPK	839
DM1	839
Liver cirrhosis	840
Primer hepatocellular cancer	840
Hyperpigmentation	840
Cirrhosis	840
Metabolic disorder	840
Genetic disorder	840
Liver disease/cirrhosis	840
Hereditary metabolic disorder	840
Liver disease	840
Diabetes mellitus	840
Cancer	840
Hemochromatosis	840
Diagnosis	840
Excess	840
Disorder	840
Hereditary hemochromatosis	840
Tumor	841
Immune disease	841
Growth	841
Associated	841
TNF	841
Alpha	841
Hyperargininemia	842
Arginase-deficient	842
Deficiency of hepatic cytosolic arginase I	842
Neurometabolic disorder	842
Diagnosis	842
Arginase deficiency	842
Disorder	842
Prenatal diagnosis	842
Artemis hyperphosphorylation	843
Hereditary disorder	843
RS-SCID	843
PK	843
Ataxia	843
RS	843
Artemis-deficient	843
Radiosensitivity	843
Striking cellular radiosensitivity	843
Associated	843
ATM	843
A-T	843
Ataxia telangiectasia	843
DSB	843
SCID	843
Disorder	843
Deafness	844
PDS	844
Hearing loss	844
Pendred-syndrome	844
CI-implantation	844
Xenopus laevis	844
Inner ear, thyroid gland	844
Familial background in hearing loss	844
Sensorineural hearing loss	844
Autosomal recessive disease	844
Recessive disease	844
Enlargement of the thyroid gland	844
Thyroid disorder	844
Disorder	844
Multiple epiphyseal dysplasia	845
Dysplasia	845
PKU	846
Phenylalanine hydroxylase deficiency	846
Newborns	846
Allelic disorders	846
PAH deficiency	846
Hyperphenylalaninemia	846
MHP	846
Phenylketonuria	846
Pancreatic cancer	847
Apoptosis	847
METHODS	847
Growth	847
Carcinoma	847
Colorectal carcinogenesis	847
Colorectal carcinoma	847
AIM	847
Cancer	847
Associated	848
Chromatography	848
Enzyme deficiency	848
Apoptosis	849
HD	849
Huntington disease	849
Huntington's disease	849
Associated	850
Aniridia	850
Enhancer	850
Enzymopathy	851
Hemolysis	851
DM	851
Acidosis	851
Hemolytic anemia	851
Glucose-6-phosphate dehydrogenase deficiency	851
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	851
Diabetes mellitus	851
Type 1 diabetes mellitus	851
Metabolic imbalances	851
Hypoglycemia	851
DM1	851
Anemia	851
G6PD deficiency	851
Glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus	851
Cleft predisposition	852
Cleft lip and palate	852
Non-syndromic cleft lip and/or palate	852
Familial non-syndromic cleft lip	852
CL	852
Van der Woude syndrome	852
Associated	852
Cleft palate	852
Cleft lip and/or palate	852
CLP	852
VWS	852
NSCL/P	852
Cleft area	852
Hypodontia	852
Breast cancer	853
Pancreatic cancer	853
Ovarian cancer	853
Breast cancers	853
Sporadic breast cancers	853
Breast carcinoma	853
Cancers	853
Carcinoma	853
Familial tumour	853
Tumours	853
Breast and ovarian cancers	853
Ovarian cancers	853
Sporadic cancers	853
Cancer	853
Breast and ovarian cancer	853
Familial breast cancer	853
Tumour	853
Familial breast and ovarian cancer	853
Other cancers	853
Neurogenetic disease	854
Mental impairment	854
METHODS	854
Fragile X	854
Fragile X syndrome	854
Neurological disease	854
Disorder	854
Increased cell death	855
Growth	855
WASp-deficient	855
WAS	855
Nonhematopoietic	855
Wiskott-Aldrich syndrome	855
Tumor	856
METHODS	856
III	856
Stage IV lesions	856
Neoplastic dissemination	856
Colorectal cancer	856
Stage III lesions	856
Adenocarcinoma	856
AIM	856
III tumors	856
Neoplastic	856
Stage I tumors	856
CEA	856
Cancer	856
Stage II tumors	856
Donors	856
Stage IV tumors	856
Tumors	856
Diagnosis	856
Stage III tumors	856
Colorectal adenocarcinoma	856
Developmental delay	857
Angelman syndrome	857
Cerebral cortex, cerebellar cortex	857
Motor impairment	857
Nonketotic hyperglycinaemia	858
Recessive disorder	858
Autosomal recessive disorder of glycine metabolism	858
A deficiency	858
Autosomal recessive disorder	858
Diagnosis	858
NKH	858
Disorder	858
Prenatal diagnosis	858
Deafness	859
Congenital syndrome	859
Progressive ataxia	859
Neurodegenerative disorder	859
Ataxia	859
Wolfram syndrome	859
Epilepsy	859
Diabetes mellitus	859
Nerve deafness	859
Optic atrophy	859
Disorder	859
Diabetes insipidus	859
Atrophy	859
Pelizaeus-Merzbacher disease	860
FMF	861
Mediterranean fever	861
MEFV	861
III	861
Fever	861
Associated	861
Autosomal recessive disease	861
Recessive disease	861
Amyloidosis	861
Diagnosis	861
Familial Mediterranean fever	861
Tumor	862
METHODS	862
Premature	862
Carcinoma	862
Associated	862
Adrenocortical carcinoma	862
Diverse-cancer	862
LFS	862
Cancer	862
Astrocytoma	862
Li-Fraumeni syndrome	862
METHODS	863
Hypercholesterolemia	863
FH	863
Familial hypercholesterolemia	863
Diagnosis	863
Myotonia	864
Myotonic dystrophy	864
Histological abnormalities	864
Associated	864
Muscle wasting	864
DMPK	864
DM1	864
HD	865
Huntington disease	865
Lysosomal storage disorder	866
GM1-gangliosidosis	866
Gangliosidosis	866
Deficiency of beta-galactosidase	866
EBP involvement	866
Elastic fiber deposition	866
Role of beta-galactosidase	866
A deficiency	866
Genetic lesions	866
Disorder	866
Alpha	866
Tumor	867
P27Kip1-negative tumors	867
P27Kip1-positive tumors	867
Demographic	867
III	867
Colorectal cancer	867
Associated	867
DCC-negative tumors	867
Neoplastic	867
DCC	867
Genetic abnormalities	867
Cancer	867
Behavior	867
Tumors	867
Premature	868
Associated	868
Inherited disorder	868
Inherited disorder of iron metabolism	868
Hemochromatosis	868
Disorder	868
Autosomal dominant	869
Familial adenomatous polyposis	869
HNPCC	869
Adenomas	869
PJS	869
Dysplastic	869
Multiple polyps	869
Adenomatous	869
JP	869
Polyposis syndromes	869
Genetic testing	869
Colorectal cancer	869
Polyposis	869
Hereditary colorectal cancer	869
Hereditary non-polyposis colorectal cancer	869
Colonic adenomas	869
Juvenile polyposis	869
APC	869
Adenomatous polyposis	869
Endometrial, ovarian, small bowel, and transitional cell cancer	869
Cancer	869
CRC	869
Autosomal dominant disorder	869
Peutz-Jegher syndrome	869
FAP	869
Criteria	869
MYH	869
Diagnosis	869
Polyps	869
Disorder	869
Autosomal recessive MYH polyposis	869
Category of polyposis	869
MBP	870
Favism	871
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	871
Diagnosis	871
G6PD deficiency	871
Tumor	872
Breast cancer	872
Abnormalities of BAF180	872
Lung cancers	872
Lung cancer	872
Cancers	872
Malignant rhabdoid and childhood central nervous system tumors	872
Central nervous system	872
Cancer	872
Tumors	872
Abnormal in lung cancers	872
Small-cell lung cancer	872
Piebaldism	873
SCF	873
Muscular dystrophies	874
Duchenne and Becker muscular dystrophies	874
Genetic disease	874
BMD	874
DMD	874
Diagnosis	874
PMD	875
WT	875
Premature	875
Associated	875
Oligodendrocyte cell death	875
Dysmyelinating disease	875
Pelizaeus-Merzbacher disease	875
Dysmyelinating	875
Neurodegenerative disease	876
Friedreich ataxia	876
Ataxia	876
Cardiac disease	876
Frataxin deficiency	876
Cardiac	876
FINDINGS	876
Autosomal recessive neurodegenerative and cardiac disease	876
HDAC	876
Neurodegenerative disease	877
Abcd1-deficient	877
Inherited neurodegenerative disease	877
Adrenoleukodystrophy protein deficiency	877
Hypothesis	877
OMIM	877
X-ALD	877
Associated	877
X-linked adrenoleukodystrophy	877
ALD	877
Deficiency in VLCFA degradation	877
Adrenoleukodystrophy	877
Mitochondrial abnormalities	877
A deficiency	877
Myotonic dystrophy	878
DM	878
DMPK	878
Muscular dystrophy	878
DM1	878
Deficiency of the hexosaminidase A enzyme	879
Sachs disease	879
Tay-Sachs	879
Tay-Sachs disease	879
Inherited neurodegenerative ganglioside storage disorder	879
TSD	879
FCD	879
Disorder	879
Rebound leukocytosis	880
Mediterranean fever	880
Myalgia	880
Leukocytosis	880
Fever	880
Renal impairment	880
Hypoglycemia	880
Lower extremity parasthesias	880
Amyloidosis	880
Alopecia	880
Amyloidosis involving the kidney	880
Familial Mediterranean fever	880
Diarrhea, abdominal pain, myalgia	880
Apoptosis	881
Ataxia	881
ATM	881
Ataxia-telangiectasia	881
PMD	882
Leukodystrophy	882
X-linked dysmyelinating disorders	882
Associated	882
Central nervous system	882
CNS	882
Spastic paraplegia	882
Pelizaeus-Merzbacher-like disease	882
Pelizaeus-Merzbacher disease	882
PMLD	882
Dysmyelinating	882
Hypomyelinating leukodystrophy	882
Alpha	882
Duchenne/Becker dystrophy	883
Duchenne/Becker and control muscle cultures	883
Duchenne/Becker muscle cultures	883
Dystrophic muscle	883
Dystrophic	883
Muscle disease	883
Muscular dystrophy	883
Duchenne muscular dystrophy	883
Neurologic diseases	883
Congenital afibrinogenaemia	884
Life-long bleeding tendency	884
Autosomal recessive coagulation disorder	884
Premature	884
Afibrinogenaemia	884
Genetic defect	884
Disorder	884
Alpha	884
Congenital chloride diarrhea	885
Tumor	886
Tumor necrosis	886
Mediterranean fever	886
Necrosis	886
Fever	886
Familial Mediterranean fever	886
Schizophrenia	887
NPL	887
Preperoxisomal compartment	888
Tumor	890
Breast cancer	890
RB	890
Retinoblastoma	890
Associated	890
Cancer	890
LOH	890
Tumors	890
Loss of heterozygosity	890
Breast tumors	890
DNA nondiploidy	890
Premature	891
Hemophilia B	891
Hemophilia	891
OBJECTIVES	892
Sensorimotor disorder	892
Restless legs syndrome	892
Disorder	892
Autosomal dominant	893
EDMD	893
Bradycardia	893
Slowly progressive skeletal myopathy	893
AV	893
Conduction defects	893
Emery-Dreifuss muscular dystrophy	893
Genetic diseases	893
Atrial tachycardia	893
Limb-girdle muscular dystrophy	893
Myopathy	893
Cardiac	893
Weakness	893
Skeletal myopathy	893
Pacemaker	893
Cardiomyopathy	893
Ankles and limb-girdle type muscular dystrophy	893
Weakness of humeroperoneal muscles	893
Muscular dystrophy	893
Contractures of the neck, elbows and ankles	893
Atrial fibrillation	893
X-linked recessive EDMD	893
Cardiac dysrhythmias	893
Sudden death	893
Autosomal dominant	894
Dementia	894
HD	894
Polyglutamine disease	894
Striatal atrophy	894
Neuropathology	894
Psychiatric syndromes	894
Disorders of striatal neurodegeneration	894
Autosomal dominant disorder	894
Huntington's disease	894
Neurodegeneration	894
Disorder	894
HDL2	894
Atrophy	894
AS	895
Uniparental disomy	895
Angelman syndrome	895
Paternal uniparental disomy	895
UPD	895
III	896
Multisystem disorder	897
Human disease	897
Mucopolysaccharidosis	897
EC	897
IDUA deficiency	897
Mucopolysaccharidosis type I	897
Genetic diseases	897
Cardiac disease	897
Cardiac	897
Associated	897
Attenuated disease	897
Deficiency compromises the degradation	897
Type I	897
Disorder	897
Alpha	897
Glycosaminoglycans	897
Bacterial infections	898
Especially meningitis	898
C7 deficiency	898
Meningitis	898
Premature	898
Associated	898
C7D	898
Deficiencies of complement	898
Neisseria	898
Complement C7 deficiency	898
Neisseria meningitidis	898
Corneal changes secondary to glaucoma	899
X-linked infantile glaucoma	899
Synechial abnormalities	899
Oculocerebrorenal syndrome	899
Angle abnormalities	899
Angle defects	899
METHODS	899
Angle anomalies	899
OCRL	899
Cataract	899
Glaucoma	899
Variable abnormalities	899
Associated	899
Oculocerebrorenal syndrome of Lowe	899
Gonioscopic abnormalities	899
Filtration angle anomaly	899
Defining abnormalities	899
Neonatal hypotonia	900
Short stature	900
Prader-Willi	900
Prader-Willi syndrome	900
Hypotonia	900
Macrocephaly	900
PWS	900
Obesity	900
METHODS	900
Feeding difficulties	900
Uniparental disomy	900
Associated	900
Hypogonadism	900
Behavior	900
Maternal uniparental disomy	900
Choriocarcinoma	901
Hemochromatosis	901
Breast cancer	902
Ovarian cancer	902
Breast/ovarian	902
Breast/ovarian cancer	902
Cancer	902
Tumor	903
Myotonia	903
Tumor necrosis	903
Necrosis	903
Myotonic dystrophy	903
Dystrophia myotonia	903
TNF	903
Type I myotonic dystrophy	903
Muscle wasting	903
DMPK	903
Type I	903
Debilitating disease	903
DM1	903
Subtotal deficiencies of C6 and C7	904
C6 generating C56	904
Molecular defect	904
C7 defect	904
C7 deficiency	904
C6 or C7 deficiency	904
Associated	904
C6-deficient	904
Deficit of circulating C7	904
Combined subtotal deficiency of C6 and C7	904
C7 deficiencies	904
Autosomal recessive omodysplasia	905
Congenital skeletal dysplasia	905
Micromelia	905
Diastrophic dysplasia	905
ARO	905
Dysplasia	905
Skeletal dysplasia	905
Anterolateral radial head dislocation	905
Diagnosis	905
Prenatal diagnosis	905
Craniofacial anomalies	905
Type II collagenopathies	906
STD-I	906
Type II	906
Growth	906
Kniest dysplasia	906
Otolaryngological abnormalities	906
KND	906
Dysplasia	906
Spondyloepiphyseal dysplasia	906
SED	906
Type I	906
Stickler dysplasia type I	906
Alpha	906
Spondylitis	907
AS	907
Associated	907
Ankylosing spondylitis	907
Ankylosis	907
Peroxisomal disorder	908
Total disability	908
Demyelination of the central nervous system	908
METHODS	908
GC	908
MS	908
X-ALD	908
Demyelination	908
X-linked adrenoleukodystrophy	908
Central nervous system	908
ALD	908
Adrenal cortex insufficiency	908
Adrenoleukodystrophy	908
Neurological symptoms	908
Diagnosis	908
Plasma	908
Disorder	908
Prenatal diagnosis	908
Voluntary control of eye movement	909
Supplementary eye fields	909
LD	909
Longer latencies	909
Autosomal recessive disorder of metabolism	910
Alkaptonuric ochronosis	910
Aortic stenosis	910
Recessive disorder	910
Nephrolithiasis	910
Pigmentation of the skin, sclera	910
Femoral fracture	910
Alkaptonuria	910
Trauma	910
Arthropathy	910
Cardiovascular abnormalities	910
Autosomal recessive disorder	910
Ochronosis	910
Diagnosis	910
Disorder	910
C4	911
Myasthenia gravis	911
TCC	911
Terminal complement complex	911
Visuospatial	912
Associated	912
Cerebral dysfunction	912
Muscular dystrophy	912
Duchenne muscular dystrophy	912
DMD	912
Cognitive impairment	912
Cystic fibrosis	913
CF	913
Fibrosis	913
Tumor	914
Malignant rhabdoid tumor of the kidney	914
Malignant rhabdoid tumor	914
Associated	914
Syndrome-like phenotype and rhabdoid tumor of the kidney	914
Wilson disease	915
Wilson copper ATPase gene ATP7B	915
Chromatography	915
Wilson copper ATPase	915
Disorder of copper metabolism	915
Disorder	915
Prader-willi syndrome	916
Prader-Willi	916
Prader-Willi syndrome	916
PWS	916
Developmental abnormalities	916
Deficit in neuronal migration	916
Dystrophic axons	916
Dystrophic	916
Associated	916
Central nervous system	916
Neurodevelopmental disorder	916
Anatomical defects	916
Abnormalities of neuronal structure	916
Disorder	916
Congenital analbuminemia	917
Analbuminemia	917
Tumor	918
Colon carcinoma	918
Carcinoma	918
Lymphoid enhancer	918
LEF	918
Cancer	918
Enhancer	918
PC	919
Major prostate cancer	919
Cancer	919
Prostate Cancer	919
Age at diagnosis	919
Diagnosis	919
Prostate cancer	919
CHM	920
Choroideremia	920
Tumor	921
METHODS	921
Hereditary nonpolyposis colon cancer	921
Uterine cancer	921
Genetic testing	921
Colorectal cancer	921
Cancers	921
Colon cancer	921
Cancer	921
Extracolonic cancers	921
Endometrial cancer	921
Malignancy	922
Apoptosis	922
Hereditary disorder	922
NBS1 deficiency	922
Autosomal recessive hereditary disorder	922
Cancer	922
Nijmegen breakage syndrome	922
Disorder	922
Immunodeficiency	923
WASP	923
WAS	923
X-linked primary immunodeficiency	923
Wiskott-Aldrich syndrome	923
Spinocerebellar ataxia type 2	924
Neurodegenerative diseases	924
Polyglutamine (polyQ) diseases	924
PC	924
Ataxia	924
Spinocerebellar ataxia	924
Premature	924
Associated	924
Neuronal dysfunction	924
PC degeneration	924
SCA2	924
SCA6	924
Complained of nyctalopia	925
Retinal dystrophy	925
METHODS	925
RDS	925
Macular atrophy	925
Associated	925
Visual acuity	925
Macular dystrophy	925
ERG abnormalities	925
Generalized retinal dysfunction	925
Macular dysfunction	925
Atrophy	925
Cone-rod dystrophy	925
Tumor	926
Von Hippel-Lindau tumor	926
Apoptosis	926
Renal cancer	926
Growth	926
Cancers	926
Von Hippel-Lindau	926
Cancer	926
Renal tumor	926
Renal cancers	926
VHL	926
Fragile X	927
Classical delay eye-blink conditioning	927
Cognitive deficits	927
Eye-blink conditioning	927
Cerebellar dysfunctions	927
Cerebellar deficits	927
Attenuates cerebellar eyelid conditioning	927
LTD	927
Fragile X syndrome	927
Tumor	928
Growth	928
PC	928
Tumorigenicity	928
Cancer	928
Tumorigenesis	928
Tumors	928
Chromosomal abnormality	928
Prostate cancer	928
Lesch-Nyhan syndrome	929
Hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiencies	929
Lesch-Nyhan	929
Ataxia	930
ATM	930
Lymphoreticular malignancies	930
T-cell lymphomas	930
Lymphomas	930
Malignancies	930
Autosomal recessive disease	930
A-T	930
Recessive disease	930
Leukemias	930
Ataxia telangiectasia	930
Loss of heterozygosity	930
Neonatal adrenoleukodystrophy	931
Infantile Refsum disease	931
Refsum disease	931
Zellweger syndrome	931
Premature	931
Associated	931
Milder disease	931
Adrenoleukodystrophy	931
Zellweger	931
Zellweger spectrum	931
CETP	932
Alzheimer's disease	932
HDL	932
AD	932
AA	932
Associated	932
Excess	932
Familial adenomatous polyposis	933
Adenoma (lower level) to carcinoma	933
Adenomas	933
Adenomatous polyposis coli	933
Adenomatous	933
Polyposis	933
Carcinoma	933
APC	933
Adenomatous polyposis	933
COX	933
Carcinomas	933
FAP	933
MYH	933
Polyposis coli	933
Glioblastomas	934
AN	934
Genetic disorders	934
Aniridia	934
Breast cancer	935
Gastrointestinal lesions	935
MYH associated polyposis coli	935
METHODS	935
Duodenal carcinoma	935
Colorectal cancer	935
Polyposis	935
Carcinoma	935
Associated	935
Attenuated and classical polyposis coli	935
APC	935
Cancer	935
MAP	935
MYH	935
Polyposis coli	935
Gastro-duodenal polyps	935
Polyps	935
Tumor	936
Stage III colorectal carcinomas	936
METHODS	936
III cancers	936
III	936
Colorectal carcinomas	936
Colorectal cancer	936
Cancers	936
Carcinoma	936
Stage III disease	936
DCC-negative tumors	936
Colorectal carcinoma	936
Allelic loss	936
DCC	936
Cancer	936
Carcinomas	936
Tumors	936
Enzymopathy	938
Newborns	938
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	938
G6PD deficient	938
G6PD-deficient	938
Hereditary enzymopathy	938
Atypical nonketotic hyperglycinemia	939
Mental retardation	939
Hyperglycinemia	939
Behavioral abnormalities	939
Associated	939
Atypical NKH	939
Neonatal and infantile atypical NKH	939
CSF	939
Nonketotic hyperglycinemia	939
Neurological symptoms	939
Plasma	939
NKH	939
Autosomal dominant	940
Hereditary coproporphyria	940
Harderoporphyria	940
Catalysis	940
CPO	940
Type I	940
Autosomal dominant disorder	940
Disorder	940
Alpha	940
Tumor	941
Familial adenomatous polyposis	941
Desmoid tumors	941
Adenomas	941
Adenomatous polyposis coli	941
Adenomatous	941
Colorectal cancer	941
Polyposis	941
Colorectal adenomas	941
Colonic adenomas	941
APC	941
Adenomatous polyposis	941
Cancer	941
Age at diagnosis	941
Tumors	941
FAP	941
Attenuated adenomatous polyposis coli	941
Polyposis coli	941
Diagnosis	941
AAPC	941
Autosomal dominant	942
Encephalopathy	942
Coma	942
FHM1	942
METHODS	942
Episodes	942
Familial hemiplagic migraine FHM	942
Associated	942
Familial hemiplegic migraine	942
Hemiplegia	942
Autosomal dominant disorder	942
Diagnosis	942
FHM	942
Disorder	942
Hemochromatosis	943
Diagnosis	943
Hereditary hemochromatosis	943
Hidradenitis	944
Lupus erythematosus	944
Pyoderma	944
Pyoderma gangrenosum	944
Chronic iron-deficiency	944
PG	944
HS	944
Systemic diseases	944
Anaemia	944
Associated	944
Systemic lupus erythematosus	944
Spasticity	945
Sensory loss	945
Facial fasciculations	945
Machado-Joseph disease	945
Postural instability	945
Include ataxia	945
Ataxia	945
Dystonic	945
Dysarthria	945
Machado-Joseph Disease	945
Nystagmus, dysarthria	945
Disorder	945
Distal atrophy	945
Atrophy	945
Autosomal dominant	946
Familial adenomatous polyposis	946
Adenomatous	946
Colorectal cancer	946
Cancers	946
Polyposis	946
Associated	946
Tumours	946
APC	946
Adenomatous polyposis	946
Cancer	946
CRC	946
Autosomal dominant disorder	946
Tumour	946
Breast and other cancers	946
FAP	946
Other cancers	946
Polyps	946
Disorder	946
WD	947
Wilson's disease	947
Associated	947
Short stature	948
Prader-Willi	948
Prader-Willi syndrome	948
Lipolysis	948
PWS	948
Adipose tissue	948
Obesity	948
Microdialysis	948
GH	948
Growth	948
Abnormal body composition	948
Genetic disease	948
BMI	948
Partial growth hormone (GH) deficiency	948
Complex genetic disease	948
Hyperphagia	948
Immunologic abnormalities	949
FMF	949
Mediterranean fever	949
MEFV	949
METHODS	949
DQ	949
Fever	949
AIMS	949
ARMS	949
Familial Mediterranean fever	949
Breast cancer	950
Ovarian cancer	950
Cancers	950
Sporadic cancers	950
Mitosis	950
Cancer	950
Breast (MCF-7) cancer	950
Tumor	951
Apoptosis	951
Growth	951
WT	951
Wild type	951
Rb	952
Cultured retinoblastoma	952
Retinoblastoma	952
Tumor	953
Restricted prostate cancer	953
Progress despite androgen ablation	953
Most cancers	953
Controlling prostate cancer	953
Growth	953
Cancers	953
Cancerous	953
Prostate cancers	953
Cancer	953
Withdrawal syndrome	953
Prostate cancer	953
Epilepsy syndrome	954
Febrile seizures	954
Genetic predisposition	954
GEFS	954
FS	954
Idiopathic epilepsies	954
Afebrile generalized and partial seizures	954
Associated	954
Epilepsy	954
Familial epilepsy syndrome	954
Generalized epilepsy	954
Disorder	954
Seizure disorder	954
Fronto-temporal dementia	955
Dementia	955
Autosomal recessive lipid storage disease	955
Mental retardation	955
Ataxia	955
Cataract	955
CTX	955
Cataract and ataxia	955
Xanthomas	955
Neuropsychiatric	955
A deficiency	955
T2 abnormalities	955
Cerebellar atrophy	955
Cerebrotendinous xanthomatosis	955
Criteria	955
Cerebellar hypoperfusion	955
Xanthomatosis	955
Atrophy	955
Crohn's disease	956
Ulcerative colitis	956
METHODS	956
DZ	956
CD	956
IBD	956
UC	956
Inflammatory bowel disease	956
OBJECTIVES	956
Bowel disease	956
Type II	957
Uremic syndrome	957
Type II disorders	957
FH	957
HUS	957
Macular degeneration	957
Associated	957
CFH	957
Factor H	957
Type I	957
Membranoproliferative glomerulonephritis	957
Glomerulonephritis	957
Plasma	957
Hemolytic uremic syndrome	957
Machado-Joseph disease	958
Ataxia	958
Spinocerebellar ataxia	958
Hereditary olivopontocerebellar atrophy	958
Spinocerebellar ataxia 1	958
SCA1 and Machado-Joseph disease	958
MJD	958
SCA1	958
Disorder	958
Atrophy	958
Ataxia	960
Premature	960
ATM	960
Ataxia-telangiectasia	960
Impaired IL-2	961
METHODS	961
NF-ATp dephosphorylation	961
AT	961
AP	961
WASP	961
Defective IL-2	961
WAS	961
Wiskott-Aldrich syndrome	961
Linkage disequilibrium	962
Admixture linkage disequilibrium	962
ALD	962
Breast cancer	963
XPC	963
Ovarian cancer	963
Osteosarcoma	963
Cyclobutane pyrimidine dimer	963
Wild type	963
U2OS osteosarcoma	963
Cancer	963
CPD	963
Breast and ovarian cancer	963
CTX	964
COS	964
Cerebrotendinous xanthomatosis	964
Xanthomatosis	964
Associated	965
Hemochromatosis	965
Hereditary hemochromatosis	965
Febrile seizures	966
GEFS	966
Epilepsy	966
Neonatal epilepsy syndromes	966
Generalized epilepsy	966
Semicircular canals	967
Deafness	967
Hearing loss	967
X-linked nonsyndromic deafness	967
Associated	967
Vestibular dysfunction	967
Temporal bone anomalies	967
Dysplasia	967
X-linked deafness	967
Mental disorders	968
Certain mental disorders	968
Type IV	969
Lysosomal storage disease	969
MPS IVA disease	969
Autosomal recessive inborn error	969
Mucopolysaccharidosis	969
OMIM	969
A syndrome	969
Bone dysplasia	969
Mucopolysaccharidosis type IVA	969
IVA	969
Associated	969
Dysplasia	969
MPS IVA	969
Diagnosis	969
Prenatal diagnosis	969
Glycosaminoglycans	969
Mucopolysaccharidosis type IV	969
Genetic process	970
HD	971
HD disease	971
Huntington disease	971
Mental retardation	973
Brain dysfunction	974
Growth	974
Leukodystrophy	974
Metachromatic leukodystrophy	974
Epidermal growth	974
Behavior	974
MLD	974
Neurodegeneration	974
Neurological diseases	974
Inherited afibrinogenemia	975
TT	975
Recessive disorder	975
Afibrinogenemia	975
Donors	975
Congenital afibrinogenemia	975
Autosomal recessive disorder	975
Plasma	975
Disorder	975
WT	976
Von Willebrand	976
COS	976
Von Willebrand disease	976
VWF	976
Congenital muscular dystrophy	977
Complex congenital muscular dystrophy	977
Muscle-eye-brain type of congenital muscular dystrophy	977
Muscle-eye-brain	977
Muscle-eye-brain disease	977
Muscular dystrophy	977
EBV	977
Diagnosis	977
Tumor	978
Breast cancer	978
Increased breast cancer	978
Ovarian cancer	978
METHODS	978
Breast tumor	978
Associated	978
Cancer	978
Breast and ovarian cancer	978
Familial breast cancer	978
Diagnosis	978
Associated	979
Autistic	979
Autism	979
Neurodevelopmental disorders	979
ASDs	979
Autism spectrum disorders	979
Necrosis	980
Wilson disease	980
Hepatocellular injury	980
Associated	980
Genetic disorder	980
Intracellular copper accumulation	980
Cholangiocarcinoma	980
Intracellular copper overload	980
Disorder	980
Intronic breakpoint definition	981
BMD	981
DMD	981
CIDP	982
Recessive disorder	982
Chronic inflammatory demyelinating polyneuropathy	982
CTX	982
Cerebrotendinous xanthomatosis	982
Autosomal recessive disorder	982
Diagnosis	982
Plasma	982
Xanthomatosis	982
Disorder	982
Acidosis	983
Cardiac	983
Genetic testing	983
Arrhythmia	983
Associated	983
Acidosis-induced arrhythmia	983
Sudden infant death	983
SIDS	983
Sudden infant death syndrome	983
Tumor	984
Rhabdoid tumors	984
Growth	984
Central nervous system	984
Atypical teratoid/rhabdoid tumor	984
Malignancies	984
Tumors	984
EC	985
GC	985
COX	985
C oxidase	985
Ovarian cancer	986
Breast/ovarian	986
Breast/ovarian cancers	986
Hereditary breast/ovarian cancer	986
Cancers	986
Associated	986
Breast/ovarian cancer	986
Ovarian cancers	986
Cancer	986
Tumor	987
Familial adenomatous polyposis	987
Adenomatous polyposis coli	987
Colorectal polyps	987
Colon tumor	987
METHODS	987
Adenomatous	987
Colorectal cancers	987
Colorectal cancer	987
Cancers	987
Polyposis	987
Colorectal tumor	987
Hyperlipidemic	987
Hyperlipidemia	987
APC	987
Adenomatous polyposis	987
Apc	987
Cancer	987
FAP	987
Polyposis coli	987
Polyps	987
Associated	988
Nijmegen breakage syndrome	988
NBS	988
Tumor	989
Plk3-deficient	989
Ataxia	989
ATM	989
Ataxia-telangiectasia	989
Tumor	991
Wilms' tumor	991
WT	991
Associated	991
WT and genital tract malformations	991
Wilms' tumors	991
Tumors	991
Villefranche criteria	992
METHODS	992
III	992
Non-vascular EDS	992
Connective tissue disorders	992
Ehlers-Danlos syndromes	992
Involvement of skin and tissue fragility	992
Abnormality of collagen I	992
Vascular EDS	992
EDS	992
Molecular testing	992
Criteria	992
Diagnosis	992
Hypermobile EDS	992
Prenatal diagnosis	992
Autosomal dominant	993
Hypermetria	993
Machado-Joseph disease	993
Spinocerebellar ataxias	993
Saccade hypometria	993
Ataxia	993
Movement abnormalities	993
Autosomal dominant cerebellar ataxias type I spinocerebellar ataxias 1	993
Autosomal dominant cerebellar ataxia	993
Type I	993
Cerebellar ataxia	993
MJD	993
SCA2	993
SCA1	993
SCA3	993
SCA3 / Machado-Joseph disease	993
Spinocerebellar ataxias 1	993
Criteria	993
Tumor	994
HNPCC	994
METHODS	994
Microsatellite instability	994
Hereditary nonpolyposis colorectal cancer	994
Colorectal cancer	994
Cancers	994
AIM	994
Colon cancer	994
Cancer	994
Colon cancers	994
Criteria	994
CVID	995
ALPS	995
Autoimmune lymphoproliferative syndrome	995
DALD	995
Lymphoproliferative disorders	995
Immunodeficiency	995
Antibody deficiency	995
Autoimmune	995
Autoimmune lymphoproliferative disorders	995
Autoimmune lymphoproliferative disease	995
Disorder	995
Breast cancer	996
Ovarian cancer	996
METHODS	996
Breast and/ovarian cancer	996
Canadian hereditary breast and/ovarian cancer	996
Breast and/or ovarian cancer	996
Associated	996
Cancer	996
Breast and ovarian cancer	996
Canadian breast cancer	996
Drosophila melanogaster	997
Apoptosis	997
Metabolic disorders	997
Neurodegenerative disorder	998
X-ALD	998
X-linked adrenoleukodystrophy	998
ALD	998
Adrenoleukodystrophy	998
Excess	998
Disorder	998
Epstein-Barr	999
Epstein-Barr virus	999
HPRT deficient	999
Wild type	999
Epstein-Barr-virus	999
GSH	1000
AT	1000
Medium	1000
DHAP-AT latency	1000
DHAP-AT	1000
Tumor	1001
Hemangioblastoma	1001
Hereditary cancer	1001
Benign vascular tumors	1001
METHODS	1001
VHL tumor	1001
Von Hippel-Lindau disease	1001
CNS hemangioblastoma	1001
Cancer syndrome	1001
Genetic testing	1001
VHL-related lesions	1001
Von Hippel-Lindau (VHL) disease	1001
Central nervous system	1001
Hereditary cancer syndrome	1001
CNS hemangioblastomas	1001
Von Hippel-Lindau	1001
Cancer	1001
CNS	1001
VHL disease	1001
Cerebellar hemangioblastoma	1001
Tumors	1001
Criteria	1001
Hemangioblastomas	1001
VHL	1001
HGF	1002
Growth	1002
SF	1002
Carcinoma	1002
CCRC	1002
Von Hippel-Lindau	1002
Tumorigenesis	1002
Renal carcinoma	1002
VHL	1002
Von Hippel-Lindau gene	1002
Demazure operators	1005
Associated	1005
Compact maximal torus T	1005
Breast cancer	1006
Breast cancers	1006
METHODS	1006
Growth	1006
Sporadic breast cancer	1006
Cancers	1006
Epidermal growth	1006
Breast carcinomas	1006
Cancer	1006
Carcinomas	1006
Hereditary disease	1006
Tumor	1007
Apoptosis	1007
Esophageal squamous cell carcinomas	1007
METHODS	1007
Esophageal cancers	1007
ROS	1007
One adenocarcinoma	1007
Cancers	1007
Carcinoma	1007
Esophageal carcinoma	1007
Adenocarcinoma	1007
Squamous cell carcinomas	1007
Cancer	1007
Carcinomas	1007
Tumorigenesis	1007
Tumors	1007
Metastatic status	1007
Adenosquamous carcinoma	1007
Esophageal cancer	1007
Insulin-like growth	1008
Growth	1008
Muscle mass	1008
Dystrophic	1008
Hypertrophy	1008
Cross-sectional area	1008
Myofiber hypertrophy	1008
Dystrophic skeletal muscle	1008
Alpha-galactosidase	1009
Alpha-galactosidase A	1009
HCM	1009
METHODS	1009
FD	1009
Cardiac	1009
Hypertrophic cardiomyopathy	1009
Hypertrophy	1009
Cardiomyopathy	1009
Fabry disease	1009
Cardiac hypertrophy	1009
Alpha	1009
Tumor	1010
CCD	1010
Mitosis	1010
Cancer	1010
PLP1 gene abnormalities	1011
METHODS	1011
Neurodegenerative disorder	1011
Pelizaeus-Merzbacher disease	1011
X-linked neurodegenerative disorder	1011
Disorder	1011
Ataxia	1012
Associated	1012
ATM	1012
Ataxia-telangiectasia	1012
Arterial thrombosis	1013
Thrombosis	1013
Breast cancer	1014
Cancer	1014
CETP	1015
HDL	1015
AA	1015
CC	1015
Coronary disease	1015
Myocardial infarction	1015
Associated	1015
Coronary heart disease	1015
Ischemic heart disease	1015
Heart disease	1015
Tumor	1016
Adenomatous polyposis coli	1016
Neoplasia	1016
GS	1016
Adenomatous	1016
Colorectal neoplasia	1016
Hereditary familial polyposis coli	1016
Gardner's syndrome	1016
Colorectal cancer	1016
Colon carcinoma	1016
Polyposis	1016
Carcinoma	1016
Colorectal tumors	1016
Familial polyposis coli	1016
APC	1016
Adenomatous polyposis	1016
Cancer	1016
Tumors	1016
FAP	1016
Polyposis coli	1016
Diagnosis	1016
Genetic information	1017
Multiple epiphyseal dysplasia	1017
Skeletal dysplasias	1017
Von Willebrand	1017
Dysplasias	1017
Dysplasia	1017
MED	1017
Fragile-X	1018
Hunter syndrome	1018
Molecular defect	1019
Type IIB vWD	1019
Von Willebrand	1019
Type IIB von Willebrand disease	1019
Type IIB von Willebrand Disease	1019
Von Willebrand disease	1019
VWF	1019
VWD	1019
Plasma	1019
Familial mediterranean fever	1020
FMF	1020
Mediterranean fever	1020
MEFV	1020
Serositis	1020
Fever	1020
Familial Mediterranean fever	1020
Inherited disease	1020
Linkage disequilibrium	1021
Fragile X	1021
Fragile X syndrome	1021
Diagnosis	1021
Prenatal diagnosis	1021
Short stature	1022
Microcephaly	1022
XLMR	1022
Postnatal growth deficiency	1022
METHODS	1022
Atrial septal defect	1022
Growth	1022
Mental retardation	1022
Porteous syndromes	1022
Cardiac	1022
XLMR disorders	1022
X linked mental retardation	1022
Haemolysis	1023
Leukodystrophy	1024
Metachromatic leukodystrophy	1024
GT	1025
CRI	1025
MAP	1025
XLG	1026
X-linked liver glycogenosis	1026
Alpha	1026
CRI	1027
MAP	1027
Excess	1027
Glucose-6-phosphate dehydrogenase deficiency	1028
G6PD deficiency	1028
Alpha-galactosidase	1029
Ags	1029
Alpha	1029
Fragile X	1030
Fragile X syndrome	1030
Tumor	1032
Autosomal dominant	1032
Familial adenomatous polyposis	1032
Familial cancer syndrome	1032
Familial cancer	1032
Adenomas	1032
Adenomatous polyposis coli	1032
Adenomatous	1032
Cancer syndrome	1032
Polyposis	1032
Colorectal adenomas	1032
APC	1032
Adenomatous polyposis	1032
Apc	1032
Cancer	1032
FAP	1032
Polyposis coli	1032
Autosomal dominant familial cancer syndrome	1032
Oral cancer	1033
Tumor	1033
Cancer	1033
Hypotonia	1034
Neurological abnormalities	1034
Lesch-Nyhan	1034
X-linked recessive genetic disorder	1034
Choreoathetosis	1034
Deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme	1034
Hyperuricaemia	1034
Recessive genetic disorder	1034
Genetic disorder	1034
LND	1034
Lesch-Nyhan disease	1034
A deficiency	1034
Cognitive impairment	1034
Diagnosis	1034
Dyskinetic cerebral palsy	1034
Disorder	1034
CNSHA	1035
Hemolysis	1035
Chronic non-spherocytic hemolytic anemia	1035
Hemolytic anemia	1035
Pallor and jaundice	1035
G6PD A	1035
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	1035
Anemia	1035
G6PD deficiency	1035
Bipolar disorders	1037
Mental illness	1037
Bipolar I disorder	1037
Bipolar disorder	1037
Criteria	1037
Diagnosis	1037
Disorder	1037
Macular function	1038
Visual disturbances	1038
SD	1038
Total error score	1038
Visual dysfunction	1038
Visual acuity	1038
Epilepsy	1038
CBZ	1038
TES	1038
Color perception defects	1038
VPA	1038
Rieger syndrome	1039
Axenfeld-Rieger syndrome	1039
METHODS	1039
Hypothesis	1039
Associated	1039
ARS	1039
Axenfeld-Rieger	1039
Disorder	1039
Deafness	1040
PDS	1040
Pendred syndrome	1040
Recessive disorder	1040
A syndrome	1040
Goiter	1040
Autosomal recessive disorder	1040
Diagnosis	1040
Disorder	1040
GT	1041
DQ	1042
Associated	1042
Obese	1043
Prader-Willi	1043
Prader-Willi syndrome	1043
PWS	1043
Obesity	1043
AS	1043
Angelman syndromes	1043
Mentally retarded	1043
Hyperphagia	1043
Polycystic kidney disease	1044
Autosomal dominant	1044
ADPKD	1044
AT	1044
Kidney disease	1044
CRI	1044
Autosomal dominant polycystic kidney disease	1044
Leukodystrophy	1045
Hydrolysis	1045
Metachromatic leukodystrophy	1045
Galactose	1045
Diagnosis	1045
XOA	1046
Albinism	1046
Diagnosis	1046
AN	1047
Aniridia	1047
Nasal primordia	1047
Congenital aniridia	1047
Hereditary breast cancer	1048
Breast cancer	1048
Ovarian cancer	1048
Breast/ovarian	1048
Breast and/or ovarian cancer	1048
Breast/ovarian cancer	1048
Cancer	1048
Italian breast/ovarian cancer	1048
Italian breast and/or ovarian cancer	1048
Female breast cancer	1048
ACADM	1049
Ataxia-telangiectasia-like disorder	1050
III	1050
Ataxia	1050
ATM	1050
Chromosomal instability	1050
ATM deficiency	1050
Nijmegen breakage syndrome	1050
Disorder	1050
Ataxia-telangiectasia	1050
Centre D	1051
Neuromuscular diseases	1052
Becker muscular dystrophy	1052
Neuromuscular disorders	1052
BMD	1052
X-linked muscular dystrophy	1052
Muscular dystrophy	1052
Various neuromuscular disorders	1052
Duchenne muscular dystrophy	1052
DMD	1052
Ataxia	1053
ATM	1053
Cancer	1053
Disorder	1053
Ataxia-telangiectasia	1053
Inherited metabolic disorders	1054
Associated	1054
Gangliosidosis	1054
Sandhoff disease	1054
HEXB	1054
Lysosomal beta-hexosaminidase	1054
Metabolic disorders	1054
Diagnosis	1054
Peripheral atherosclerosis	1055
Myeloma	1055
Hyperbeta lipoproteinemia	1055
Autoimmune hyperlipidemia	1055
Hyperlipidemia	1055
Autoimmune	1055
Multiple myeloma	1055
Hyper-IgA globulinemia	1055
Xanthomas	1055
Atherosclerosis	1055
Atherosclerotic lesions	1055
Plasma	1055
Xanthomatosis	1055
PKU	1056
Serbia	1056
Associated	1056
Inborn error of amino acid metabolism	1056
Phenylketonuria	1056
Total deficiency	1057
C6 deficiency	1057
Associated	1057
C6-deficient	1057
Total C6 deficiency	1057
Deficiency of the sixth component of human complement	1057
Meningococcal disease	1057
Recurrent disease	1057
Molecular defects	1057
FSD	1058
GM2 gangliosidosis	1058
SD	1058
Associated	1058
Autosomal recessive GM2 gangliosidosis	1058
Gangliosidosis	1058
Sandhoff disease	1058
From SD mice	1058
HEXB	1058
Neurosomatic	1058
Lysosomal beta-hexosaminidase	1058
Alpha	1058
Linkage disequilibrium	1059
METHODS	1059
Spondylitis	1059
AS	1059
Associated	1059
Ankylosing spondylitis	1059
Prader-Willi	1060
Prader-Willi syndrome	1060
Hypotonia	1060
PWS	1060
Obesity	1060
Postnatal growth retardation	1060
Motor delay	1060
Feeding difficulties	1060
Growth	1060
Uniparental disomy	1060
Maternal uniparental disomy 14	1060
Associated	1060
Growth retardation	1060
Neonatal feeding problems	1060
Muscular hypotonia	1060
Maternal uniparental disomy	1060
Criteria	1060
METHODS	1061
DM	1061
Inheriting diabetes	1061
OBJECTIVES	1061
Diabetes mellitus	1061
B  rjeson-Forssman-Lehman syndrome	1062
Rjeson-Forssman-Lehman syndrome	1062
Mental retardation	1062
X-chromosome linked mental retardation syndrome	1062
Diagnosis	1062
BFLS	1062
Retinal dystrophy	1063
METHODS	1063
RDS	1063
Retinitis pigmentosa	1063
Associated	1063
OBJECTIVES	1063
Macular dystrophy	1063
Stargardt-like macular dystrophy	1063
Classic retinitis pigmentosa	1063
Fundus flavimaculatus	1063
Retinal disease	1063
Pattern dystrophy	1063
Tumor	1064
Tumor necrosis	1064
ONL	1064
Apoptosis	1064
Necrosis	1064
Retinal detachment	1064
METHODS	1064
Growth	1064
Ganglion cell layer	1064
Retinal layers	1064
RD	1064
Photoreceptor degeneration	1064
Associated	1064
TNF	1064
Outer nuclear layer	1064
Alpha	1064
Cardiac defect	1065
Cardiac	1065
VCFS	1065
DiGeorge/velocardiofacial syndrome	1065
Velocardiofacial syndrome	1065
DiGeorge syndrome	1065
Congenital anomalies	1065
DGS	1065
Diagnosis	1065
Disorder	1065
Prenatal diagnosis	1065
FH	1066
MD	1066
Associated	1066
Neisseria	1066
Neisseria meningitidis	1066
Factor H	1066
Meningococcal disease	1066
PKU	1067
Deficiency of phenylalanine hydroxylase	1067
EC	1067
Hypothesis	1067
Autosomal recessive metabolic disorder	1067
Metabolic disorder	1067
A deficiency	1067
Phenylketonuria	1067
Disorder	1067
Developmental delay	1068
Muscular dystrophy	1068
Duchenne muscular dystrophy	1068
DMD	1068
Autosomal dominant	1069
Autosomal dominant cancer predisposition syndrome	1069
Autosomal dominant cancer	1069
Hereditary nonpolyposis colorectal cancer	1069
Genetic testing	1069
Colorectal cancer	1069
Colon cancer	1069
Cancer	1069
Type IV	1070
Ehlers-Danlos syndrome	1070
III	1070
Type IV Ehlers-Danlos syndrome	1070
Autosomal dominant	1071
Pfeiffer syndrome	1071
Digital abnormalities	1071
Growth	1071
Craniofacial involvement and hand abnormalities	1071
Craniofacial involvement	1071
Autosomal dominant condition	1071
Craniosynostosis	1071
Characteristic of the craniosynostosis syndromes	1071
Craniosynostosis syndromes	1071
Aarskog-Scott syndrome	1072
Tumor	1073
HNPCC	1073
Extra-colonic cancers	1073
Gastric cancer	1073
METHODS	1073
Microsatellite instability	1073
Microsatellite stable	1073
Colorectal cancer	1073
Cancers	1073
Polyposis	1073
Hereditary colorectal cancer	1073
Hereditary non-polyposis colorectal cancer	1073
MSS tumors	1073
Cancer	1073
Tumors	1073
MSI-H tumors	1073
MSI	1073
MSS	1073
Diagnosis	1073
C7 deficiency	1074
C7 defects	1074
Associated	1074
Complement C7 deficiency	1074
Molecular defects	1074
Hypotonia	1075
Microcephaly	1075
Feeding difficulties	1075
Mental retardation	1075
Other abnormalities	1075
Vomiting	1075
Newborns	1075
Cerebral atrophy	1075
Autism	1075
Deficiency of dihydropyrimidine dehydrogenase	1075
DPD-deficiency	1075
Inborn error of pyrimidine metabolism	1075
Slight motor retardation	1075
Hypertonia	1075
A deficiency	1075
DPD deficiency	1075
DPD	1075
Generalized hypotonia	1075
Atrophy	1075
Tumor	1076
Autosomal dominant	1076
Hemangioblastoma	1076
Hypoxia	1076
Vasoproliferative tumors	1076
Vasoproliferative tumor	1076
VHL tumor	1076
Growth	1076
Ocular tumor	1076
Von Hippel-Lindau disease	1076
Defect of the VHL tumor	1076
Vasoproliferative retinal tumor	1076
Autosomal dominant disease	1076
Retinal hemangioblastoma	1076
Large retinal hemangioblastomas	1076
Associated	1076
Von Hippel-Lindau [VHL] disease	1076
Hypoxia-inducible factor 1alpha	1076
Von Hippel-Lindau	1076
Vascular lesions	1076
Retinal lesions	1076
VHL disease	1076
Tumors	1076
Retinal vascular lesions	1076
Loss of heterozygosity	1076
Hemangioblastomas	1076
VHL	1076
AGU	1077
Lysosomal disorders	1077
Aspartylglucosaminuria	1077
Neuronal ceroid lipofuscinosis	1077
Cardiac arrhythmias	1078
Arrhythmias	1078
Myotonic dystrophy	1078
DM	1078
Cardiac	1078
Symptoms of the disease	1078
Central nervous system	1078
Muscle wasting	1078
CNS	1078
DMPK	1078
Muscular dystrophy	1078
DM1	1078
Alzheimer's disease	1079
Mediterranean fever	1079
METHODS	1079
AD	1079
Fever	1079
Associated	1079
Familial Mediterranean fever	1079
X-linked RP	1080
METHODS	1080
XLRP	1080
RP	1080
XLRP status	1080
Retinitis pigmentosa	1080
Myopia	1080
Lysosomal storage disease	1081
Neuromotor disabilities	1081
Neuropathological abnormalities	1081
Biochemical abnormalities	1081
Deficiency of arylsulfatase A	1081
Leukodystrophy	1081
Neuromotor disability	1081
Metachromatic leukodystrophy	1081
Associated	1081
Demyelination	1081
Galactocerebroside	1081
Central nervous system	1081
Gangliosides	1081
CNS	1081
MLD	1081
UEY	1082
Rous sarcoma	1082
PMD	1083
Wild type	1083
Hypomyelination	1083
CNS	1083
Pelizaeus-Merzbacher disease	1083
MBP	1083
Dysmyelinating	1083
Dysmyelination	1083
Encephalopathy	1084
Coma	1084
Proximal myopathy	1084
Medium	1084
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency	1084
Renal, cardiac and hepatic failures	1084
Medium-chain acyl-CoA dehydrogenase deficiency	1084
Myopathy	1084
Cardiac	1084
MCAD deficiency	1084
Diagnosis	1084
Disorder	1084
Mesenchymal tumors	1085
GISTs	1085
Growth	1085
Non-GIST mesenchymal tumors	1085
Gastrointestinal stromal tumors	1085
GIST	1085
Tumors	1085
Diagnosis	1085
Alpha	1085
Human disease	1086
Macular degeneration	1086
Retinitis pigmentosa	1086
Associated	1086
Retinal diseases	1086
Retinal disease	1086
Lysosomal storage disorder	1087
Mucopolysaccharidosis	1087
Maroteaux-Lamy syndrome	1087
Mucopolysaccharidosis type VI	1087
MPS VI	1087
Deficiency of ARSB	1087
A deficiency	1087
Disorder	1087
HDL	1088
III	1088
LCAT deficiency	1088
Alpha	1088
FADD	1089
Breast cancer	1089
Cancer	1089
Familial breast cancer	1089
Dystrophinopathy	1090
X-linked dilated cardiomyopathy	1090
Myopathy	1090
Skeletal myopathy	1090
XLDCM	1090
Dilated cardiomyopathy	1090
Cardiomyopathy	1090
Muscular dystrophy	1090
Duchenne muscular dystrophy	1090
DMD	1090
Myocardial involvement	1090
Prader-Willi	1091
Prader-Willi and Angelman syndromes	1091
Developmental delay	1091
METHODS	1091
Angelman syndromes	1091
Uniparental disomy	1091
Angelman syndrome	1091
Paternal uniparental disomy	1091
Associated	1091
ASD	1091
Autism	1091
Methylation abnormalities	1091
Autism spectrum disorders	1091
FMF	1092
Mediterranean fever	1092
CC	1092
US	1092
TT	1092
Fever	1092
Associated	1092
Secondary amyloidosis	1092
Amyloidosis	1092
Familial Mediterranean fever	1092
Tumor	1093
GISTs	1093
Neurofibromatosis	1093
US	1093
Familial GIST syndrome	1093
Gastrointestinal stromal tumors	1093
GIST	1093
Neurofibromatosis 1	1093
Tumors	1093
Diagnosis	1093
Gastric GISTs, tumors	1093
Murine hematopoiesis	1094
CSF	1094
Polyuria	1095
Nephrogenic diabetes insipidus	1095
Polydipsia	1095
NDI	1095
Diabetes insipidus	1095
Papillon-Lef  vre syndrome	1096
PLS	1096
Periodontal disease	1096
Impacts	1096
Alveolar	1096
Palmoplantar hyperkeratosis of the skin	1096
Palmoplantar hyperkeratosis	1096
Emphasis	1097
Peroxisomal disorders	1098
Human disease	1098
Cerebro-hepato-renal syndrome	1098
Emphasis	1098
Malfunction	1098
Vestigial structure	1098
Associated	1098
Peroxisomal disease	1098
Zellweger cerebro-hepato-renal syndrome	1098
Zellweger	1098
Cellular abnormalities	1099
WASP	1099
WAS	1099
Wiskott-Aldrich syndrome	1099
Tumor	1100
Familial adenomatous polyposis	1100
Adenomatous	1100
Polyposis	1100
Autosomal-dominant cancer predisposition syndrome of the colorectum	1100
APC	1100
Adenomatous polyposis	1100
Cancer	1100
Microglia	1101
Apoptosis	1101
METHODS	1101
Vesicular trafficking	1101
RS	1101
Retinoschisin-deficient	1101
Photoreceptor degeneration	1101
Rs1h-deficiency	1101
Retinoschisis	1101
X-linked juvenile retinoschisis	1101
Unexplained pericarditis	1103
Her pericarditis	1103
METHODS	1103
Sporadic hyperphosphatasia syndrome	1103
Symmetric hyperostosis	1103
Radiographic abnormalities	1103
Familial expansile osteolysis	1103
Accelerated skeletal turnover	1103
Expansile skeletal hyperphosphatasia	1103
Hyperphosphatasemia	1103
Periostitis	1103
Gene defects	1103
ALP	1103
Osteocalcin and urinary hydroxyproline	1103
OPG deficiency	1103
Restrictive lung disease	1103
Widespread periostitis	1103
Vascular mortality	1104
Excess second cancers	1104
Hodgkin lymphoma	1104
METHODS	1104
Solid tumors	1104
Immunologic impairment	1104
Lung cancer	1104
Non-Hodgkin lymphomas	1104
Thyroid cancer	1104
Cancers	1104
Lymphoma	1104
Associated	1104
Hairy cell leukemia	1104
Hodgkin lymphomas	1104
Treatment modalities	1104
Lymphomas	1104
Non-Hodgkin lymphoma	1104
Cancer	1104
Leukemia	1104
Tumors	1104
Thyroid cancers	1104
Decrease in lung cancer	1104
Diagnosis	1104
Excess	1104
Non-Hodgkin lymphoma, and thyroid cancer	1104
CETP	1105
HDL	1105
Associated	1105
Coronary heart disease	1105
CHD	1105
Heart disease	1105
Plasma	1105
Upper respiratory tract infection	1106
Glomerular	1106
Uremic syndrome	1106
Complete factor H deficiency	1106
FH	1106
Acute renal failure	1106
Episodes	1106
HUS	1106
Micro-angiopathic hemolytic anemia	1106
Glomerular involvement	1106
Complement dysregulation	1106
Hemolytic anemia	1106
FH deficiency	1106
Renal failure	1106
Factor H deficiency	1106
Associated	1106
AHUS	1106
Factor H	1106
Complete FH deficiency	1106
Anemia	1106
Plasma	1106
Hemolytic uremic syndrome	1106
Pits in the lower lip and bilateral cleft of the lip	1107
Cleft palate	1107
Van Der Woude Syndrome	1107
Van der woude syndrome	1107
III	1108
NM	1108
Von Willebrand	1108
COS	1108
Type I	1108
VWF	1108
Alpha	1108
Bleeding disorder	1109
Growth	1109
IX-deficient	1109
Epidermal growth	1109
Hemophilia B	1109
Diagnosis	1109
Disorder	1109
Prenatal diagnosis	1109
Hemophilia	1109
FMF	1110
Mediterranean fever	1110
MEFV	1110
METHODS	1110
Serositis	1110
Leukocytosis	1110
Fever	1110
Rare disease	1110
Familial Mediterranean fever	1110
Becker muscular dystrophy	1111
METHODS	1111
AIMS	1111
BMD	1111
Muscular dystrophy	1111
Duchenne muscular dystrophy	1111
DMD	1111
Diagnosis	1111
Prenatal diagnosis	1111
Familial cancer	1112
Breast cancer	1112
Breast cancers	1112
Medullary breast cancer	1112
Cancers	1112
Associated	1112
Cancer	1112
Xenopus laevis	1113
Gorilla gorilla	1113
Tumor	1114
Oligodendrogliomas	1114
Neuropathology	1114
Tumors	1114
III	1115
Alpha	1115
METHODS	1116
Von Willebrand	1116
Von Willebrand disease	1116
Multimeric VWF	1116
VWF	1116
Plasma	1116
Ovarian carcinoma	1117
Simple abnormalities	1117
Ovarian cancer	1117
Cytogenetic abnormalities	1117
AS	1117
AC	1117
Residual tumour	1117
Seropapillary tumours	1117
Carcinoma	1117
Associated	1117
Tumours	1117
Prognostic impact of chromosome aberrations	1117
Cancer	1117
Malignant ovarian tumours	1117
Tumour	1117
Premature	1118
FMF	1119
Mediterranean fever	1119
MEFV	1119
METHODS	1119
Autosomal-recessive disease	1119
Fever	1119
Associated	1119
Recessive disease	1119
Diagnosis	1119
Familial Mediterranean fever	1119
Angelman syndrome	1120
HH	1121
Haemochromatosis	1121
Hereditary haemochromatosis	1121
Ovarian cancer	1122
Epithelial ovarian cancer	1122
Breast and epithelial ovarian cancer	1122
Cancer	1122
Breast and ovarian cancer	1122
X-linked congenital stationary night blindness	1123
Blindness	1123
X-linked CSNB	1123
GLD	1124
Lysosomal storage disorders	1124
Neurological disorder	1124
Galactocerebrosidase	1124
Leukodystrophy	1124
Krabbe disease	1124
Central nervous system	1124
Globoid cell leukodystrophy	1124
CNS	1124
Disorder	1124
Tumor	1125
Pediatric kidney cancer	1125
Denys-Drash syndromes	1125
Wilms' tumor	1125
Pseudohermaphroditism	1125
Variety of disorders	1125
M  llerian duct syndrome	1125
Cancer	1125
Phenotypic anomalies	1125
Denys-Drash syndrome	1125
Kidney cancer	1125
Intestinal cancer	1126
Adenomatous polyposis coli	1126
Colonic polyps	1126
Adenomatous	1126
Juvenile polyps	1126
Autosomal recessive condition	1126
Polyposis syndromes	1126
Colorectal cancer	1126
Polyposis	1126
AFAP	1126
MYH-associated polyposis	1126
Associated	1126
Familial adenamatous polyposis	1126
Juvenile polyposis	1126
Adenomatous polyposis	1126
Cancer	1126
Juvenile polyposis syndrome	1126
FAP	1126
MYH	1126
Polyposis coli	1126
Polyps	1126
DiGeorge/velo-cardio-facial syndrome	1127
Immunodeficiency	1127
Cognitive deficits	1127
Palatal defects	1127
Hypocalcemia	1127
Minor ear anomalies	1127
Galactose metabolism	1128
Galactose	1128
Bretschneider, T	1129
Alpha	1129
Hypoxanthine phosphoribosyl transferase deficiency	1130
Lesch-Nyhan	1130
Neuropsychiatric	1130
Lesch-Nyhan disease	1130
HPRT deficiency	1130
A deficiency	1130
Neuropsychiatric symptoms	1130
Neuroblastoma	1130
Aneuploidy	1131
Uniparental disomy	1131
Associated	1131
Genetic disorder	1131
Isodisomy	1131
Disorder	1131
Haploinsufficiency of numerous	1132
Smith-Magenis syndrome	1132
METHODS	1132
Associated	1132
Cleft palate	1132
Congenital anomalies	1132
Psychomotor delay	1132
SMS	1132
Visual acuity	1133
Autosomal dominant	1134
Van der Woude syndrome	1134
Cheiloplasty and/or palatoplasty	1134
Associated	1134
Isolated clefts	1134
Lip pits	1134
Cleft lip/palate	1134
Brazil, emphasizing the range of anomalies	1134
Growth	1135
Sarcoma of dermal	1135
Dermatofibrosarcoma protuberans	1135
Type I	1135
DFSP	1135
Alpha	1135
Galactosemia	1136
Disease information	1136
Recessive disorder	1136
Galactose	1136
Autosomal recessive disorder	1136
Criteria	1136
Disorder	1136
Classical galactosemia	1136
Lange syndrome	1137
Mental and growth retardation	1137
Characteristic facial anomalies	1137
Facial anomalies	1137
Growth	1137
Growth retardation	1137
CdLS	1137
Cornelia-de Lange syndrome	1137
Congenital disorders	1137
HDL	1138
Obesity	1138
Associated	1138
Coronary artery disease	1138
Plasma	1138
Ovarian cancer	1139
Breast/ovarian	1139
METHODS	1139
Breast and/ovarian cancer	1139
Kerala	1139
Breast-ovarian	1139
Hereditary Breast/Ovarian cancer	1139
Breast-ovarian cancer	1139
Hereditary breast and breast-ovarian cancer	1139
Breast/ovarian cancer	1139
Cancer	1139
Breast/Ovarian cancer	1139
Prader-Willi	1140
Prader-Willi syndrome	1140
PWS	1140
AS	1140
AS-PWS	1140
Mental retardation	1140
Angelman syndrome	1140
Ataxia	1140
Neurodevelopmental disorder	1140
Disorder	1140
Pseudohypertriglyceridaemia	1141
Muscular weakness	1141
Adrenal hypoplasia	1141
Congenital adrenal hypoplasia	1141
Hyperpotassaemia	1141
Acidosis	1141
Congenital suprarenal hypoplasia	1141
Hyponatraemia	1141
Mental retardation	1141
Progressive muscular weakness	1141
Suprarenal hypoplasia	1141
Duchenne's muscular dystrophy	1141
Duchenne'	1141
Vomiting	1141
Weakness	1141
Associated	1141
Metabolic acidosis	1141
Hypoglycaemia	1141
AHC	1141
Complex glycerol kinase (GK) deficiency	1141
Muscular dystrophy	1141
GK deficit	1141
Hydroelectrolytic disorders	1141
Moderate mental retardation	1141
DMD	1141
Hypoplasia	1141
Rare disease	1141
Plasma	1141
Ketoacidosis	1141
Glycerol kinase deficiency	1141
Inherited deficiency	1142
Mass spectrometry	1142
Medium	1142
Newborns	1142
Fatal disorder	1142
Deficiency of medium-chain acyl-CoA dehydrogenase	1142
Disorder	1142
Tumor	1143
Hypoxia	1143
Ovarian cancer	1143
Apoptosis	1143
Associated	1143
Cancer	1143
Behavior	1143
Breast and ovarian cancer	1143
VWD 1/N	1144
Recessive VWD type Normandy	1144
CB	1144
Von Willebrand	1144
Von Willebrand disease type 2	1144
Associated	1144
Von Willebrand disease	1144
A deficiency	1144
VWF	1144
VWD	1144
Hemophilia	1144
Skin fragility	1145
Patchy alopecia	1145
Dental abnormalities	1145
Alopecia	1145
Nail dystrophy	1145
Chondrosarcoma	1146
Multiple epiphyseal dysplasia	1146
Wiley-Liss	1146
Dysplasia	1146
C-terminal globular domain	1146
CTD	1146
Pseudoachondroplasia	1146
Behavior	1146
MED	1146
PSACH	1146
Autosomal recessive inborn error	1147
Mass spectrometry	1147
IVD deficiency	1147
Autosomal recessive inborn error of the leucine metabolism	1147
IVD	1147
IVA	1147
Deficiency of isovaleryl-CoA dehydrogenase	1147
Isovaleric acidemia	1147
Isovaleryl-CoA dehydrogenase	1147
Korean IVA	1147
A deficiency	1147
Alcoholism	1148
Unipolar depression	1148
FMF	1149
Mediterranean fever	1149
METHODS	1149
CC	1149
TT	1149
Fever	1149
Familial Mediterranean fever	1149
Infantile spasm syndrome	1150
XLMR	1150
X-linked mental retardation	1150
Non-syndromic X-linked mental retardation	1150
Mental retardation	1150
Partington syndrome	1150
Fragile XA syndrome	1150
Diagnosis	1150
Familial cancer syndrome	1151
Familial cancer	1151
Cerebellar haemangioblastoma	1151
Haemangioblastoma	1151
Familial RCC	1151
Renal cell carcinoma	1151
Hypothesis	1151
Familial and sporadic RCC	1151
Familial forms of kidney cancer	1151
Cancer syndrome	1151
RCC	1151
Retinal angioma	1151
Carcinoma	1151
Sporadic renal cell carcinoma	1151
Cancer	1151
FINDINGS	1151
VHL disease	1151
Von Hippel Lindau	1151
Kidney cancer	1151
Cell carcinoma	1151
VHL	1151
Autosomal dominant	1152
Autosomal recessive cancer	1152
Breast cancer	1152
Adult cancers	1152
Autosomal dominant cancer	1152
Ataxia	1152
Anaemia	1152
Colorectal cancer	1152
Cancers	1152
Associated	1152
Childhood cancer	1152
Cancer	1152
Fanconi anaemia	1152
Ataxia-telangiectasia	1152
METHODS	1153
Submicroscopic WT1 deletion	1153
Aniridia	1153
Tumour	1153
Wilms tumour	1153
Machado-Joseph disease	1154
Neuronal loss	1154
Spinocerebellar ataxia type 3	1154
Hypothesis	1154
Ataxia	1154
Spinocerebellar ataxia	1154
Toxic fragment hypothesis	1154
Associated	1154
Movement disorder	1154
Neurodegenerative movement disorder	1154
MJD	1154
SCA3	1154
Brain of Machado-Joseph disease	1154
Neuroblastoma	1154
Disorder	1154
Genomic instability	1155
Ataxia	1155
Recessive disorder	1155
Immunodeficiency	1155
ATM	1155
Cancer	1155
A-T	1155
DSB	1155
Autosomal recessive disorder	1155
Neurodegeneration	1155
Disorder	1155
Ataxia-telangiectasia	1155
Diagnosis	1156
HH	1157
Disorders particularly liver disease	1157
Wild type	1157
Associated	1157
Genetic disease	1157
Liver disease	1157
Hemochromatosis	1157
Hereditary Hemochromatosis	1157
Alpha	1157
Hereditary hemochromatosis	1157
Tumor	1158
Metastatic tumors	1158
Breast cancer	1158
Cancers	1158
Breast carcinomas	1158
Cancer	1158
Carcinomas	1158
Tumors	1158
Glycosphingolipid in the renal glomeruli	1159
Alpha-galactosidase	1159
Lysosomal storage disease	1159
Angiokeratomas	1159
Alpha-galactosidase A	1159
X-linked recessive disorder	1159
FD	1159
Renal disease	1159
Recessive disorder	1159
Cardiac	1159
Nephrotic range	1159
Hypertension	1159
Neuropathic	1159
Cardiac, renal or cerebrovascular complications	1159
Fabry kidney disease	1159
Deficiency of lysosomal alpha-galactosidase A	1159
Proteinuria	1159
Corneal lesions	1159
Microscopic hematuria	1159
X-linked disorder	1159
Kidney disease	1159
LSD	1159
Fabry disease	1159
A deficiency	1159
Lipiduria	1159
Dialysis	1159
Disorder	1159
End-stage renal disease	1159
Hematuria	1159
Alpha	1159
Thyroidectomy	1160
Neuromuscular disorders	1160
Myotonic dystrophy	1160
Total thyroidectomy	1160
Fragile X (FRAX) syndrome	1161
Fragile X	1161
Mental retardation	1161
Fragile X mental retardation	1161
Delay eyeblink conditioning	1161
FRAX	1161
Linkage disequilibrium	1162
American (GEC) consortia	1162
Chromosomal abnormalities	1162
Lymphoproliferative disorders	1162
Chronic lymphocytic leukemia	1162
CLL	1162
Leukemia	1162
NPL	1162
Congenital heart disease	1163
Glucose-6-phosphate dehydrogenase deficiency	1163
Heart disease	1163
Bacterial infections	1164
Lupus erythematosus	1164
C4	1164
Neutrophilic leukocytosis	1164
Hereditary deficiency of the fifth component of complement	1164
Leukocytosis	1164
C5D	1164
Glomerulonephritis	1164
C5 deficiency	1164
Arthritis	1164
Systemic lupus erythematosus	1164
Vasculitis	1164
C5-deficient	1164
HRPC	1165
METHODS	1165
Growth	1165
Advanced hormone-refractory prostate cancers	1165
Cancers	1165
Associated	1165
AIM	1165
Prostate cancers	1165
Metastatic disease	1165
Cancer	1165
Refractory prostate cancer	1165
Prostate cancer	1165
Deficiency of arylsulfatase A	1166
Sphingolipid activator B deficiency	1166
Leukodystrophy	1166
Metachromatic leukodystrophy	1166
Genetic disease	1166
Metachromatic leukodystrophies	1166
MLD	1166
Diagnosis	1166
Submicroscopic copy number variations	1167
Developmental delays	1167
Inherited eye abnormality	1167
Chromosomal abnormalities	1167
Associated	1167
Central nervous system	1167
Cancer	1167
Aniridia	1167
Diagnosis	1167
Hearing loss	1169
Autosomal recessive non-syndromic hearing loss	1169
Non-syndromic hearing loss	1169
Associated	1169
Breast cancer	1170
Ovarian cancer	1170
Hypothesis	1170
Cancers	1170
Breast and ovarian cancers	1170
Ovarian cancers	1170
Cancer	1170
Breast and ovarian cancer	1170
Other cancers	1170
Breast , ovarian , or other cancers	1170
Activation-induced cell death	1171
ALPS	1171
Autoimmune lymphoproliferative syndrome	1171
Apoptosis	1171
Fas deficiency	1171
AICD	1171
Autoimmune	1171
Perforin-deficient	1171
Fas-deficient	1171
Canavan disease	1172
Dysautonomia	1172
Bloom syndrome	1172
AJ	1172
Sachs disease	1172
Gaucher disease	1172
Genetic testing	1172
Familial dysautonomia	1172
Genetic disorders	1172
Gaucher	1172
Mucolipidosis IV	1172
Recessive genetic disorders	1172
Anemia	1172
Fanconi anemia	1172
Fanconi anemia type C	1172
Type IV	1174
Ehlers-Danlos syndrome	1174
Hereditary disorder	1174
III	1174
Growth	1174
Ehlers-Danlos syndrome type IV	1174
EDS	1174
Type IV EDS	1174
EDS IV	1174
Disorder	1174
Carotidcavernous fistula	1174
Deficiency of the ninth component of human complement	1175
Deficient individuals	1175
C9 deficiency	1175
Complement deficiency	1175
Meningitis	1175
Japanese complement C9 deficiency	1175
C9-deficient	1175
Meningococcal meningitis	1175
Phlebotomy therapy can avert serious chronic disease	1176
Cirrhosis	1176
Absence of cirrhosis	1176
Hemochromatosis	1176
Illness and early death	1176
Diagnosis	1176
Ataxia	1177
Premature	1177
ATM	1177
A-T	1177
Recessive disease	1177
Ataxia-telangiectasia	1177
Genetic lesion	1178
Muscular dystrophy	1178
Duchenne muscular dystrophy	1178
DMD	1178
Muscle symptoms	1180
VLCAD deficiency	1180
Cardiac	1180
Cardiac and muscle symptoms	1180
ACD	1180
Tumor	1181
Hereditary retinoblastoma	1181
Premature	1181
Nonocular tumors	1181
Retinoblastoma	1181
Heteroduplex	1181
Age at diagnosis	1181
Tumors	1181
Diagnosis	1181
Associated	1183
Blindness	1183
Color pigments	1183
Abnormality of color perception	1183
GCL	1184
METHODS	1184
Neuronal dendrites	1184
Ganglion cell layer	1184
Central nervous system	1184
Corneal epithelium	1184
Tumor	1185
Rhabdomyosarcoma	1185
Alveolar rhabdomyosarcoma	1185
Alveolar	1185
Tumors	1185
Fragile ecosystems	1186
ADRP	1188
Autosomal dominant	1188
Autosomal dominant retinitis pigmentosa	1188
Retinitis pigmentosa	1188
AD	1189
WASP	1190
WAS	1190
X-linked thrombocytopenia	1190
Wiskott-Aldrich syndrome	1190
Thrombocytopenia	1190
Hypothyroidism	1191
PDS	1191
Hearing loss	1191
CH	1191
Congenital hypothyroidism	1191
Diagnostic criteria	1191
OMIM	1191
Pendred syndrome	1191
Recessive disorder	1191
Sensorineural hearing loss	1191
Thyroid dyshormonogenesis	1191
Autosomal recessive disorder	1191
Criteria	1191
Diagnosis	1191
Disorder	1191
X-linked dilated cardiomyopathy	1192
XLCM	1192
Vacuolar myopathy	1192
HCM	1192
Retinopathy	1192
Myopathy	1192
Cardiac	1192
Danon disease	1192
Hypertrophic cardiomyopathy	1192
Skeletal myopathy	1192
Cardiac pre-excitation	1192
Associated	1192
Pigmentary retinopathy	1192
Dilated cardiomyopathy	1192
Pigmentary dystrophy	1192
Cardiomyopathy	1192
DMD	1192
Diagnosis	1192
Neurological disorder	1193
Metabolism deficiencies	1193
PD	1193
CNS disorder	1193
Associated	1193
Ubiquitin-proteasome dysfunction	1193
CNS	1193
LND	1193
Basal ganglia disorder	1193
HPRT deficiency	1193
Lesch Nyhan disease	1193
Basal ganglia	1193
Neurodegeneration	1193
Disorder	1193
Ganglia	1193
WAGR syndrome	1194
Tumor	1194
Frasier syndrome	1194
FS	1194
WT1 haploinsufficiency	1194
Mental retardation	1194
XY	1194
Genital abnormalities	1194
Associated	1194
WAGR	1194
DDS	1194
Genitourinary abnormalities	1194
Genitalia	1194
Hypospadias	1194
Aniridia	1194
Cryptorchidism	1194
Denys-Drash syndrome	1194
Wilms tumor	1194
Tumor	1195
Apoptosis	1196
HD	1196
Associated	1196
Huntington disease	1196
Disorder	1196
Diabetic retinopathy	1197
PDT	1197
METHODS	1197
Retinopathy	1197
Macular degeneration	1197
Associated	1197
OBJECTIVES	1197
AMD	1197
Neovascular AMD	1197
Blindness	1197
Legal blindness group	1197
Tumor	1198
Bilateral retinoblastoma	1198
Hypermethylation	1198
Unilateral retinoblastoma	1198
Retinoblastoma	1198
Associated	1198
LOH	1198
Isolated unilateral retinoblastoma	1198
Tumors	1198
Multifocal tumors	1198
Tumor	1199
Genetic predisposition	1199
Adenomatous	1199
Dysmorphism	1199
OMIM	1199
Polyposis	1199
Familial Adenomatous polyposis	1199
Von-Hippel-Lindau syndrome	1199
APC	1199
Adenomatous polyposis	1199
Cancer	1199
VHL	1199
Oral cancer	1200
Aneuploidy	1200
Carcinomas than in the dysplasias	1200
Oral dysplasias	1200
Centrosome number	1200
Centrosome abnormalities	1200
Dysplasias	1200
Associated	1200
Tumours	1200
Squamous cell carcinomas	1200
OSCC	1200
Chromosomal instability	1200
Attenuated checkpoints	1200
Cancer	1200
CIN	1200
Centrosomal abnormalities	1200
Oral epithelial dysplasias	1200
Carcinomas	1200
Centrosome defects	1200
Tumor	1202
Retinoblastoma	1202
Unilateral tumors	1202
Tumors	1202
METHODS	1203
Hypercholesterolemic	1203
PS	1203
AIMS	1203
Plant sterols	1203
Hepatic inflammation	1204
FMF	1204
Mediterranean fever	1204
Necrosis	1204
MEFV	1204
Liver cell necrosis	1204
Bile duct injury	1204
Episodes	1204
Serositis	1204
Hereditary syndrome	1204
Fever	1204
Hepatitis	1204
Acute hepatitis	1204
Interface hepatitis	1204
Familial Mediterranean fever	1204
Spondylitis	1205
Ankylosing spondylitis	1205
Diagnosis	1205
METHODS	1206
Renal cell carcinoma	1206
RCC	1206
Carcinoma	1206
Tumours	1206
Von Hippel-Lindau	1206
Tumour	1206
Renal Cell Carcinoma	1206
Cell carcinoma	1206
VHL	1206
WASP	1208
Fatal lymphoreticular disease	1208
Wiskott-Aldrich syndrome	1208
Dementia	1210
Depression or dementia	1210
HD	1210
Degenerative disorders	1210
Huntington's disease	1210
Plasma	1210
HDL	1211
ApoM-deficient	1211
ApoM deficiency	1211
Associated	1211
Atherosclerosis	1211
Smaller atherosclerotic lesions	1211
Atherosclerotic lesions	1211
Plasma	1211
Alpha	1211
AT	1212
Alpha	1212
Hypothyroidism	1213
CH	1213
Congenital hypothyroidism	1213
DUOXA2 deficiency	1213
DUOX2 deficiency	1213
TSH	1213
Goiter	1213
Dyshormonogenic goiter	1213
Sachs disease	1214
Tay-Sachs	1214
Tay-Sachs disease	1214
Cerebellar degeneration	1215
Breast cancer	1215
Hodgkin lymphoma	1215
Ataxia	1215
Lymphoma	1215
Associated	1215
ATM	1215
Cancer	1215
A-T	1215
Leukemia	1215
Ataxia-telangiectasia	1215
Lesch-Nyhan syndrome	1216
Deficiencies of hypoxanthine-guanine	1216
Lesch-Nyhan	1216
Tumor	1217
Breast cancer	1217
Growth	1217
Cancer	1217
Apoptosis	1218
Neurodegenerative disorders	1218
MDA	1218
Malondialdehyde	1218
Tumor	1219
Tumor necrosis	1219
NFTC	1219
Necrosis	1219
Normophosphatemic familial tumoral calcinosis	1219
Recessive disorder	1219
Skin infections	1219
Associated	1219
TNF	1219
Trauma	1219
Autosomal recessive disorder	1219
Disorder	1219
Tumoral	1219
Alpha	1219
Tumor	1220
Inherited colorectal polyposis	1220
Familial adenomatous polyposis	1220
Adenomas	1220
Sporadic colorectal carcinogenesis	1220
Adenomatous polyps and . or colorectal cancer	1220
Neoplasia	1220
Increased adenoma formation	1220
Adenomatous	1220
Colorectal neoplasia	1220
Familial adenomatous polyposis syndrome	1220
Colorectal cancers	1220
Genetic testing	1220
Colorectal cancer	1220
Cancers	1220
Polyposis	1220
Associated	1220
Colorectal carcinogenesis	1220
Colorectal tumor	1220
APC	1220
Adenomatous polyposis	1220
Adenomatous polyps	1220
Cancer	1220
Age at diagnosis	1220
Diagnosis	1220
Polyps	1220
Tumor	1221
MEF death	1221
Apoptosis	1221
Ataxia	1221
Spontaneous lymphoma	1221
Burkitt lymphoma	1221
Colorectal cancer	1221
Lysosomal protein degradation	1221
Lymphoma	1221
Atm-deficient	1221
Cancer	1221
Ataxia telangiectasia	1221
Retinoblastoma	1222
Tumorigenesis	1222
Hypercoagulability	1224
SZ	1224
Von Willebrand	1224
Coronary heart disease	1224
CHD	1224
VWF	1224
Heart disease	1224
Breast cancer	1225
US	1225
Cancer	1225
Breast Cancer	1225
Diagnosis	1225
Hispanic	1225
Female breast cancer	1225
Iris hypoplasia	1226
Developmental defects	1226
Eye abnormalities	1226
Brain abnormalities	1226
Developmental abnormalities	1226
Associated	1226
Semidominant developmental disorders	1226
Aniridia	1226
Hypoplasia	1226
Developmental disorders	1226
Multisystem disease	1227
Osteopenia	1227
Cataracts	1227
Premature	1227
CTX	1227
Psychiatric symptoms	1227
SEP	1227
Atherosclerosis	1227
Neurological manifestations	1227
Ischemic heart disease	1227
Cerebrotendinous xanthomatosis	1227
Heart disease	1227
Plasma	1227
Xanthomatosis	1227
Osteoporosis	1227
Mental deterioration	1227
Sensory abnormalities	1228
FMR	1228
Fragile X	1228
WT	1228
Associated	1228
Hyperactivity	1228
Dopaminergic changes in 'fragile X	1228
X-linked disorder	1228
Anxiety	1228
Fragile X syndrome	1228
Disorder	1228
Autosomal recessive inborn error of metabolism	1229
PKU	1229
Major disease	1229
Autosomal recessive inborn error	1229
Derive denominators	1229
OMIM	1229
Phenylketonuria	1229
Autism	1230
Genetic instability	1230
RB	1231
Retinoblastoma	1231
Diagnosis	1231
Prenatal diagnosis	1231
Tumor	1232
Breast cancer	1232
HC	1232
Growth	1232
Hydrocortisone	1232
Cancer	1232
Tumorigenesis	1232
Obese	1233
Prader-Willi	1233
Prader-Willi syndrome	1233
PWS	1233
Obesity	1233
GH	1233
Cardiac illness	1233
Respiratory infection	1233
Prader-Willi Syndrome	1233
UPD15	1233
Cardiac	1233
Diagnosis	1233
Abnormality of the neural tube	1235
TWis/TWis	1235
Embryonic death	1235
T/T	1235
Becker muscular dystrophy	1236
Myotonic dystrophy	1236
Diagnostic criteria	1236
Duchenne and Becker muscular dystrophy	1236
Muscular dystrophy	1236
Criteria	1236
Familial adenomatous polyposis	1237
Desmoid tumors	1237
Adenomatous polyposis coli	1237
Gastric and desmoid tumors	1237
Adenomatous	1237
Colorectal tumorigenesis	1237
Polyposis	1237
Associated	1237
Extracolonic tumors	1237
Colorectal tumors	1237
Attenuated-type retained 2	1237
APC	1237
Adenomatous polyposis	1237
Tumorigenesis	1237
Tumors	1237
FAP	1237
Polyposis coli	1237
Gastric tumors	1237
FAP duodenal tumors	1237
Facioscapulohumeral muscular dystrophy	1238
FSH dystrophies	1238
Muscle disease	1238
Muscular dystrophy	1238
Duchenne muscular dystrophy	1238
DMD	1238
Carcinoma	1239
Associated	1239
Controls cervical cancer	1239
Cancer	1239
Benign parathyroid tumours	1240
Associated	1240
Tumours	1240
Parathyroid	1240
Various tumours	1240
Multisystem disease	1241
Myotonic dystrophy	1241
DMPK	1241
Muscular dystrophy	1241
Spasticity	1242
Autosomal recessive (AR) GTP cyclohydrolase I (GTPCH) deficiency	1242
Episodes	1242
Dystonia	1242
Movement disorder	1242
Extrapyramidal movement disorder	1242
Hyperphenylalaninemia	1242
Spasticity, dystonia	1242
Autosomal recessive GTP cyclohydrolase I deficiency	1242
CNS	1242
CSF	1242
Neurological symptoms	1242
GTPCH deficiency	1242
GTPCH I deficiency	1242
Diagnosis	1242
Disorder	1242
Hepatomegaly	1243
Hypotonia	1243
Facial dysmorphy	1243
METHODS	1243
Cerebro-hepato-renal syndrome	1243
Peroxisomal matrix protein import machinery	1243
Zellweger syndrome	1243
Peroxisomal alpha- and beta-oxidation	1243
Axial hypotonia	1243
Arterial hyperplasia	1243
Associated	1243
Hypoketotic dicarboxylic aciduria	1243
Recessive disorders	1243
Icterus, dystrophy	1243
Peroxisome biogenesis disorders	1243
Hyperplasia	1243
PEX14-deficient	1243
Genetic defect	1243
Zellweger	1243
Autosomal recessive disorders	1243
Hyperbilirubinaemia	1243
Plasma	1243
PEX14-deficiency	1243
Cholestasis	1243
Alpha	1243
Tumor	1244
Pancreatic cancer	1244
Solid tumors	1244
Cancers	1244
Cancer	1244
Tumors	1244
Pancreatic tumors	1244
Other cancers	1244
Cardiac	1245
HD	1246
Huntington disease	1246
Healthy donors	1247
Spondylitis	1247
AS	1247
Injury of arthrosis	1247
Autoimmune	1247
Ankylosing spondylitis	1247
Autoimmune diseases	1247
Donors	1247
Alpha	1247
Sensorineural deafness	1248
Type IV	1248
Deafness	1248
Mendelian inheritance disorders	1248
BS	1248
Bartter syndrome	1248
Chronic renal failure	1248
Hypokalaemic	1248
Inherited diseases	1248
Renal failure	1248
Neonatal volume depletion	1248
Genetic disorder	1248
Monogenic disorders	1248
SND	1248
Disorder	1248
Lesch-Nyhan syndrome	1249
Deficiency of HPRT	1249
Lesch-Nyhan	1249
X-linked recessive inborn error of metabolism	1249
OMIM	1249
Associated	1249
Neurological manifestations	1249
HPRT deficiency	1249
Partial deficiency	1249
Excess	1249
Dementia	1250
Linkage disequilibrium	1250
AD	1250
Associated	1250
A/T	1250
Alzheimer disease	1250
Tumor	1251
WT	1251
XY	1251
Associated	1251
Pseudohermaphroditism	1251
DDS	1251
Urogenital abnormalities	1251
DMS	1251
Denys-Drash syndrome	1251
Mesangial sclerosis	1251
Wilms tumor	1251
IDMS	1251
Defects in T cell maturation	1252
Apoptosis	1252
Growth	1252
Ataxia	1252
Thymomas	1252
Atm-deficient	1252
Pleiotropic defects	1252
Ataxia-telangiectasia	1252
Spondylitis	1253
AS	1253
Associated	1253
Ankylosing spondylitis	1253
Hurler/Scheie syndromes	1254
Mucopolysaccharidosis	1254
HD	1254
Mucopolysaccharidosis type I	1254
Associated	1254
Type I	1254
Huntington disease	1254
Huntington's disease	1254
Disorder	1254
Alpha	1254
Myotonia	1255
Non-dystrophic myotonia	1255
Weakness	1255
Dystrophic	1255
Hypertrophy	1255
Non-dystrophic myotonias	1255
Grip myotonia	1255
Absence of hypertrophy and exacerbation	1255
Tongue myotonia	1255
Dystrophic myotonia	1255
Percussion myotonia	1255
Lid myotonia	1255
Autosomal dominant	1256
HDL disorders	1256
Huntington disease-like 2	1256
HDL	1256
HD	1256
Ataxia	1256
Spinocerebellar ataxia	1256
Dentatorubralpallidoluysian atrophy	1256
Spinocerebellar ataxia 17	1256
Autosomal dominant disorder	1256
Huntington disease	1256
Diagnosis	1256
Disorder	1256
HDL2	1256
Autosomal dominant disorder of the nervous system	1256
Atrophy	1256
Apoptosis	1257
Glucosylceramide	1257
CNS disease	1257
Gaucher disease	1257
Wild type	1257
Gaucher	1257
CNS abnormalities	1257
CBE	1257
CNS	1257
Neuronopathic	1257
Glucocerebrosidase	1257
Conduritol B epoxide	1257
Histologic abnormalities	1257
Neuronal degeneration	1257
Neuronopathic Gaucher disease	1257
Mucopolysaccharidosis	1258
Mucopolysaccharidosis type I	1258
Type I	1258
Huntington disease	1258
Dysmorphism	1259
Skeletal abnormalities	1259
LGS	1259
Genetic defect	1259
Craniofacial dysmorphism	1259
Langer-Giedion syndrome	1259
METHODS	1260
CHED	1260
Associated	1260
Autosomal recessive congenital hereditary endothelial dystrophy	1260
Myotonic dystrophy	1261
DMPK	1261
Complement deficiency and disease	1262
Deficient individuals	1262
Complement deficiencies	1262
Complement deficiency	1262
Pyogenic infections and immune complex disease	1262
Associated	1262
Hereditary complement deficiencies	1262
Uremic syndrome	1263
CFH haploinsufficiency	1263
Complement factor H (CFH) deficiency	1263
Hemolytic and uremic syndrome	1263
C3 deposits	1263
Thrombotic microangiopathy	1263
Glomerulopathy	1263
Isolated C3 deposits	1263
Hemolytic anemia	1263
Renal failure	1263
Factor H deficiency	1263
Associated	1263
Kidney diseases	1263
CFH	1263
Factor H	1263
Thrombotic	1263
Glomerulonephritis	1263
Regulator abnormalities	1263
Complement factor H deficiency	1263
Anemia	1263
Plasma	1263
Sachs disease	1264
Tay-Sachs	1264
Gaucher disease	1264
Tay-Sachs disease	1264
Gaucher	1264
Associated	1264
Plasma	1264
Myotonic dystrophy	1265
DM	1265
Genetic disorder	1265
Dominantly inherited genetic disorder	1265
Dystrophia myotonica	1265
DMPK	1265
Muscular dystrophy	1265
DM1	1265
Disorder	1265
Breast cancer	1266
Ovarian cancer	1266
Breast/ovarian	1266
Breast / ovarian cancer	1266
German breast/ovarian cancer	1266
Breast-ovarian	1266
Breast-ovarian cancer	1266
Associated	1266
Breast/ovarian cancer	1266
Cancer	1266
Adenomatous polyposis coli	1267
Adenomatous	1267
HRT	1267
Colorectal cancer	1267
Polyposis	1267
Associated	1267
Colorectal carcinogenesis	1267
APC	1267
Adenomatous polyposis	1267
Cancer	1267
CRC	1267
Polyposis coli	1267
HNPCC	1268
METHODS	1268
Adenomatous	1268
Colorectal Cancer	1268
Colorectal cancer	1268
Polyposis	1268
Familial Adenomatous Polyposis	1268
Cancer	1268
FAP	1268
Hereditary Non-Polyposis Colorectal Cancer	1268
NPL	1268
Alpha	1268
Breast cancer	1269
AT	1269
Ataxia	1269
Recessive disorder	1269
Immunodeficiency	1269
Radiosensitivity	1269
ATM	1269
Cancer	1269
Genetic damage	1269
Ataxia telangiectasia	1269
Autosomal recessive disorder	1269
Disorder	1269
Breast cancer	1270
Ataxia	1270
ATM	1270
Cancer	1270
A-T	1270
Ataxia-telangiectasia	1270
A rare disorder	1271
Venous thrombosis	1271
Arterial and venous thrombosis	1271
Rare disorder	1271
Episodes	1271
Afibrinogenemia	1271
Associated	1271
Dysfibrinogenemia	1271
Thrombosis	1271
Buerger's disease	1271
Thrombotic	1271
Atherosclerosis	1271
Congenital afibrinogenemia	1271
Vasculitis	1271
Disorder	1271
Alpha	1271
Inherited metabolic disease	1272
FAO disorders	1272
Hypothesis	1272
CPT	1272
Metabolic disease	1272
METHODS	1273
Becker (BMD) muscular dystrophies	1273
Muscular dystrophies	1273
BMD	1273
DMD	1273
Diagnosis	1273
Adenocarcinoma of the esophagus	1274
METHODS	1274
EA	1274
Gastroesophageal reflux	1274
Carcinoma	1274
Lymphoma	1274
Associated	1274
Adenocarcinoma	1274
Esophageal atresia	1274
Cancer	1274
Leukemia	1274
Intestinal metaplasia	1274
Esophageal cancer	1274
Adjacent disease	1275
METHODS	1276
DZ	1276
Spondylitis	1276
AS	1276
Ankylosing spondylitis	1276
Criteria	1276
Diagnosis	1276
Familial adenomatous polyposis	1277
Adenomas	1277
FAP adenomas	1277
Adenomatous polyposis coli	1277
Colorectal polyps	1277
Colonic polyps	1277
METHODS	1277
Adenomatous	1277
Polyposis	1277
Colorectal adenomas	1277
APC	1277
Adenomatous polyposis	1277
Gastrointestinal polyps typically retaining	1277
Tumour	1277
Gastrointestinal polyps	1277
FAP	1277
Polyposis coli	1277
Loss of heterozygosity	1277
Polyps	1277
Paroxysmal nocturnal hemoglobinuria	1278
Healthy donors	1278
PNH	1278
METHODS	1278
Genetic abnormalities	1278
Donors	1278
Episodic ataxia	1279
Ataxia	1279
METHODS	1280
AL	1280
Acute leukemia	1280
Leukemia	1280
Tumor	1281
Familial adenomatous polyposis	1281
Adenomatous	1281
Tumorigenicity	1281
Polyposis	1281
Adenomatous polyposis	1281
Genomic disorder	1282
Prader-Willi	1282
Prader-Willi syndrome	1282
PWS	1282
Recurrence for the syndrome	1282
Donors	1282
Disorder	1282
Familial adenomatous polyposis	1283
Adenomas	1283
Ulcerative colitis	1283
FAP adenomas	1283
Adenomatous	1283
Polyposis	1283
Colorectal adenomas	1283
Adenomatous polyposis	1283
Dysplasia	1283
FAP	1283
Hepatocellular carcinoma	1284
Endocytosis	1284
Cirrhosis	1284
Carcinoma	1284
Fibrosis	1284
Porphyria	1284
Cutanea tarda	1284
Hemochromatosis	1284
Diagnosis	1284
Prader-Willi	1285
Prader-Willi syndrome	1285
PWS	1285
Schizophrenia	1285
Visuospatial	1285
Frontal dysfunction	1285
PWS-IC	1285
Autism	1285
Neurodevelopmental disorder	1285
Neuropsychiatric	1285
Frontal abnormalities	1285
Neuropsychiatric abnormalities	1285
Disorder	1285
Tumor	1286
Ovarian cancer	1286
Cancer	1286
Breast and ovarian cancer	1286
Breast and ovarian cancer-specific tumor	1286
Peroxisomal beta-oxidation	1287
ALDP	1287
Deficiency in ALDP	1287
X-ALD	1287
X-linked adrenoleukodystrophy	1287
ALD	1287
Adrenoleukodystrophy	1287
A deficiency	1287
Plasma	1287
Ameloblastomas	1288
Adenomatous polyposis coli	1288
Adenomatous	1288
OC	1288
Odontogenic tumors	1288
Cancers	1288
Polyposis	1288
Carcinoma	1288
Epithelial odontogenic tumors	1288
APC	1288
Adenomatous polyposis	1288
Odontogenic carcinoma	1288
Tumors	1288
Ameloblastoma	1288
Polyposis coli	1288
Genetic disease	1289
Sotos syndrome	1290
SoS	1290
Haploinsufficiency of the NSD1	1290
Familial adenomatous polyposis	1291
Obvious	1291
Cancers of the colon	1291
Adenomatous	1291
Colonic polyposis	1291
Colorectal carcinomas	1291
Cancers	1291
Colorectal neoplasias	1291
Polyposis	1291
APC	1291
Adenomatous polyposis	1291
Carcinomas	1291
Inherited familial syndromes	1291
Diagnosis	1291
Recessive multiple epiphyseal dysplasia	1292
Multilayered patella	1292
Multiple epiphyseal dysplasia	1292
Skeletal dysplasias	1292
Bone dysplasia	1292
Dysplasias	1292
Dysplasia	1292
Pseudoachondroplasia-MED bone dysplasia	1292
Pseudoachondroplasia	1292
MED	1292
RMED	1292
Von Willebrand factor ( vWf ) deficiency	1293
Human disease	1293
Vascular injury	1293
Von Willebrand	1293
Hemostasis	1293
Defective thrombosis	1293
Thrombosis	1293
Von Willebrand disease	1293
Plasma	1293
Associated	1294
Alpha-galactosidase	1295
Alpha-galactosidase A	1295
Cardiac	1295
Deficiency of the human lysosomal hydrolase alpha-galactosidase	1295
Genetic lesion	1295
Intronic lesion	1295
Fabry disease	1295
Genetic lesions	1295
Partial deficiency	1295
X-linked inborn error of glycosphingolipid metabolism	1295
Alpha	1295
Tumor	1296
Neoplasms	1296
Thymoma	1296
Myotonic dystrophy	1296
Genetic testing	1296
Diplopia	1296
Associated	1296
Myasthenia gravis	1296
Ptosis	1296
Multisystemic disorder	1296
Malignant neoplasms	1296
DMPK	1296
Myotonic discharges	1296
DM1	1296
Autosomal-dominant multisystemic disorder	1296
Diagnosis	1296
Disorder	1296
Potential target for the galactose chaperone; after the addition of galactose	1297
GM1-gangliosidosis	1297
Glycosphingolipid storage disorder	1297
METHODS	1297
Medium	1297
Lysosomal defects	1297
Beta galactosidases	1297
Gangliosidosis	1297
AIMS	1297
Galactose	1297
COS	1297
Neurodegenerative condition	1297
Disorder	1297
Alpha	1297
Molecular defect	1298
METHODS	1298
AT	1298
Recessive disorder	1298
Premature	1298
Heteroduplex	1298
Hereditary analbuminemia	1298
Analbuminemia	1298
Autosomal recessive disorder	1298
Diagnosis	1298
Disorder	1298
Tumor	1299
Growth	1299
Renal cell carcinoma	1299
RCC	1299
Carcinoma	1299
Associated	1299
Cell carcinoma	1299
FXS	1300
Fragile X	1300
Mental retardation	1300
Fragile X syndrome	1300
VPA	1300
Inherited mental retardation	1300
Quality of life via linear regression	1301
HD	1301
Genetic testing	1301
Huntington disease	1301
Pathophysiological abnormalities	1302
Cardiac	1302
Dystrophic	1302
Associated	1302
Dystrophic dystrophin	1302
Genetic disorder	1302
Muscle wasting	1302
Cardiac failure	1302
Muscular dystrophy	1302
Duchenne muscular dystrophy	1302
DMD	1302
Sarcolemma	1302
DGC	1302
Disorder	1302
A rare disorder	1304
Multilineage cytopenias	1304
ALPS	1304
Autoimmune lymphoproliferative syndrome	1304
Rare disorder	1304
Apoptosis	1304
CD	1304
Lymphoma	1304
TNF	1304
Autoimmune	1304
Autoimmune disorders	1304
Autoimmune diseases	1304
Rare disease	1304
Genetic defect	1304
Disorder	1304
Breast cancer	1305
AT	1305
Ataxia	1305
Recessive disorder	1305
Associated	1305
ATM	1305
Absence of disease	1305
Recessive disorders	1305
Studied ataxia telangiectasia	1305
Cancer	1305
Atherosclerosis	1305
Ataxia telangiectasia	1305
Heart disease	1305
Disorder	1305
Papillon-Lef  vre syndrome	1306
Hyperkeratosis of the palms of hands	1306
PLS	1306
METHODS	1306
PK	1306
Palmoplantar keratosis	1306
Recessive disorder	1306
Periodontitis	1306
Papilion-Lef  vre syndrome	1306
Autosomal recessive disorder	1306
Disorder	1306
Fragile X	1307
Mental retardation	1307
Fragile X mental retardation	1307
Involved in mental retardation	1307
Fragile X syndrome	1307
Inherited mental retardation	1307
Neurological disorders	1307
Tumor	1308
Short stature	1308
Hodgkin lymphoma	1308
Identified cancers	1308
Malignancy	1308
Cancers	1308
Carcinoma	1308
Lymphoma	1308
Nine of the 14 cancers	1308
Basal cell carcinoma	1308
Spectrum of cancer	1308
Non-Hodgkin lymphoma	1308
One tumor	1308
CHH	1308
Cancer	1308
Malignancies	1308
Leukemia	1308
Cartilage-hair hypoplasia	1308
Hypoplasia	1308
Chondrodysplasia	1308
Squamous cell carcinoma	1308
Diagnosis	1308
Cell carcinoma	1308
Autosomal recessive chondrodysplasia	1308
Growth	1309
Genetic disease	1309
Cancer	1309
Inherited disease	1309
III	1310
Von Willebrand	1310
Type III vWD	1310
Von Willebrand's disease	1310
VWF	1310
VWD	1310
Autosomal dominant	1311
METHODS	1311
RP	1311
Autosomal dominant retinitis pigmentosa	1311
Retinitis pigmentosa	1311
Retinal degeneration	1311
Associated	1311
Congenital amaurosis	1311
Autosomal dominant RP	1311
Leber congenital amaurosis	1311
Bleeding disorder	1312
Von Willebrand	1312
Mucocutaneous bleeding disorder	1312
Von Willebrand disease	1312
VWF	1312
VWD	1312
Plasma	1312
Disorder	1312
Tumor	1313
Adenomatous polyposis coli (APC) tumor	1313
Adenomatous polyposis coli	1313
Adenomatous	1313
Polyposis	1313
DDEF	1313
Associated	1313
APC	1313
Adenomatous polyposis	1313
Polyposis coli	1313
Adenomatous polyposis coli tumor	1313
Breast cancer	1314
Pancreatic cancer	1314
Breast cancers	1314
Sporadic breast cancers	1314
Cancers	1314
Adenocarcinomas	1314
Cancer	1314
Pancreatic cancers	1314
Other cancers	1314
Pancreatic adenocarcinomas	1314
Insulin-like growth	1315
Rhabdomyosarcoma	1315
Growth	1315
RMS	1315
Involvement of insulin-like growth	1315
Associated	1315
Alveolar	1315
Alveolar RMS	1315
ARMS	1315
Tumors	1315
Obesity/nonalcoholic fatty liver disease	1316
High fat	1316
Hepatic steatosis	1316
Adipose tissue	1316
Obesity	1316
METHODS	1316
HF	1316
SF	1316
Steatohepatitis	1316
Fibrosis	1316
Fatty liver	1316
Nonalcoholic fatty liver disease	1316
ACC	1316
Liver disease	1316
Fatty acid synthase	1316
FAS	1316
Standard fat	1316
Alpha	1316
Hepatic fibrosis	1316
Lesch-Nyhan	1317
Lesch-Nyhan disease	1317
Linkage disequilibrium	1319
NS/NS	1319
DQ	1319
NS	1319
Episodes	1319
LD	1319
Associated	1319
Donors	1319
Cancers	1320
Breast and ovarian cancers	1320
Ovarian cancers	1320
DSB	1320
Myotonia	1321
Myotonic dystrophy	1321
Emphasis	1321
Genetic defects	1321
Nondystrophic myotonias	1321
Myotonic dystrophies	1321
DMPK	1321
Myotonic disorders	1321
Tumor	1322
Tissue sarcomas	1322
Hospital of Philadelphia	1322
Neck tumors	1322
Sarcomas	1322
Pediatric undifferentiated soft tissue sarcomas	1322
Malignant rhabdoid tumor	1322
Genetic criteria	1322
Extremity tumors	1322
Small round blue cell tumors	1322
Soft tissue tumors	1322
Genetic abnormalities	1322
Five tumors	1322
Tumors	1322
Criteria	1322
Soft tissue sarcomas	1322
Diagnosis	1322
Paraspinal tumor	1322
Lipid storage disorder	1323
Medium	1323
Wilson disease	1323
Genetic disorder	1323
Niemann-Pick disease type C	1323
NPC	1323
Disorder	1323
Biliary copper excretion	1323
Type III von Willebrand disease	1324
Platelet vWF	1324
III	1324
Episodes	1324
Von Willebrand	1324
Von Willebrand disease	1324
VWF	1324
VWD	1324
Hemostatic process	1324
Wilson's disease	1325
Associated	1325
Disorder of copper homoeostasis	1325
Diagnosis	1325
Disorder	1325
Psychiatric abnormalities	1325
Ovarian carcinoma	1326
Adult granulose cell tumour	1326
Ovarian cancer	1326
METHODS	1326
Dysgerminoma	1326
III	1326
Stage III-IV disease	1326
Carcinoma	1326
Adenocarcinoma	1326
Cystic adenocarcinoma	1326
Cancer	1326
Tumour	1326
Diagnosis	1326
METHODS	1327
Mucopolysaccharidosis	1327
Keratan-sulfate	1327
IVA	1327
MPS IVA	1327
Deficiency of N	1327
A deficiency	1327
Genetic defect	1327
Enzyme deficiency	1327
Morquio A disease	1327
Mucopolysaccharidosis IVA	1327
Glycosaminoglycans	1327
METHODS	1328
Spinocerebellar ataxias	1328
Ataxia	1328
SD	1328
SCA	1328
AAO	1328
SCA2	1328
SCA1	1328
SCA3	1328
Spinocerebellar ataxias 1	1328
CAG repeat lengths	1328
METHODS	1329
New deficit	1329
Transient deficit	1329
Tumours	1329
Extraparenchymal lesions	1329
Vascular lesions	1329
MEP	1329
Symptoms of the disease	1330
Neurological status	1330
Phenylketonuric	1330
Phenylketonuria	1330
Myotonic dystrophy	1331
Muscular dystrophy	1331
Duchenne muscular dystrophy	1331
Myoblast culture	1331
Copper toxicosis	1332
WD	1332
Genetic mapping	1332
Wilson disease	1332
Copper overload disease	1332
Cirrhosis	1332
BAC	1332
Inherited disorder	1332
Autosomal recessive copper toxicosis	1332
Hepatic copper accumulation	1332
Liver disease	1332
Bedlington terriers	1332
Disorder	1332
Abnormal hepatic copper accumulation	1332
Autosomal dominant	1333
METHODS	1333
MD	1333
Growth	1333
Ultrasonographic eye length measurement	1333
Non-syndromic character of the refractive disorder	1333
NPL	1333
Disorder	1333
Myopia	1333
Muscular disorder	1335
Myotonic dystrophy	1335
DM	1335
DMPK	1335
Disorder	1335
Linkage disequilibrium	1336
Myotonic dystrophy	1336
DM	1336
Ataxia	1336
Friedreichs ataxia	1336
Maxillary deficiency	1337
Class III malocclusion	1337
III	1337
Growth	1337
Class III dentofacial	1337
Craniofacial disorders	1337
Class III	1337
Hispanic	1337
Protein C deficiency	1338
Hereditary deficiencies	1338
XI	1338
Protein S deficiency	1338
Antithrombin deficiency	1338
Non-deficient	1338
Hyperhomocysteinemia	1338
Thrombophilic defects	1338
Thromboembolism	1338
EDMD	1339
Cardiac defects	1339
Emery-Dreifuss muscular dystrophy	1339
Hypothesis	1339
Cardiac	1339
Associated	1339
Muscular dystrophy	1339
Prader-Willi	1340
Prader-Willi syndrome	1340
Hypotonia	1340
Infantile hypotonia	1340
Neurobehavioral disorder	1340
PWS	1340
Obesity	1340
Feeding difficulties	1340
Diagnostic criteria	1340
Angelman syndrome	1340
Prader-Willi/Angelman syndrome	1340
Neurobehavioral	1340
Hypogonadism	1340
Morbid obesity	1340
Hyperphagia	1340
Criteria	1340
Disorder	1340
Oculocerebrorenal syndrome	1341
Lowe syndrome	1341
Tubulopathy	1341
Neurological deficits	1341
X-linked disorder of phosphatidylinositol metabolism	1341
Cataracts	1341
Oculocerebrorenal syndrome of Lowe	1341
Observed abnormalities	1341
Proximal tubulopathy	1341
X-linked disorder	1341
Deficiency of the phosphatidylinositol 4	1341
Congenital cataracts	1341
Renal proximal tubulopathy	1341
Disorder	1341
Chronic cough and dyspnea	1342
Bronchiectasis	1342
METHODS	1342
MM	1342
MS	1342
SZ	1342
Alpha	1342
Emphysema	1342
Congenital nystagmus	1343
Episodic ataxia	1343
Spinocerebellar ataxia type 6	1343
Familial haemiplegic migraine	1343
METHODS	1343
Episodic ataxia type 2	1343
Ataxia	1343
Spinocerebellar ataxia	1343
Atypical nystagmus/cerebellar	1343
Allelic disorders	1343
Associated	1343
EA2	1343
SCA6	1343
FHM	1343
GBM	1344
Glomerular	1344
C3 deposits	1344
Alternative complement pathway	1344
AP	1344
Glomerular deposits	1344
Renal disease	1344
Complement dysregulation	1344
Nephrotic range	1344
Hypertension	1344
Mesangial C3 deposits	1344
Dense deposit disease	1344
Associated	1344
Chronic progressive renal disease	1344
DDD	1344
Proteinuria	1344
Kidney disease	1344
Membranoproliferative glomerulonephritis	1344
Glomerulonephritis	1344
MPGN	1344
Autosomal recessive inborn error of metabolism	1345
Myoglobinuria	1345
VLCAD deficiency	1345
Autosomal recessive inborn error	1345
Rhabdomyolysis	1345
Episodes	1345
Myalgia	1345
Weakness	1345
Associated	1345
Chronic myalgia	1345
Hypoketotic hypoglycemia	1345
Hypoglycemia	1345
Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency	1345
Muscle weakness	1345
Epstein-Barr	1346
Epstein-Barr virus	1346
Hypercholesterolemia	1346
FH	1346
Familial hypercholesterolemia	1346
EBV	1346
Flow cytometry	1346
Breast cancer	1347
Cancer	1347
Lysosomal storage disorder	1348
Mucopolysaccharidosis	1348
N-acetylgalactosamine-6-sulfate sulfatase	1348
IVA	1348
MPS IVA	1348
Autosomal recessive lysosomal storage disorder	1348
Genetic defect	1348
Disorder	1348
Mucopolysaccharidosis IVA	1348
FMF	1349
MEFV	1349
METHODS	1349
AA	1349
RA	1349
Familiar Mediterranean Fever	1349
Rheumatoid arthritis	1349
Amyloid A	1349
Fever	1349
Japanese rheumatoid arthritis	1349
Amyloidosis	1349
Arthritis	1349
Erythrocyte abnormality	1350
SAO	1350
Malaria	1350
Southeast Asian ovalocytosis	1350
Excess	1350
Cerebral malaria	1350
Dementia	1351
PMD	1351
X-linked spastic paraplegia	1351
Mental retardation	1351
Associated	1351
Personality disorders	1351
SPG	1351
Spastic paraplegia	1351
Pelizaeus-Merzbacher disease	1351
Glycemia	1352
Obese	1352
Impaired glucose tolerance	1352
HDL	1352
IGT	1352
Diagnostic criteria	1352
Body mass index	1352
Associated	1352
Glucose homeostasis	1352
Metabolic syndrome	1352
Criteria	1352
Plasma	1352
FMF	1353
Mediterranean fever	1353
MEFV	1353
Attacks of abdominal pain, synovitis	1353
Recessive disorder	1353
Fever	1353
Associated	1353
Pleuritis	1353
Autosomal recessive disorder	1353
Familial Mediterranean fever	1353
Disorder	1353
Genetic information	1354
Melanoma	1354
Multiple sporadic melanomas	1354
Melanomas	1354
Premature	1355
Retinoblastoma	1355
Lysosomal storage disorder	1356
Assessment of cancer	1356
GD	1356
Demographic	1356
Myeloma	1356
Visceral/hematologic disease	1356
Gaucher disease	1356
Cancers	1356
Gaucher	1356
Gammopathy	1356
Hematologic malignancies	1356
Overall cancer	1356
Multiple myeloma	1356
Cancer	1356
Malignancies	1356
Glucocerebrosidase	1356
Type 1 Gaucher Disease	1356
Skeletal disease	1356
Other cancers	1356
Disorder	1356
Ovarian cancer	1357
Cancer	1357
Breast and ovarian cancer	1357
Tumor	1358
X-linked nephrogenic diabetes insipidus	1358
Abdominal mass	1358
Polyuria	1358
Hypernatremia	1358
WTX	1358
WT	1358
Nephrogenic diabetes insipidus	1358
Associated	1358
Wilms tumor	1358
NDI	1358
Diabetes insipidus	1358
Becker muscular dystrophy	1359
Duchenne or Becker muscular dystrophy	1359
Muscular dystrophy	1359
Duchenne muscular dystrophy	1359
Author	1360
HD	1361
Behavioral abnormalities	1361
Absence of disease	1361
Huntington disease	1361
Ovarian Cancer	1362
Fallopian tube and peritoneal cancer	1362
Breast cancer	1362
Ovarian cancer	1362
Epithelial ovarian cancer	1362
Genetic testing	1362
Breast and/or ovarian cancer	1362
Cancers	1362
Ovarian cancers	1362
Cancer	1362
Prophylactic salpingoophorectomy	1362
Cerebellar degeneration	1363
Ataxia	1363
Recessive disorder	1363
Morocco and Tunisia	1363
Immunodeficiency	1363
ATM	1363
Cancer	1363
A-T	1363
Autosomal recessive disorder	1363
Disorder	1363
Ataxia-telangiectasia	1363
ONL	1364
Apoptosis	1364
METHODS	1364
RP	1364
Retinitis pigmentosa	1364
Retinal degeneration	1364
Associated	1364
Central nervous system	1364
CNS	1364
NAD	1364
Outer nuclear layer	1364
Neonatal hypotonia	1365
Prader-Willi	1365
Prader-Willi syndrome	1365
Hypotonia	1365
Multisystem disorder	1365
PWS	1365
Obesity	1365
MS	1365
Mental retardation	1365
Diagnostic criteria	1365
Uniparental disomy	1365
Contiguous gene syndrome	1365
Hypogonadism	1365
Failure to thrive, mental retardation	1365
Short hands	1365
Hyperphagia	1365
Maternal uniparental disomy	1365
Criteria	1365
Diagnosis	1365
Diagnosis of the syndrome	1365
Disorder	1365
UPD	1365
Ovarian Cancer	1366
Ovarian cancer	1366
METHODS	1366
Associated	1366
Cancer	1366
Chorioretinal degeneration	1367
Associated	1367
REP-1	1367
Blindness	1367
Atrophy of the choroid, retinal pigment epithelium	1367
CHM	1367
Choroideremia	1367
Atrophy	1367
Non-ketotic hyperglycinemia	1368
Hyperglycinemia	1368
Associated	1368
Central nervous system	1368
Multiple genomic lesions	1368
Familial adenomatous polyposis	1369
Adenomas	1369
Norwegian FAP	1369
Adenomatous polyposis coli	1369
METHODS	1369
Adenomatous	1369
Autosomal dominantly inherited disease	1369
Polyposis	1369
Premature	1369
Colorectal adenomas	1369
Adenocarcinomas	1369
APC	1369
Adenomatous polyposis	1369
Chromatography	1369
FAP	1369
Polyposis coli	1369
Diagnosis	1369
Inherited disease	1369
HIV	1370
AC	1370
AD	1370
Epidemic	1370
Myotonic dystrophy	1371
Cardiac	1371
Cardiac troponin T	1371
Genetic disorder	1371
DMPK	1371
DM1	1371
CTNT	1371
Disorder	1371
Basal ganglia dysfunction	1372
Neurological involvement	1372
Lesch-Nyhan	1372
Associated	1372
Genetic disorder	1372
LND	1372
Lesch-Nyhan disease	1372
Basal ganglia	1372
Enzyme deficiency	1372
Excess	1372
Disorder	1372
Ganglia	1372
Autosomal dominant	1373
Myotonia	1373
Recessive generalized myotonia	1373
MC	1373
Pathophysiologic abnormality	1373
Myotonia congenita	1373
Weakness	1373
Diffuse myotonia	1373
Tumor	1374
GBM	1374
Glioblastoma	1374
Glioma	1374
PTPRD	1374
Lung cancers	1374
Neck squamous cell carcinomas	1374
Growth	1374
Much less	1374
Hypermethylation	1374
Cancers	1374
Neoplasm	1374
Squamous cell carcinomas	1374
Cancer	1374
Carcinomas	1374
Intragenic loss	1374
Tumors	1374
GBM tumors	1374
Papillon-Lef  vre syndrome	1375
Melanoma	1375
Malignant melanoma	1375
Autosomal recessive von Willebrand disease type Normandy	1376
FVIII-von Willebrand	1376
Von Willebrand	1376
Factor VIII-von Willebrand	1376
Von Willebrand disease	1376
VWF	1376
VWD	1376
Hemophilia A	1376
Hemophilia	1376
Six melanoma	1377
METHODS	1377
Associated	1377
OBJECTIVES	1377
Melanoma	1377
Familial melanoma	1377
Cutaneous melanoma	1377
Hereditary melanoma	1377
SBLA syndrome	1378
Breast cancer	1378
Cancers	1378
Associated	1378
Ovarian, endometrial and cancers	1378
Cancer	1378
Benign breast disease	1378
Familial breast cancer	1378
Breast disease	1378
PLS	1379
Recessive disorder	1379
Palmoplanter hyperkeratosis	1379
Treatment modalities	1379
Periodontitis	1379
Papillon-Lefevre syndrome	1379
Autosomal recessive disorder	1379
Disorder	1379
WND	1380
Autosomal recessive condition	1380
Wilson disease	1380
Diagnosis	1380
Autosomal dominant	1381
HGF	1381
Rare disorder	1381
METHODS	1381
Hereditary gingival fibromatosis	1381
Associated	1381
Non-parametric linkage	1381
AIM	1381
NPL	1381
Disorder	1381
Metastasis	1382
Colorectal tumours	1382
Adenomatous polyposis coli	1382
Adenomatous	1382
Polyposis	1382
Associated	1382
Tumours	1382
APC	1382
Adenomatous polyposis	1382
Cancer	1382
CSN	1382
Tumour	1382
Adenomatous polyposis coli destruction via USP15	1382
Polyposis coli	1382
UPS	1382
RCCs	1383
Von Hippel-Lindau disease	1383
RCC	1383
Associated	1383
Von Hippel-Lindau	1383
Renal cell carcinomas	1383
Carcinomas	1383
Tumors	1383
VHL	1383
Growth	1384
Excess	1384
Tumor	1385
Metastasis	1385
Gastric carcinoma	1385
Growth	1385
Rb	1385
Fibrosarcoma	1385
KKLS	1385
Carcinoma	1385
Associated	1385
Intestinal-type carcinoma	1385
Cancer	1385
Tumors	1385
Orthotopic TMK-1 tumors	1385
Murine fibrosarcoma	1385
Peroxisomal beta-oxidation	1386
Tumor	1386
Tumor necrosis	1386
Myeloneuropathy	1386
Impaired peroxisomal beta-oxidation	1386
Necrosis	1386
ALDP	1386
X-adrenoleukodystrophy	1386
Adrenomyeloneuropathy	1386
X-ALD	1386
Associated	1386
Peroxisomal disease	1386
Demyelination	1386
Neuropathology	1386
X-linked adrenoleukodystrophy	1386
Cerebral ALD	1386
Cerebral demyelination	1386
Course of the disease	1386
ALD	1386
AMN	1386
Gonadal insufficiency	1386
CSF	1386
Adrenoleukodystrophy	1386
Peroxisomal disease affecting the nervous system, adrenal cortex and testis	1386
Addison's disease	1386
Alpha	1386
Myotonic dystrophy	1387
Muscle disease	1387
Familial adenomatous polyposis	1388
Adenomas	1388
Ileorectal anastomosis	1388
METHODS	1388
Adenomatous	1388
Polyposis	1388
Associated	1388
Colorectal tumour	1388
APC	1388
Adenomatous polyposis	1388
Cancer	1388
Tumour	1388
Age at diagnosis	1388
FAP	1388
Duodenal and jejunal-ileal adenomas	1388
Diagnosis	1388
Ileoanal anastomosis	1388
Hallmark of the syndrome	1389
Sensorineural deafness	1389
Goitre and defective iodide organification	1389
Deafness	1389
Congenital and profound hearing loss	1389
Hearing loss	1389
Pendred syndrome	1389
Recessive disorder	1389
While goitre and thyroid dysfunction	1389
Inner ear, thyroid gland	1389
Sensorineural hearing loss	1389
Congenital sensorineural deafness	1389
Dysplasia	1389
Goitre	1389
Autosomal recessive disorder	1389
Bilateral Mondini's dysplasia	1389
Disorder	1389
Venous thrombosis	1390
Disorders of thrombosis	1390
ADAMTS13 deficiency	1390
Hemostatic disorders	1390
Hemostasis	1390
Associated	1390
TTP	1390
Thrombosis	1390
VWF	1390
VWD	1390
Plasma	1390
Familial thrombocythemias	1391
Hearing loss	1392
Acidosis	1392
SNHL	1392
Inner-ear abnormalities	1392
Associated	1392
Sensorineural hearing loss	1392
Inner ear abnormalities	1392
Autosomal recessive primary distal renal tubular acidosis	1392
EVA	1392
Enlarged vestibular aqueduct	1392
METHODS	1393
Bilateral retinoblastoma	1393
IVF	1393
Retinoblastoma	1393
Associated	1393
Diagnosis	1393
Cardiac failure, endocrine complications	1394
HH	1394
Cardiac	1394
Cirrhosis	1394
Hemochromatosis	1394
Cardiac failure	1394
Type I	1394
Arthritis	1394
Iron overload syndrome	1394
Hereditary Hemochromatosis	1394
Diagnosis	1394
Retinoblastoma	1395
Anhaptoglobinemia	1396
SD	1396
Anomalous	1396
Anomalous inheritance of Hp	1396
Hypohaptoglobinemia	1396
Alpha	1396
AKU	1397
Chromatography	1397
Alkaptonuria	1397
Tumor	1398
Apoptosis	1398
Fertile and lack tumors	1398
Growth	1398
Cancers	1398
Associated	1398
Gastrulation	1398
Breast and ovarian cancers	1398
Ovarian cancers	1398
Tumors	1398
Mitochondrial deficits	1399
PMD	1399
CNS (central nervous system) disease	1399
Central nervous system	1399
CNS	1399
Neural dysfunction	1399
Pelizaeus-Merzbacher disease	1399
Muscular weakness	1400
Myotonic dystrophy	1400
DM	1400
Feeding difficulties	1400
Weakness	1400
Congenital myotonic dystrophy	1400
Mentally retarded	1400
Spinocerebellar ataxia type 3	1401
Ataxia	1401
Spinocerebellar ataxia	1401
Hyperactivity	1401
Anxiety	1401
Neuronal dysfunction	1401
SCA3	1401
Type II disease	1402
Type II	1402
III	1402
Gaucher disease	1402
Gaucher	1402
Associated	1402
Type I disease of the 8	1402
Type I	1402
Neuronopathic	1402
Glucocerebrosidase	1402
Type I disease	1402
Diagnosis	1402
Neuronopathic Gaucher disease	1402
Prenatal diagnosis	1402
Hyperparathyroidism	1403
Pituitary adenomas	1403
Adenomas	1403
Neoplasia	1403
MEN1	1403
Neuroendocrine neoplasm of the parathyroid glands	1403
Multiple endocrine neoplasia	1403
Associated	1403
Multiple endocrine neoplasia type 1	1403
Neoplasm	1403
Parathyroid lesions	1403
Parathyroid	1403
Tumors	1403
Becker muscular dystrophy	1404
Muscular dystrophies	1404
Duchenne and Becker muscular dystrophies	1404
BMD	1404
Muscular dystrophy	1404
Duchenne muscular dystrophy	1404
DMD	1404
Autosomal recessive inherited platelet function defect	1405
METHODS	1405
GT	1405
OBJECTIVES	1405
Type I	1405
Glanzmann thrombasthenia	1405
Flow cytometry	1405
Molecular defects	1405
Alpha	1405
Sporadic tumours	1406
Tumours	1406
Tumour	1406
Leiomyosarcoma	1406
Li-Fraumeni syndrome	1406
Movement Disorder	1407
HD	1407
Associated	1407
Comparison of the mean AO	1407
Huntington disease	1407
Disorder	1407
Hypoechoic areas	1408
Lobulated bilaterally enlarged kidneys	1408
Diffuse large B cell lymphoma	1408
Mediastinal DLBL	1408
DLBL	1408
Bilateral lung involvement	1408
Left lung	1408
Lymphoma	1408
Lymphoma literature	1408
Hypermetabolism	1408
Bilateral kidneys	1408
Lower lip pits	1409
Hypothesis	1409
Van der Woude syndrome	1409
OMIM	1409
Clefts of the lip and/or palate	1409
Cleft repair	1409
Associated	1409
Cleft palate	1409
Lip pits	1409
Bilateral cleft lip	1409
Surgical repair	1409
Cleft lip/palate	1409
VWS	1409
Inherited afibrinogenemia	1410
Autosomal recessive bleeding disease	1410
TT	1410
Afibrinogenemia	1410
CMFDA	1411
METHODS	1411
Associated	1411
5-chloromethylfluorescein diacetate	1411
WASP	1411
WASP deficiency	1411
WAS	1411
Wiskott-Aldrich syndrome	1411
Thrombocytopenia	1411
Aneuploidy	1412
Secondary infertility	1412
Donors	1412
Ataxia	1413
A-T	1413
Ataxia telangiectasia	1413
Classical phenylketonuria	1415
Hypothesis	1415
Phenylalanine hydroxylase deficiency	1415
Hyperphenylalaninemia	1415
Phenylketonuria	1415
Rd	1416
Retinitis pigmentosa	1416
Retinal degeneration	1416
Hereditary retinal degeneration	1416
Prader-Willi	1417
Prader-Willi syndrome	1417
PWS	1417
PWS-IC	1417
Linkage disequilibrium	1418
Hemophilia B	1418
Diagnosis	1418
Prenatal diagnosis	1418
Hemophilia	1418
CNSHA	1419
Chronic non-spherocytic hemolytic anemia	1419
Glucose-6-phosphate (G6PD) deficiency	1419
Enzymatic disorder	1419
Hemolytic anemia	1419
G6PD-MutDB	1419
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	1419
Anemia	1419
Disorder	1419
G6PD deficiency	1419
III	1420
Petunia	1420
Petunia hybrida	1420
VII	1420
Tumor	1421
Smad4-deficient	1421
Apoptosis	1421
Growth	1421
Cancers	1421
Gastrulation	1421
Growth retardation	1421
Gastrulation defect	1421
Pancreatic cancers	1421
Familial adenomatous polyposis	1422
Adenomas	1422
MUTYH germline defects	1422
FH	1422
Adenomatous	1422
MCRA	1422
Colorectal cancer	1422
Polyposis	1422
AFAP	1422
Colorectal adenomas	1422
APC	1422
Adenomatous polyposis	1422
Cancer	1422
FAP	1422
METHODS	1423
Cataract	1423
Unrelated healthy individuals	1423
Aniridia	1423
Congenital aniridia	1423
HRAS	1424
TH	1424
Wilson disease	1425
Leukocyte neoplasia	1426
PBGD	1426
Malignancy	1426
Neoplasia	1426
Associated	1426
Several nonrandom neoplasia	1426
Psychiatric illness	1427
Leukodystrophy	1427
Metachromatic leukodystrophy	1427
Associated	1427
MLD	1427
Metabolic disease	1427
Criteria	1427
METHODS	1428
Benign familial infantile convulsions	1428
Associated	1428
Epilepsy	1428
Familial neonatal convulsion	1428
BFIC	1428
Iron deficiency	1429
Premature	1429
Deficiency anemia	1429
Iron deficiency anemia	1429
Milder disease	1429
Anemia	1429
Leukodystrophy	1430
Recessive disorder	1430
Metachromatic leukodystrophy	1430
ARMS	1430
MLD	1430
Autosomal recessive disorder	1430
Diagnosis	1430
Disorder	1430
Prenatal diagnosis	1430
Neurological dysfunction	1431
X-linked recessive disorder	1431
Dysuria	1431
Adrenomyeloneuropathy	1431
Recessive disorder	1431
Adrenal insufficiency	1431
X-linked adrenoleukodystrophy	1431
Adrenoleukodystrophy	1431
Addison's disease	1431
Disorder	1431
Beta-thalassemia	1432
Beta-Thalassemia	1432
Genetic disease	1432
Thalassemia	1432
Hereditary disease	1432
Diagnosis	1433
Alpha	1433
Neonatal thrombocytopenia	1434
Von Willebrand	1434
Associated	1434
Type I von Willebrand disease	1434
Platelet abnormalities	1434
Isolated thrombocytopenia	1434
Platelet disorder	1434
Type I	1434
Von Willebrand disease	1434
Disorder	1434
Thrombocytopenia	1434
Congenital eye malformations	1435
Congenital nystagmus	1435
Hypothesis	1435
Premature	1435
Aniridia	1435
Tumor	1436
Glioblastoma	1436
III	1436
Associated	1436
Anaplastic astrocytoma	1436
Malignancies	1436
Astrocytoma	1436
Tumoral	1436
Dermatofibrosarcoma protuberans	1437
Ovarian cancer	1438
Breast/ovarian	1438
Associated	1438
Breast/ovarian cancer	1438
Cancer	1438
Lesch-Nyhan syndrome	1439
Lesch-Nyhan	1439
Neurogenetic disorder	1439
Congenital deficiency	1439
Disorder	1439
Obesity	1440
Monogenic endocrine disorder	1440
OMIM	1440
Inherited POMC defect	1440
Associated	1440
Adrenal insufficiency	1440
ACTH deficiency	1440
Genetic defect	1440
Disorder	1440
Alpha	1440
Breast and other epithelial cancers	1441
Sarcomas	1441
Prostate and lung carcinoma	1441
Cancers	1441
Carcinoma	1441
Tumours	1441
Epithelial cancers	1441
Prostate cancers	1441
Carcinomas	1441
Leukaemias	1441
Congenital goitrous hypothyroidism	1442
Sensorineural deafness	1442
Deafness	1442
Hypothyroidism	1442
PDS	1442
Pendred syndrome	1442
Recessive disorder	1442
Pendred or pseudo-Pendred syndrome	1442
Associated	1442
Autoimmune	1442
Inner ear abnormality	1442
Inner ear malformations	1442
Goiter	1442
Congenital deafness	1442
Goitrous hypothyroidism	1442
Autosomal recessive disorder	1442
Diagnosis	1442
Disorder	1442
Tumor	1443
Lumbar dermatofibrosarcoma	1443
Abdominal mass	1443
METHODS	1443
GISTs	1443
Growth	1443
Associated	1443
Metachronous gastrointestinal stromal tumor	1443
Gastrointestinal stromal tumor	1443
GIST	1443
Dermatofibrosarcoma protuberans	1443
Malignancies	1443
Tumors	1443
DFSP	1443
Alpha	1443
HLA-linked disease	1444
Adenocarcinoma of the stomach	1444
Growth	1444
HH	1444
Hypersensitivity	1444
Cutaneous-type hypersensitivity anergy	1444
Metabolic disorder	1444
Adenocarcinoma	1444
Cancer	1444
Hemochromatosis	1444
Diagnosis	1444
Disorder	1444
Hereditary hemochromatosis	1444
Autosomal dominant	1445
Peripheral retina	1445
Geographic atrophy of the macula	1445
Visual disturbances	1445
METHODS	1445
Chorioretinal atrophy	1445
RDS	1445
Visual acuity	1445
Autosomal dominant central areolar choroidal dystrophy	1445
CACD	1445
Parafoveal pigment	1445
Atrophy	1445
Heteroduplex	1447
Alpha	1447
Cancer	1448
Xanthomas	1449
Sitolsterolemia	1449
Autosomal recessive disease	1449
Recessive disease	1449
Sitosterolaemia	1449
Diagnosis	1449
Cystic fibrosis	1450
CF	1450
Fibrosis	1450
Associated	1450
Hearing loss	1451
Hypothesis	1451
Associated	1451
Sensorineural hearing loss	1451
Non-syndromic low-frequency sensorineural hearing loss	1451
LFSNHL	1451
Medium	1452
Growth	1452
Wild type	1452
Behavior	1452
Hepatoma	1452
Phenylketonuria	1452
Neurodegenerative disorder	1453
HD	1453
Huntington's disease	1453
Disorder	1453
Obesity	1454
Episodes	1454
POMC deficiency	1454
Multifactorial disorder	1454
BMI	1454
Hydrocortisone	1454
Hypoglycemia	1454
Behavior	1454
Hypocortisolism	1454
Diagnosis	1454
Overgrowth syndrome	1454
Mineralocorticoid deficiency	1454
POMC-deficiency	1454
Disorder	1454
METHODS	1455
Genetic testing	1455
Cancer	1455
Criteria	1455
METHODS	1456
Mental retardation	1456
VCFS-like phenotype	1456
Schizophrenia	1456
VCFS	1456
Velocardiofacial syndrome	1456
BAC	1456
CHD	1456
Heart defects	1456
Congenital heart defects	1456
VCF	1456
Multifocal dystonia	1457
Parkinson's disease	1457
Bradykinesia	1457
Dystonia	1457
Associated	1457
Dopa-response dystonia	1457
Dopa-responsive dystonia	1457
DRD	1457
Molecular abnormalities	1458
Neurodegenerative disorder	1458
Infantile or later-onset forms of the disease	1458
Sachs disease	1458
Tay-Sachs	1458
Tay-Sachs disease	1458
Premature	1458
TSD	1458
Disorder	1458
Familial cancer	1459
Neoplasia	1459
METHODS	1459
Colorectal neoplasia	1459
Colorectal cancer	1459
Cancers	1459
Noncolonic neoplasia	1459
AIMS	1459
APC	1459
Cancer	1459
Increased cancer	1459
VLCADD	1460
Fatal hypoglycemia	1460
Recessive disorder	1460
Attenuated phenotype	1460
Associated	1460
Hypoglycemia	1460
Autosomal recessive disorder	1460
Very-long-chain acyl-CoA dehydrogenase deficiency	1460
Diagnosis	1460
Sudden death	1460
Disorder	1460
Familial cancer syndrome	1461
Familial cancer	1461
Breast cancer	1461
Familial cancer predisposition syndrome	1461
Breast, thyroid, and endometrial cancers	1461
Cowden syndrome	1461
Cancer syndrome	1461
Cancers	1461
Associated	1461
Cancer	1461
Tumors	1461
Eczema	1462
Immunodeficiency	1462
WAS	1462
Wiskott-Aldrich syndrome	1462
Wiskott-Aldrich Syndrome	1462
Diagnosis	1462
Thrombocytopenia	1462
WD	1463
SD	1463
Recessive disorder	1463
Wilson disease	1463
Associated	1463
Autosomal recessive disorder	1463
Disorder	1463
Lange syndrome	1464
Short stature	1464
Gastrointestinal or cardiac abnormalities	1464
Hearing loss	1464
Cornelia de Lange syndrome	1464
Growth	1464
Mental retardation	1464
Limb defects	1464
OMIM	1464
Chromosomal abnormalities	1464
Cardiac	1464
Genital abnormalities	1464
Multiple congenital anomaly	1464
Cardiac abnormalities	1464
Hearing impairments	1464
CdLS	1464
Bilateral hearing loss	1464
Growth delay	1464
Associated	1465
Disorder	1465
Intrinsic disorder	1465
FLC	1466
FHC	1466
Familial cancer syndrome	1467
Familial cancer	1467
Drosophila melanogaster	1467
Nonsense-Mediated mRNA Decay	1467
Von Hippel-Lindau disease	1467
Cancer syndrome	1467
Premature	1467
Drosophila UAS	1467
Von Hippel-Lindau	1467
Cancer	1467
VHL	1467
NMD	1467
Associated	1468
Alkaptonuria	1468
Parkinson's disease	1469
Alzheimer's disease	1469
Neurodegenerative diseases	1469
AD	1469
Associated	1469
Hemochromatosis	1469
Putamen, globus pallidus	1469
Morquio B disease	1470
Psychomotor deterioration	1470
Gangliosidosis	1470
Lysosomal acid beta-galactosidase	1470
Dysostosis of infantile	1470
Dysostosis	1470
COS	1470
Neurologic involvement	1470
MBD	1470
Genetic lesions	1470
GM1 gangliosidosis	1470
GEF	1471
Adenomatous polyposis coli	1471
Adenomatous	1471
Colorectal cancers	1471
Cancers	1471
Polyposis	1471
APC	1471
Adenomatous polyposis	1471
Cancer	1471
Polyposis coli	1471
Human disease	1472
Uniparental disomy	1472
UPD	1472
Associated	1473
Norrie disease-deletion	1473
Norrie disease	1473
Genetic enzyme deficiency	1473
Enzyme deficiency	1473
Plasma	1473
Metabolite abnormalities	1473
Familial adenomatous polyposis	1474
KRAS	1474
Adenomas	1474
FAP adenomas	1474
Adenomatous	1474
Polyposis	1474
Carcinoma	1474
Associated	1474
Tumours	1474
APC	1474
Adenomatous polyposis	1474
Familial adenomatous polyposis (FAP) tumours	1474
LOH	1474
FAP	1474
Tumourigenesis	1474
Adenoma-carcinoma	1474
APC-FAP tumours	1474
Tumor	1475
Metastasis	1475
Glioblastoma	1475
Breast cancer	1475
Glioblastomas	1475
Growth	1475
Cancers	1475
PTEN	1475
Cancer	1475
Prostate cancer	1475
Defect of dystrophin	1476
Congenital muscular dystrophy	1476
Neuromuscular disorders	1476
Fukuyama congenital muscular dystrophy	1476
Genetic diseases	1476
Alpha-dystroglycan	1476
Dystrophic	1476
Dysbindin, syncoilin, and beta-synemin	1476
Muscular dystrophies	1476
Muscular dystrophy	1476
FCMD	1476
Duchenne muscular dystrophy	1476
DMD	1476
Dystrophic muscles	1476
Alpha	1476
CETP	1477
HDL	1477
METHODS	1477
LS	1477
Associated	1477
Coronary heart disease	1477
CHD	1477
Longevity syndrome	1477
Criteria	1477
Heart disease	1477
Breast cancer	1478
Cancer	1478
Immunodeficiency and myelokathexis	1479
WHIM syndrome	1479
Immunodeficiency	1479
Hypogammaglobulinemia	1479
B-cell lymphopenia	1479
Warts	1479
Eye abnormalities	1480
Galactosemia	1481
Diagnosis	1481
Von Willebrand	1482
Associated	1482
Von Willebrand disease	1482
VWF	1482
VWD	1482
Osteosclerotic skeletal dysplasia	1483
METHODS	1483
Pycnodysostosis	1483
Lysosomal cysteine protease	1483
Autosomal recessive pycnodysostosis	1483
Dysplasia	1483
Skeletal dysplasia	1483
Autosomal dominant	1484
Machado-Joseph disease	1484
Spinocerebellar ataxia type 3	1484
WT	1484
Ataxia	1484
Spinocerebellar ataxia	1484
Neuropathology	1484
Autosomal dominant disorder	1484
MJD	1484
SCA3	1484
Disorder	1484
Fructosuria	1486
Spondylitis	1487
Ankylosing spondylitis	1487
Growth	1488
Associated	1488
WT	1489
Arylalkylamine-N-acetyltransferase	1489
Wild type	1489
Peripheral retina	1490
FEVR	1490
Norrie disease	1490
Blindness	1490
Vitreoretinopathy	1490
Familial exudative vitreoretinopathy	1490
Diagnosis	1490
NDP	1490
Breast cancer	1491
Ataxia	1491
ATM	1491
Cancer	1491
Ataxia-telangiectasia	1491
Human disease	1492
Lesch-Nyhan	1492
Associated	1492
Lesch-Nyhan disease	1492
Machado-Joseph disease	1494
METHODS	1494
Ataxia	1494
Spinocerebellar ataxia	1494
SCA	1494
Associated	1494
MJD	1494
SCA3	1494
AT	1495
Insulin-dependent diabetes mellitus	1495
NIDDM	1495
Diabetes mellitus	1495
Insulin-dependent diabetes	1495
Non-insulin-dependent diabetes mellitus	1495
Autosomal dominant	1496
Involuntary contralateral movements	1496
Congenital mirror movements	1496
Growth	1496
Carcinoma	1496
Associated	1496
Central nervous system	1496
Colorectal carcinoma	1496
DCC	1496
HD	1497
Associated	1497
Huntington disease	1497
Encephalopathy	1498
METHODS	1498
Hemolysis	1498
Wilson disease	1498
Associated	1498
Liver disease	1498
Hepatic failure	1498
Diagnosis	1498
Campomelic dysplasia	1499
Hypotonia	1499
Brachydactyly	1499
Female external genitalia	1499
Gonadal dysgenesis	1499
Dysmorphism	1499
XY	1499
Cleft palate	1499
Campomelia	1499
Dysplasia	1499
Muscular hypotonia	1499
Genitalia	1499
Acampomelic campomelic dysplasia	1499
Malformation syndrome	1499
Craniofacial dysmorphism	1499
Ochronotic arthropathy	1500
HGD	1500
Alkaptonuria	1500
Arthropathy	1500
Lysosomal storage disorder	1501
Left ventricular mass	1501
NM	1501
Total disease	1501
Ventricular hypertrophy	1501
Cerebrovascular white matter lesions	1501
Hypertrophy	1501
Deficiency of alpha-Galactosidase A	1501
Fabry disease	1501
X-linked lysosomal storage disorder	1501
Diagnosis	1501
Plasma	1501
Disorder	1501
Alpha	1501
White matter lesions	1501
Breast cancer	1502
Ovarian cancer	1502
Bilateral breast cancer	1502
Breast cancers	1502
METHODS	1502
Cancers	1502
Associated	1502
Cancer	1502
Breast and ovarian cancer	1502
Diagnosis	1502
METHODS	1503
WD	1503
Wilson's disease	1503
Associated	1503
Hepatic failure	1503
FHF	1503
Eczema	1504
HCT	1504
Immunodeficiency	1504
X-linked disorder	1504
WAS	1504
X-linked thrombocytopenia	1504
Wiskott-Aldrich syndrome	1504
Disorder	1504
Thrombocytopenia	1504
Endocytosis	1505
Medium	1505
Desferrioxamine	1505
Melanoma	1505
MEM	1505
Copy number abnormalities	1506
Number abnormalities	1506
Associated	1506
Cat-eye syndromes	1506
CES	1506
Cognitive impairment	1506
Congenital malformations	1506
Neurodegenerative disease	1507
Autosomal dominant	1507
Autosomal dominant neurodegenerative disease	1507
Machado-Joseph disease	1507
Neuronal loss	1507
Tract dysfunction	1507
Autonomic failure	1507
MJD	1507
CETP	1508
HDL	1508
Associated	1508
Coronary heart disease	1508
Lipid droplets	1508
Heart disease	1508
Plasma	1508
Retinoblastoma	1509
CETP	1510
METHODS	1510
Hypertension	1510
Associated	1510
OBJECTIVES	1510
Charcot-Marie-Tooth disease type 1D	1511
Hypoxia	1512
GBM	1512
Glomerular	1512
Glomerular development	1512
Growth	1512
Von Hippel-Lindau in glomerular podocytes	1512
Proteinuria	1512
Von Hippel-Lindau	1512
VHL	1512
Alpha	1512
Autosomal dominant	1513
Gastric cancer	1513
Signet-ring adenocarcinoma	1513
Autosomal dominant cancer	1513
Gastric cancers	1513
Cancers	1513
Adenocarcinoma	1513
Autosomal dominant cancer susceptibility syndrome	1513
Cancer	1513
HDGC	1513
Alpha-galactosidase	1514
Lesch-Nyhan syndrome	1514
Lesch-Nyhan	1514
Fabry's disease	1514
Alpha	1514
Inherited deficiency	1515
C7 deficiency	1515
C4	1515
C4 deficiency	1515
Associated	1515
Complete C7 deficiency	1515
Deficiency of the seventh component of complement, C7	1515
Autoimmune	1515
Autoimmune diseases	1515
Deficiency of the seventh component of complement	1515
Meningococcal infections	1515
Autoimmune disease	1515
Plasma	1515
Growth	1516
Active trachoma	1516
Chlamydia trachomatis	1516
Associated	1516
Trachoma	1516
Blindness	1516
HbAS	1516
FINDINGS	1516
AF	1517
Hypothesis	1517
Cardiac	1517
Malfunction	1517
Wild type	1517
Arrhythmia	1517
Associated	1517
Atrial fibrillation	1517
Plasma	1517
Cardiac arrhythmia	1517
Alpha	1517
Autosomal dominant	1518
CCD	1518
Dysplasia	1518
Autosomal dominant inherited disease	1518
Cleidocranial dysplasia	1518
Inherited disease	1518
METHODS	1519
Cataract	1519
Microcornea	1519
Associated	1519
Congenital cataract	1519
HDL	1520
Much less	1520
Diacylphosphocholine	1520
Less information	1520
Cardiac	1521
Next-generation sequencing	1521
Neurodegenerative disorder	1522
X-ALD	1522
X-linked adrenoleukodystrophy	1522
ALD	1522
Adrenoleukodystrophy	1522
ABCD1 adrenoleukodystrophy	1522
Disorder	1522
Hodgkin lymphoma	1523
Hypothesis	1523
Lymphoma	1523
Associated	1523
Deficiency impairs cytokinesis	1523
Growth	1524
Multimer deficiency	1525
Von Willebrand	1525
Hemostasis	1525
LVAD	1525
VWF impairment	1525
HMWM loss	1525
A deficiency	1525
VWF	1525
Colorectal adenomatous polyposis	1526
Adenomatous	1526
Polyposis	1526
APC	1526
Adenomatous polyposis	1526
Phenylketonuria	1527
X- ALD	1528
METHODS	1528
X-ALD	1528
X-linked adrenoleukodystrophy	1528
ALD	1528
Adrenoleukodystrophy	1528
CALD	1528
Autosomal dominant	1529
Polyuria	1529
Progressive Polyuria	1529
Familial neurohypophysial diabetes insipidus	1529
FNDI	1529
Autosomal dominant disorder	1529
Disorder	1529
Diabetes insipidus	1529
Familial Neurohypophysial Diabetes Insipidus	1529
C7 deficiency	1530
C7-deficient	1530
Peroxisomal disorder	1531
ALDP	1531
X-ALD	1531
X-linked adrenoleukodystrophy	1531
ALD	1531
Adrenoleukodystrophy	1531
Peroxisomal VLCFA beta-oxidation	1531
Plasma	1531
Disorder	1531
Abnormalities in the bilateral cerebellar hemispheres	1532
AD	1532
Insidious lesion	1532
Demyelination	1532
ALD	1532
Alzheimers disease	1532
CSF	1532
Adrenoleukodystrophy	1532
Neuronal degeneration	1532
Serotonin abnormalities	1534
Neuropathologic	1534
PDD	1534
Developmental disorder	1534
TS	1534
Autism	1534
Tourette syndrome	1534
Alcoholism	1534
PDD----TS	1534
Behavior	1534
Genetic defect	1534
Autism-pervasive developmental disorder	1534
Disorder	1534
Pervasive developmental disorder	1534
Cancers	1535
Melanoma	1535
Other cancers	1535
Tumor	1536
Tumor necrosis	1536
Necrosis	1536
PK	1536
Episodes	1536
Malarial parasites	1536
Antimalarial drugs	1536
Malaria	1536
Inherited disorders	1536
PK deficiency	1536
Hemoglobin-inherited disorders	1536
Thalassemia	1536
G6PD deficiency	1536
Gal lesions	1537
GalT	1537
Galactose	1537
KRAS	1538
Breast cancer	1538
Ovarian cancer	1538
Breast cancers	1538
Lung cancer	1538
Cancers	1538
Associated	1538
Cancer	1538
Non-small cell lung cancer	1538
Breast and ovarian cancer	1538
Hereditary breast and ovarian cancer	1538
BRCA1 breast cancer	1538
Tumor	1539
Autosomal dominant	1539
Hereditary retinoblastoma	1539
Rb	1539
Retinoblastoma	1539
Cancer	1539
Tumors	1539
Hereditary disease	1539
Diagnosis	1539
Breast cancer	1541
Genetic testing	1541
Cancer	1541
Myotonic dystrophy	1542
Pancreas	1542
CpG methylation	1542
DM1	1542
Premature	1543
Muscular dystrophy	1543
Duchenne muscular dystrophy	1543
Metastasis	1544
Neoplasms	1544
Apoptosis	1544
Colorectal neoplasm	1544
III	1544
Colorectal cancer	1544
Neoplasm	1544
Peroxiredoxins in colorectal neoplasms	1544
Cancer	1544
Tumors	1544
Growth	1545
Renal cell carcinoma	1545
Cancers	1545
Carcinoma	1545
CA IX	1545
Von Hippel-Lindau	1545
Cancer	1545
Cell carcinoma	1545
VHL	1545
Von Hippel-Lindau transgenes	1545
Alpha	1545
Myotonic dystrophy	1547
DM	1547
Cardiac	1547
Cardiac troponin T	1547
CTNT	1547
METHODS	1549
AF	1549
Demylination of the brain, adrenal insufficiency	1549
X-ALD	1549
Adrenal insufficiency	1549
X-linked adrenoleukodystrophy	1549
Genetic disease	1549
ALD	1549
Adrenoleukodystrophy	1549
Neurodegenerative genetic disease	1549
ARMS	1549
Diagnosis	1549
Prenatal diagnosis	1549
Colorectal cancer	1550
Cancer	1550
Prader-Willi	1551
Prader-Willi syndrome	1551
PWS	1551
AS	1551
Angelman syndrome	1551
Autosomal dominant	1552
OMD	1552
METHODS	1552
Visual acuity	1552
Macular dystrophy	1552
Pyoderma	1553
Pyoderma gangrenosum	1553
PG	1553
Associated	1553
AOS	1553
Aortitis syndrome	1553
Vasculitis	1553
Hepatomegaly	1554
Lysosomal storage disease	1554
Autosomal recessive lysosomal storage disease	1554
METHODS	1554
GD	1554
AJ	1554
Gaucher disease	1554
Osteopenia	1554
Erlenmeyer flask deformities	1554
Gaucher	1554
Splenomegaly	1554
Anemia	1554
GD medical complaints	1554
Osteoporosis	1554
Thrombocytopenia	1554
Tumor	1555
Sporadic renal cell carcinomas	1555
Von Hippel-Lindau tumor	1555
Growth	1555
Cancer syndrome	1555
RCC	1555
Associated	1555
VHL cancer syndrome	1555
Von Hippel-Lindau ( VHL ) tumor	1555
Von Hippel-Lindau	1555
Cancer	1555
Renal cell carcinomas	1555
Cellular defect	1555
Carcinomas	1555
VHL-negative RCC cancer	1555
Hemangioblastomas	1555
VHL	1555
Tumor	1556
HIF-1a	1556
Hypoxia	1556
HIF	1556
Adenomatous polyposis coli	1556
Solid tumors	1556
Adenomatous	1556
Colorectal cancers	1556
Cancers	1556
Polyposis	1556
APC	1556
Adenomatous polyposis	1556
Tumors	1556
Polyposis coli	1556
Alpha	1556
Type II	1557
Familial Endometrial Cancer	1557
Ovarian cancer	1557
Breast/ovarian	1557
METHODS	1557
EC	1557
Hereditary Non-Polyposis Colon Cancer	1557
Hereditary breast/ovarian cancer	1557
Endometrioid carcinoma	1557
Polyposis	1557
Carcinoma	1557
Associated	1557
OBJECTIVES	1557
Breast/ovarian cancer	1557
Cancer	1557
Type I	1557
Clear cell cancer	1557
Age at diagnosis	1557
Diagnosis	1557
Endometrioid	1557
Endometrial cancer	1557
Paroxysmal nocturnal hemoglobinuria	1558
Genetic disease	1558
GPI anchor deficiency	1558
Neonatal adrenoleukodystrophy	1559
Metabolic disturbances	1559
Defect of nsLTP	1559
Zellweger syndrome	1559
Peroxisome-deficient disorders	1559
ALD	1559
Adrenoleukodystrophy	1559
Deficient peroxisomes	1559
Zellweger	1559
Peroxisome-deficient	1559
Tumor	1560
Growth	1560
Renal cell carcinoma	1560
Cancers	1560
Carcinoma	1560
Epithelial cancers	1560
Von Hippel-Lindau	1560
Tumors	1560
Cell carcinoma	1560
VHL	1560
Visual acuity	1561
Pattern dystrophy of the retinal pigment epithelium	1561
Pattern dystrophy	1561
PKU	1562
RA	1562
PAH deficiency	1562
Phenylketonuric	1562
Hyperphenylalaninaemic	1562
Diagnosis	1562
Plasma	1562
Breast cancer	1563
Familial lobular breast cancers	1563
Breast cancers	1563
Gastric cancer	1563
Lobular breast cancer	1563
Familial lobular breast cancer	1563
Cancers	1563
Associated	1563
Cancer	1563
Breast Cancer	1563
Copper metabolism disorder	1565
Wilson disease	1565
Liver cancer	1565
Cancer	1565
Diagnosis	1565
Disorder	1565
FADD	1567
Death domain	1567
DD	1567
Mass spectrometry	1567
Chromatography	1567
HPRT-deficiency' syndrome	1568
Neurological dysfunction	1568
HPRT-deficiency	1568
Hypoxanthine phosphoribosyltransferase-deficient	1568
Lesch-Nyhan	1568
Gross sex-linked neurological dysfunction	1568
Splenic, kidney and ovarian tissues	1568
Associated	1568
Hypoxanthine phosphoribosyltransferase (HPRT) deficiency	1568
Neurological manifestations	1568
Lesch-Nyhan or 'complete HPRT-deficiency' syndrome	1568
Enzyme deficiency	1568
Autosomal dominant	1569
METHODS	1569
Cataract	1569
Aniridia	1569
Autosomal dominant congenital aniridia	1569
Congenital aniridia	1569
METHODS	1570
WASP	1570
X-linked thrombocytopenia	1570
Thrombocytopenia	1570
White matter volume	1571
Measures of brain volume	1571
Normalised brain, cortical and cerebellar volumes	1571
METHODS	1571
Neurological impairment	1571
CB	1571
Volume decrease	1571
MR	1571
Normalised cerebellar volumes	1571
RS	1571
Cortical volume	1571
Inherited disorder	1571
CTX	1571
Cerebrotendinous xanthomatosis	1571
Neurological disorders	1571
Xanthomatosis	1571
Disorder	1571
Lesch-Nyhan	1572
Hypoxanthine-guanine phosphoribosyltransferase (HGprt) deficiency	1572
Neurogenetic disorders	1572
Neurogenetic disorder	1572
Lesch-Nyhan disease	1572
Disorder	1572
Hypochloremic metabolic alkalosis	1573
Angiofibromas	1574
Mental deficiency	1574
Tuberous sclerosis	1574
Mandibular cysts	1574
TS	1574
Tuberous Sclerosis	1574
Fibromatosis of the facial soft tissues	1574
Epilepsy	1574
Skeletal disorders	1574
Tumours	1574
Inherited disorder	1574
Dominantly inherited disorder	1574
Fibromas	1574
Hypopigmented skin lesions	1574
Enamel hypoplasia	1574
Hypoplasia	1574
Periungual fibromas	1574
Disorder	1574
Myoclonic epilepsy	1576
Friedreich ataxia	1576
Myotonic dystrophy	1576
Spinocerebellar ataxias	1576
Fragile X	1576
Genome-wide association studies	1576
Ataxia	1576
Epilepsy	1576
Polyglutamine diseases	1576
Monogenic disorders	1576
Mitosis	1576
Fragile X syndrome	1576
Huntington's disease	1576
Polyalanine disorders	1576
Visual acuity	1577
Autoimmune lymphoproliferative syndrome	1578
Multifactorial disorder	1578
Autoimmune	1578
Disorder	1578
Bleeding disorder	1579
Pathological angiogenesis	1579
VWF-deficient	1579
Gastrointestinal bleeding	1579
Growth	1579
Angiodysplasia	1579
Increased vascular endothelial growth	1579
Vascular malformations	1579
Ischemia	1579
Von Willebrand	1579
Hemostasis	1579
Associated	1579
Defect or deficiency	1579
Cancer	1579
ECs	1579
Von Willebrand disease	1579
VWF	1579
VWD	1579
Vascular diseases	1579
Disorder	1579
Myeloid	1580
Myeloid cell line HL-60	1580
Tumor	1581
Ovarian cancer	1581
METHODS	1581
III	1581
OC	1581
OS	1581
Epithelial ovarian cancer	1581
BRCA-associated ovarian cancer	1581
Wild type	1581
Associated	1581
Disease-free survival	1581
Cancer	1581
DFS	1581
Short stature	1582
CTSK gene defects	1582
Dental anomalies	1582
METHODS	1582
Pycnodysostosis	1582
Autosomal recessive skeletal dysplasia	1582
Acro-osteolysis	1582
Osteosclerosis	1582
Gene defects	1582
Dysplasia	1582
Skeletal dysplasia	1582
Hypoplastic	1582
Disorder	1582
Familial pycnodysostosis	1582
Renal lithiasis	1584
Oculocerebrorenal Dystrophy	1584
Renal Fanconi syndrome	1584
Glomerular	1584
Rachitism	1584
Polyuria	1584
Lowe syndrome	1584
Fanconi syndrome	1584
Metabolic disturbances	1584
Tubulopathy	1584
Neuropsychomotor	1584
Acidosis	1584
OCRL	1584
Glaucoma	1584
Bicarbonaturia	1584
Nephrocalcinosis	1584
Hypercalciuria	1584
Cataracts	1584
Cognitive deficits	1584
Metabolic acidosis	1584
Proteinuria	1584
Polydipsia	1584
Phosphaturia	1584
Height deficits	1584
Diagnosis	1584
Hyperuricosuria	1584
Inherited deficiency	1585
Mucopolysaccharidosis storage disease	1585
Mucopolysaccharidosis	1585
EC	1585
Deficiency of beta-glucuronidase	1585
Skeletal deformities	1585
Premature	1585
Mucopolysaccharidosis VII	1585
Sly syndrome	1585
VII	1585
Glycosaminoglycans	1585
Hearing loss	1586
Total disability	1587
Attention deficit disorder	1587
ALDP	1587
Sexual dysfunction	1587
Adrenocortical insufficiency	1587
Neurologic abnormality	1587
Adrenomyeloneuropathy	1587
Addison disease	1587
Demyelination	1587
X-linked adrenoleukodystrophy	1587
Hyperactivity	1587
ALD	1587
Milder disease	1587
Adrenoleukodystrophy	1587
Behavior	1587
Impairment of cognition	1587
Progressive central demyelination	1587
Disorder	1587
Mental retardation	1588
Urogenital malformation	1588
Aniridia	1588
Xanthomas	1590
Atherosclerosis	1590
WHHL	1590
Aortic atherosclerosis	1590
FMF	1591
Mediterranean fever	1591
METHODS	1591
Demographic	1591
FMF amyloidosis	1591
Impact of kidney transplantation	1591
Renal failure	1591
Fever	1591
OBJECTIVES	1591
Typical serosal attacks	1591
Amyloidosis	1591
Familial Mediterranean fever	1591
Lesch-Nyhan syndrome	1592
Deficiency of HPRT	1592
Lesch-Nyhan	1592
Deficiency of activity	1592
LNS	1592
Nonsyndromic hearing impairment	1593
Autosomal recessive nonsyndromic hearing impairment	1593
ARNSHI	1593
Obese	1594
Microcephaly	1594
Obesity	1594
Macrocephalic	1594
AS	1594
Uniparental disomy	1594
Angelman syndrome	1594
Neurobehavioral	1594
Neurodevelopmental disorder	1594
Behavior	1594
Angelman Syndrome	1594
Diagnosis	1594
Disorder	1594
UPD	1594
Cardiac	1596
Muscular dystrophies	1596
Cardiac involvement	1596
Haemochromatosis	1597
Hereditary haemochromatosis	1597
Diagnosis	1597
Genetic disorders	1598
Breast cancer	1600
Linkage disequilibrium	1600
Ovarian cancer	1600
Breast or ovarian cancer	1600
Cancer	1600
Breast and ovarian cancer	1600
Albinism	1602
Chromosomal abnormalities	1602
Associated	1602
Foveal hypoplasia	1602
Aniridia	1602
Hypoplasia	1602
Isolated foveal hypoplasia	1602
Ovarian cancer	1603
Breast / ovarian cancer	1603
Heteroduplex	1603
Cancer	1603
Breast and ovarian cancer	1603
Familial breast and ovarian cancer	1603
Lesch-Nyhan syndrome	1604
Lesch-Nyhan	1604
Tumor	1605
Adenomatous	1605
Polyposis	1605
Associated	1605
APC	1605
Colon cancer	1605
CHO	1605
Cancer	1605
Golgi-lysozome	1605
Plasma	1605
Adenomatous Polyposis Coli	1605
Multipolar mitosis	1606
Bipolar mitosis	1606
Growth	1606
Chromosomal instability	1606
Genome instability	1606
Mitosis	1606
Tumorigenesis	1606
Familial adenomatous polyposis	1607
Adenomatous	1607
Genetic testing	1607
Colorectal cancer	1607
Cancers	1607
Polyposis	1607
Familial Adenomatous Polyposis	1607
Adenomatous polyposis	1607
Cancer	1607
FAP	1607
Mendelian inherited syndromes	1607
Colorectal cancer predisposition syndromes	1607
Deficiency of aspartoacylase	1608
Canavan disease	1608
Deficiency of ASPA	1608
A deficiency	1608
Galactosemia	1609
Associated	1609
Genetic disorder	1609
Galactose	1609
Diagnosis	1609
Disorder	1609
Classical galactosemia	1609
Ovarian cancer	1610
Breast / ovarian cancer	1610
Breast / ovarian tumorigenesis	1610
Hypothesis	1610
Cancer	1610
Tumorigenesis	1610
Corneal opacities	1612
FLD	1612
Glomerular	1612
Dyslipidemia	1612
Renin-angiotensin-aldosterone system	1612
HDL	1612
Glomerular disorders	1612
Haemolytic anaemia	1612
Serpiginous fibrillar deposits	1612
Renal disease	1612
Anaemia	1612
Genetic disorder of lipid metabolism	1612
Renal failure	1612
Familial lecithin-cholesterol acyltransferase (LCAT) deficiency	1612
Usually renal disease	1612
Ankle oedema	1612
Genetic disorder	1612
Familial lecithin-cholesterol acyltransferase deficiency	1612
Proteinuria	1612
Kidney disease	1612
Corticosteroid treatment of kidney disease	1612
LCAT-deficient	1612
Diagnosis	1612
Plasma	1612
Disorder	1612
Ichthyosis	1613
Autosomal recessive metabolic disorder	1613
Congenital ichthyosis	1613
Associated	1613
Metabolic disorder	1613
Chanarin-Dorfman syndrome	1613
CDS	1613
Lipid droplets	1613
Genetic defect	1613
Diagnosis	1613
Disorder	1613
Much less	1614
CCAAT	1614
Cyprinus carpio	1614
Essential component of hemostasis	1615
Von Willebrand	1615
Body mass index	1615
Hemostasis	1615
Associated	1615
Thrombosis	1615
Von Willebrand disease	1615
VWF	1615
Plasma	1615
Bleeding disorder	1616
METHODS	1616
Von Willebrand disease population	1616
Von Willebrand	1616
Autosomal recessive bleeding disorder	1616
Von Willebrand disease	1616
VWF	1616
VWD	1616
Plasma	1616
Disorder	1616
Hereditary condition	1617
WD	1617
Wilson disease	1617
Hepatic copper accumulation	1617
Liver failure	1617
Genetic defect	1617
Myotonic dystrophy	1618
Associated	1618
Huntington disease	1618
CpG methylation	1618
Neurological involvement	1619
Parkinson's disease	1619
Neurological abnormalities	1619
GD	1619
NS	1619
PD	1619
Recessive disorder	1619
Gaucher disease	1619
Gaucher	1619
Pearson coefficient	1619
PD in type 1 GD	1619
Neurological symptoms	1619
Glucocerebrosidase	1619
Neurological manifestations	1619
Autosomal recessive disorder	1619
Disorder	1619
METHODS	1620
Von Willebrand	1620
Wild type	1620
Von Willebrand disease	1620
Plasma	1620
Lenticular-corneal attachment	1621
Unilateral Peters anomaly	1621
Peters anomaly	1621
Associated	1621
Aniridia	1621
Molecular defect	1622
Becker muscular dystrophy	1622
Cardiac	1622
Allelic disorders	1622
Associated	1622
Duchenne and Becker muscular dystrophy	1622
BMD	1622
Muscle dystrophin deficiency	1622
Muscular dystrophy	1622
DMD	1622
Dystrophinopathic	1622
Diagnosis	1622
Dystrophin deficiency	1622
Cardiac impairment	1622
Growth	1623
OD	1623
Edema	1623
RAP	1623
Macular degeneration	1623
Choroidal neovascularization	1623
Retinal angiomatous proliferation	1623
Retinal edema	1623
Retinitis pigmentosa	1623
Retino-choroidal anastomosis	1623
AMD	1623
Muenke syndrome	1624
Dysplastic	1624
Ankylosis of the elbow, fusion of cervical vertebrae	1624
A syndrome	1624
Epilepsy	1624
Ptosis	1624
Chotzen syndrome	1624
Craniosynostosis	1624
Syndromal craniosynostosis	1624
Saethre-Chotzen syndrome	1624
Craniosynostosis syndromes	1624
Upper eyelid ptosis	1624
Hypoplasia	1624
Ankylosis	1624
Upper eyelids	1624
Diagnosis	1624
Dysplastic elbow joints	1624
Cardiac	1625
Dilated cardiomyopathy	1625
Cardiomyopathy	1625
Growth	1626
Gastrulation	1626
Cartilage primordia	1626
Autosomal dominant	1627
Gastric cancer	1627
Adenocarcinoma of the stomach	1627
METHODS	1627
Signet ring cell adenocarcinoma	1627
Autosomal dominant cancer	1627
PG	1627
Cancer syndrome	1627
N0 cancer	1627
Autosomal dominant cancer syndrome	1627
Adenocarcinoma	1627
Cell adenocarcinoma	1627
Cancer	1627
CDH1-positive hereditary diffuse gastric cancer	1627
Diagnosis	1627
HDGC	1627
Tumor	1628
Nephrosis	1628
Neonatal renal failure	1628
Dysgenetic gonads	1628
Renal failure	1628
Nephrotic syndrome	1628
Pseudohermaphroditism	1628
Denys-Drash syndrome	1628
Wilms tumor	1628
Metastasis	1629
Adenomatous polyposis coli	1629
Adenomatous	1629
Deadly disease	1629
Colorectal cancer	1629
Polyposis	1629
APC	1629
Adenomatous polyposis	1629
Apc	1629
Cancer	1629
CIS	1629
CRC	1629
Tumorigenesis	1629
Polyposis coli	1629
Common insertion sites	1629
Polyps	1629
Lesch-Nyhan syndrome	1630
Lesch-Nyhan	1630
Lesch-Nyhan variant syndrome	1630
Genetic diseases	1630
LNS	1630
HGD	1631
Homogentisate 1,2 dioxygenase gene	1631
Alkaptonuria	1631
Tumor	1632
Copy number abnormalities	1632
CNAs	1632
Number abnormalities	1632
VHL tumor	1632
Renal cell carcinoma	1632
Von Hippel-Lindau disease	1632
Sporadic VHL wild-type cRCC	1632
RCC	1632
Carcinoma	1632
Von Hippel-Lindau (VHL) disease	1632
Von Hippel-Lindau	1632
Cancer	1632
Tumors	1632
Cell carcinoma	1632
VHL	1632
Von Hippel-Lindau disease renal cell carcinoma	1632
Copy number abnormality	1632
Microdontia (LAMM) Syndrome	1633
LAMM syndrome	1633
Middle ear dysplasia	1633
LAMM Syndrome	1633
Associated	1633
Dysplasia	1633
Labyrinthine aplasia	1633
Absence of otodental syndrome	1633
Microtia	1633
METHODS	1634
Visual acuity	1634
Aniridia	1634
Global gait index	1635
Gait abnormality	1635
Gait abnormalities	1635
Golden retriever muscular dystrophy	1635
Gait quality	1635
METHODS	1635
Growth	1635
Muscular dystrophy	1635
GRMD	1635
Gait disorders	1635
Dystrophin-deficient	1635
Myoclonus	1636
Primary dystonia	1636
Inherited myoclonus-dystonia	1636
CH	1636
Myoclonus-dystonia syndrome	1636
Dystonia	1636
Associated	1636
Myoclonus dystonia syndrome	1636
Myoclonic dystonia	1636
Dopa-responsive dystonia	1636
Psychiatric symptoms	1636
Vitamin E deficiency	1636
Myoclonus and dystonia	1636
MDS	1636
Usually dystonia	1636
Disorder	1636
Fragile X	1637
Mental retardation	1637
Fragile X mental retardation	1637
Fragile X syndrome	1637
FST	1638
METHODS	1638
Newborns	1638
G6PD-deficient	1638
G6PD deficiency	1638
Isolated bicoronal synostosis	1639
Growth	1639
Premature	1639
Associated	1639
Craniosynostosis	1639
Hereditary breast cancer	1640
Breast cancer	1640
Breast cancers	1640
Sporadic breast cancers	1640
Hypothesis	1640
Cancers	1640
Associated	1640
Breast and ovarian cancers	1640
Ovarian cancers	1640
Cancer	1640
Tumors	1640
Ovarian Cancer	1641
Ovarian cancer	1641
Cancers	1641
Gynecologic Cancer	1641
Gynecologic cancers	1641
Cancer	1641
Recurrent disease	1641
Ovarian Cancer	1642
Ovarian cancer	1642
Breast and Ovarian Cancer	1642
Cancers	1642
Breast and ovarian cancers	1642
Female breast and ovarian cancer	1642
Ovarian cancers	1642
Cancer	1642
Breast and ovarian cancer	1642
GT	1643
Familial adenomatous polyposis-coli	1645
Tumor	1645
Familial adenomatous polyposis	1645
Adenomas	1645
Adenomatous polyposis coli	1645
Familial Adenomatous Polyposis coli	1645
Adenomatous	1645
KD	1645
Rb	1645
Polyposis	1645
Familial Adenomatous Polyposis	1645
Retinoblastoma	1645
APC	1645
Adenomatous polyposis	1645
Apc	1645
FAP	1645
Polyposis coli	1645
Adenomatous Polyposis Coli	1645
BRCA testing	1646
Genetic testing	1646
Short stature	1647
Renal anomalies	1647
Developmental delay	1647
Mental retardation	1647
KS	1647
Kabuki syndrome	1647
Anomalies/mental retardation syndromes	1647
Urogenital tract anomalies	1647
Muscular dystrophies	1648
Breast cancer	1649
Ovarian cancer	1649
Glioma	1649
Renal cancer	1649
Growth	1649
Cancers	1649
Associated	1649
Cancer	1649
ACHN renal cancer	1649
Tumor	1650
Hypoxia	1650
HIF	1650
Neoplasia	1650
Growth	1650
Increased vascular density	1650
Vascular abnormalities	1650
Associated	1650
Von Hippel-Lindau (VHL) disease	1650
Von Hippel-Lindau	1650
Von Hippel-Lindau heterozygosity	1650
Stromal inflammation	1650
Vascular lesions	1650
Hepatic vascular lesions	1650
Vascular density	1650
VHL deficiency	1650
Tumors	1650
VHL	1650
Prostatic intraepithelial neoplasia	1650
Alpha	1650
VHL- and EAF2-deficiency	1650
Tumor	1652
Microsatellite instability	1652
Lymphoma	1652
Associated	1652
LOH	1652
Carcinomas	1652
Tumorigenesis	1652
Tumors	1652
Tumor	1653
METHODS	1653
Colorectal cancers	1653
Colorectal cancer	1653
Cancers	1653
AIMS	1653
Allelic loss	1653
Cancer	1653
Pancreatic cancers	1653
Dystonia	1654
Dopa-responsive dystonia	1654
Galactosemia	1655
Autosomal recessive inborn error of metabolism	1655
Autosomal recessive inborn error	1655
Deficiency of the galactose-1-phosphate uridyltransferase	1655
Galactose	1655
A deficiency	1655
Classical galactosemia	1655
Hematological malignancies	1656
Malignancies	1656
Loss of heterozygosity	1656
Neisseria	1657
Neisseria gonorrhoeae	1657
Normocholesterolemic dysbetalipoproteinemia	1658
Hypercholesterolemic	1658
Hypercholesterolemia	1658
III	1658
Dysbetalipoproteinemia	1658
Associated	1658
Characteristic of dysbetalipoproteinemia	1658
Xanthomas	1658
Palmar xanthomatosis	1658
Type III hyperlipoproteinemia	1658
Plasma	1658
Excess	1658
Xanthomatosis	1658
Colorectal carcinogenesis	1659
Hypothalamus	1660
Clinical syndrome	1660
Polyuria	1660
Neurohypophyseal diabetes insipidus	1660
Nephrogenic diabetes insipidus	1660
Neurohypophysis	1660
Polydipsia	1660
Renal or nephrogenic diabetes insipidus	1660
Vasopressin deficiency	1660
Diagnosis	1660
Diabetes insipidus	1660
X-linked recessive disorder	1662
Recessive disorder	1662
Genital abnormalities	1662
Aarskog-Scott syndrome	1662
Disorder	1662
Ovarian Cancer	1663
Ovarian cancer	1663
Breast / ovarian cancer	1663
Heteroduplex	1663
Cancer	1663
Familial Ovarian Cancer	1663
Breast and / or ovarian cancer	1663
Breast cancer	1664
Apoptosis	1664
Associated	1664
Variants of unknown significance	1664
Cancer	1664
VUS	1664
Tumor	1665
Oligodendroglioma	1665
Hereditary breast cancer	1665
Breast cancer	1665
Ovarian cancer	1665
Breast-ovarian	1665
Lung cancer	1665
Cancers	1665
Premature	1665
Pancreas	1665
Breast-ovarian cancer	1665
Associated	1665
Heteroduplex	1665
BRCA1 breast and ovarian cancer	1665
Melanoma	1665
Ovarian cancers	1665
Malignant melanoma	1665
Cancer	1665
Breast and ovarian cancer	1665
Tumors	1665
Carcinosarcoma	1665
Hereditary breast and ovarian cancer	1665
Pancreas , skin , and lung cancer	1665
Myotonic dystrophy	1666
Uniparental disomy	1667
Von Willebrand	1667
Von Willebrand disease type 3	1667
Maternal uniparental disomy 12	1667
Von Willebrand disease	1667
Maternal uniparental disomy	1667
Breast cancer	1668
Ovarian cancer	1668
Renal cell carcinoma	1668
Cancers	1668
Carcinoma	1668
Associated	1668
Cancer	1668
Multiple cancer	1668
Breast and ovarian cancer	1668
Variety of cancers	1668
Cell carcinoma	1668
French melanoma	1669
Familial Melanoma	1669
Melanoma	1669
Familial melanoma	1669
Criteria	1669
Copper-induced hepatotoxicity	1670
WD	1670
Wilson disease	1670
Wilson's disease	1670
Associated	1670
Neurological manifestations	1670
Copper-induced toxicity	1670
Hydrolysis	1671
Duchenne Muscular Dystrophy	1672
X-linked recessive disorder	1672
Recessive disorder	1672
Weakness	1672
Functional deficits	1672
Muscle wasting	1672
Postural abnormalities	1672
DMD	1672
Disorder	1672
Demyelination of the central nervous system	1673
Addisons disease	1673
X-Linked adrenoleukodystrophy	1673
Hypothesis	1673
Adrenocortical insufficiency	1673
Adrenomyeloneuropathy	1673
Associated	1673
Demyelination	1673
Adrenal insufficiency	1673
X-linked adrenoleukodystrophy	1673
Cerebral ALD	1673
Central nervous system	1673
Genetic disease	1673
ALD	1673
AMN	1673
Adrenoleukodystrophy	1673
Addison's disease	1673
Diagnosis	1673
Plasma	1673
Cerebral involvement	1673
Recessive abetalipoproteinemia	1674
Golgi apparatus	1674
Associated	1674
Abetalipoproteinemia	1674
Corneal opacities	1675
FLD	1675
Dyslipidemia	1675
HDL	1675
Lipid deposition	1675
Nephrologists	1675
ID	1675
Glomerulopathy	1675
OMIM	1675
Renal disease	1675
Hypoalphalipoproteinemia	1675
Autosomal recessive condition	1675
Chronic renal failure	1675
Deficiency of lecithin- cholesterol acyltransferase	1675
Renal failure	1675
Associated	1675
Eye disease	1675
Nephropathy	1675
Proteinuric nephropathy	1675
Primary hypoalphalipoproteinemia	1675
Coronary artery disease	1675
LCAT deficiency	1675
Anemia	1675
Diagnosis	1675
FED	1675
Dialysis	1675
End-stage renal disease	1675
Parkinson's disease	1676
PD	1676
Associated	1676
Autosomal dominant	1677
HypoPP	1677
Weakness	1677
Associated	1677
Hypokalemic periodic paralysis	1677
Autosomal dominant disorder	1677
Hypokalemic	1677
Muscle weakness	1677
Disorder	1677
Breast cancer	1678
Canadian cancer	1678
Ovarian cancer	1678
Breast / ovarian cancer	1678
Cancer	1678
Breast and ovarian cancer	1678
Canadian breast and ovarian cancer	1678
Canadian breast cancer	1678
Lawsonia inermis	1679
Hemolysis	1679
Hemolytic anemia	1679
G6PD-deficiency	1679
Associated	1679
Voluntary ingestion of Henna decoction	1679
G6PD-deficient	1679
Voluntary ingestion of henna	1679
Anemia	1679
Diagnosis	1679
G6PD deficiency	1679
X-linked disorders	1680
Eczema	1680
METHODS	1680
WAS	1680
X-linked thrombocytopenia	1680
Flow cytometry	1680
Wiskott-Aldrich syndrome	1680
Thrombocytopenia	1680
Galactosemia	1681
Duarte-2	1681
Galactose	1681
Duarte galactosemia	1681
Classical galactosemia	1681
Adenomatous polyposis coli	1682
Adenomatous	1682
Polyposis	1682
APC	1682
Adenomatous polyposis	1682
Polyposis coli	1682
Apc-deficient	1683
Neoplasia	1683
Dysplastic	1683
Visible neoplasia	1683
Colorectal cancer	1683
APC	1683
Apc	1683
Cancer	1683
CRC	1683
Breast cancer	1684
Cancer	1684
Hyperreflexia	1685
Multiple lesions	1685
Mental retardation	1685
Ataxia	1685
Cataracts	1685
Epilepsy	1685
MRI abnormalities	1685
CTX	1685
Cerebellar ataxia	1685
Cerebrotendinous xanthomatosis	1685
Xanthomatosis	1685
Audiovestibular morbidity	1686
Tumor	1686
Determination of audiometric endolymphatic sac tumor	1686
Microscopic endolymphatic sac tumors	1686
METHODS	1686
Von Hippel-Lindau disease	1686
Treatment of endolymphatic sac tumors	1686
Imaging-visible endolymphatic sac tumors	1686
Associated	1686
Central nervous system	1686
Endolymphatic sac tumors	1686
First-line endolymphatic sac tumor	1686
Von Hippel-Lindau	1686
Audiometric abnormalities	1686
Tumors	1686
Endolymphatic sac tumor	1686
Sac tumor	1686
Diagnosis	1686
VHL	1686
III	1687
WD	1687
Wilson disease	1687
Deficiency of ATP7B	1687
Neurological disease	1687
Wolfram syndrome	1688
GLD	1689
AO-GLD	1689
Leukodystrophy	1689
Krabbe disease	1689
IF-GLD	1689
Globoid cell leukodystrophy	1689
COS	1689
Spastic paraplegia	1689
Galactosylceramidase	1689
Tumor	1690
Hypoxia	1690
HIF	1690
VHL19 interactome	1690
ARF tumor	1690
Von Hippel-Lindau (VHL) tumor	1690
ARF	1690
Von Hippel-Lindau	1690
Tumorigenesis	1690
VHL	1690
Alpha	1690
Choriocarcinoma	1691
Placental choriocarcinoma	1691
Desferrioxamine	1691
DFO	1691
20-lyase deficiency	1692
Congenital adrenal hyperplasia	1692
Hypertension	1692
Autosomal recessive disease	1692
Recessive disease	1692
Hypokalemia	1692
Hyperplasia	1692
EBV	1692
PK	1693
Hemolytic anemia	1693
Embden-Meyerhof glycolytic pathway	1693
Hereditary nonspherocytic hemolytic anemia	1693
PK deficiency	1693
Pyruvate kinase deficiency	1693
Anemia	1693
Hypotonia	1694
Lowe syndrome	1694
Endocytosis	1694
OCRL	1694
Cataracts	1694
WASP	1694
Renal proximal tubular dysfunction	1694
Central hypotonia	1694
Congenital cataracts	1694
Hepatomegaly	1695
XI	1695
Genetic testing	1695
Fanconi- Bickel Syndrome	1695
Renal tubular dysfunction	1695
Premature	1695
Galactose intolerance	1695
Galactose	1695
Fanconi -Bickel Syndrome	1695
Diagnosis	1695
FBS	1695
Disorder	1695
Prenatal diagnosis	1695
Hemophiliacs	1696
Hemophilia B	1696
Fitness	1696
Hemophilia	1696
Controversial cancer	1697
Associated	1697
Cancer	1697
MTP deficiency	1698
Rare disorder	1698
Rhabdomyolysis	1698
OMIM	1698
Myalgia	1698
Neuromyopathic	1698
MTP	1698
Diagnosis	1698
Extremely rare disorder	1698
Disorder	1698
Hepatic disease	1699
Hepatosplenomegaly	1699
Wilson disease	1699
Anemia	1699
Diagnosis	1699
Thrombocytopenia	1699
X-linked muscular dystrophy	1700
Muscular dystrophy	1700
GHD	1701
Cognitive dysfunction	1701
Short stature	1701
Prader-Willi	1701
Prader-Willi syndrome	1701
Ten impaired glucose tolerance	1701
Impaired glucose tolerance	1701
Hypotonia	1701
Insulin-like growth	1701
PWS	1701
Obesity	1701
GH	1701
Growth	1701
Hormone deficiency	1701
Lipid and glucose metabolism	1701
Abnormal body composition	1701
BMI	1701
Muscular hypotonia	1701
Hyperphagia	1701
Growth hormone deficiency	1701
Autosomal dominant	1702
HCP	1702
Hereditary coproporphyria	1702
Deficiency of coproporphyrinogen oxidase	1702
Autosomal dominant disease	1702
C-T	1702
CPO	1702
A deficiency	1702
Tumor	1703
Breast cancer	1703
Breast cancers	1703
Sporadic breast cancer	1703
Sporadic breast cancers	1703
Cancers	1703
Cancer	1703
Tumors	1703
Growth	1704
Associated	1704
Neurodevelopmental disorders	1704
UMD-BRCA1/BRCA2 databases	1705
Ovarian cancer	1705
Cancers	1705
Breast and ovarian cancers	1705
Ovarian cancers	1705
Cancer	1705
Breast and ovarian cancer	1705
Hereditary breast and ovarian cancer	1705
Type IV	1706
Alport syndrome	1706
Glomerular	1706
Autosomal recessive Alport syndrome	1706
Obvious	1706
Associated	1706
Hematuric glomerulonephritis	1706
Glomerulonephritis	1706
Membrane abnormalities	1706
Autosomal dominant	1707
Craniofacial abnormalities	1707
METHODS	1707
Osteochondritis dissecans	1707
Osteoarthritis	1707
Abnormal uvula	1707
Joint abnormalities	1707
Tortuosity	1707
Hypertelorism	1707
Cutaneous anomalies	1707
AOS	1707
Arterial aneurysms	1707
Cardiovascular abnormalities	1707
Aneurysms-osteoarthritis syndrome	1707
Lowe syndrome	1708
METHODS	1708
OCRL	1708
Genetic testing	1708
FMF	1709
METHODS	1709
OBJECTIVES	1709
Multiple prostate cancer	1710
Hereditary prostate cancer	1710
Genome-wide association studies	1710
HPC	1710
GWAS	1710
Associated	1710
Sporadic disease	1710
Cancer	1710
Prostate Cancer	1710
Diagnosis	1710
Prostate cancer	1710
Linkage disequilibrium	1711
VTR	1711
Chronic lymphocytic leukemia	1712
ATM	1712
Leukemia	1712
Hepatocellular carcinoma	1714
OMIM	1714
Hereditary hypertriglyceridemia	1714
Carcinoma	1714
Fibrosis	1714
Monogenic dyslipidemias	1714
Fatty liver	1714
Hypertriglyceridemia	1714
Hepatic fibrosis	1714
Unexplained thiamine deficiency	1715
Brain atrophy	1715
Amnestic syndrome	1715
Autonomic neuropathy	1715
Neuropathy	1715
Wolfram syndrome	1715
Mendelian disorders	1715
Genetic disorders	1715
Nerve atrophy	1715
Mitochondrial diseases	1715
Diabetes mellitus	1715
Thiamine deficiency	1715
Diagnosis	1715
Mitochondrial disorder	1715
Next-generation sequencing	1715
Disorder	1715
Atrophy	1715
Heart failure	1716
METHODS	1716
SF	1716
Genetic testing	1716
Wild type	1716
Associated	1716
Hemochromatosis	1716
Arthritis	1716
Inherited deficiency	1717
Wiskott-Aldrich lymphocytes	1717
Deficiency and/or defects	1717
Deficiency of T	1717
Wiskott-Aldrich syndrome	1717
White matter volume	1718
Prader-Willi	1718
Prader-Willi syndrome	1718
Type II	1718
PWS	1718
WMV	1718
Uniparental disomy	1718
HWC	1718
Body mass index	1718
Maternal uniparental disomy 15	1718
BMI	1718
Type I	1718
Maternal uniparental disomy	1718
UPD	1718
Deficiency of arylsulfatase A	1719
Leukodystrophy	1719
Metachromatic leukodystrophy	1719
MLD	1719
DTDST chondrodysplasias	1720
Diastrophic dysplasia	1720
Atelosteogenesis type 2	1720
Premature	1720
Associated	1720
AO2	1720
Dysplasia	1720
Chondrodysplasias	1720
DTD	1720
Amelogenesis imperfecta	1721
Retinal layers	1722
XLRS	1722
Macular degeneration	1722
Associated	1722
Visual acuity	1722
Retinoschisis	1722
X-linked juvenile retinoschisis	1722
Diagnosis	1722
CCALD	1723
Adrenomyeloneuropathy	1723
Childhood cerebral ALD	1723
X-ALD	1723
X-linked adrenoleukodystrophy	1723
Cerebral ALD	1723
ALD	1723
AMN	1723
Adrenoleukodystrophy	1723
Plasma	1723
ADRP	1724
Autosomal dominant	1724
ONL	1724
Human disease	1724
Autosomal dominant retinitis pigmentosa	1724
Retinitis pigmentosa	1724
Associated	1724
Outer nuclear layer	1724
Neurological involvement	1725
Lysosomal storage disorder	1725
Haematological changes	1725
OMIM	1725
Hepatosplenomegaly	1725
Deficiency in the enzyme glucocerebrosidase	1725
Gaucher disease and the synucleinopathies	1725
Gaucher disease	1725
Gaucher	1725
Neurodegenerative disorders	1725
Cancer	1725
Neuronopathic	1725
Glucocerebrosidase	1725
A deficiency	1725
Disorder	1725
Von Willebrand	1726
METHODS	1727
OBJECTIVES	1727
Melanoma	1727
Hungarian melanoma	1727
Familial melanoma	1727
Autosomal dominant	1728
Dmpk deficient	1728
Myotonic dystrophy	1728
DM	1728
Myopathy	1728
Increased fibre degeneration	1728
Skeletal myopathy	1728
Fibrosis	1728
DMPK	1728
Autosomal dominant disorder	1728
Disorder	1728
FMF	1729
Mediterranean fever	1729
Amyloid A	1729
Fever	1729
AIM	1729
Amyloidosis	1729
Familial Mediterranean fever	1729
Tub-deficient	1730
Juvenile retinitis pigmentosa	1730
METHODS	1730
Hearing loss	1730
Photoreceptor degeneration	1730
Retinitis pigmentosa	1730
Retinal degeneration	1730
Associated	1730
Endocytosis	1731
WASP	1731
Wiskott-Aldrich syndrome	1731
METHODS	1732
Neurofibromatosis	1732
Donors	1732
Myotonic dystrophy	1733
Associated	1733
Dystrophia myotonica	1733
DMPK	1733
DM1	1733
Alpha-galactosidase	1734
Alpha-galactosidase A	1734
METHODS	1734
AIM	1734
Alpha	1734
Ataxia	1735
ATM	1735
A-T	1735
Ataxia-telangiectasia	1735
Tumor	1736
Autosomal dominant	1736
Chinese VHL disease	1736
Hemangioblastoma	1736
Familial cancer syndrome	1736
Familial cancer	1736
Papillary cystadenoma	1736
VHL tumor	1736
Renal cell carcinoma	1736
Von Hippel-Lindau disease	1736
Cancer syndrome	1736
Carcinoma	1736
Endolymphatic-sac tumor	1736
Von Hippel-Lindau (VHL) disease	1736
Central nervous system	1736
Von Hippel-Lindau	1736
Cancer	1736
Epididymis	1736
VHL disease	1736
Pheochromocytoma	1736
Sac tumor	1736
Cell carcinoma	1736
VHL	1736
Autosomal dominant familial cancer syndrome	1736
Autosomal dominant	1737
Huntington disease-like 2	1737
METHODS	1737
Neurodegenerative disorder	1737
HD	1737
Autosomal dominant neurodegenerative disorder	1737
Huntington disease	1737
Disorder	1737
HDL2	1737
TD	1738
Autism	1738
FHS	1738
Framingham Heart Study	1738
VLCAD deficiency	1739
Euglycemia	1739
Very long-chain acyl-coA dehydrogenase deficiency	1739
Mass spectrometry	1739
MS	1739
Cardiac	1739
Associated	1739
Energy deficiency	1739
Hypoglycemia	1739
VLCAD-deficient	1739
Ocular coloboma	1740
CES	1740
Preauricular tags	1740
Preauricular anomalies	1740
Congenital heart malformations	1740
Cat eye syndrome	1740
Developmental delay	1741
Becker muscular dystrophy	1741
Adrenal hypoplasia	1741
BMD	1741
Muscular dystrophy	1741
Hypoplasia	1741
Glycerol kinase deficiency	1741
Lesch-Nyhan	1742
Hypothesis	1742
Complete deficiency of the hypoxanthine-guanine phosphoribosyltransferase enzyme	1742
LND	1742
Lesch-Nyhan disease	1742
Neurological manifestations	1742
Basal ganglia	1742
Ganglia	1742
Lesch-Nyhan	1743
Lesch-Nyhan disease	1743
Tumor	1744
Ovarian cancer	1744
GS	1744
Genetic testing	1744
Breast and/or ovarian cancer	1744
Cancer	1744
NGS	1744
Next-generation sequencing	1744
Autosomal dominant	1745
Autosomal dominant anomaly syndrome	1745
Coffin-Siris syndrome	1745
CSS	1745
Non-syndromic oral clefts	1746
Cleft lip only	1746
Exception of the lower lip pit	1746
Van der Woude Syndrome	1746
CLO	1746
Enhancer	1746
VWS	1746
Galactosemia	1747
PKU	1747
METHODS	1747
Defect beyond physical disease	1747
AIM	1747
Galactose-1-phosphate uridyltransferase deficiency	1747
Galactose	1747
Classic galactosemia	1747
Phenylketonuria	1747
Autosomal dominant	1748
Autosomal dominant keratitis	1748
Familial foveal dysplasia	1748
Peters anomaly	1748
Dysplasia	1748
Genetic haploinsufficiency	1748
Aniridia	1748
Proline-serine-threonine	1748
Familial adenomatous polyposis	1749
Adenomatous polyposis coli	1749
AT	1749
Adenomatous	1749
Polyposis	1749
APC	1749
Adenomatous polyposis	1749
FAP	1749
Polyposis coli	1749
Myotonic dystrophy	1750
DM	1750
Associated	1750
Myotonic dystrophy	1751
DM	1751
Genetic diseases	1751
DMPK	1751
Growth	1752
Insulin-dependent diabetes mellitus	1752
Associated	1752
Epidermal growth	1752
IDDM	1752
Diabetes mellitus	1752
Insulin-dependent diabetes	1752
HALP	1753
CETP	1753
Cholesteryl ester transfer protein, hepatic lipase	1753
Hyperalphalipoproteinemia	1753
Associated	1753
Shorter half-life	1754
Proteasome-dependent degradation	1754
Gastric cancer	1754
Hypothesis	1754
Hereditary Diffuse Gastric Cancer	1754
Premature	1754
Associated	1754
Cancer	1754
Age at diagnosis	1754
Diagnosis	1754
HDGC	1754
Ovarian cancer	1755
Medium	1755
Cancer	1755
Breast and ovarian cancer	1755
Spasticity	1756
Developmental delay	1756
PMD	1756
Leukodystrophy	1756
Associated	1756
X-linked leukodystrophy	1756
Pelizaeus-Merzbacher disease	1756
Tumor	1757
Hypothesis	1757
Numerous cancer	1757
Cancer	1757
Prader-Willi	1758
Prader-Willi syndrome	1758
Myotonia	1759
Myotonic dystrophy	1759
DM	1759
Cataract	1759
Myopathy	1759
Hypertrophic cardiomyopathy	1759
Male-infertility	1759
Associated	1759
Dependent atrophy	1759
DMPK	1759
Cardiomyopathy	1759
Enhanced neonatal mortality	1759
Atrophy	1759
Spasticity	1760
Medium	1760
Mental retardation	1760
Hypersensitivity	1760
Ichtyosis	1760
SLS	1760
Sj  gren Larsson Syndrome	1760
METHODS	1761
FS	1761
Urogenital defects	1761
Autosomal recessive malformation syndrome	1761
Premature	1761
FS-like defects	1761
Malformation syndrome	1761
Fraser syndrome	1761
Myotonia	1762
Impaired muscle relaxation	1762
Myotonia congenita	1762
Weakness	1762
Muscle disorder	1762
Muscle weakness	1762
Disorder	1762
Breast cancer	1763
Cancer	1763
Tumor	1764
Familial adenomatous polyposis	1764
Adenomas	1764
Neoplasms	1764
Adenomatous	1764
Growth	1764
Benign neoplasms	1764
Colorectal carcinomas	1764
Colorectal tumorigenesis	1764
Polyposis	1764
Colorectal tumors	1764
Malignant tumors	1764
Adenomatous polyposis	1764
Malignancies	1764
Carcinomas	1764
Tumorigenesis	1764
Tumors	1764
Growth	1765
Type II	1767
Spondylometaphyseal dysplasias	1767
Kyphoscoliosis	1767
SEMD	1767
Type II collagen disorder	1767
Enchondroma-like lesions	1767
Hypothesis	1767
Rare skeletal dysplasia	1767
Dysplasias	1767
Diaphyseal portions of the long tubular bones	1767
Dysspondyloenchondromatosis	1767
Dysplasia	1767
Skeletal dysplasia	1767
DSC	1767
Spondyloepimetaphyseal dysplasia	1767
Disorder	1767
Lynch syndrome	1768
LS	1768
Colorectal cancer	1768
Associated	1768
Hereditary colorectal cancer	1768
Cancer	1768
Myotonia	1769
Short stature	1769
Blepharophimosis	1769
Micrognathia	1769
Generalized attrition and hypodontia of the permanent dentition	1769
Autosomal recessive skeletal dysplasia	1769
Mandibular hypoplasia	1769
Atypical facies	1769
Associated	1769
Cleft palate	1769
Schwartz-Jampel syndrome	1769
Dysplasia	1769
Muscular abnormalities	1769
Malignant hyperthermia	1769
Microstomia	1769
Skeletal dysplasia	1769
Dentigerous cysts	1769
SJS	1769
Hyperthermia	1769
Hypoplasia	1769
General anesthesia	1769
Skeletal anomalies	1769
Hypodontia	1769
Short stature	1770
Inherited bone disease	1770
Juvenile Paget disease	1770
Altered bone turnover	1770
JPD	1770
Bone deformities	1770
Antimalarial drug design	1771
Malaria infections	1771
Malarial parasites	1771
Antimalarial drugs	1771
Malaria	1771
G6PD deficiency	1771
Myotonia	1772
METHODS	1772
MC	1772
Myotonia congenita	1772
Recessive myotonia congenita	1772
Associated	1772
Clinical syndrome	1773
METHODS	1773
Shprintzen-Goldberg syndrome	1773
Impairment of plasma	1774
Familial hypobetalipoproteinemia	1774
HDL	1774
METHODS	1774
Hypoalphalipoproteinemia	1774
Familial LCAT deficiency	1774
Metabolic disorder	1774
Familial lecithin:cholesterol acyltransferase deficiency	1774
Hypobetalipoproteinemia	1774
Kidney disease	1774
LCAT deficiency	1774
Codominant disorder	1774
Plasma	1774
Chronic kidney disease	1774
Disorder	1774
Benign gastrointestinal lesions	1775
Hamartomas	1775
Gastrointestinal lesions	1775
Colonic lesions	1775
Colorectal cancer	1775
Cancers	1775
Benign gastrointestinal polyps	1775
Carcinoma	1775
Various malignancies	1775
PTEN	1775
Colorectal carcinoma	1775
AIM	1775
Hamartomatous lesions	1775
Upper gastrointestinal cancers	1775
Cancer	1775
Malignancies	1775
Gastrointestinal polyps	1775
Diagnosis	1775
Polyps	1775
Hamartomas	1776
Macrocephaly	1776
Developmental delay	1776
Intestinal polyposis	1776
Mental retardation	1776
Polyposis	1776
Lipomas	1776
Hypertelorism	1776
Haemangiomas	1776
PTEN	1776
Bannayan-Riley-Ruvalcaba syndrome	1776
Juvenile polyposis	1776
Pigmented maculae	1776
Rare disease	1776
Diagnosis	1776
Type II collagenopathies	1778
Type II	1778
Platyspondylic lethal skeletal dysplasia	1778
Platyspondylic lethal dysplasia torrance type	1778
Skeletal dysplasias	1778
Dysplasias	1778
Lethal dysplasia	1778
Dysplasia	1778
Skeletal dysplasia	1778
PLSD-T	1778
Tumor	1779
Genomic instability	1779
Ataxia	1779
Associated	1779
ATM	1779
Atm-deficient	1779
Embryonic lethality	1779
Lymphomas	1779
Thymic lymphomas	1779
Ataxia telangiectasia	1779
Tumor	1780
Colorectal cancer	1780
Cancer	1780
Recurrent disease	1780
Genomic disorder	1781
Malignancy	1781
Genetic predisposition	1781
Hereditary prostate cancer	1781
Associated	1781
Prostate malignancy	1781
Cancer	1781
Prostate cancer	1781
Disorder	1781
Haematopoietic	1782
Neurological deficits	1782
X-ALD	1782
Adrenal insufficiency	1782
X-linked adrenoleukodystrophy	1782
Hyperactivity	1782
ALD	1782
Adrenoleukodystrophy	1782
Attention deficit/hyperactivity disorder	1782
Addison's disease	1782
Cognitive impairment	1782
Chronic fatigue, anorexia	1782
Diagnosis	1782
Disorder	1782
Enzymopathy	1783
Hereditary nonspherecytary hemolytic anemia	1783
Hemolytic anemia	1783
Asymptomatic gene carrying	1783
Associated	1783
Deficiency of erythrocyte G6PD	1783
Anemia	1783
G6PD deficiency	1783
Immunostains	1784
Tumor	1784
Growth	1784
Dermatofibrosarcoma protuberans	1784
Tumors	1784
DFSP	1784
Diagnosis	1784
Growth	1785
Associated	1785
DCC	1785
Alzheimer disease	1785
Lisosomal diseases	1786
Sachs disease	1786
Tay-Sachs	1786
Tay-Sachs disease	1786
Sandhoff disease	1786
HEXB	1786
Autosomal recessive lysosomal storage diseases	1786
Lysosomal storage diseases	1786
A deficiency	1786
Familial adenomatous polyposis	1787
Birt-Hogg-Dub   syndrome	1787
Adenomatous polyposis coli	1787
Adenomatous	1787
Colon carcinoma	1787
Polyposis	1787
Carcinoma	1787
APC	1787
Adenomatous polyposis	1787
Colon cancer	1787
Cancer	1787
BHDS	1787
FAP	1787
Polyposis coli	1787
Hemihypertrophy	1788
WAGR syndrome	1788
Genitourinary anomalies	1788
Tumor	1788
Bilateral disease	1788
Genetic predisposition	1788
METHODS	1788
Phenotypic abnormalities	1788
Mental retardation	1788
A syndrome	1788
Overgrowth syndromes	1788
Associated	1788
BWS	1788
WAGR	1788
Beckwith-Wiedemann syndrome	1788
Wiedemann syndrome	1788
Congenital anomalies	1788
Aniridia	1788
Tumour	1788
Denys-Drash syndrome	1788
Wilms tumor	1788
Wilms tumour	1788
Breast cancer	1789
Ovarian cancer	1789
Hereditary Breast Cancer	1789
Premature	1789
BOC	1789
Cancer	1789
Breast and ovarian cancer	1789
Breast Cancer	1789
Oculocerebrorenal syndrome	1790
Lowe syndrome	1790
Fanconi syndrome	1790
Growth	1790
OCRL	1790
Nephrocalcinosis	1790
Cataracts	1790
Renal tubular dysfunction	1790
Renal failure	1790
Cognitive deficits	1790
Associated	1790
Oculocerebrorenal syndrome of Lowe	1790
Nephrolithiasis	1790
Growth retardation	1790
Proteinuria	1790
X-linked disorder	1790
Congenital cataracts	1790
Disorder	1790
OCRL syndrome	1790
Growth	1791
Dermatofibrosarcoma protuberans	1791
DFSP	1791
Diagnosis	1791
GLD	1792
Neurodegenerative disorder	1792
Galactocerebrosidase	1792
Leukodystrophy	1792
Pediatric neurodegenerative disorder	1792
Globoid cell leukodystrophy	1792
CNS	1792
Oligodendroglial progeny	1792
Galactosylceramidase	1792
GALC deficiency	1792
Lysosomal galactosylceramidase	1792
Disorder	1792
Ambiguous functional deficiency	1793
Breast cancer	1793
Ovarian cancer	1793
METHODS	1793
Breast or ovarian cancer	1793
BRCA-X	1793
Family cancer	1793
Associated	1793
Cancer	1793
Breast and ovarian cancer	1793
Uremic syndrome	1794
Lupus erythematosus	1794
METHODS	1794
FH	1794
LA	1794
RA	1794
Deficiency of CFHR1	1794
Rheumatoid arthritis	1794
Associated	1794
AHUS	1794
Thrombosis	1794
Factor H	1794
SLE	1794
Arthritis	1794
Systemic lupus erythematosus	1794
Hemolytic uremic syndrome	1794
Hearing loss	1795
Wolfram syndrome	1795
Inner ear hearing loss	1795
Diabetes mellitus	1795
Optic atrophy	1795
Atrophy	1795
Hyperkyphosis	1796
Mammalian disease	1796
Megaesophagus	1796
Anemia	1796
National Ataxia	1797
Friedreich ataxia	1797
Ataxia	1797
Friedreich ataxia research pipeline	1797
Alliance, Muscular Dystrophy	1797
Friedreich Ataxia	1797
Ataxia	1798
Chronic lymphocytic leukemia	1798
ATM	1798
In ataxia telangiectasia	1798
CLL	1798
Leukemia	1798
Ataxia telangiectasia	1798
Vitamin A deficiency	1800
Clinical malaria	1800
Iron deficiency	1800
Anaemia	1800
Malaria	1800
Blood disorder	1800
Thalassaemia	1800
HbAS	1800
Inherited blood disorders	1800
Malaria parasitaemia	1800
A deficiency	1800
Disorder	1800
G6PD deficiency	1800
Alpha	1800
Ovarian cancer	1801
Cancer	1801
Breast and ovarian cancer	1801
Mediterranean fever	1802
MEFV	1802
Episodes	1802
Fever	1802
Familial Mediterranean fever	1802
Alveolar capillary dysplasia	1803
ACD	1803
Alveolar	1803
Dysplasia	1803
Capillary dysplasia	1803
Disorder	1803
Developmental lung disorder	1803
Prognosis lesions	1804
Tumor	1804
Pediatric tumors	1804
Rhabdoid tumors	1804
Adult cancers	1804
AT	1804
Cancers	1804
Central nervous system	1804
Atypical teratoid/rhabdoid tumor	1804
Pediatric rhabdoid tumors	1804
Tumors	1804
Combating cancer	1805
Idiopathic immune deficiency	1805
Cancer	1805
Immune deficiency	1805
Cartilage-hair hypoplasia	1805
Hypoplasia	1805
Renal cell carcinoma	1806
AXIS	1806
Carcinoma	1806
Advanced renal cell carcinoma	1806
Cell carcinoma	1806
Eczema	1807
JMML	1807
X-linked immunodeficiency	1807
Micro-thrombocytopenia	1807
Myeloid	1807
RAS	1807
Leukocytosis	1807
Immunodeficiency	1807
WASP	1807
Leukaemia	1807
Dysplasia	1807
Splenomegaly	1807
WAS	1807
Myelomonocytic leukaemia	1807
Flow cytometry	1807
Wiskott-Aldrich syndrome	1807
Diagnosis	1807
FCM	1807
PROCEDURES	1807
Thrombocytopenia	1807
EPN	1808
Heterogeneous cancer	1809
Cancers	1809
Associated	1809
Cancer	1809
Prostate Cancer	1809
High-risk disease	1809
Diagnosis	1809
Prostate cancer	1809
FXS	1810
Fragile X	1810
Behavior	1810
Fragile X syndrome	1810
Fragile x syndrome	1810
Spine abnormalities	1810
Criteria	1811
Hypoxanthine phosphoribosyl transferase deficiency	1812
Diagnosis of hypoxanthine phosphoribosyl transferase deficiency	1812
Diagnosis	1812
Muscle symptoms	1813
Associated	1813
Cardiomyopathy	1813
Muscular dystrophy	1813
Duchenne muscular dystrophy	1813
DMD	1813
PKU disease	1814
PKU	1814
METHODS	1814
Familial adenomatous polyposis	1815
Hepatoblastoma	1815
Congenital abnormalities	1815
METHODS	1815
HB	1815
Adenomatous	1815
HB-familial polyposis connection	1815
Genetic testing	1815
Polyposis	1815
Carcinoma	1815
Associated	1815
Colorectal carcinoma	1815
APC	1815
Adenomatous polyposis	1815
Hepatoblastoma-familial polyposis connection	1815
FAP	1815
Diagnosis	1815
Prader-Willi	1816
Prader-Willi syndrome	1816
Microcephaly	1816
Albinism	1816
Micro syndrome	1816
Mental retardation	1816
Dysmorphism	1816
Uniparental disomy	1816
Angelman syndrome	1816
Ataxia	1816
Paternal uniparental disomy	1816
Angelman-like syndrome	1816
Associated	1816
Neurodevelopmental disorder	1816
Facial dysmorphism	1816
Speech disorder	1816
Disorder	1816
Obese	1817
HDL	1817
WTD	1817
Obesity	1817
METHODS	1817
Osteoarthritis	1817
OA	1817
Associated	1817
Metabolic syndrome	1817
Plasma	1817
Breast cancer	1818
Associated	1818
Unrelated healthy individuals	1818
Cancer	1818
Carcinomas	1818
Canadian breast cancer	1818
Breast cancer	1819
Ovarian cancer	1819
METHODS	1819
Colorectal cancer	1819
Cancers	1819
Cancer	1819
Breast and ovarian cancer	1819
Other cancers	1819
Prostate cancer	1819
Breast cancer	1820
IBC	1820
DCIS	1820
Carcinoma	1820
Invasive breast cancer	1820
Ductal carcinoma	1820
Cancer	1820
Ovarian Cancer	1821
Ovarian cancer	1821
METHODS	1821
Associated	1821
Cancer	1821
Hereditary ovarian cancer	1821
Familial hypobetalipoproteinaemia	1822
Abetalipoproteinaemia	1822
Urticaria overlaps	1823
DZ	1823
Atopic diseases	1823
Fever	1823
Urticaria	1823
Atopic dermatitis	1823
Aldosterone or deoxycorticosterone	1824
Hypothyroidism	1824
METHODS	1824
Hearing loss	1824
Pendred syndrome	1824
AIMS	1824
Inner ear, thyroid gland	1824
Goiter	1824
Enlarged vestibular aqueducts	1824
Disorder	1824
Autosomal dominant	1825
Hauwere syndrome	1825
Congenital hip dysplasia	1825
Dental anomalies	1825
Rieger syndrome	1825
Axenfeld-Rieger syndrome	1825
Dysplastic	1825
Valvar anomalies	1825
Heart failure	1825
Atrial septal defect	1825
Anterior chamber abnormalities	1825
Anterior segment abnormalities	1825
Congenital heart disease	1825
Glaucoma	1825
Cardiac	1825
Atrial septum	1825
Autosomal dominant condition	1825
Associated	1825
ASD	1825
ARS	1825
Hip dysplasia	1825
Dysplasia	1825
Axenfeld-Rieger	1825
Molecular testing	1825
Femoral head dysplasia	1825
Hypoplastic	1825
Cardiac anomalies	1825
Heart disease	1825
Umbilical abnormalities	1825
Extraocular anomalies	1825
Tumor	1826
Autosomal dominant	1826
Neoplasms	1826
Cylindroma	1826
Spiradenomas	1826
CYLD	1826
BSS	1826
Multiple adnexal cutaneous neoplasms	1826
Spiradenoma	1826
Trichoepitheliomas	1826
Spiradenocylindroma	1826
Trichoepithelioma	1826
Multiple familial trichoepitheliomas	1826
Autosomal dominant disorder	1826
MFT	1826
Brooke-Spiegler syndrome	1826
Spiradenocylindromas	1826
Tumors	1826
Loss of heterozygosity	1826
Disorder	1826
Cylindromas	1826
Autosomal dominant	1827
Autosomal dominant keratitis	1827
Cataracts	1827
Peters anomaly	1827
Foveal hypoplasia	1827
C-T	1827
Aniridia	1827
Congenital cataracts	1827
Hypoplasia	1827
Isolated foveal hypoplasia	1827
Genetic predisposition	1828
Sarcomas	1828
Cancers	1828
Associated	1828
Childhood cancer	1828
Acute lymphocytic leukemia	1828
Familial leukemia	1828
ALL	1828
Fraumeni syndrome-associated cancers	1828
Cancer	1828
Leukemia	1828
Gardner syndrome	1829
NH	1830
Neonatal hemochromatosis	1830
Course of the disease	1830
Liver disease	1830
Liver failure	1830
Hemochromatosis	1830
Benign prostate hyperplasia	1831
Breast cancer	1831
METHODS	1831
Hereditary prostate cancer	1831
Increased prostate cancer	1831
Colorectal cancer	1831
Associated	1831
BPH	1831
Cancer	1831
Prostate Cancer	1831
CRC	1831
Hyperplasia	1831
Increased cancer	1831
Diagnosis	1831
Prostate cancer	1831
Prader-Willi	1832
Prader-Willi syndrome	1832
Vertebral anomalies	1832
PWS	1832
METHODS	1832
Congenital defects	1832
Renoureteral malformations	1832
Congenital Anomalies	1832
Agenesis/hypoplasia of the corpus callosum	1832
Hip dysplasia	1832
Dysplasia	1832
Heart defects	1832
Congenital heart defects	1832
Hypoplasia	1832
Diagnosis	1832
METHODS	1833
Cowden syndrome	1833
PTEN	1833
Bannayan-Riley-Ruvalcaba syndrome	1833
Allelic loss	1833
Tumor	1834
Familial adenomatous polyposis	1834
Adenomatous polyposis coli	1834
Apoptosis	1834
Adenomatous	1834
APC tumor	1834
Familial adenomatous polyposis coli	1834
Colorectal cancer	1834
Polyposis	1834
Carcinoma	1834
APC	1834
Adenomatous polyposis	1834
Cancer	1834
CRC	1834
FAP	1834
Polyposis coli	1834
Benign (adenoma) and invasive (carcinoma) disease	1834
Diagnosis	1834
Fragile X	1835
Autistic	1835
Social dysfunction	1835
Autism	1835
Pervasive disorder	1835
Fragile X syndrome	1835
Single-gene disorder	1835
Neurodevelopmental syndrome	1835
Disorder	1835
Hereditary breast and colon cancer	1836
Breast cancer	1836
Contralateral breast cancer	1836
METHODS	1836
Ataxia	1836
Breast and colorectal cancers	1836
Colorectal cancers	1836
Cancer syndrome	1836
Colorectal cancer	1836
Cancers	1836
Associated	1836
ATM	1836
OBJECTIVES	1836
Colon cancer	1836
Cancer	1836
Ataxia Telangiectasia	1836
Criteria	1836
Hereditary breast and colorectal cancer syndrome	1836
Breast and colorectal cancer	1836
ATR	1837
ATM	1837
BAF	1837
Cystoid maculopathy	1838
Retinopathy	1838
Hypersensitivity	1838
Retinal degeneration	1838
SWS	1838
Blindness	1838
Myotonia	1839
Deficiencies of skeletal muscle chloride	1839
Heritable disorder	1839
Myotonic disorders	1839
Disorder	1839
Hypoxia	1840
Von Hippel-Lindau protein	1840
Growth	1840
Associated	1840
Tumours	1840
Von Hippel-Lindau	1840
Tumour	1840
VHL	1840
Lowe syndrome	1841
Tubulopathy	1841
METHODS	1841
OCRL	1841
Psychomotor retardation	1841
Cataracts	1841
X-linked recessive hereditary disease	1841
Abnormalities of eyes, nervous system, and kidneys	1841
Proximal tubulopathy	1841
Congenital cataracts	1841
Hereditary disease	1841
Alpha	1842
Short stature	1843
Hypotonia	1843
Developmental delay	1843
Developmental delays	1843
Episodes	1843
Sudden loss of muscle tonus	1843
Autistic	1843
Norrie disease	1843
Sudden loss of muscle tone	1843
Behavior	1843
NDP	1843
Disorder	1843
Expanded syndrome	1844
Sensorineural deafness	1844
Deafness	1844
Piebaldism	1844
Auditory anomalies	1844
Waardenburg syndrome	1844
Congenital sensorineural deafness	1844
Developmental delay	1845
Microcephaly	1845
AS	1845
Uniparental disomy	1845
Neurodevelopmental disorder	1845
Speech impairment	1845
Angelman Syndrome	1845
Molecular defects	1845
Diagnosis	1845
Disorder	1845
Genetic disease	1846
Alpha	1846
Intracranial retinoblastoma	1847
Retinal and the pineal tumours	1847
Retinoblastoma	1847
Tumours	1847
Pineal and retinal tumours	1847
Inherited deficiency	1848
Hypersensitivity	1848
Hypothesis	1848
Wild type	1848
DOPA-responsive dystonia	1848
Dystonia	1848
Associated	1848
Congenital deficiency	1848
Hyperphenylalaninemia	1848
DRD	1848
Motor impairment	1848
Congenital deficiency of GCH1	1848
RCCs	1849
Von Hippel Lindau disease	1849
Renal cell carcinoma	1849
RCC	1849
Carcinoma	1849
Associated	1849
Von Hippel Lindau (VHL) disease	1849
Renal cell carcinomas	1849
Carcinomas	1849
VHL disease	1849
Tumors	1849
Von Hippel Lindau	1849
Cell carcinoma	1849
VHL	1849
Lesch-Nyhan syndrome	1850
Lesch-Nyhan	1850
LNS	1850
X-linked adrenoleukodystrophy	1851
Adrenoleukodystrophy	1851
III	1852
Autosomal recessive inborn error	1853
Hyperglycinemia	1853
Neurologic impairment	1853
Autosomal recessive inborn error of glycine metabolism	1853
Nonketotic hyperglycinemia	1853
Diagnosis	1853
Plasma	1853
NKH	1853
Tumor	1854
Tumorigenesis	1854
Li-Fraumeni syndrome	1854
Tourette syndrome	1855
Misophonia	1855
MYCN(A) tumour	1856
METHODS	1856
Childhood retinal cancer	1856
Retinoblastoma tumours	1856
Unilateral retinoblastoma	1856
Retinoblastoma	1856
Tumours	1856
Unilateral retinoblastoma tumours	1856
Cancer	1856
FINDINGS	1856
Tumour	1856
Age at diagnosis	1856
Retinoblastomas	1856
Diagnosis	1856
Non-familial retinoblastoma tumours	1856
WASP	1857
Wiskott-Aldrich syndrome	1857
Alveolar capillary dysplasia	1858
Developmental disorder	1858
Nonpulmonary anomalies	1858
Disorder of the lung defined	1858
ACD	1858
Alveolar	1858
Dysplasia	1858
Capillary dysplasia	1858
Disorder	1858
Skin fragility	1859
Neurodegenerative disorder	1861
Autosomal recessive neurodegenerative disorder of the myelin metabolism	1861
Leukodystrophy	1861
Metachromatic leukodystrophy	1861
Autosomal recessive neurodegenerative disorder	1861
MLD	1861
Diagnosis	1861
Disorder	1861
Lysosomal enzyme arylsulfatase A	1861
Hemolysis	1862
Enzymatic disorder	1862
Hemolytic anemia	1862
Geriatric trauma	1862
Geriatric G6PD deficiency	1862
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	1862
Trauma	1862
Anemia	1862
Disorder	1862
G6PD deficiency	1862
Geriatric Trauma	1862
Familial adenomatous polyposis	1863
Adenomatous polyposis coli	1863
Adenomatous	1863
Colorectal cancer	1863
Polyposis	1863
Attenuated phenotype	1863
Associated	1863
APC	1863
Adenomatous polyposis	1863
Adenomatous polyps	1863
Cancer	1863
FAP	1863
Attenuated adenomatous polyposis coli	1863
Polyposis coli	1863
Polyps	1863
AAPC	1863
Neurodegenerative disease	1864
Neurodegenerative diseases	1864
Friedreich's Ataxia	1864
Ataxia	1864
FRDA	1864
HH	1865
Hemochromatosis	1865
Diagnosis	1865
Hereditary hemochromatosis	1865
Wild type	1866
Hemochromatosis	1866
Hereditary hemochromatosis	1866
Lesch-Nyhan diagnosis	1867
Lesch-Nyhan syndrome	1867
Lesch-Nyhan	1867
Diagnosis	1867
Muscle gamma	1868
Sex-linked disorder	1869
Hearing loss	1869
Associated	1869
Demyelination	1869
ALD	1869
Hypogonadism	1869
Central and peripheral nervous system impairment due to demyelination	1869
Adrenoleukodystrophy	1869
Neurological symptoms	1869
Hypoadrenalism	1869
Disorder	1869
Adrenal cortex, gonads and nervous system	1869
Familial amyloidotic polyneuropathy	1870
Obesity	1871
Monogenic obesity	1871
Metabolic abnormalities	1871
Fatal disease	1872
Associated	1872
CHS	1872
Autosomal recessive disease	1872
Recessive disease	1872
Enzyme deficiency	1872
Chediak-Higashi syndrome	1872
Diagnosis	1872
Prenatal diagnosis	1872
Obese	1874
Adrenocorticotropic hormone deficiency	1874
Complete proopiomelanocortin (POMC) deficiency	1874
Hormone deficiency	1874
POMC deficiency	1874
Coincidental concomitant type 1 diabetes	1874
Genetic defects	1874
Glucose homeostasis	1874
Complete POMC deficiency and type 1 diabetes mellitus	1874
Diabetes mellitus	1874
Type 1 diabetes mellitus	1874
Complete genetic defects	1874
CETP	1875
METHODS	1875
AI	1875
Diabetes mellitus	1875
Atherosclerosis	1875
Plasma	1875
Tumor	1876
Sporadic prostate carcinoma	1876
Carcinoma	1876
PTEN	1876
Fatal cancer	1876
Cancer	1876
Prostate tumors	1876
Tumors	1876
Sporadic prostate cancer	1876
Loss of heterozygosity	1876
Prostate cancer	1876
Prostate carcinoma	1876
Male cancer	1876
Von Willebrand	1877
Hemophilia  A	1877
Hemophilia	1877
Devastating disease	1878
Farber's lipogranulomatosis	1878
Autosomal recessive disease	1878
Recessive disease	1878
Acid ceramidase deficiency	1878
Farber disease	1878
BRCA testing	1879
Genetic testing	1879
Associated	1879
Cancer	1879
Encephalopathy	1880
Hepatomegaly	1880
Heart failure	1880
Mass spectrometry	1880
MS	1880
Premature	1880
Carnitine deficiency	1880
Hypoglycemic encephalopathy	1880
Diagnosis	1880
Paroxysmal nocturnal hemoglobinuria	1881
PNH	1881
Autosomal gene PIGT	1881
GPI-anchored protein deficiency	1881
Next-generation sequencing	1881
Breast cancer	1882
Insulin-like growth	1882
Growth	1882
Inherited breast cancer	1882
Cancer	1882
Prostate cancer	1882
Associated	1883
Brown-Vialetto-Van Laere syndrome	1883
Tumor	1884
Breast cancer	1884
Loss of information	1884
Early-onset disease	1884
Genome-wide association studies	1884
Cancer syndrome	1884
Associated	1884
Cancer	1884
Next-generation sequencing	1884
METHODS	1885
Genetic testing	1885
Cancer	1885
Repair deficiency	1886
Malignancy	1886
Hereditary nonpolyposis colorectal cancer	1886
Neurofibromatosis	1886
Colorectal cancer	1886
MLH1 deficiency	1886
Lymphoma	1886
Associated	1886
Cancer	1886
Leukemia	1886
Hematological malignancy	1886
Arrhythmias	1887
QT syndrome	1887
Cardiac	1887
Associated	1887
Brugada syndrome	1887
BrS	1887
White matter hyperintensities	1888
WMH	1888
WMHs	1888
Premature	1888
Disorder of early language delay	1888
Plasma	1888
Disorder	1888
CETP	1890
Hyperlipidaemia	1891
Cardiovascular disease	1891
Neurodegenerative disease	1893
Inherited neurodegenerative disease	1893
Spinocerebellar ataxia type-1	1893
Ataxia	1893
Spinocerebellar ataxia	1893
CIC	1893
Tumorigenesis	1893
Neurodegeneration	1893
PC	1894
Hemolytic anemia	1894
G6PD- subjects	1894
Anemia	1894
G6PD deficiency	1894
Familial mediterranean fever	1895
FMF	1895
Mediterranean fever	1895
METHODS	1895
TR	1895
Fever	1895
Course of the disease	1895
Familial Mediterranean fever	1895
Sachs disease	1896
Tay-Sachs	1896
Tay-Sachs disease	1896
TSD	1896
Anxiety	1896
Import defect	1897
GD	1898
Glucosylceramide	1898
Gaucher disease	1898
Wild type	1898
Gaucher	1898
Associated	1898
COS	1898
Glucocerebrosidase	1898
Diploid number	1899
Autosomal segmental duplications	1899
BAC	1899
Friedreich ataxia	1900
Demographic	1900
III	1900
Ataxia	1900
Mitochondrial dysfunction	1900
FRDA	1900
Neuropsychological outcome	1901
Friedreich ataxia	1901
Ataxia	1901
Associated	1901
Later disease	1901
Burden of disease	1901
Inherited ataxia	1901
Cognitive impairment	1901
FRDA	1901
Human gene mutation data base	1902
METHODS	1902
Piebaldism	1902
HGMD	1902
Diagnosis	1902
Lange syndrome	1903
Haploinsufficiency of TRPS1	1903
Type II	1903
Ehlers-Danlos syndrome	1903
Cornelia de Lange syndrome	1903
Dysmorphism	1903
Cardiovascular defects	1903
Gastroesophageal reflux	1903
Cornelia de Lange syndrome-4	1903
Associated	1903
Epilepsy	1903
Facial dysmorphism	1903
Trichorhinophalangeal syndrome type II/Langer-Giedion syndrome	1903
Langer-Giedion syndrome	1903
Machado-Joseph Disease	1904
Sensorimotor neuropathy	1905
Sensorimotor axonal neuropathy	1905
Obvious	1905
Axonal neuropathy	1905
Recessive ataxias	1905
METHODS	1905
Progressive cerebellar ataxia	1905
Ataxia	1905
Neuropathy	1905
ATM	1905
OBJECTIVES	1905
AFP	1905
A-T	1905
Cerebellar ataxia	1905
Cerebellar atrophy	1905
Facial dyskinesia	1905
Ataxia-telangectasia	1905
Were gait ataxia	1905
Atrophy	1905
Alpha	1905
Autosomal dominant	1906
Acrocephalosyndactyly	1906
XY	1906
Congenital disorder	1906
Chotzen syndrome	1906
High-arched palate	1906
Craniosynostosis	1906
Autosomal dominant congenital disorder	1906
Limb anomalies	1906
Disorder	1906
Heart development	1908
Cardiac	1908
Heart defects	1908
Congenital heart defects	1908
Cardiovascular disease	1908
Cardiac tissue repair	1908
Fetal peters' plus syndrome	1909
Growth	1909
Autosomal recessive ocular genetic syndrome	1909
Growth-retarded	1909
Peters' plus syndrome	1909
Diagnosis	1909
Prenatal diagnosis	1909
Breast cancer	1910
ROI	1910
Cancer	1910
Behavior	1910
SSMD	1910
Breast cancer	1911
Bilateral breast cancer	1911
BC	1911
Associated	1911
Cancer	1911
CpG methylation	1911
Breast Cancer	1911
Criteria	1911
Loss of heterozygosity	1911
Associated	1912
Behavior	1912
GLD	1913
Leukodystrophy	1913
Cognitive deficits	1913
Demyelination	1913
Globoid cell leukodystrophy	1913
CNS	1913
Deficiency of the lysosomal enzyme galactosylceramidase	1913
Galactosylceramidase	1913
Neurological disease	1913
Plasma	1913
Myotonic Dystrophy type 1	1914
Tumor	1915
Non-neoplastic mucosa	1915
Gastric cancer	1915
METHODS	1915
Sporadic diffuse gastric cancer	1915
PS	1915
Pyrosequencing	1915
Gastric mucosa	1915
AIM	1915
Neoplastic	1915
Precursor lesions	1915
Cancer	1915
DGC	1915
Gastric mucosa samples	1915
Tumor	1916
Adenomatous polyposis coli	1916
Adenomatous	1916
Cancers	1916
Polyposis	1916
APC	1916
Adenomatous polyposis	1916
Chromosomal instability	1916
CIN	1916
Colon cancers	1916
Polyposis coli	1916
Ovarian cancer	1917
FA-Q	1917
Breast/ovarian	1917
FA	1917
Breast/ovarian cancer	1917
Cross-link repair	1917
Cancer	1917
Breast and ovarian cancer	1917
Familial breast/ovarian cancer	1917
Familial breast and ovarian cancer	1917
Anemia	1917
Fanconi anemia	1917
FG syndrome	1918
ID	1918
Dysmorphism	1918
Malar area	1918
Lujan syndrome	1918
Cognitive impairment	1918
Ohdo syndrome	1918
C3 deficiencies	1919
FMF	1920
Mediterranean fever	1920
METHODS	1920
Fever	1920
Breast milk composition	1920
Familial Mediterranean fever	1920
Uremic syndrome	1921
Hemolytic uremic syndrome	1921
PKU	1922
METHODS	1922
Neurocognitive impairment	1922
OBJECTIVES	1922
Phenylketonuria	1922
Insulin-dependent diabetes mellitus	1923
Associated	1923
IDDM	1923
Diabetes mellitus	1923
Insulin-dependent diabetes	1923
Inherited arrhythmia syndromes	1924
Arrhythmia	1924
Diagnosis	1924
METHODS	1925
DZ	1925
Spondylitis	1925
AS	1925
Associated	1925
Ankylosing spondylitis	1925
Autosomal dominant	1926
HCP	1926
Hereditary coproporphyria	1926
Harderoporphyria	1926
Associated	1926
Autosomal recessive harderoporphyria	1926
Deficiency of the enzyme coproporphyrinogen oxidase	1926
Porphyria	1926
Partial deficiency	1926
Inherited disease	1926
HCP disease	1926
Less harderoporphyrinogen	1926
Diagnostic criteria for the disease	1927
METHODS	1927
Asymmetric limb weakness	1927
Diagnostic criteria	1927
Krabbe disease	1927
Weakness	1927
Demyelination	1927
Galactocerebroside	1927
Electromyography suggested peripheral nerve demyelination	1927
Criteria	1927
Neonatal hypotonia	1928
Short stature	1928
Prader-Willi	1928
Prader-Willi syndrome	1928
Hypotonia	1928
PWS	1928
Obesity	1928
III	1928
Mitochondrial dysfunction	1928
Cardiac	1928
Associated	1928
Genetic disorder	1928
Hypogonadism	1928
Defect in energy metabolism	1928
Morbid obesity	1928
Hyperphagia	1928
Cognitive impairment	1928
Disorder	1928
Prader-Willi	1929
Obesity	1929
Heterogeneous disease	1929
Prader-Willi-like phenotype	1929
Associated	1929
Hyperphagia	1929
Intellectual deficiency	1929
Tumor	1930
Ovarian carcinoma	1930
Insulin-like growth	1930
Ovarian cancer	1930
Malignancy	1930
Growth	1930
Carcinoma	1930
Cancer	1930
Hereditary breast cancer	1931
Breast cancer	1931
Malignancy	1931
HBC	1931
Cancers	1931
Associated	1931
Treatment modalities	1931
Cancer	1931
Areas of uncertainty	1931
Anxiety	1931
Diagnosis	1931
Nonhereditary disease	1932
Ovarian cancer	1932
METHODS	1932
AJ	1932
Epithelial ovarian cancer	1932
Cancer	1932
Age at diagnosis	1932
Diagnosis	1932
EOC	1932
Hispanic	1932
Tumor	1933
PTEN hamartoma tumor syndrome	1933
Cowden syndrome	1933
PTEN	1933
Define rare genetic syndromes	1933
Hamartoma	1933
Hereditary breast cancer	1934
Breast cancer	1934
Ovarian cancer	1934
Hypothesis	1934
Breast or ovarian cancer	1934
Genetic testing	1934
Cancer	1934
Diagnosis	1934
Prader-Willi	1936
Prader-Willi syndrome	1936
PWS	1936
PG	1937
Glucosephosphate isomerase deficiency	1937
Ataxia	1938
Spinocerebellar ataxia	1938
Hereditary spinocerebellar ataxia type 1	1938
Hereditary spinocerebellar ataxia	1938
CIC	1938
SCA1	1938
Uremic syndrome	1939
C3 glomerulopathies	1939
FH	1939
Alternative complement pathway	1939
Acute renal failure	1939
Thrombotic microangiopathy	1939
HUS	1939
Hemolytic anemia	1939
FH deficiency	1939
Renal failure	1939
Associated	1939
CFH	1939
Factor H	1939
Thrombotic	1939
Atypical HUS	1939
Anemia	1939
Diagnosis	1939
Plasma	1939
Hemolytic uremic syndrome	1939
Thrombocytopenia	1939
ARG1 gene defect	1940
Spastic tetraplegia	1940
Mass spectrometry	1940
Hereditary deficiency of hepatocytes arginase	1940
Hydrolysis	1940
Argininemia	1940
Metabolic disorder	1940
Cerebella atrophy	1940
Chromatography	1940
Inborn errors of metabolism	1940
Diagnosis	1940
Autosomal recessive, metabolic disorder	1940
Disorder	1940
Prenatal diagnosis	1940
Atrophy	1940
Tumor	1941
Rb	1941
Retinoblastoma	1941
Associated	1941
Hereditary and nonhereditary retinoblastoma	1941
Retinoblastoma tumor	1941
Rb tumors	1941
Tumors	1941
Hereditary status	1941
Diagnosis	1941
Loss of heterozygosity	1941
Immunodeficiency disease	1942
X-linked immunodeficiency	1942
Immunodeficiency	1942
Associated	1942
WASP	1942
Gene defects	1942
Isolated thrombocytopenia	1942
WAS	1942
X-linked immunodeficiency disease	1942
Wiskott-Aldrich syndrome	1942
Thrombocytopenia	1942
HD	1943
Huntington disease	1943
Hemophilia B	1944
Hemophilia	1944
Myotonia	1945
Short stature	1945
Moderate bone dysplasia	1945
Pyle disease	1945
Kniest dysplasia	1945
Bone dysplasia	1945
Chondrodystrophic myotonia	1945
Schwartz-Jampel syndrome	1945
Dysplasia	1945
SJS	1945
Mass spectrometry	1946
Adrenal insufficiency	1946
X-linked adrenoleukodystrophy	1946
ALD	1946
Adrenoleukodystrophy	1946
Chromatography	1946
Neurologic involvement	1946
Plasma	1946
Tumor	1947
Metastasis	1947
Breast cancer	1947
Infectious disease	1947
Infectious diseases	1947
Cancer	1947
Myotonia	1948
Myotonic dystrophy	1948
DM	1948
Progressive skeletal muscle weakness	1948
Hypothesis	1948
Cardiac	1948
Systemic disease	1948
Weakness	1948
Impacts	1948
Central nervous system	1948
Muscle disease	1948
DM muscle disease	1948
CNS	1948
Muscle weakness	1948
Disorder	1948
Reduced lifespan, heart conduction	1948
PLS	1949
Genetic mapping	1949
Papillon-lef  vre syndrome	1949
Associated	1949
Periodontitis	1949
Palmoplantar hyperkeratosis	1949
Papillon-Lefevre syndrome	1949
Genetic defect	1949
Diagnosis	1949
Papillon-lefevre syndrome	1949
Developmental disorder	1950
AS	1950
III	1950
Diagnostic criteria	1950
Asperger's syndrome	1950
Autism	1950
Tourette syndrome	1950
Personality disorders	1950
Criteria	1950
Disorder	1950
Pervasive developmental disorder	1950
Tumor	1951
Hereditary breast and / or ovarian cancer	1951
Ovarian cancer	1951
Associated	1951
Cancer	1951
Breast and / or ovarian cancer	1951
Familial amyloidosis	1952
HCM	1952
Restrictive cardiomyopathy	1952
Heart failure	1952
METHODS	1952
Familial restrictive cardiomyopathy	1952
Hypertrophic cardiomyopathy	1952
RCM	1952
Associated	1952
Cardiomyopathy	1952
Amyloidosis	1952
Inherited cardiomyopathies	1952
Premature	1953
Complete   -ureidopropionase deficiency	1953
B-ureidopropionase deficiency	1953
ALDP	1954
Adrenoleukodystrophy	1954
FD	1955
Associated	1955
Fabry disease	1955
Flow cytometry	1955
PDS	1956
GT	1956
Pendred syndrome	1956
BAC	1956
CLD	1956
Congenital chloride diarrhea	1956
Tumor	1957
Denys-Drash or Frasier syndrome	1957
Frasier syndrome	1957
Isolated nephrotic syndrome	1957
Wilms' tumor	1957
Isolated SRNS	1957
Nephrotic syndrome	1957
Drash or Frasier syndrome	1957
SRNS	1957
Steroid-resistant nephrotic syndrome	1957
Limb ataxia	1958
Friedreich ataxia	1958
METHODS	1958
Areflexia	1958
Ataxia	1958
Lower limb areflexia	1958
Recessive disorder	1958
Dysarthria	1958
Movement abnormality	1958
Autosomal recessive disorder	1958
Criteria	1958
FRDA	1958
Disorder	1958
Extensor plantar response and dysarthria	1958
X-linked multisystem disease	1959
Neurological abnormalities	1959
Multisystem disease	1959
Paranodal demyelination	1959
Neuropathological abnormalities	1959
McLeod neuroacanthocytosis syndrome	1959
Wild type	1959
Associated	1959
McLeod	1959
Demyelination	1959
MLS	1959
Severe neonatal jaundice	1960
Newborns	1960
Associated	1960
Glucose-6-phosphate dehydrogenase deficiency	1960
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	1960
G6PD-deficient	1960
Neonatal jaundice	1960
Hyperbilirubinaemia	1960
G6PD deficiency	1960
Tumor	1961
Cervical lymphadenopathy	1961
Tumor necrosis	1961
Obvious	1961
Rhabdomyosarcoma	1961
Necrosis	1961
Lymphadenopathy	1961
Alveolar rhabdomyosarcoma	1961
Lymphoma	1961
Killer/T-cell lymphoma	1961
Alveolar	1961
Neoplastic	1961
Nasopharyngeal mass	1961
ARMS	1961
Diagnosis	1961
ENKTL	1961
Nasopharyngeal small blue round cell tumor	1961
Tumor	1962
Simpson-Golabi-Behmel syndrome	1962
Hepatoblastoma	1962
Macrocephaly	1962
Congenital abnormalities	1962
Cancers	1962
Overgrowth syndromes	1962
Associated	1962
Embryonal tumors	1962
Tumorigenesis	1962
Tumors	1962
Overgrowth syndrome	1962
Other cancers	1962
Hypoxia	1963
Immune or hypoxic challenge	1963
Systemic inflammation	1963
Hypothesis	1963
Ataxia	1963
Associated	1963
ATM	1963
A-T disease	1963
A-T	1963
Ataxia-telangiectasia	1963
Prader-Willi	1964
Prader-Willi syndrome	1964
Associated	1964
Chronic myeloid leukemia	1965
Myeloid leukemia	1965
Myeloid	1965
Myeloproliferative diseases	1965
APC	1965
Colon cancer	1965
Cancer	1965
CML	1965
Leukemia	1965
NGS	1965
Next-generation sequencing	1965
Iron overload disorders	1966
DMT1 dysfunction	1966
Neurodegenerative diseases	1966
Associated	1966
Tumor	1967
Malignancy	1967
DF	1967
Growth	1967
Dermatofibrosarcoma protuberans	1967
Dermatofibrosarcoma protuberans tumor	1967
MEK	1967
Dermatofibroma	1967
DFSP	1967
Tumor	1968
Apoptosis	1968
Ataxia	1968
ATM	1968
Cancer	1968
Ataxia-telangiectasia	1968
Genetic conditions	1969
Generalized brown discoloration	1969
Hypomaturation	1969
Autosomal recessive hypomaturation	1969
Amelogenesis imperfecta	1969
Retinal dystrophy	1970
Heterogeneous retinal dystrophy	1970
Macular involvement	1970
Retinitis pigmentosa	1970
Associated	1970
Genetic defects	1970
Macular nummular pigmentation	1970
Healthy donors	1971
PMN	1971
PNH	1971
III	1971
Paroxysmal nocturnal haemoglobinuria	1971
SD	1971
Anaemia	1971
Haemoglobinuria	1971
DAF	1971
Decay-accelerating factor	1971
Donors	1971
Galactosemia	1972
GalT	1972
Classic Galactosemia	1972
GSH	1972
Growth	1972
OMIM	1972
Edema	1972
Cerebral edema	1972
Absence of galactose-1 phosphate uridylyltransferase	1972
Galactose	1972
FST	1973
Newborns	1973
Associated	1973
Neonatal icter	1973
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	1973
Enzyme deficiency	1973
Disorder	1973
G6PD deficiency	1973
Pendred syndrome	1974
Bipolar disorder	1974
Disorder	1974
METHODS	1975
Pancreas	1975
Enhancer	1975
Denys-Drash syndrome	1976
HDL	1977
METHODS	1977
Associated	1977
Coronary heart disease	1977
CHD	1977
Heart disease	1977
Excess	1977
Postnatal growth retardation	1978
Growth	1978
Uniparental disomy	1978
Mandibuloacral dysplasia	1978
Recessive disorder	1978
HGPS	1978
Hutchinson-Gilford Progeria Syndrome	1978
Growth retardation	1978
Dysplasia	1978
Maternal UPD	1978
MAD	1978
Autosomal recessive disorder	1978
Disorder	1978
UPD	1978
Craniofacial anomalies	1978
Ovarian cancer	1979
Carcinoma	1979
SCCOHT tumors	1979
Cancer	1979
Tumors	1979
Cell carcinoma	1979
Facioscapulohumeral dystrophy	1980
Neuromuscular diseases	1980
Myotonic dystrophy	1980
Gain of function muscular diseases	1980
DMPK	1980
Pilomatricomas are tumors	1981
Skin tumors	1981
Pilomatricomas	1981
METHODS	1981
Matrical tumors	1981
Trichoepithelioma	1981
Carcinomas	1981
Tumorigenesis	1981
Trichoblastomas	1981
Pilomatricoma	1981
Tumors	1981
Basal cell carcinomas	1981
Matricomas	1981
Adenomatous polyposis coli	1982
METHODS	1982
BreakDancer	1982
Adenomatous	1982
Polyposis	1982
Premature	1982
Adenomatous colon polyps too numerous	1982
APC	1982
Adenomatous polyposis	1982
Polyposis coli	1982
Next-generation sequencing	1982
Polyps	1982
Tumor	1983
Breast cancer	1983
Malignancy	1983
Apoptosis	1983
Cancer cell malignancy	1983
Cancers	1983
Cancer	1983
Diagnosis	1983
CETP	1984
HDL	1984
Associated	1984
Coronary heart disease	1984
CETP deficiency	1984
CHD	1984
Heart disease	1984
Plasma	1984
Retinoschisis	1985
X-linked retinoschisis	1985
Tumor	1986
Benign neoplasm	1986
Lipomatous tumors	1986
Lipoblastomas	1986
Lipoblastoma tumor	1986
Neoplasm	1986
Tumors	1986
Diagnosis	1986
Lipoblastoma	1986
Lipoma	1986
METHODS	1987
Wild type	1987
Diagnosis	1987
G6PD deficiency	1987
G6PD/6PGD	1987
Tumor	1988
Isolated hypertrophy	1988
WTX	1988
Denys-Drash syndromes	1988
WT	1988
Embryologic tumor	1988
Associated	1988
Hypertrophy	1988
Neoplasm	1988
WAGR	1988
Treatment modalities	1988
Beckwith-Wiedemann syndrome	1988
Genetic abnormalities	1988
Wiedemann syndrome	1988
Precursor lesions	1988
Tumors	1988
Wilms tumor	1988
Loss of heterozygosity	1988
Autosomal dominant	1989
Familial neurohypophyseal diabetes insipidus	1989
Neurohypophyseal diabetes insipidus	1989
Premature	1989
Autosomal dominant disease	1989
FNDI	1989
Diabetes insipidus	1989
CETP	1990
Atherosclerosis	1990
Anti-atherosclerosis	1990
Lysosomal storage disorder	1991
Gait deficits	1991
Lysosomal storage disease	1991
Postural imbalance	1991
Deficiency of lysosomal b-galactosidase	1991
Associated	1991
Gangliosidosis	1991
Normalization of disease	1991
Progressive debilitating neurological defects	1991
Gangliosidosis disease	1991
Feline G(M1) gangliosidosis	1991
Deep cerebellar nuclei	1991
Neurological disease	1991
Disorder	1991
BCD syndrome	1992
Blepharo-cheilo-dontic (BCD) syndrome	1992
Autosomal dominant	1992
Bilateral cleft lip and palate	1992
Distichiasis	1992
Lumbosacral meningomyelocele	1992
Cleft lip and palate	1992
Involve eyelids, lip, and teeth abnormalities	1992
Lagophthalmia	1992
Autosomal dominant condition	1992
BCD	1992
Bilateral cleft lip	1992
Lower eyelids	1992
Oligodontia	1992
Hypothyroidism	1993
Retinal detachment	1993
Neovascularization and tractional retinal detachments	1993
Retinal and iris neovascularization	1993
Dysplasia	1993
Spondyloepiphyseal dysplasia	1993
Beta thalassemia	1994
Thalassemia	1994
Paroxysmal nocturnal hemoglobinuria	1995
PNH	1995
Hemolytic anemia	1995
Associated	1995
Autologous plasma complement	1995
Anemia	1995
Plasma	1995
Membrane abnormalities	1995
Disorder	1995
HC	1996
Haemochromatosis	1996
Early infancy	1996
Cardiac and endocrine disorders	1996
Cardiac	1996
Cirrhosis	1996
Inherited disorder	1996
Diagnosis	1996
Disorder	1996
Autosomal dominant	1997
Familial adenomatous polyposis	1997
Adenomas	1997
Adenomatous polyposis coli	1997
Adenomatous	1997
Colorectal cancer	1997
Polyposis	1997
Carcinoma	1997
Autosomal dominant disease	1997
Associated	1997
Colorectal tumors	1997
Colorectal adenomas	1997
APC	1997
Adenomatous polyposis	1997
Metaplastic polyps of the colorectum	1997
Cancer	1997
Tumors	1997
FAP	1997
Attenuated adenomatous polyposis coli	1997
Polyposis coli	1997
Polyps	1997
Alpha	1998
Peroxisomal beta-oxidation	1999
Deficiency, bifunctional protein deficiency, acyl-CoA oxidase deficiency	1999
Neonatal adrenoleukodystrophy	1999
Infantile Refsum disease	1999
Zellweger-like syndrome	1999
Hyperoxaluria type I	1999
Peroxisomal disorders	1999
Genetic diseases	1999
Refsum disease	1999
Acatalasaemia	1999
Zellweger syndrome	1999
Peroxisomal dysfunction	1999
Genetic disorders	1999
Role in human cellular metabolism	1999
X-linked adrenoleukodystrophy	1999
Type I	1999
Adrenoleukodystrophy	1999
Chondrodysplasia	1999
Zellweger	1999
Diagnosis	1999
Disorder	1999
Prenatal diagnosis	1999
Rhizomelic chondrodysplasia	1999
May-Hegglin anomaly	2000
Colon adenocarcinoma	2001
Colorectal carcinomas	2001
Polyposis	2001
Familial polyposis coli	2001
Adenocarcinoma	2001
Carcinomas	2001
FAP	2001
Polyposis coli	2001
Colorectal adenocarcinoma	2001
GT	2002
III	2002
Growth	2002
Von Willebrand factor, complement factors B and C2	2002
Von Willebrand	2002
Epidermal growth	2002
CMP	2002
Alpha	2002
Aarskog syndrome	2003
Epstein-Barr	2004
Epstein-Barr virus	2004
Ataxia	2004
Comparison of gamma-radiation-induced accumulation	2004
Radiosensitivity	2004
In ataxia telangiectasia	2004
A-T	2004
Ataxia telangiectasia	2004
Adenomatous polyposis coli	2005
Adenomatous	2005
Polyposis	2005
Associated	2005
Inherited disorder	2005
Dominantly inherited disorder	2005
APC	2005
Adenomatous polyposis	2005
Polyposis coli	2005
Disorder	2005
Rd	2006
Growth	2007
PKDs	2008
Polycystic kidney diseases	2008
Kidney diseases	2008
Linkage disequilibrium	2009
Myotonic dystrophy	2009
DM	2009
Chronic lymphocytic leukemia	2009
Leukemia	2009
Muscular dystrophy	2009
Alpha	2009
Norrie disease	2010
Diagnosis	2010
Prenatal diagnosis	2010
Prader-Willi	2011
Aneuploidy	2011
Prader-Willi syndrome	2011
PWS	2011
Mentally retarded	2011
Diagnosis	2011
Inherited metabolic disease	2012
Metabolic disease	2012
Diagnosis	2013
Deficient individuals	2014
Related disorders	2014
III	2014
C4	2014
Hypothesis	2014
Immunodeficiency	2014
IgA deficiency	2014
Associated	2014
Immunodeficiency or IgA deficiency	2014
Class III	2014
Immunodeficiency are heritable disorders	2014
Immunodeficiency and IgA deficiency	2014
Combined abnormalities	2015
Familial adenomatosis	2015
Other abnormalities	2015
Abnormalities of jaw bones	2015
Orthopantomography	2015
Osteomas and peripheral osteomas	2015
Osteomas	2015
Radiopaque lesions	2015
Multiple abnormalities	2015
FAC	2015
Osteomatous radiopaque lesions	2015
Osteoma	2015
Familial adenomatosis coli	2015
Myasthenia gravis	2016
Congenital defect	2017
Familial central diabetes insipidus	2017
Isolated AVP deficiency	2017
Diabetes insipidus	2017
DD	2018
ND	2018
Plasma	2018
Pediatric oncology	2020
Lymphoma	2020
Retinoblastoma	2020
Cancer	2020
Malignancies	2020
Tumors	2020
Hypothesis	2022
Sachs disease	2023
Tay-Sachs	2023
Hex A deficiency	2023
Tay-Sachs disease	2023
Associated	2023
Gangliosidosis	2023
TSD	2023
COS	2023
Subacute G(M2) gangliosidosis	2023
A deficiency	2023
Enzyme deficiency	2023
Alpha	2023
Muscular dystrophy	2024
Duchenne muscular dystrophy	2024
DMD	2024
Bipolar affective disorder	2025
Disorder	2025
Emery-Dreifuss syndrome	2026
Autosomal dominant	2026
Cardiac pacemaker	2026
Emery-Dreifuss muscular dystrophy	2026
Cardiac	2026
Weakness	2026
Contractures of the elbows, Achilles tendons, and postcervical muscles	2026
Muscle wasting	2026
Pacemaker	2026
Cardiomyopathy	2026
Muscular dystrophy	2026
Disorder	2026
Ataxia	2027
Radiosensitivity	2027
Associated	2027
Inherited disorder	2027
Cancer	2027
A-T	2027
Cancer-proneness	2027
Disorder	2027
Ataxia-telangiectasia	2027
Lesch-Nyhan syndrome	2028
Treatment of the disorder	2028
Lesch-Nyhan	2028
Lesch-Nyhan syndrome, the disease	2028
Psychomotor retardation	2028
Genetic consulting	2028
Lesch-Nyhan syndrome whose disease	2028
Behavior	2028
Diagnosis	2028
Disorder	2028
CHRPE	2030
Congenital hypertrophy of the retinal pigment epithelium	2030
Concentric lamellar structure	2030
Hypertrophy	2030
Congenital hypertrophy of the pigment epithelium	2030
Deafness	2031
Wolfram syndrome	2031
Genetic disorder	2031
Diabetes mellitus	2031
DIDMOAD	2031
Optic atrophy	2031
Disorder	2031
Diabetes insipidus	2031
Atrophy	2031
Coats' disease	2032
Becker muscular dystrophy	2033
Benign muscular dystrophy	2033
X linked Becker muscular dystrophy	2033
Muscular dystrophy	2033
Autosomal recessive limb girdle muscular dystrophy	2033
Osteosarcoma	2034
Retinoblastoma	2034
Tumors	2034
Aspartylglycosaminuria	2035
Enzyme deficiency	2036
Bilateral meatal atresia	2037
Autosomal dominantly inherited popliteal pterygium syndrome	2037
PPS	2037
Genital hypoplasia	2037
Lip pits	2037
Popliteal pterygium syndrome	2037
Hypoplasia	2037
Clefts, gingival synechiae, popliteal pterygia	2037
Becker muscular dystrophy	2039
Weakness	2039
Dystrophic	2039
BMD	2039
Muscular dystrophy	2039
DMD	2039
Muscle weakness	2039
Muscular dystrophy	2040
Duchenne muscular dystrophy	2040
Von Willebrand	2041
Hemostasis	2041
Peripheral arthritis	2042
Spondylitis	2042
AS	2042
Course of the disease	2042
Ankylosing spondylitis	2042
Arthropathy	2042
Arthritis	2042
Anemia	2042
Hypergammaglobulinemia	2042
Dichroism spectroscopy	2043
Growth	2043
Architecture of human complement component C6	2043
Epidermal growth	2043
Oligosaccharide groups	2043
Circular dichroism	2043
Alpha	2043
Muscular atrophy	2044
Myotonic discharge	2044
Myotonia	2044
Facial diplegia	2044
Myotonic dystrophy	2044
Areflexia	2044
Mental retardation	2044
Weakness	2044
Myotonia of the tongue, generalized muscular atrophy	2044
Ventricular dilatation	2044
Associated	2044
Autistic	2044
Autism	2044
Degree of mental retardation	2044
Congenital myotonic dystrophy	2044
High-arched palate	2044
Lipid droplets	2044
Behavior	2044
Congenital cataracta	2044
Lordosis	2044
Percussion myotonia	2044
Atrophy	2044
Tumor	2045
Autosomal dominant	2045
Familial adenomatous polyposis	2045
Adenomatous	2045
Hypothesis	2045
Colorectal cancer	2045
Polyposis	2045
Adenomatous polyposis	2045
Familial and non-familial cases of the tumor	2045
Cancer	2045
Malignancies	2045
Rare disease	2045
FAP	2045
Loss of heterozygosity	2045
AT	2046
Alpha	2046
Hemophilia A	2047
Hemophilia	2047
Breast, and ovarian cancer	2048
Obvious	2048
Ovarian cancer	2048
Malignancy	2048
Genetic predisposition	2048
Lymphoma	2048
Cancer	2048
Tumorigenesis	2048
Tumour	2048
Tumor	2049
Wilms' tumor	2049
Chromosomal abnormalities	2049
Associated	2049
WAGR	2049
Familial aniridia	2049
Hypogonadism	2049
Aniridia	2049
Cytochrome c oxidase deficiency	2050
Lipid droplets	2050
Cytochrome c oxidase (CCO) deficiency	2050
Encephalomyopathic	2050
C oxidase	2050
Simian sarcoma	2051
Growth	2051
Lesch-Nyhan	2052
Lesch-Nyhan disease	2052
TH	2053
Tyrosine hydroxylase	2053
X-linked muscular dystrophy	2054
Muscular dystrophy	2054
Linkage disequilibrium	2055
X linked muscular dystrophy	2055
Becker muscular dystrophy	2055
Associated	2055
BMD	2055
Duchenne or Becker muscular dystrophy	2055
Muscular dystrophy	2055
DMD	2055
Diagnosis	2055
Prenatal diagnosis	2055
Emery Dreifuss muscular dystrophy	2056
X-linked muscular dystrophy	2056
Muscular dystrophy	2056
Duchenne muscular dystrophy	2056
DMD	2056
Epstein-Barr virus infection	2057
Epstein-Barr	2057
Epstein-Barr virus	2057
Virus infection	2057
Mononucleosis	2057
Lymphoproliferative disorders	2057
Immunodeficiency	2057
Associated	2057
X-linked lymphoproliferative syndrome	2057
Genetic mapping	2060
Muscular dystrophies	2061
Duchenne and Becker muscular dystrophies	2061
Diagnosis	2061
Hereditary retinoblastoma	2062
Retinoblastoma	2062
Muscular disorder	2063
X-linked muscular disorder	2063
Biochemical defect	2063
Muscular dystrophy	2063
Duchenne muscular dystrophy	2063
DMD	2063
Diagnosis	2063
Disorder	2063
Prenatal diagnosis	2063
Recessive disorder	2064
ABL	2064
Disorder	2064
Abetalipoproteinemia	2064
HD	2065
Genetic mapping	2065
Huntington's disease	2065
Neisseria infection	2066
Acute meningitis	2066
Complement deficiency	2066
Meningitis	2066
Episodes	2066
Recurrent meningitis	2066
Complement-deficient	2066
Neisseria	2066
Neisseria meningitidis	2066
Bacterial meningitis	2066
Bacteria	2066
Tumor	2067
Ovarian cancer	2067
Ovarian tumors	2067
Five tumor	2067
Ovarian carcinomas	2067
Cancer	2067
Carcinomas	2067
Behavior	2067
Tumors	2067
Loss of heterozygosity	2067
Obesity	2068
Associated	2068
Tumor	2069
RCCs	2069
Nonpapillary renal cell carcinomas	2069
Renal cell carcinoma	2069
RCC	2069
Carcinoma	2069
Associated	2069
Renal cell carcinomas	2069
Carcinomas	2069
Cell carcinoma	2069
Loss of heterozygosity	2069
Cone dystrophy	2071
Retinitis pigmentosa	2071
Macular dystrophy	2071
X-linked retinitis pigmentosa	2071
Retinal disease	2071
PKU	2072
Phenylketonuria	2072
Abnormalities of beta-hexosaminidase A	2073
Tay-Sachs	2073
Anomalous	2073
Deficiency of activity	2073
Alpha	2073
Fragile X	2074
Autosomal dominant	2075
Neurological disorder	2075
HD	2075
Huntington disease	2075
Disorder	2075
Autosomal dominant neurological disorder	2075
Sachs disease	2076
Tay-Sachs	2076
Tay-Sachs disease	2076
Sandhoff disease	2076
Obvious	2077
HD	2077
Huntington's disease	2077
Dementia	2078
Alzheimer's disease	2078
HD	2078
AD	2078
Caudate atrophy	2078
HD disease	2078
Psychiatric symptoms	2078
Huntington's disease	2078
Diagnosis	2078
Apathy	2078
Atrophy	2078
Glomerulonephritis	2079
Neoplasms	2080
PRCA	2080
PD	2080
Myeloid	2080
Red cell aplasia	2080
Leukemia	2080
Anemia	2080
Associated	2081
Dictyostelium discoideum	2081
Complex glycerol kinase deficiency syndrome	2082
Glycerol kinase deficiency	2082
Alpha	2083
Adrenoleucomyeloneuropathy	2087
Adrenomyeloneuropathy	2087
Adult adrenoleucodystrophy	2087
Hypercortisolemia	2087
Adrenoleucodystrophy	2087
Plasma	2087
Disorder	2087
Fragile X	2088
Fragile X syndrome	2088
Immunodeficiency	2089
Familial combined immunodeficiency	2089
Cystic fibrosis	2090
CF	2090
Fibrosis	2090
Hypothesis	2091
Primary dystonias	2093
Dystonias	2093
Muscular dystrophy	2094
Duchenne muscular dystrophy	2094
Permanent atrial paralysis	2095
Myosclerosis	2095
Spine syndrome	2095
Cardiac	2095
A syndrome	2095
Scapulo-humeroperoneal muscle weakness	2095
Weakness	2095
Fibrosis	2095
Cardiac conduction abnormalities	2095
Muscular abnormalities	2095
Cardiac and muscular abnormalities	2095
Emery-Dreifuss dystrophy	2095
Cardiac conduction	2095
Muscle weakness	2095
Duchenne'	2096
Muscular dystrophy	2096
Breast cancer	2097
Associated	2097
Cancer	2097
Tumour	2097
Liver dysfunction	2098
Hyperlysinemia	2098
Pyruvate carboxylase deficiency	2098
Deficiency in ATP generation	2098
Septicemia	2098
Acidosis	2098
Hyperammonemia	2098
Enzyme deficiency	2098
Plasma	2098
Carboxylase deficiency	2098
Hypercitrullinemia	2098
DQ	2099
AC	2099
Norrie-Warburg syndrome	2100
Polycythemia	2101
Von Willebrand	2101
Associated	2101
Von Willebrand's syndrome	2101
VWF	2101
Plasma	2101
Von Willebrand	2102
Nephrogenic diabetes insipidus	2102
VWF	2102
Plasma	2102
NDI	2102
Diabetes insipidus	2102
Short stature	2103
Developmental delay	2103
Hernia	2103
Mucopolysaccharidosis	2103
Hepatosplenomegaly	2103
Kyphosis	2103
Beta-glucuronidase deficiency	2103
Disorder	2103
Lupus erythematosus	2104
Myasthenia gravis	2104
Systemic lupus erythematosus	2104
Tumor	2105
Autosomal dominant	2105
Chromosome abnormality	2105
Cancer-prone genetic disease	2105
Benign and malignant tumors	2105
Malignant tumors	2105
Genetic disease	2105
Von Hippel-Lindau	2105
Mitosis	2105
Cancer	2105
Autosomal dominant disorder	2105
Von Hippel-Lindau syndrome	2105
Tumors	2105
Disorder	2105
Tumor	2106
Tissue sarcomas	2106
Sarcomas	2106
Osteosarcoma	2106
RB	2106
Retinoblastoma	2106
Associated	2106
One osteosarcoma	2106
Osteosarcomas or soft tissue sarcomas	2106
Osteosarcomas	2106
Soft tissue sarcomas	2106
Retinoblastomas	2106
Epithelial tumor	2106
Wild type	2107
NM	2108
KD	2108
Desferrioxamine	2108
Iron deficiency	2108
Classical phenylketonuria	2109
Phenylketonuria	2109
Associated	2111
Tumor	2112
Pneumonia	2112
Grade I tumors	2112
Grade II tumors	2112
Ovarian cancer	2112
Resultant pancytopenia	2112
III	2112
Associated	2112
III tumors	2112
Neoplastic	2112
Cancer	2112
Disseminated carcinomatosis	2112
Grade III tumors	2112
Tumors	2112
Infection and carcinomatosis	2112
Diagnosis	2112
HAM	2114
Minor abnormalities	2114
Definite abnormalities	2114
Myelopathy	2114
Associated	2114
MRI abnormalities	2114
Leukoencephalopathy	2114
Abnormalities on brain MRI	2114
CNS	2114
Type I	2114
Nineteen of 22	2114
Cerebral involvement	2114
Type II	2116
Type II collagen deficiency	2116
Cerebrotendinous xanthomatosis	2117
Xanthomatosis	2117
HAM	2118
Myelopathy	2118
Associated	2118
Tabes dorsalis	2118
ALD	2118
CTX	2118
Adrenoleukodystrophy	2118
Cerebrotendinous xanthomatosis	2118
Xanthomatosis	2118
Breakpoint of ataxia telangiectasia	2121
III	2121
Ataxia	2121
Ataxia telangiectasia	2121
Pyoderma	2122
Pyoderma gangrenosum	2122
Systemic diseases	2122
Systemic disease	2122
Diagnosis	2122
Galactosemia	2123
Prader-Willi	2124
Prader-Willi syndrome	2124
PWS	2124
Muscular dystrophy	2125
Duchenne muscular dystrophy	2125
Diagnosis	2125
Growth	2126
Hypothesis	2126
CHO	2126
Genetic defect	2126
Tumor	2127
Osteosarcoma	2127
Cancers	2127
Retinoblastoma	2127
Associated	2127
Adult cancer	2127
Tumors retinoblastoma	2127
Mitosis	2127
Cancer	2127
Familial mixed cancers	2127
Tumors	2127
Childhood cancers	2127
Neonatal hypoglycemia	2128
Giant cell hepatitis	2128
Multisystem failure	2128
Growth	2128
Coagulopathy	2128
Familial neonatal hemochromatosis	2128
Cirrhosis	2128
Hyperbilirubinemia	2128
Neonatal hemochromatosis	2128
Fibrosis	2128
Pancreas	2128
Hepatitis	2128
Idiopathic neonatal hepatitis	2128
Hemochromatosis	2128
Hypoglycemia	2128
Iron deposits	2128
NHC	2128
Disorder	2128
INHP	2128
Meningitis	2129
C5 deficiency	2129
Reticulocytosis	2130
Hemolysis	2130
PK	2130
Hemolytic anemia	2130
Deficiency in 1	2130
Phosphoglycerate kinase deficiency	2130
Enzyme deficiencies	2130
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	2130
Adenylate kinase deficiency	2130
Anemia	2130
Glucose phosphate isomerase deficiency	2130
Diagnosis	2130
Canavan disease	2131
Aspartoacylase deficiency	2131
Spongy degeneration of the brain	2131
Cerebral spongy degeneration	2131
Diagnosis	2131
Plasma	2131
Prenatal diagnosis	2131
Galactocerebrosidase	2132
Krabbe disease	2132
Infantile Krabbe disease	2132
Febrile infection	2132
Deficiency of galactocerebrosidase	2132
Partial deficiency	2132
Related disorders	2133
Cerebro-hepato-renal (Zellweger) syndrome	2133
Zellweger	2133
Proximal myopathy	2134
Myopathy	2134
Riboflavin-responsive multiple acyl coenzyme A dehydrogenase deficiency	2134
Deafness	2135
Lipolysis	2135
Myopathy	2135
Fatty liver	2135
Inherited disorder	2135
Vacuolated leukocytes	2135
Metabolic defect	2135
Cardiomyopathy	2135
Abnormalities in carnitine metabolism	2135
Triacylglycerol synthesis	2135
Disorder	2135
Lung tumors	2136
G6PD-deficient	2136
Tumors	2136
Tumoral	2136
Such diseases	2137
CB	2137
Associated	2137
Chronic bronchitis	2137
Bronchial asthma	2137
Liver cirrhosis	2138
Shortened life expectancy	2138
SD	2138
Liver cancer	2138
Cirrhosis	2138
Cirrhotic	2138
Diabetes mellitus	2138
Extrahepatic cancer	2138
Cancer	2138
Hemochromatosis	2138
Cardiomyopathy	2138
Diagnosis	2138
Medium	2139
IHC	2140
Haemochromatosis	2140
Clinical disorder	2140
Disorder	2140
Duchenne dystrophy	2141
Myofiber plasma	2141
Decreased density of orthogonal arrays	2141
Muscular dystrophy	2141
Chromosome-linked muscular dystrophy	2141
X chromosome-linked muscular dystrophy	2141
Plasma	2141
Autosomal dominant	2143
XS	2143
Associated	2143
Autosomal dominant	2144
Frontonasal dysplasia	2144
Extracranial abnormalities	2144
Autosomal dominant syndrome	2144
Nail abnormalities	2144
Craniosynostosis	2144
Dysplasia	2144
Malformation syndrome	2144
Diagnosis	2144
Craniofrontonasal dysplasia	2144
Aarskog syndrome	2144
Wolfram's syndrome	2145
Chronic renal disease	2146
Growth	2146
Renal disease	2146
Hemolysis	2147
C5-deficient	2147
G6PD A	2148
HLA-linked hereditary hemochromatosis	2149
Hemochromatosis	2149
HLA-linked hemochromatosis	2149
Hereditary hemochromatosis	2149
Medium	2150
Machado-Joseph disease	2151
Hemolytic anemia	2152
Glucose-6-phosphate dehydrogenase deficiency	2152
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	2152
Anemia	2152
Diagnosis	2152
Breast cancer	2153
Cancer	2153
Immunodeficiency diseases	2154
Immunodeficiency	2154
WAS-DXS14	2154
WAS	2154
Wiskott-Aldrich syndrome	2154
Carcinoma	2155
Adrenocortical tumors	2155
Adrenocortical carcinoma	2155
Cancer	2155
Tumors	2155
Cancers	2157
Spondylitis	2158
AS	2158
Ankylosing spondylitis	2158
Glioma	2159
Medium	2159
Gliomas	2159
Growth	2159
XY	2159
Malignant glioma biopsy	2159
Epidermal growth	2159
Spondylitis	2160
Ankylosing spondylitis	2160
Psoriatic arthritis	2160
Arthritis	2160
Reiter's syndrome	2160
Storage pool disease	2161
Von Willebrand	2161
Capillary thrombometer thrombosis time	2161
Hemostasis	2161
Associated	2161
Capillary thrombometer	2161
Von Willebrand's disease	2161
Thrombosis	2161
SPD	2161
VWD	2161
Phagocytosis	2162
Inherited deficiency	2162
Nephritis	2162
Chronic pyelonephritis	2162
C7-consuming	2162
Associated	2162
Chronic nephritis	2162
C7-deficient	2162
Chromatography	2162
Deficiency of the seventh component of complement	2162
Plasma	2162
C4-deficient	2164
Bacterial infections	2164
Inherited deficiency	2164
Obvious	2164
Deficiency of the third component of complement	2164
C4	2164
C3 deficiency	2164
Associated	2164
Hereditary deficiency of the third component of complement	2164
Hereditary C3 deficiency	2164
C3a receptor deficiency	2164
C3-deficient	2164
Alloantisera	2164
C3-depletion	2164
C3 defect	2164
Plasma	2164
Lesch-Nyhan	2165
Lesch-Nyhan disease	2165
Laryngeal involvement	2166
Atrophicans generalisata mitis	2166
Dystrophic or simplex form of epidermolysis bullosa	2166
Dystrophic	2166
Diagnosis	2166
Atrophy	2166
Argon laser under general anaesthesia	2167
Vasculopathy	2167
Advanced disease	2167
Isolated vascular malformation	2167
Coats' disease	2167
Arteriosclerosis	2168
Von Willebrand	2168
Factor/von Willebrand	2168
Von Willebrand's disease	2168
Thrombosis	2168
VWF	2168
Plasma	2168
Breast cancer	2169
Cancer	2169
Hereditary blood disorder	2170
Glucose-6-phosphate dehydrogenase deficiency	2170
Blood disorder	2170
Disorder	2170
MR	2171
Pelizaeus-Merzbacher disease	2171
Chorioretinal degeneration	2172
X-linked recessive retinitis pigmentosa	2172
Hereditary chorioretinal degeneration	2172
Autosomal recessive inheritance	2172
Gyrate atrophy	2172
Retinitis pigmentosa	2172
Associated	2172
Recessive retinitis pigmentosa	2172
A deficiency	2172
Atrophy	2172
Lesch-Nyhan syndrome	2173
Lesch-Nyhan	2173
Mentally retarded	2173
L-N syndrome	2173
Lesch-Nyhan (L-N) syndrome	2173
CETP	2174
Endocytosis	2174
Catabolism	2174
Atherosclerosis	2174
Plasma	2174
Excess	2174
HDL	2175
Column void volume	2175
Chromatography	2175
Plasma	2175
HDL2	2175
Lupus erythematosus	2176
Systemic lupus erythematosus	2176
Plasma	2176
Myotonic dystrophy	2177
DM	2177
Neuromuscular disorder	2177
Myotonic features	2177
Inherited neuromuscular disorder	2177
Diagnosis	2177
Excess	2177
Disorder	2177
Tay-Sachs	2178
Tay-Sachs problem	2178
X-linked recessive condition	2179
Arrhythmias	2179
Muscular weakness	2179
Muscular involvement	2179
Facial involvement	2179
Dystrophic males	2179
Emery-Dreifuss muscular dystrophy	2179
Cardiac rhythm abnormality	2179
Bradyarrhythmias	2179
Cardiac	2179
Weakness	2179
Dystrophic	2179
Associated	2179
Variable degree	2179
Pacemaker	2179
Muscular dystrophy	2179
Supraventricular arrhythmias	2179
Sudden death	2179
Cardiac involvement	2179
Deficiency of the sixth component of complement	2180
Meningococcal infection	2180
Meningitis	2180
C6 deficiency	2180
Associated	2180
C6D	2180
Neisseria meningitidis infection	2180
Primary meningitis	2180
Neisseria	2180
Complement component C6 deficiency	2180
Neisseria meningitidis	2180
Diagnosis	2180
Glucose-6-phosphate dehydrogenase deficiency	2181
Neutrophil dysfunction	2181
Autosomal dominant	2182
Rhizomelic short limbed dwarfism	2182
Deafness	2182
Spondyloepimetaphyseal dwarfism	2182
Autosomal recessive inheritance	2182
New' dysplasia	2182
Cleft palate	2182
Dysplasia	2182
Kniest disease	2182
Lipolysis	2183
Deficiencies of the enzymes	2183
Plasma	2183
Muscular dystrophy	2185
Duchenne muscular dystrophy	2185
Atypical sector pigmentary dystrophy	2186
Pigmentary dystrophy	2186
Facial anomalies	2187
Growth	2187
Acromicric dysplasia	2187
Bone dysplasia	2187
Growth retardation	2187
Dysplasia	2187
Autosomal dominant	2188
Conduction defects	2188
Emery-Dreifuss muscular dystrophy	2188
Cardiac conduction defects	2188
Myopathy	2188
Cardiac	2188
A syndrome	2188
Weakness	2188
Unusual contractures; humeroperoneal muscle wasting	2188
Autosomal dominant humeroperoneal myopathy	2188
Genetic disorders	2188
Muscle wasting	2188
Muscular dystrophy	2188
Cardiac conduction	2188
Pancerebellar deficits	2189
Autosomal dominant	2189
Type II disease	2189
Type IV	2189
Type II	2189
Machado-Joseph disease	2189
Amyotrophy	2189
III	2189
Neuropathy	2189
Associated	2189
Mild cerebellar deficits	2189
Cerebellar deficits	2189
Type I	2189
MJD	2189
Type I disease	2189
Sensory polyneuropathy	2189
Copper toxicosis	2190
Bedlington terrier liver	2190
Associated	2190
Inherited copper toxicosis	2190
Bedlington terriers	2190
Chromatography	2190
Copper-loading disease	2190
Bedlington terrier disorder	2190
Disorder	2190
Retinoblastoma	2191
Diagnosis	2191
Cystic fibrosis	2192
CF	2192
Fibrosis	2192
Autosomal recessive disease	2192
Recessive disease	2192
Diagnosis	2192
Prenatal diagnosis	2192
Muscular dystrophy	2193
Obvious	2194
Retinal layers	2194
Macular degeneration	2194
Associated	2194
Congenital amaurosis	2194
Retinal layer disease	2194
Nerve disease	2194
Macular dystrophy	2194
Fundus flavimaculatis	2194
Autosomal dominant	2195
Myotonia	2195
Myotonia congenita	2195
Recessive myotonia congenita	2195
Acetazolamide-responsive myotonia congenita	2195
Emery-Dreifuss myopathy	2196
Amyotrophy	2196
Muscle anomalies	2196
Cardiac conduction anomalies	2196
Myopathy	2196
Cardiac	2196
Secondary disorders	2196
Amyotrophy syndrome	2196
Cardiac conduction abnormalities	2196
Atrophy predominant on the scapulohumeroperoneal muscles	2196
X-linked heredity	2196
Contractures and secondary cardiac conduction abnormalities	2196
Muscle contractures	2196
Criteria	2196
Cardiac conduction	2196
Syndrome of amyotrophy	2196
Atrophy	2196
Epstein-Barr Virus transformation	2197
CESD	2197
Wolman disease	2197
Epstein-Barr	2197
Genetic diseases	2197
Deficiency of acid lipase	2197
Cholesterol ester storage disease	2197
Cholesteryl ester storage disease	2197
Genetic defects	2197
Diagnosis	2197
Lysosomal genetic diseases	2197
Papillary cystadenoma	2198
Adenomatoid leiomyoma	2198
Papillary cystadenoma of the epididymis	2198
Epididymis	2198
Mental disorders	2199
Hemolytic anemia	2199
Associated	2199
Congenital nonspherocytic hemolytic anemia	2199
Anemia	2199
Enzyme deficiency	2199
Familial congenital myasthenia	2200
Familial limb-girdle myasthenia	2200
Myasthenia gravis	2200
Familial myasthenia gravis	2200
HCL	2201
Histidinemia	2201
Medium	2201
Diagnosis	2201
Associated	2202
Hypomethylation	2202
Donors	2203
Ataxia	2204
Single-gene disorder	2204
Disorder	2204
Ataxia-telangiectasia	2204
Van der Woude syndrome	2205
Van der Woude syndrome	2206
Flow cytometry	2207
FCM	2207
Spondylitis	2208
AS	2208
Osteophytes	2208
A syndrome	2208
Psoriasis	2208
Anterior uveitis	2208
Ankylosing spondylitis	2208
Vertebrae and bridging syndesmophytes	2208
Acute anterior uveitis	2208
Ankylosis	2208
Criteria	2208
Bechterew's syndrome	2208
Definite sacro-iliitis	2208
Defined disease entity	2208
Sacro-iliitis	2208
Spondylitis	2209
Associated	2209
AAU	2209
Anterior uveitis	2209
Ankylosing spondylitis	2209
Acute anterior uveitis	2209
Autosomal dominant	2210
Hypotonia	2210
Neonatal syndrome	2210
Myotonic dystrophy	2210
Physical deformities	2210
Feeding difficulties	2210
Growth	2210
Mental retardation	2210
Hyperinsulinemia	2210
Muscular hypotonia	2210
Myotonic dystrophy syndrome	2210
Carboxylase deficiencies	2211
Biotin-responsive multiple carboxylase deficiency	2211
Isolated or multiple deficiencies	2211
PCC-deficiency	2211
Medium	2211
PC	2211
Diagnosis	2211
Plasma	2211
Carboxylase deficiency	2211
Comparison of the porcine	2212
Alpha	2212
Ataxia	2213
Disorder	2213
Ataxia-telangiectasia	2213
Type IV	2214
HDL	2214
Coronary heart disease	2214
Dyslipoproteinemias	2214
CHD	2214
DLP	2214
Heart disease	2214
Plasma	2214
Dyslipoproteinemia	2214
Rhabdomyosarcoma	2215
Alveolar rhabdomyosarcoma	2215
Alveolar	2215
PD	2216
Paroxysmal nocturnal hemoglobinuria	2217
PNH	2217
III	2217
Acetylcholinesterase-deficient	2217
Chromatography	2217
Spondylitis	2218
AS	2218
Radiographic abnormalities	2218
Radiographic abnormalities of the spine	2218
Non-ankylosing disease	2218
Psoriasis	2218
Associated	2218
Grade IV sacro-iliitis	2218
Ankylosing spondylitis	2218
Grade V sacro-iliitis	2218
Arthritis	2218
Ankylosis	2218
Criteria	2218
Abnormalities of the spine	2218
Sacro-iliitis	2218
C4	2219
Alpha	2219
FMF	2220
Mediterranean fever	2220
Retinal circulatory disorders	2220
Fever	2220
Arterial branch occlusion	2220
Familial Mediterranean fever	2220
Tumor	2221
Cancer of the ovary	2221
Ovarian cancer	2221
Malignancy	2221
III	2221
Treatment modalities	2221
Cancer	2221
Diagnosis	2221
Cytoplasmic lamellar inclusions	2222
Biochemical abnormalities	2222
Adrenomyeloneuropathy	2222
AMN	2222
Adenocarcinoma	2223
Von Hippel-Lindau	2223
Von Hippel-Lindau syndrome	2223
Renal adenocarcinoma	2223
Psychiatric disorder	2224
Adrenoleukodystrophy	2224
Disorder	2224
Familial adenomatosis	2225
Familial adenomatosis coli/Gardner's syndrome	2225
Adenomatous	2225
Gardner's syndrome	2225
Polyposis	2225
Fundic gland polyps	2225
Gastric radiography	2225
Gland polyposis	2225
Malignant or adenomatous changes of fundic gland polyps	2225
Fundic gland polyposis	2225
Polyps	2225
Familial adenomatosis coli	2225
Glomerular	2226
Hereditary disorder	2226
Hereditary disorder of lipid metabolism	2226
Renal failure	2226
Familial lecithin-cholesterol acyltransferase deficiency	2226
Proteinuria	2226
Disorder	2226
Autosomal dominant	2227
Macular area	2227
Tortuosity	2227
Progressive inherited retinal arteriolar tortuosity	2227
Arteriolar tortuosity	2227
Retinal arteriolar tortuosity	2227
Inherited retinal arteriolar tortuosity	2227
Various liver disease	2228
Liver disease	2228
Plasma	2228
Growth	2229
Role of fatty aldehyde dehydrogenases	2229
Hexadecane and hexadecanol metabolism	2229
Wild type	2229
NAD	2229
Autosomal dominant	2232
Cranial diabetes insipidus	2232
Familial cranial diabetes insipidus	2232
Diagnosis	2232
Plasma	2232
Diabetes insipidus	2232
Lysosomal acid beta-galactosidase	2233
G6PD kuanyama	2234
Author	2235
Myotonic disturbances	2235
Hereditary error of immunoglobulin catabolism	2236
Myotonic dystrophy	2236
Catabolism	2236
Neuromuscular disease	2237
Diagnosis	2237
Congenital tapeto-retinal degeneration	2238
Retinal degeneration	2238
Associated	2238
Nephropathy	2238
Keratoconus	2238
Cell phosphoglycerate kinase deficiency	2239
Hemolytic anemia	2239
Phosphoglycerate kinase deficiency	2239
Anemia	2239
Hereditary cancer	2240
Cancer syndrome	2240
Hereditary cancer syndrome	2240
Cancer	2240
Carcinoma	2241
Carcinoma of the breast	2241
Familial hyperlipidemias	2242
Diagnosis	2242
Cataract	2243
Hemolytic anemia	2243
Congenital nonspherocytic hemolytic anemia	2243
Glucose-6-phosphate dehydrogenase deficiency	2243
Anemia	2243
PD	2244
Hemolytic anemia	2244
Anemia	2244
Myotonia	2245
Inactivator of the third component of complement	2246
Deficiency of the C3	2246
Retinal degeneration	2248
Familial mediterranean fever	2249
Mediterranean fever	2249
Fever	2249
Norrie's disease	2250
Complement profile and C3	2251
Mediterranean fever	2252
Fever	2252
Familial Mediterranean fever	2252
Wiskott-Aldrich syndrome	2253
Xanthomatosis	2254
Trichilemmoma	2255
Benign verrucous acanthoma	2255
Cowden's syndrome	2255
Facial lesions	2255
Trichilemmomas	2255
Benign keratosis	2255
Fibromas	2255
C2 deficiency	2256
Cold urticaria and complement C2 deficiency	2256
Urticaria	2256
Retinoblastoma	2257
Lesch-Nyhan syndrome	2258
Erythrocyte hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity	2258
Lesch-Nyhan	2258
Bisalbuminemia	2259
Retinoblastoma	2262
Retinal dystrophy	2264
Pigmentary tapeto-retinal dystrophy	2264
Hemolytic anemia	2265
Associated	2265
Anemia	2265
Hypercholesterolemia	2266
Familial hypercholesterolemia	2266
Lange syndrome	2268
Glucose-6-phosphate dehydrogenase deficiency	2269
Hemolytic anemia	2270
Hereditary nonspherocytic hemolytic anemia	2270
Glucose-phosphate-isomerase deficiency	2270
Anemia	2270
Glucose-6-phosphate dehydrogenase-deficient	2271
Galactosemia	2272
Immune disease	2274
G6PD deficient neonate	2274
G6PD A	2274
Glucose-6-phosphate dehydrogenase deficiency	2274
Glucose-6-phosphate dehydrogenase (G6PD) deficiency	2274
G6PD deficient	2274
Neonatal jaundice	2274
G6PD deficiency	2274
Diabetes insipidus	2275
Glucose-6-phosphate dehydrogenase deficiency	2276
Author	2277
Spondylitis	2278
Ankylosing spondylitis	2278
Tumor	2279
Hypothesis	2279
Multiple tumors	2279
Retinoblastoma	2279
Unilateral tumors	2279
Bilateral tumors	2279
Cancer	2279
Tumors	2279
Retinoblastomas	2279
X-linked haematological traits	2280
Von Wllebrands disease	2281
Associated	2281
Hemophilia	2281
Anxiety	2284
Trauma	2284
Galactosemic	2285
Leukocyte transferase: galactokinase ratios	2285
Growth	2285
Galactose	2285
Donors	2285
Fibroblast galactokinase	2285
Congenital nonspherocytic hemolytic disease	2286
Thomsen's disease	2287
Hereditary torsion dystonias	2288
Dystonias	2288
Dystonia	2288
Dystonia musculorum deformans	2288
Glucose-6-phosphate-dehydrogenase deficiency	2289
Hemolytic anemia	2289
Anemia	2289
Pure periadnexal adventitial tumors	2290
Perifollicular fibromas	2290
Fibromas	2290
Tumors	2290
Hemolytic anemia	2291
Autoimmune	2291
A deficiency	2291
Anemia	2291
Alkaptonuria	2292
Retrolental fibroplasia	2293
Cataract	2293
Retinoblastoma	2293
Neonatal or juvenile leucocoria	2293
Leucocoria	2293
Von Hippel's disease	2293
Congenital cataract	2293
Norrie's disease	2293
Diagnosis	2293
Coats' disease	2293
Hemolytic anemia	2295
Anemia	2295
Glomerulonephritis	2296
HDL	2298
Familial lecithin: cholesterol acyltransferase deficiency	2298
Familial lecithin: cholesterol acyltransferase (LCAT) deficiency	2298
Plasma	2298
Degree of deformity	2299
Spondylitis	2299
AS	2299
Anterior uveitis	2299
Ankylosing spondylitis	2299
Acute anterior uveitis	2299